Sentence,class,file
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/42/29/10.1177_2325967116S00157.PMC4968367.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/2a/76/10.1177_2325967116S00102.PMC4968368.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/2a/76/10.1177_2325967116S00102.PMC4968368.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/5a/ec/10.1177_2325967116S00191.PMC4968369.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/5a/ec/10.1177_2325967116S00191.PMC4968369.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/cc/f3/10.1177_2325967116S00132.PMC4968371.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/cc/f3/10.1177_2325967116S00132.PMC4968371.pdf
"2015 New Zealand Knee and Sport Society Annual Meeting     This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the  original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f9/2d/10.1177_2325967116S00081.PMC4968373.pdf
"For reprints and permission  queries, please visit SAGE’s Web  site at http://www.sagepub.com /journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f9/2d/10.1177_2325967116S00081.PMC4968373.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/75/7a/10.1177_2325967116S00144.PMC4968374.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/75/7a/10.1177_2325967116S00144.PMC4968374.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/95/e6/10.1177_2325967116S00193.PMC4968375.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/95/e6/10.1177_2325967116S00193.PMC4968375.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/a4/01/10.1177_2325967116S00174.PMC4968376.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a4/01/10.1177_2325967116S00174.PMC4968376.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/58/ca/10.1177_2325967116S00155.PMC4968377.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/58/ca/10.1177_2325967116S00155.PMC4968377.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/10.1177_2325967116S00197.PMC4968378.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8c/d8/10.1177_2325967116S00197.PMC4968378.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/10.1177_2325967116S00119.PMC4968381.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ed/2e/10.1177_2325967116S00119.PMC4968381.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/61/2f/10.1177_2325967116S00101.PMC4968382.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/61/2f/10.1177_2325967116S00101.PMC4968382.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/10.1177_2325967116S00195.PMC4968383.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/cd/d1/10.1177_2325967116S00195.PMC4968383.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e5/f1/10.1177_2325967116S00188.PMC4968384.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e5/f1/10.1177_2325967116S00188.PMC4968384.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e2/15/10.1177_2325967116S00113.PMC4968386.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e2/15/10.1177_2325967116S00113.PMC4968386.pdf
"2015 New Zealand Knee and Sport Society Annual Meeting     This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the  original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/cd/89/10.1177_2325967116S00095.PMC4968387.pdf
"For reprints and permission  queries, please visit SAGE’s Web  site at http://www.sagepub.com /journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/cd/89/10.1177_2325967116S00095.PMC4968387.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/a3/33/10.1177_2325967116S00204.PMC4968388.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a3/33/10.1177_2325967116S00204.PMC4968388.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/bd/68/10.1177_2325967116S00171.PMC4968389.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/bd/68/10.1177_2325967116S00171.PMC4968389.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/a9/60/10.1177_2325967116S00177.PMC4968390.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a9/60/10.1177_2325967116S00177.PMC4968390.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/96/6a/10.1177_2325967116S00112.PMC4968391.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/96/6a/10.1177_2325967116S00112.PMC4968391.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f3/70/10.1177_2325967116S00108.PMC4968392.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f3/70/10.1177_2325967116S00108.PMC4968392.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/07/d5/10.1177_2325967116S00148.PMC4968394.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/07/d5/10.1177_2325967116S00148.PMC4968394.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/79/47/10.1177_2325967116S00186.PMC4968395.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/79/47/10.1177_2325967116S00186.PMC4968395.pdf
"2015 New Zealand Knee and Sport Society Annual Meeting     This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the  original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/0f/ed/10.1177_2325967116S00085.PMC4968405.pdf
"For reprints and permission  queries, please visit SAGE’s Web  site at http://www.sagepub.com /journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/0f/ed/10.1177_2325967116S00085.PMC4968405.pdf
"AOSSM 2016 Annual Meeting   1    This open-access article is published and distributed under the  Creative Commons Attribution - NonCommercial - No Derivatives License  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which perm its the noncommercial use, distribution, and reproduction of th e article in any medium, provided the original  author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/54/95/10.1177_2325967116S00187.PMC4968407.pdf
"For reprints and permission queries, please  visit SAGE’s Web site a t http://www.sagepub.com/journalsPermiss ions.nav.",Non-OADS,/arxiv_data1/oa_pdf/54/95/10.1177_2325967116S00187.PMC4968407.pdf
"Biophysical Journal 111, 373–385, July 26, 2016 373http://dx.doi.org/10.1016/j.bpj.2016.06.010 /C2112016 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/35/03/main.PMC4968425.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/bf/f2/jpts-28-1953.PMC4968484.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/57/5b/jpts-28-1957.PMC4968485.pdf
"All statistical analyses were performed using the statistical software EZR 31) (Saitama Medical Center,  Jichi Medical University [Saitama, Japan], which is a graphical user interface for R (The R Foundation for Statistical Com- puting, version 2.13.0 [Vienna, Austria, URL: http://www.R-project.org/]).",OADS,/arxiv_data1/oa_pdf/57/5b/jpts-28-1957.PMC4968485.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/74/4b/jpts-28-1964.PMC4968486.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/36/e1/jpts-28-1968.PMC4968487.pdf
REFERENCES 1) Scoliosis Research Society Web site: http://www.SRS.org/htm/glossary/medterms.htm.,Non-OADS,/arxiv_data1/oa_pdf/36/e1/jpts-28-1968.PMC4968487.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/66/08/jpts-28-1972.PMC4968488.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f1/8f/jpts-28-1981.PMC4968489.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/07/75/jpts-28-1988.PMC4968490.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/23/12/jpts-28-1993.PMC4968491.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/37/27/jpts-28-1998.PMC4968492.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/40/b2/jpts-28-2002.PMC4968493.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c6/35/jpts-28-2005.PMC4968494.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/e1/13/jpts-28-2009.PMC4968495.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/05/0d/jpts-28-2014.PMC4968496.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/19/1c/jpts-28-2019.PMC4968497.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/d2/b9/jpts-28-2025.PMC4968498.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f6/c1/jpts-28-2027.PMC4968499.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/8a/c4/jpts-28-2031.PMC4968500.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/3a/0a/jpts-28-2034.PMC4968501.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/85/e9/jpts-28-2041.PMC4968502.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/fd/2e/jpts-28-2044.PMC4968503.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/d6/e0/jpts-28-2048.PMC4968504.pdf
(Home Page of the Department of Neurosurgery of Vilnius Emer - gency Hospital) http://www.neurosurgery.lt/neurosurgery/apie.html.,Non-OADS,/arxiv_data1/oa_pdf/d6/e0/jpts-28-2048.PMC4968504.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/82/4e/jpts-28-2055.PMC4968505.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/08/2f/jpts-28-2059.PMC4968506.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/60/5a/jpts-28-2063.PMC4968507.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b0/c5/jpts-28-2069.PMC4968508.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/15/0e/jpts-28-2072.PMC4968509.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ea/98/jpts-28-2078.PMC4968510.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/56/2d/jpts-28-2082.PMC4968511.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/57/1d/jpts-28-2088.PMC4968512.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/70/a2/jpts-28-2094.PMC4968513.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/28/36/jpts-28-2097.PMC4968514.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/7e/8e/jpts-28-2099.PMC4968515.pdf
"http://www.musictherapy.org/about/quotes/  (Copyright, 1998–2016.)",Non-OADS,/arxiv_data1/oa_pdf/7e/8e/jpts-28-2099.PMC4968515.pdf
https://handtutorblog.wordpress.com/.,Non-OADS,/arxiv_data1/oa_pdf/7e/8e/jpts-28-2099.PMC4968515.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/2b/45/jpts-28-2102.PMC4968516.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b1/be/jpts-28-2105.PMC4968517.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b3/ed/jpts-28-2110.PMC4968518.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/62/bb/jpts-28-2114.PMC4968519.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/60/58/jpts-28-2119.PMC4968520.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/65/d7/jpts-28-2123.PMC4968521.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/ac/4e/jpts-28-2128.PMC4968522.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f1/03/jpts-28-2140.PMC4968523.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/61/05/jpts-28-2144.PMC4968524.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/c7/67/jpts-28-2148.PMC4968525.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original	Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/3a/cc/jpts-28-2151.PMC4968526.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/87/4a/jpts-28-2154.PMC4968527.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/7c/0b/jpts-28-2159.PMC4968528.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Review  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b0/47/jpts-28-2164.PMC4968529.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Case Study  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f4/77/jpts-28-2175.PMC4968530.pdf
Available from http://www.aihw.go v.au/acim-books/ [accessed 14 July 2014].,Non-OADS,/arxiv_data1/oa_pdf/0b/77/JMRS-62-253.PMC4968555.pdf
"In Canada, our AP roles have developed in radiation therapy initially as a provincially funded, data-driven (and evidence-based) project in Ontario for over 10 years before a national framework was established.2The concept is now expanded beyond Ontario and the national certiﬁcation process is currently undergoing a pilot testing phase (http://www.camrt.ca/wp-content/uploads/2015/02/Advan ced-Practice-in-Medical-Radiation-Technology-A-Canadian- Framework.pdf).",Non-OADS,/arxiv_data1/oa_pdf/31/9b/JMRS-62-292.PMC4968557.pdf
Retrieved from http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/ 4102.0main+features102014.,Non-OADS,/arxiv_data1/oa_pdf/03/cc/JMRS-62-246.PMC4968558.pdf
Available from: http://wiki.cancer.org.au/ australia/COSA: Head_and_neck_cancer_nutrition_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/d2/60/JMRS-62-267.PMC4968562.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmedhealth/PMH0070223/pdf/TOC.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d2/60/JMRS-62-267.PMC4968562.pdf
Available from: http://evs.nci.nih.gov/ftp1/CTCAE/ CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf.,OADS,/arxiv_data1/oa_pdf/b4/5c/JMRS-62-286.PMC4968563.pdf
Available from: http://www.estroeducation.org/ publications/Documents/Booklet_n9_P3.pdf.10.,Non-OADS,/arxiv_data1/oa_pdf/b4/5c/JMRS-62-286.PMC4968563.pdf
FUCA1 mutations found in human cancers were analyzed using the COSMIC database(http://cancer.sanger.ac.uk/cosmic).,OADS,/arxiv_data1/oa_pdf/57/79/CAS-107-734.PMC4968591.pdf
Expression of FUCA1 (NM_000147) was analyzed using the ONCOMINE database (https://www.oncomine.org/).,OADS,/arxiv_data1/oa_pdf/57/79/CAS-107-734.PMC4968591.pdf
"The images were ana- lyzed by ImageJ (http://imagej.nih.gov/ij/), and the area of cells were measured from three independent ﬁelds.",OADS,/arxiv_data1/oa_pdf/05/6a/CAS-107-791.PMC4968592.pdf
Peptide and protein assignment and validation (false discovery rate<1%) were carried out using the Trans Proteomic Pipeline version 4.5 (http://www.proteomecenter.org).,OADS,/arxiv_data1/oa_pdf/f4/9f/CAS-107-828.PMC4968593.pdf
(14)Ingenuity Pathway Analysis (http://www.ingenuity.com) was used to determine the subcellular localization and biological function of proteins.,OADS,/arxiv_data1/oa_pdf/f4/9f/CAS-107-828.PMC4968593.pdf
The HPA version 9.0 (http://www.proteinatlas.org) is a publicdatabase with millions of immunohistochemical images and was used to compare protein expressions between normal and BC tissues.,OADS,/arxiv_data1/oa_pdf/f4/9f/CAS-107-828.PMC4968593.pdf
"Oncomine version 4.4.4.4 (https://www.oncomine.org), a cancer microarray database and Web-based data-mining platform, was used to evaluate geneexpression levels in BC tissues.",OADS,/arxiv_data1/oa_pdf/f4/9f/CAS-107-828.PMC4968593.pdf
"Exon sequence data was submitted to the NCBI BioSample database (http://www.ncbi.nlm.nih.gov/biosample), and theaccession numbers of 93 samples were SAMN04492029 – SAMN04492121.",OADS,/arxiv_data1/oa_pdf/39/a4/CAS-107-820.PMC4968595.pdf
Known variants reported in thedbSNP (http://www.ncbi.nlm.nih.gov/SNP) and JSNP database (http://snp.ims.u-tokyo.ac.jp/map/Dump/) were ﬁltered out.,OADS,/arxiv_data1/oa_pdf/39/a4/CAS-107-820.PMC4968595.pdf
"Each signiﬁcant mutation was reviewed by Integra-tive Genomica Viewer (http://www.broadinstitute.org/igv/), including allele frequency and location.",OADS,/arxiv_data1/oa_pdf/39/a4/CAS-107-820.PMC4968595.pdf
"Apoptotic cells were detected by the DeadEnd Fluorometric TUNEL system (Promega, Madison, WI, USA).The ﬂuorescence signal in the tissues was quantiﬁed using theImageJ (http://rsb.info.nih.gov/ij/download.html) program, and the statistical signiﬁcance of these results was evaluated by Stu- dent’s t-test.",OADS,/arxiv_data1/oa_pdf/fb/79/CAS-107-773.PMC4968607.pdf
"To date, more than 50 mutations in Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> Received 3 April 2016 | Accepted 28 July 2016 | Published 30 July 2016© 2016 Molecular Vision 917Novel mutations in FZD4  and phenotype–genotype correlation in  Chinese patients with familial exudative vitreoretinopathy Miao Tang, Xiaoyan Ding, Jiaqing Li, Andina Hu, Miner Yuan, Yu Yang, Zongyi Zhan, Zijing Li, Lin Lu (The first two authors contributed equally to this study.)",Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  918FZD4  have been described in FEVR (see Appendix 1).,Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  919Statistics:  All analyses were performed using SPSS software  version 16.0.,OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  920Table  1.,Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  921avascular zone and neovascularization with exudates were  observed in both eyes.,Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
"Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  922SNV ( rs764357846 ) in NCBI, the minor allele frequency of  this change was 0.01273% in the East Asian population (data  from the ExAC database).",OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
"Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  923conserved across all members of the Frizzled protein family,  as well as in the FZD4 protein in other vertebrate species.",Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
"Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  924mother also had FEVR, with bilateral retinal avascularization  and exudates; however, after DNA sequencing, her mother  did not harbor the same variants (I437T).",Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  925Table  2. m uTaTions in FZD4 anD associa TeD clinical  FinDings.,Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  926Family No.,Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
"Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  927deletion mutation was found in a 12-year-old boy with retinal  folding in his right eye (Family 28, Figure 4; Figure 5B; Table  2).",Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
"Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  928Phenotype–genotype correlations based on modified classifi - cation system:  To delineate the possible genotype–phenotype  correlation, all probands were categorized into four subgroups  according to the new classification system, which was modi - fied from the criteria described by Pendergast et al.",OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
"Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  929Interestingly, 20 of 21 patients with disease-causing  mutations in FZD4  were categorized in Group III FEVR (15  retinal folds and five with an ectopic macula).",Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
"Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  930II FEVR (moderate cases, manifested with vitreous hemor - rhage or rhegmatogenous retinal detachment; Table 4).",Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  931RW.,Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
Molecular Vision  2016; 22:917-932 <http://www.molvis.org/molvis/v 22/917> © 2016 Molecular Vision  93224.,Non-OADS,/arxiv_data1/oa_pdf/72/44/mv-v22-917.PMC4968609.pdf
"Several studies  have shown that RPE cell density decreases with increasing Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> Received 1 March 2016 | Accepted 28 July 2016 | Published 30 July 2016© 2016 Molecular Vision 898Analysis of RPE morphometry in human eyes Shagun K. Bhatia,1 Alia Rashid,1 Micah A. Chrenek,1 Qing Zhang,1 Beau B. Bruce,1,2,3 Mitchel Klein,2,4 Jeffrey  H. Boatright,1,5 Yi Jiang,6 Hans E. Grossniklaus,1 John M. Nickerson1 1Department of Ophthalmology, School of Medicine, School of Medicine, Emory University, Atlanta, GA; 2Department of  Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA; 3Department of Neurology, School of Medicine,  Emory University, Atlanta, GA; 4Department of Environmental Health, Rollins School of Public Health, Emory University,  Atlanta, GA; 5Center for Visual and Neurocognitive Rehabilitation, Atlanta VA Medical Center, Decatur, GA; 6Department of  Mathematics and Statistics, Georgia State University, Atlanta, GA Purpose:  To describe the RPE morphometry of healthy human eyes regarding age and topographic location using mod - ern computational methods with high accuracy and objectivity.",Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  899Table  1.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
"Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  900distance from the optic nerve [ 5,6,11].",Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  901 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  902CellProfiler by comparing data from hand-traced images to  data from CellProfiler.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  903 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  904analysis was performed to provide descriptive statistics  for each morphometric measurement.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  905 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
"Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  906with one central pyknotic cell surrounded by five to six larger  cells, which appeared to migrate toward the central cell.",Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
"Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  907the average cell area and the average form factor (r2 = 0.62  and 0.57, respectively; Figure 6E,F).",Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  908the far periphery than in the mid-periphery and the macula.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
"Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  9094,960±1,040 cells/mm2.",Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  910 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  911 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  912 Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
"Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  913trend of decreasing RPE cell density with age was seen in the  far periphery (r2 = 0.45, p = 0.001; Figure 8A).",Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
"Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  914studies, we observed that RPE cells became less dense and  larger with increasing distance from the optic nerve [ 5].",Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  915hexagonal with increasing age.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
Molecular Vision  2016; 22:898-916 <http://www.molvis.org/molvis/v 22/898> © 2016 Molecular Vision  91610.,Non-OADS,/arxiv_data1/oa_pdf/b6/96/mv-v22-898.PMC4968610.pdf
This study was registered with the NationalInstitutes of Health (https://clinicaltrials.gov/ct2/show/NCT01830387).,Non-OADS,/arxiv_data1/oa_pdf/cc/5e/e2016.00045.PMC4968612.pdf
"32(4) : 281-289 (2016) http://dx.doi.org/10.5423/PPJ.OA.12.2015.0267  pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal †Current affiliation: Laboratory of Biochemistry and Genetics,  National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, MD 20852, USA*Corresponding author.Phone) +82-2-880-4677, FAX) +82-2-873-2317 E-mail) kookkim@snu.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/5b/ppj-32-281.PMC4968638.pdf
Nucleotide sequences from the  NCBI database were assembled using the Seqman pro- gram in DNASTAR (http://www.dnastar.com).,OADS,/arxiv_data1/oa_pdf/30/5b/ppj-32-281.PMC4968638.pdf
"The align-ment of FgSwi6 and Swi6 ortholog amino acid sequences was performed by the MegAlign program in DNASTAR, using a default setting and GeneDoc programs (http://www.nrbsc.org/gfx/genedoc/).",OADS,/arxiv_data1/oa_pdf/30/5b/ppj-32-281.PMC4968638.pdf
32(4) : 290-299 (2016) http://dx.doi.org/10.5423/PPJ.OA.01.2016.0007pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal †These authors contributed equally to this work.,Non-OADS,/arxiv_data1/oa_pdf/3c/5b/ppj-32-290.PMC4968639.pdf
"32(4) : 300-310 (2016) http://dx.doi.org/10.5423/PPJ.OA.01.2016.0032 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-63-850-0841, FAX) +82-63-850-0834E-mail) yonghoonlee@jbnu.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/5d/ppj-32-300.PMC4968640.pdf
32(4) : 311-320 (2016) http://dx.doi.org/10.5423/PPJ.OA.12.2015.0256 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal,Non-OADS,/arxiv_data1/oa_pdf/f1/db/ppj-32-311.PMC4968641.pdf
"32(4) : 321-328 (2016) http://dx.doi.org/10.5423/PPJ.OA.12.2015.0259 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-63-238-6340, FAX) +82-63-238-6305E-mail) chbn7567@korea.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/06/ppj-32-321.PMC4968642.pdf
We performed densitometric analysis of protein bands using the public-domain software ImageJ (http://imagej.nih.gov/ij/index.htmls).,OADS,/arxiv_data1/oa_pdf/90/06/ppj-32-321.PMC4968642.pdf
32(4) : 329-339 (2016) http://dx.doi.org/10.5423/PPJ.OA.12.2015.0272  pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Co-corresponding authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/3d/ppj-32-329.PMC4968643.pdf
32(4) : 340-346 (2016) http://dx.doi.org/10.5423/PPJ.OA.01.2016.0025 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal,Non-OADS,/arxiv_data1/oa_pdf/aa/ff/ppj-32-340.PMC4968644.pdf
"32(4) : 347-356 (2016) http://dx.doi.org/10.5423/PPJ.OA.11.2015.0241 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-53-810-2942, FAX) +82-53-810-4659E-mail) haekeun@ynu.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/f6/ppj-32-347.PMC4968645.pdf
"To verify the presence of  the hydrolase like domain, the VfCXE protein sequences were analyzed using the Simple Modular Architecture Research Tool (SMART; http://smart.embl-heidelberg.de/smart/set_mode.cgi?GENOMIC=1).",OADS,/arxiv_data1/oa_pdf/a4/f6/ppj-32-347.PMC4968645.pdf
Nucleotide sequences of genes were transmuted to amino acid se-quences using translation software (http://web.expasy.org/translate/).,OADS,/arxiv_data1/oa_pdf/a4/f6/ppj-32-347.PMC4968645.pdf
"The primary structure analysis of genes was performed using protParam (http://web.expasy.org/protparam/), while the secondary structure was analyzed by the Self-Optimized Prediction Method with Alignment (SOPMA; https://npsa-prabi.ibcp.fr/cgi-bin/npsa_au-tomat.pl?page=npsa_sopma.html).",OADS,/arxiv_data1/oa_pdf/a4/f6/ppj-32-347.PMC4968645.pdf
Multiple alignment  of protein sequences was performed using ClustalW (http://www.genome.jp/tools/clustalw/).,OADS,/arxiv_data1/oa_pdf/a4/f6/ppj-32-347.PMC4968645.pdf
Homologue pro-tein sequences of the genes were identified by a BLAST (Basic Local Alignment Search Tool) search of the NCBI database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) by the BLASTp tool using the ‘‘nr’’ database.,OADS,/arxiv_data1/oa_pdf/a4/f6/ppj-32-347.PMC4968645.pdf
The serine hy-drolase genes were blasted (http://blast.ncbi.nlm.nih.gov/Blast.cgi) against each other to check for gene duplication events.,Non-OADS,/arxiv_data1/oa_pdf/a4/f6/ppj-32-347.PMC4968645.pdf
The VfCXE genes were then compared by BLAST searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi) of each other to investigate gene duplica-tion events.,OADS,/arxiv_data1/oa_pdf/a4/f6/ppj-32-347.PMC4968645.pdf
The primary structure and the characteristics of the six VfCXE genes were analyzed using the bioinfor - matic tool protParam (http://web.expasy.org/protparam/) (Table 3).,OADS,/arxiv_data1/oa_pdf/a4/f6/ppj-32-347.PMC4968645.pdf
32(4) : 357-362 (2016) http://dx.doi.org/10.5423/PPJ.NT.10.2015.0213pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal Articles can be freely viewed online at www.ppjonline.org.†These authors contributed equally in this study.,Non-OADS,/arxiv_data1/oa_pdf/4c/0f/ppj-32-357.PMC4968646.pdf
"32(4) : 363-370 (2016) http://dx.doi.org/10.5423/PPJ.NT.01.2016.0006 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal Articles can be freely viewed online at www.ppjonline.org.†Current affiliation: Bioenergy Crop Research Institute,  National Institute for Crop Science, Muan 58545, Korea*Corresponding author.Phone) +82-31-201-2678, FAX) +82-31-204-8116E-mail) co35@khu.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/38/ppj-32-363.PMC4968647.pdf
32(4) : 371-376 (2016) http://dx.doi.org/10.5423/PPJ.NT.11.2015.0237pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal †These authors contributed equally to this work.,Non-OADS,/arxiv_data1/oa_pdf/15/6d/ppj-32-371.PMC4968648.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/57/5a/ceg-9-191.PMC4968664.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/57/5a/ceg-9-191.PMC4968664.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/57/5a/ceg-9-191.PMC4968664.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 191–195Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  191 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S84018Translational and clinical perspectives on  sphincter of Oddi dysfunction Kondal Rao Kyanam  Kabir Baig1,2 Charles Melbern Wilcox1 1Division of Gastroenterology and  Hepatology, University of Alabama,   2Birmingham VA Medical Center,   Birmingham, AL, USAAbstract: Sphincter of Oddi dysfunction is a complex pathophysiologic entity that is associated  with significant morbidity causing abdominal pain, nausea, and vomiting.",Non-OADS,/arxiv_data1/oa_pdf/57/5a/ceg-9-191.PMC4968664.pdf
"Rome IV criteria are the newest version and incorporate detailed clinical criteria along with objective imaging and biochemical parameters to classify SOD into three types based on the presence of objective radiologic and laboratory Correspondence: Charles Melbern  WilcoxDivision of Gastroenterology and Hepatology, University of Alabama, 1720 Second Ave South, BDB 380, Birmingham, Al 35294-0013, USAEmail: melw@uab.eduJournal name: Clinical and Experimental Gastroenterology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Kyanam Kabir Baig and WilcoxRunning head recto: Perspectives on sphincter of Oddi dysfunctionDOI: http://dx.doi.org/10.2147/CEG.S84018",Non-OADS,/arxiv_data1/oa_pdf/57/5a/ceg-9-191.PMC4968664.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/57/5a/ceg-9-191.PMC4968664.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 195 Perspectives on sphincter of Oddi dysfunction  9.,Non-OADS,/arxiv_data1/oa_pdf/57/5a/ceg-9-191.PMC4968664.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/ac/b1/amep-7-423.PMC4968665.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ac/b1/amep-7-423.PMC4968665.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ac/b1/amep-7-423.PMC4968665.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 423–428Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 423 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S107115 Student-centered tutoring as a model for   patient-centeredness and empathy Adaya Meirovich1 Rosalie Ber2 Michael Moore3 Avi Rotschild4 1Department of Management of  Service Organizations, Hadassah  Academic College, Jerusalem, 2Medical  Education Unit, Ruth and Bruce Faculty of Medicine,  3Faculty of  Education in Science & T echnology,   4Department of Neonatology, Carmel  Medical Center, Ruth and Bruce Faculty of Medicine, T echnion, Israeli Institute of T echnology, Haifa, IsraelBackground: Curriculum planners and medical teachers attempt to enhance medical students’  empathy and patient-centeredness.",Non-OADS,/arxiv_data1/oa_pdf/ac/b1/amep-7-423.PMC4968665.pdf
"2–5 Despite these educational Correspondence: Adaya Meirovich Department of Management of Service Organizations, Hadassah Academic College, Arlozorove 8, Raanana 4360804, IsraelTel +972 5 4442 2838Email adayameirovich@gmail.comJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Meirovich et alRunning head recto: Student-centered tutoring for patient-centeredness and empathyDOI: http://dx.doi.org/10.2147/AMEP .S107115",Non-OADS,/arxiv_data1/oa_pdf/ac/b1/amep-7-423.PMC4968665.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/ac/b1/amep-7-423.PMC4968665.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 428 Meirovich et al  9.,Non-OADS,/arxiv_data1/oa_pdf/ac/b1/amep-7-423.PMC4968665.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/a7/3c/ceg-9-197.PMC4968666.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a7/3c/ceg-9-197.PMC4968666.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a7/3c/ceg-9-197.PMC4968666.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 197–207Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  197 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S84358Hereditary pancreatitis: current perspectives Kara L Raphael   Field F Willingham Division of Digestive Diseases,   Department of Medicine,  Emory University School of Medicine, Atlanta,  GA, USAAbstract:  Hereditary pancreatitis (HP) is a rare cause of acute, recurrent acute, and chronic  pancreatitis.",Non-OADS,/arxiv_data1/oa_pdf/a7/3c/ceg-9-197.PMC4968666.pdf
"More specifi-cally, it has been suggested that the diagnosis of HP can be made without genetic testing if the patient has both a personal history of pancreatitis and recurrent acute or chronic pancreatitis diagnosed in two first-degree relatives or in three or more second-degree rela- Correspondence: Field F Willingham  Division of Digestive Diseases, Department of Medicine, Emory University Hospital, 1364 Clifton Road, NE, Atlanta, GA 30322, USA Tel +1 404 778 3184   Fax +1 404 778 2925   Email field.willingham@emoryhealthcare.orgJournal name: Clinical and Experimental Gastroenterology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Raphael and WillinghamRunning head recto: Hereditary pancreatitisDOI: http://dx.doi.org/10.2147/CEG.S84358",Non-OADS,/arxiv_data1/oa_pdf/a7/3c/ceg-9-197.PMC4968666.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/a7/3c/ceg-9-197.PMC4968666.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 207 Hereditary pancreatitis  98.,Non-OADS,/arxiv_data1/oa_pdf/a7/3c/ceg-9-197.PMC4968666.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/25/3d/cia-11-985.PMC4968667.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 985–995Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  985OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11163 7 First-ever ischemic stroke in elderly patients:  predictors of functional outcome following  carotid artery stenting  Chih-Ming lin1,2 Yu-Jun Chang3 Chi-Kuang liu4 Cheng-sheng Yu5 henry horng-shing lu5 1Department of neurology, stroke  Center, Changhua Christian hospital,   Changhua, 2Department of Biological  science and Technology, national  Chiao T ung University, hsinchu,   3epidemiology and Biostatistics  Center, Changhua Christian hospital,   Changhua, 4Department of Medical  Imaging, Changhua Christian hospital,   Changhua, 5Institute of statistics and  Big Data research Center, national  Chiao T ung University, hsinchu, TaiwanAbstract:  Age is an important risk factor for stroke, and carotid artery stenosis is the primary  cause of first-ever ischemic stroke.",Non-OADS,/arxiv_data1/oa_pdf/25/3d/cia-11-985.PMC4968667.pdf
"Between 2000 and 2005, stroke mortality increased from  50 per 100,000 to 2,300 per 100,000 in the 50- to 90-year age group.3 For men, the  highest prevalence of stroke mortality was in the 80- to 84-year age group, whereas  for women, it was highest in those .85 years.3 Correspondence: henry horng-shing lu Institute of statistics and Big Data  research Center, national Chiao  Tung University, 1001 Ta hsueh road,  hsinchu 30010, Taiwan Tel +886 3 5731 870 Fax +886 3 5728 745 email hslu@stat.nctu.edu.t w Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lin et al Running head recto: Predictors of functional outcome in elderly ischemic stroke patients DOI: http://dx.doi.org/10.2147/CIA.S111637",Non-OADS,/arxiv_data1/oa_pdf/25/3d/cia-11-985.PMC4968667.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/25/3d/cia-11-985.PMC4968667.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/25/3d/cia-11-985.PMC4968667.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a3/33/copd-11-1705.PMC4968668.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1705–1712International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1705OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10891 9 Critical role of tumor necrosis factor receptor 1  in the pathogenesis of pulmonary emphysema  in mice Masaki Fujita1 hiroshi Ouchi2 satoshi Ikegame2 eiji harada2 Takemasa Matsumoto1 Junji Uchino1 Y oichi nakanishi2 Kentaro Watanabe1 1Department of respiratory Medicine,   Faculty of Medicine, Fukuoka  University, 2research Institute for  Diseases of the Chest, graduate  school of Medical sciences, Kyushu  University, Fukuoka, JapanAbstract:  COPD is a major cause of chronic morbidity and mortality throughout the world.",Non-OADS,/arxiv_data1/oa_pdf/a3/33/copd-11-1705.PMC4968668.pdf
"Inflammation in the periph - eral airspaces at different stages of disease severity has been investigated.8 Furthermore, Correspondence: Masaki Fujita Department of respiratory Medicine,  Faculty of Medicine, Fukuoka University,  7-45-1 nanakuma, Jonan-ku, Fukuoka  814-0180, Japan Tel +81 92 801 1011 Fax +81 92 865 6220 email mfujita@fukuoka-u.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Fujita et al Running head recto: The role of TNFR1 in COPD pathogenesis DOI: http://dx.doi.org/10.2147/COPD.S108919",OADS,/arxiv_data1/oa_pdf/a3/33/copd-11-1705.PMC4968668.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a3/33/copd-11-1705.PMC4968668.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/33/copd-11-1705.PMC4968668.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7c/b1/copd-11-1713.PMC4968669.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1713–1719International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1713OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11008 9 alteration of spontaneous brain activity in COPD  patients Jiaxing Zhang1 Ji Chen1 Qian Yu1 Cunxiu Fan1 ran Zhang1 Jianzhong lin2 Tianhe Yang2 Ming Fan3 1Department of Physiology, Medical  College of Xiamen University,   Xiangan, 2Magnetic resonance Center,   Department of radiology, Zhongshan  hospital Xiamen University,   Xiamen, Fujian, 3Department of  Cognitive sciences, Institute of Basic  Medical  sciences, Beijing, People’s  republic of ChinaBackground and objective:  Airflow limitation in chronic obstructive pulmonary disease  (COPD) results in a decrease in oxygen transport to the brain.",Non-OADS,/arxiv_data1/oa_pdf/7c/b1/copd-11-1713.PMC4968669.pdf
"Hypoxia has been proven  to change the microenvironment around neurons,18,19 inhibit synaptic transmission,20,21  and impair spontaneous and task-stimulated neuronal activity.22–26 Taken together, we Correspondence: Jiaxing Zhang Department of Physiology, Medical  College of Xiamen University,  Xiang’an south road 168, Xiamen  361102, People’s republic of China Tel +86 592 2188 421 email zhangjiaxing@xmu.edu.c n Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhang et al Running head recto: Altered brain activity in COPD DOI: http://dx.doi.org/10.2147/COPD.S110089",Non-OADS,/arxiv_data1/oa_pdf/7c/b1/copd-11-1713.PMC4968669.pdf
ALFF was calculated with RESting-state fMRI data  analysis Toolkit (REST) ( http://restfmri.ne t).,OADS,/arxiv_data1/oa_pdf/7c/b1/copd-11-1713.PMC4968669.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/7c/b1/copd-11-1713.PMC4968669.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/b1/copd-11-1713.PMC4968669.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1d/89/copd-11-1733.PMC4968670.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1733–1743International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1733OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10221 8 nrf2 expression is increased in peripheral blood  mononuclear cells derived from mild–moderate  ex-smoker COPD patients with persistent  oxidative stress anna Maria Fratta Pasini1 Marcello Ferrari2 Chiara stranieri1 Paola Vallerio1 Chiara Mozzini1 Ulisse garbin1 giorgia Zambon1 luciano Cominacini1 1Department of Medicine, section  of Internal Medicine, 2Department  of Medicine, Unit of respiratory  Diseases, University of Verona,   Verona,  ItalyAbstract:  Inadequacy of antioxidant nuclear factor-E2-related factor 2 (Nrf2) and endoplasmic  reticulum stress-mediated unfolded protein response has been implicated in severe chronic  obstructive pulmonary disease (COPD) and cigarette smoking-induced emphysema.",Non-OADS,/arxiv_data1/oa_pdf/1d/89/copd-11-1733.PMC4968670.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1d/89/copd-11-1733.PMC4968670.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/89/copd-11-1733.PMC4968670.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f8/1b/copd-11-1689.PMC4968671.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1689–1703International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1689OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10896 7 Impact of lung function on exacerbations,  health care utilization, and costs among patients  with COPD Xuehua Ke1 Jessica Marvel2 Tzy-Chyi Yu2 Debra Wertz1 Caroline geremakis1 liya Wang1 Judith J stephenson1 David M Mannino3 1healthCore Inc., Wilmington,   De, 2novartis Pharmaceuticals  Corporation, east hanover,   nJ, 3University of Kentucky,   lexington, KY, UsaObjective:  To evaluate the impact of lung function, measured as forced expiratory volume in  1 second (FEV1) % predicted, on health care resource utilization and costs among patients with  COPD in a real-world US managed-care population.",Non-OADS,/arxiv_data1/oa_pdf/f8/1b/copd-11-1689.PMC4968671.pdf
"The Global Initiative for Chronic Obstructive Lung Disease (GOLD) classifies COPD  based on history of exacerbations and symptoms, as well as objective measures of  airflow limitation.2 Spirometry – specifically, forced expiratory volume in 1 second Correspondence: Xuehua Ke healthCore Inc., 123 Justison  street – suite 200, Wilmington,  De 19801-5134, Usa email xke@healthcore.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ke et al Running head recto: Impact of lung function on outcomes of COPD patients DOI: http://dx.doi.org/10.2147/COPD.S108967",Non-OADS,/arxiv_data1/oa_pdf/f8/1b/copd-11-1689.PMC4968671.pdf
"Available from: http://data.bls.gov/timeseries/CUUR0000SAM?output_ view=pct_12mth s. Accessed September 10, 2015.",OADS,/arxiv_data1/oa_pdf/f8/1b/copd-11-1689.PMC4968671.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f8/1b/copd-11-1689.PMC4968671.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/1b/copd-11-1689.PMC4968671.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/copd-11-1663.PMC4968684.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1663–1669International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1663OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10917 3 Cause-specific mortality in individuals with severe  alpha 1-antitrypsin deficiency in comparison with  the general population in Sweden Hanan A Tanash1 Magnus Ekström2 Philippe Wagner3 eeva Piitulainen1 1Department of Respiratory  Medicine, Skåne University Hospital,   2Department of Respiratory Medicine,   Blekinge Hospital Karlskrona, Lund  University, Lund, 3Centre for Clinical  Research, Västmanland, Uppsala  University, Uppsala, SwedenBackground:  Severe alpha 1-antitrypsin deficiency (PiZZ) predisposes to morbidity and  mortality due to early-onset emphysema and liver disease.",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/copd-11-1663.PMC4968684.pdf
"AAT deficiency  contributes to protein degradation and increased inflammation because of proinflamma - tory effects of polymerized AAT and the loss of anti-inflammatory and antiproteo  lytic  functions.2 In Sweden, the prevalence of AAT deficiency is 1/1,600, a figure firmly  established by a nationwide screening program of all 200,000 newborns over the period  1972–1974, when 127 homozygotes were identified.3Correspondence: Hanan A Tanash Department of Respiratory Medicine,  Skåne University Hospital, Inga Marie  Nilssons gata 46, S-205 02 Malmö,  sweden Tel +46 40 33 1000 Fax +46 40 33 6225 email hanan.tanash@med.lu.s e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Tanash et al Running head recto: Causes of death in PiZZ individuals DOI: http://dx.doi.org/10.2147/COPD.S109173",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/copd-11-1663.PMC4968684.pdf
Available from: http://www.who.int/classifications/ network/en/ report200 0.pdf.,OADS,/arxiv_data1/oa_pdf/6f/f4/copd-11-1663.PMC4968684.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/copd-11-1663.PMC4968684.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/f4/copd-11-1663.PMC4968684.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/5e/copd-11-1671.PMC4968685.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1671–1677International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1671OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10886 0 respiratory muscle strength effect on linear and  nonlinear heart rate variability parameters in  COPD patients Cássia Da luz goulart1 Julio Cristiano simon1 Paloma De Borba  schneiders1 elisabete antunes san  Martin1 ramona Cabiddu2 audrey Borghi-silva2 renata Trimer2 andréa lúcia gonçalves  da silva1 1Course of Physiotherapy,   Department of health and Physical  education, University of santa  Cruz do sul (U nIsC), santa Cruz  do sul, rio grande do sul, Brazil;   2Cardiopulmonary Physiotherapy  laboratory, nucleus of research in  Physical exercise, Federal University  of são Carlos (UFsCar), são Carlos,   são Paulo, BrazilIntroduction:  Chronic obstructive pulmonary disease (COPD) is recognized as a multisystemic  inflammatory disease associated with extrapulmonary comorbidities, including respiratory  muscle weakness and cardiovascular and cardiac autonomic regulation disorders.",Non-OADS,/arxiv_data1/oa_pdf/4d/5e/copd-11-1671.PMC4968685.pdf
"Conclusion:  COPD patients with impaired RMS presented altered cardiac autonomic control,  characterized by marked sympathetic modulation and a reduced parasympathetic response;  reduced HRV complexity was observed during the RSA-M. Keywords:  COPD, heart rate, muscle strength, autonomic nervous system, sinus arrhythmia Introduction Chronic obstructive pulmonary disease (COPD) is characterized by persistent and  progressive airflow limitation resulting from abnormal inflammatory response of the  airways and lungs to noxious particles inhalation.1 Apart from inducing lung damage,  COPD is recognized as a multisystemic inflammatory disease associated with extra - pulmonary comorbidities that can substantially affect the disease prognosis.1,2 The  prevalence of comorbidities in COPD patients ranges between 65% and 81%,2 and  they represent the primary causes of death in more than 60% of COPD patients.3  Specifically, the prevalence of cardiovascular disorders in COPD patients is ~40%;2  such disorders are directly associated with cardiac autonomic regulation.4,5Correspondence: andréa lúcia  gonçalves da silva rua Vereador Benno Kist, 1780/15,  Bairro santo Inácio, santa Cruz do sul,  rio grande do sul, Brazil Tel +55 51 3717 7374 email andreag@unisc.b r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Goulart et al Running head recto: Respiratory muscle strength and heart rate variability in COPD DOI: http://dx.doi.org/10.2147/COPD.S108860",Non-OADS,/arxiv_data1/oa_pdf/4d/5e/copd-11-1671.PMC4968685.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/4d/5e/copd-11-1671.PMC4968685.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/5e/copd-11-1671.PMC4968685.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/86/cia-11-1003.PMC4968686.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1003–1008Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1003OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10911 0 expression levels of the BAK1  and BCL2 genes  highlight the role of apoptosis in age-related  hearing impairment Masoumeh Falah1,2 Mohammad najafi2 Massoud houshmand3 Mohammad Farhadi1 1enT and head & neck research  Center and Department, Iran  University of Medical sciences, T ehran,   Iran; 2Cellular and Molecular research  Center, Biochemistry Department,   Iran University of Medical sciences,   T ehran, Iran; 3Department of  Medical genetics, national Institute  for genetic engineering and  Biotechnology, T ehran, IranAbstract:  Age-related hearing impairment (ARHI) is a progressive and a common sensory  disorder in the elderly and will become an increasingly important clinical problem given the  growing elderly population.",Non-OADS,/arxiv_data1/oa_pdf/75/86/cia-11-1003.PMC4968686.pdf
"Genes  of this family are divided into two categories that include proapoptotic genes ( BAK1 ,  BAX, BAD ) and antiapoptotic genes ( BCL2 , BCLXL ).5 An investigation of early-onset  hearing loss (HL) in a mouse model demonstrated upregulation of the apoptosis- related genes Bak1  and Casp3  during the development of ARHI.6 In addition, the  MCAT transgenic mice exhibit delayed onset of age-related HL, and investigation of  the underlying molecular mechanisms revealed a decreased in the mRNA expression  level of Bak1 in the cochlea and a reduction in cell death.7 Moreover, C57BL/6J mice Correspondence: Mohammad Farhadi enT and head & neck research Center  and Department, Iran University of  Medical sciences, niayesh st, sattarkhan  Ave, Tehran, Iran Tel +98 912 422 4834 Fax +98 21 6652 5329 email mfa.ent@gmail.co m Mohammad Najafi Cellular and Molecular research Center,  Biochemistry Department, Iran University  of Medical sciences, shahid hemmat  highway, Tehran, 1449614535, Iran email nbsmmsbn@iums.ac.i r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Falah et al Running head recto: Expressions of the BAK1  and BCL2  genes for the diagnosis of ARHI DOI: http://dx.doi.org/10.2147/CIA.S109110",Non-OADS,/arxiv_data1/oa_pdf/75/86/cia-11-1003.PMC4968686.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/75/86/cia-11-1003.PMC4968686.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/75/86/cia-11-1003.PMC4968686.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/0a/cia-11-997.PMC4968687.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 997–1002Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  997OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10680 8 surveying the effects of an exercise program on  the sleep quality of elderly males saba Karimi1 Ali soroush2 Farhad T owhidi3 Behnam reza Makhsosi3 Maryam Karimi4 saeid Jamehshorani3 Afshin Akhgar3 Mahmoud Fakhri4 Alireza Abdi5 1Internal and surgical Department,   school of n ursing and Midwifery,   2lifestyle Modification research  Department, 3exercise Physiology,   Imam reza hospital, Kermanshah  University of Medical sciences,   4Paramedical science, Kermanshah  University of Medical sciences,   Kermanshah, 5Internal and surgical  nursing Department, nursing and  Midwifery school, shahid Beheshti  University of Medical science,   T ehran,  IranBackground:  Old age is a stage of life featured with many physiological and mental changes.",Non-OADS,/arxiv_data1/oa_pdf/95/0a/cia-11-997.PMC4968687.pdf
"Adopting an active lifestyle featured with physical activities and doing exercise have Correspondence: Ali soroush Lifestyle Modification Research  Department, Kermanshah University  of Medical sciences, Parastar Bolvar,  sorkhalizhe street, Post Box 6718934881,  Kermanshah, Iran Tel +98 831 918 830 9157 Fax +98 831 833 428 2668 email ali.soroush.mhr@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Karimi et al Running head recto: Effects of an exercise program on the sleep quality of elderly males DOI: http://dx.doi.org/10.2147/CIA.S106808",Non-OADS,/arxiv_data1/oa_pdf/95/0a/cia-11-997.PMC4968687.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/95/0a/cia-11-997.PMC4968687.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/95/0a/cia-11-997.PMC4968687.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/91/f5/copd-11-1679.PMC4968688.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1679–1688International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1679OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10730 3 Quality of life and adherence to inhaled  corticosteroids and tiotropium in COPD  are related Kirsten Koehorst-ter  huurne1 sharina Kort1 Job van der Palen1,3 Wendy JC van Beurden1 Kris ll Movig2 Paul van der Valk1 Marjolein Brusse-Keizer1 1Department of Pulmonary  Medicine, 2Department of Clinical  Pharmacy, Medisch spectrum  T wente, 3Department of research  Methodology, Measurement, and  Data analysis, University of T wente,   enschede, the netherlandsBackground:  Poor adherence to inhaled medications in COPD patients seems to be  associated with an increased risk of death and hospitalization.",Non-OADS,/arxiv_data1/oa_pdf/91/f5/copd-11-1679.PMC4968688.pdf
"It is expected to be the third leading cause of mortality in 2020.1 Treat - ment of COPD is supportive, aimed at relieving symptoms, decreasing the number of  exacerbations, and improving the quality of life.2 Pharmacotherapy consists of inhaled  medications, including short- and long-acting bronchodilators, such as tiotropium bro - mide, to relieve dyspnea symptoms and inhalation corticosteroids (ICS) to suppress the  prominent pulmonary inflammation.2 Large randomized trials have demonstrated that  long-term use of long-acting bronchodilators and ICS reduces symptoms, improves Correspondence: sharina Kort Department of Pulmonary Medicine,  Medisch spectrum Twente, PO  Box 50000, 7500 Ka enschede,  the netherlands Tel +31 53 487 2643 Fax +31 53 487 2676 email s .kort@mst.n l Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Koehorst-ter Huurne et al Running head recto: ICS and tiotropium in COPD DOI: http://dx.doi.org/10.2147/COPD.S107303",Non-OADS,/arxiv_data1/oa_pdf/91/f5/copd-11-1679.PMC4968688.pdf
Available from:  http://goldcopd.org/global-strategy-diagnosis-management-prevention- copd-2016 /.,Non-OADS,/arxiv_data1/oa_pdf/91/f5/copd-11-1679.PMC4968688.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/91/f5/copd-11-1679.PMC4968688.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/f5/copd-11-1679.PMC4968688.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fd/27/copd-11-1721.PMC4968689.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1721–1731International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1721OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10739 6 The inhibitory mechanism of Cordyceps sinensis   on cigarette smoke extract-induced senescence  in human bronchial epithelial cells ailing liu1,2,* Jinxiang Wu1,* aijun li2 Wenxiang Bi3 Tian liu1 liuzhao Cao1 Yahui liu1 liang Dong1 1Department of Pulmonary Diseases,   Qilu hospital, shandong University,   Jinan, shandong, People’s republic of  China; 2Department of Pulmonary  Diseases, Weihai Municipal hospital,   Weihai, shandong, People’s republic  of China; 3Institute of Biochemistry  and Molecular Biology, school of  Medicine, shandong University, Jinan,   shandong, People’s republic of China *These authors contributed equally  to this workObjectives:  Cellular senescence is a state of irreversible growth arrest induced either by telomere  shortening (replicative senescence) or stress.",Non-OADS,/arxiv_data1/oa_pdf/fd/27/copd-11-1721.PMC4968689.pdf
Available from:  http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014.pdf.,OADS,/arxiv_data1/oa_pdf/fd/27/copd-11-1721.PMC4968689.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fd/27/copd-11-1721.PMC4968689.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/27/copd-11-1721.PMC4968689.pdf
"18–25The capillary-free zone (CFZ) was outlined and measured in images taken at a magniﬁcation of 34, as previously described,18using ImageJ software (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA; Fig.",OADS,/arxiv_data1/oa_pdf/af/ff/i1552-5783-57-9-OCT204.PMC4968770.pdf
"CNV Area Quantiﬁcation To calculate the area of the CNV lesions in the vis-OCTAimages, two masked graders (RS, BTS) independently delineat-ed the outlines of the CNV lesions, using the lasso tool in ImageJ software (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health, Bethesda,MD, USA).",OADS,/arxiv_data1/oa_pdf/49/f2/i1552-5783-57-9-OCT86.PMC4968775.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/4d/opth-10-1411.PMC4968848.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1411–1417Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1411Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10475 1 an upright eyedrop bottle: accuracy, usage of  excess drops, and contamination compared to  a conventional bottle isaiah J Davies1 ninita h Brown2 Joanne C Wen3 sandra s stinnett1 Kelsey Kubelick4,5 roma P Patel6 Kristin l Benokraitis7 latoya greene1 Curry Cheek1 Kelly W Muir1,8 1Department of Ophthalmology,   Duke University school of Medicine,   Durham, nC, Usa; 2Metrolina eye  associates, Charlotte, nC, Usa;   3Department of Ophthalmology,   University of Washington, seattle, W a,   Usa; 4Wallace h Coulter Department  of Biomedical engineering, georgia  institute of T echnology, 5Wallace h  Coulter Department of Biomedical  engineering, emory University school  of Medicine, atlanta, georgia, Usa;   6University of California Davis health  system eye Center, sacramento, C a,   Usa; 7eg-giler O, Durham, nC,   Usa; 8health services research &  Development, Durham V a Medical  Center, Durham, nC, UsaPurpose:  This study tested the feasibility of using an upright eyedrop bottle (UEB), a device  designed to assist patients with eyedrop placement without reclining their head.",Non-OADS,/arxiv_data1/oa_pdf/9a/4d/opth-10-1411.PMC4968848.pdf
"As many as 25% of patients who instill their own drops were unable to place a drop  in their eye during a trial of drop instillation.1 When patients with visual impairment  are taken into account, this percentage has been reported to be as high as 30%.2  In addition to struggling to place a drop in the eye, as many as 59% of patients have  been observed to express multiple drops from the bottle in an attempt to get only one  drop into the eye.1 Furthermore, 80% of patients have been observed to make contact  between the tip of the eyedrop bottle and the eye.3 Defining successful eyedrop instil - lation as placing one drop in the conjunctival cul-de-sac without contaminating the tip  of the bottle, one study found as few as 8.5% of patients to be successful.4 Therefore,  for many glaucoma patients who administer eyedrops, there is room for improvement Correspondence: Kelly W Muir Duke University school of Medicine,  Duke University Medical Center,  Box 3802, Durham, nC 27710, Usa Tel +1 919 684 3283 Fax +1 919 681 8267 email kelly.muir@duke.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Davies et al Running head recto: Glaucoma medication adherence DOI: http://dx.doi.org/10.2147/OPTH.S104751",Non-OADS,/arxiv_data1/oa_pdf/9a/4d/opth-10-1411.PMC4968848.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9a/4d/opth-10-1411.PMC4968848.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/4d/opth-10-1411.PMC4968848.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dd/81/opth-10-1419.PMC4968849.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1419–1422Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1419Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11373 3 etiologic analysis of 100 anatomically failed  dacryocystorhinostomies Tarjani Vivek Dave Faraz ali Mohammed Mohammad Javed ali Milind n naik The institute of Dacryology,   l V Prasad eye institute,   hyderabad, indiaBackground:  The aim of this study was to assess the etiological factors contributing to the  failure of a dacryocystorhinostomy (DCR).",Non-OADS,/arxiv_data1/oa_pdf/dd/81/opth-10-1419.PMC4968849.pdf
"Keywords:  failed DCR, etiologies, cicatricial closure, osteotomy, endoscopy Introduction Dacryocystorhinostomy (DCR) is commonly performed by an external or endoscopic  approach for managing nasolacrimal duct obstructions, with high success rates.1–7  However, failures have been reported in up to 12% of the patients.1–10 Endo - scopic evaluation of failed cases may show many possible causes of tear drain - age failure and include cicatricial ostium closures, scarred common canaliculus,  obstructed distal canaliculi, organizing granulomas, and bone neogenesis.2,11–22  The intraoperative surgical causes that may lead or contribute to subsequent  failures include inability to correctly localize the sac, inappropriate osteotomy,  inadequate sac opening, significant septal deviations, and concha bullosa.2,11–21  The present study reports the causes of failures in 100 consecutive patients who  presented with anatomical failure of a previously performed external or endoscopic  dacryocystorhinostomy.Correspondence: Mohammad Javed ali The institute of Dacryology, l V Prasad  eye institute, road no 2, Banjara hills,  hyderabad 34, india Tel +91 40 3061 2345/2612 email drjaved007@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Dave et al Running head recto: Etiologies of DCR failures DOI: http://dx.doi.org/10.2147/OPTH.S113733",Non-OADS,/arxiv_data1/oa_pdf/dd/81/opth-10-1419.PMC4968849.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/dd/81/opth-10-1419.PMC4968849.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/81/opth-10-1419.PMC4968849.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/8a/ott-9-4639.PMC4968850.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4639–4644OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4639Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10124 1 Efficacy of cisplatin/pemetrexed with bevacizumab  to treat advanced lung adenocarcinoma  with different drive genes: case report and  literature review Haiyong Wang1,2 Hui Zhu2 Li Kong2 Jinming Yu2 1Department of Oncology, school  of Medicine, shandong University,   2Department of radiation Oncology,   shandong Cancer Hospital affiliated  to shandong University, shandong  academy of Medical sciences, Jinan,   Shandong, People’s Republic of ChinaBackground:  Bevacizumab combined with chemotherapy has become the first-line therapy  in advanced nonsquamous non-small-cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/37/8a/ott-9-4639.PMC4968850.pdf
"In addition, the correlation between EGFR mutations or ALK rearrangements and the  efficacy of bevacizumab in combination with chemotherapy has been problematic in Correspondence: Jinming Yu Department of radiation Oncology,  Shandong Cancer Hospital affiliated to  shandong University, shandong academy  of Medical sciences, 440 Ji Yan road,  Jinan, shandong, 250117, People’s  Republic of China Tel +86 531 8798 4777 Fax +86 531 8798 4079 email sdyujinming@126.co m Journal name: OncoTargets and Therapy Article Designation: Case Series Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Efficacy of cisplatin/pemetrexed with bevacizumab in advanced lung cancer DOI: http://dx.doi.org/10.2147/OTT.S101241",Non-OADS,/arxiv_data1/oa_pdf/37/8a/ott-9-4639.PMC4968850.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/37/8a/ott-9-4639.PMC4968850.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/8a/ott-9-4639.PMC4968850.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fd/dc/ijn-11-3347.PMC4968851.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3347–3356International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3347OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10979 5 gallic acid conjugated with gold nanoparticles:  antibacterial activity and mechanism of action  on foodborne pathogens Narintorn rattanata1 sompong Klaynongsruang1 chanvit leelayuwat2 T emduang limpaiboon2 aroonlug lulitanond2 Patcharee Boonsiri3 sirinart chio-srichan4 siriwat soontaranon4 supagorn rugmai4 Jureerut Daduang2 1Department of Biochemistry, Faculty  of science, 2centre for research and  Development of Medical Diagnostic  laboratories, Faculty of associated  Medical sciences, 3Department of  Biochemistry, Faculty of Medicine,   Khon Kaen University, Khon Kaen,   4synchrotron light research Institute  (Public Organization), Nakhon  ratchasima, ThailandAbstract:  Foodborne pathogens, including  Plesiomonas shigelloides  and Shigella flexneri  B,  are the major cause of diarrheal endemics worldwide.",Non-OADS,/arxiv_data1/oa_pdf/fd/dc/ijn-11-3347.PMC4968851.pdf
"Owing to beta-lactam production, partial  resistance to ampicillin, tetracycline, cotrimoxazole, and chloramphenicol has been  reported (72%, 67%, 12%, and 5%, respectively).7 At present, increasing antibiotic  resistance of P. shigelloides  implies that fewer antibiotic drugs can produce bactericidal  minimum inhibitory concentration (MIC).6,8,9 S. flexneri  is highly infectious at low   counts.10 First-line antimicrobial drugs, including sulfonamides, tetracycline, ampi - cillin, and trimethoprim–sulfamethoxazole, have become ineffective due to plasmid-   encoded resistance to S. flexneri , which causes more than a million deaths worldwide.11,12  Recently, the emergence of resistance to fluoroquinolones and cephalosporins  in  correspondence: supagorn rugmai synchrotron light research Institute  (Public Organization), 111 University  avenue, Nakhon ratchasima 30000,  Thailand email supagorn@slri.or.t h  Jureerut Daduang centre for research and Development of  Medical Diagnostic laboratories, Faculty  of associated Medical sciences, Khon  Kaen University, 123 Mitraparb road,  Khon Kaen 40002, Thailand email jurpoo@kku.ac.t h Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Rattanata et al Running head recto: Gallic acid conjugated with gold nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S109795",Non-OADS,/arxiv_data1/oa_pdf/fd/dc/ijn-11-3347.PMC4968851.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fd/dc/ijn-11-3347.PMC4968851.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/dc/ijn-11-3347.PMC4968851.pdf
"Avail - able from: http://kur.web.psi.ch/sans1/SANSSoft/sasfit.htm l. Accessed  January 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fd/dc/ijn-11-3347.PMC4968851.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/95/4c/mder-9-247.PMC4968852.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/95/4c/mder-9-247.PMC4968852.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/95/4c/mder-9-247.PMC4968852.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 247–255Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 247 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S91102 Myoelectric control of prosthetic hands:   state-of-the-art review Purushothaman Geethanjali School of Electrical Engineering  Department of Control and Automation VIT University, Vellore,  Tamil Nadu, IndiaAbstract:  Myoelectric signals (MES) have been used in various applications, in particular, for  identification of user intention to potentially control assistive devices for amputees, orthotic  devices, and exoskeleton in order to augment capability of the user.",Non-OADS,/arxiv_data1/oa_pdf/95/4c/mder-9-247.PMC4968852.pdf
"Tamil Nadu, IndiaTel +91 994 498 0194Email pganjali78@hotmail.comJournal name: Medical Devices: Evidence and Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: GeethanjaliRunning head recto: Myoelectric control of prosthetic handsDOI: http://dx.doi.org/10.2147/MDER.S91102",Non-OADS,/arxiv_data1/oa_pdf/95/4c/mder-9-247.PMC4968852.pdf
Reproduced from: http://www.ottobock.com.,Non-OADS,/arxiv_data1/oa_pdf/95/4c/mder-9-247.PMC4968852.pdf
Available from: http://www.ottobock.com.,Non-OADS,/arxiv_data1/oa_pdf/95/4c/mder-9-247.PMC4968852.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/95/4c/mder-9-247.PMC4968852.pdf
Available from: http://www.touchbionics.com/products/active-   prostheses/i-limb-ultra.,Non-OADS,/arxiv_data1/oa_pdf/95/4c/mder-9-247.PMC4968852.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/81/ott-9-4687.PMC4968853.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4687–4694OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4687Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9769 9 The impact of the extent of surgical resection  on survival of gastric cancer patients Kostadin georgiev angelov Mariela Borisova Vasileva Konstantin savov grozdev svetoslav Y ordanov T oshev Manol Bonev sokolov georgi T odorov T odorov Department of surgery, Medical  University of sofia, aleksandrovska  University hospital, sofia, BulgariaObjective:  The aim of this study was to examine the significance of the extent of gastric resec ­ tion on the postoperative and overall gastric cancer survival.",Non-OADS,/arxiv_data1/oa_pdf/c5/81/ott-9-4687.PMC4968853.pdf
"The distal gastrectomy is the method of  choice only when the surgeons can achieve clean proximal margins.3correspondence: Kostadin georgiev  angelov Department of surgery, Medical  University of Sofia, Aleksandrovska  University Hospital, 1 Georgi Sofiiski   Str, 1431 Sofia, Bulgaria email dr.k.angelov@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Angelov et al Running head recto: The impact of the extent of surgical resection on survival DOI: http://dx.doi.org/10.2147/OTT.S97699",Non-OADS,/arxiv_data1/oa_pdf/c5/81/ott-9-4687.PMC4968853.pdf
"Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.asp x.  Accessed May 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c5/81/ott-9-4687.PMC4968853.pdf
"Available from: http://www.sbaloncology.bg/en/ncr.htm l.  Accessed May 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c5/81/ott-9-4687.PMC4968853.pdf
"Available from: http://www.nccn.org/PDF/gastric.pd f. Accessed  October 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c5/81/ott-9-4687.PMC4968853.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer ­reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c5/81/ott-9-4687.PMC4968853.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/81/ott-9-4687.PMC4968853.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3f/20/ndt-12-1869.PMC4968854.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1869–1882Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1869Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6865 2 Critical appraisal of omega-3 fatty acids in  attention-deficit/hyperactivity disorder treatment Anja Königs Amanda J Kiliaan Department of Anatomy, Donders  institute for Brain, Cognition &  Behaviour, Radboud University  Medical Center, Nijmegen, the  NetherlandsAbstract:  Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental  disorder.",Non-OADS,/arxiv_data1/oa_pdf/3f/20/ndt-12-1869.PMC4968854.pdf
"Correspondence: Amanda J Kiliaan Department of Anatomy, Radboud  University Medical Center, Geert  Grooteplein Noord 21, 6525 eZ  Nijmegen, the Netherlands Tel +31 24 361 4378 Fax +31 24 361 3789 email amanda.kiliaan@radboudumc.n l Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Königs and Kiliaan Running head recto: ω-3 fatty acids as ADHD treatment DOI: http://dx.doi.org/10.2147/NDT.S68652",Non-OADS,/arxiv_data1/oa_pdf/3f/20/ndt-12-1869.PMC4968854.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3f/20/ndt-12-1869.PMC4968854.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/20/ndt-12-1869.PMC4968854.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/f6/ijn-11-3417.PMC4968855.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3417–3434International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3417OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11204 5 Optimization, formulation, and characterization  of multiflavonoids-loaded flavanosome by bulk  or sequential technique govindarajan Karthivashan1 Mas Jaffri Masarudin2 aminu Umar Kura1 Faridah Abas3,4 Sharida Fakurazi1,5 1Laboratory of Vaccines and  Immunotherapeutics, Institute of  Bioscience, 2Department of cell  and Molecular Biology, Faculty of  Biotechnology and Biomolecular  sciences, 3Department of Food  Science, Faculty  of Food Science and  T echnology, 4Laboratory of Natural  Products, Institute of Bioscience,   5Department of Human Anatomy,   Faculty of Medicine and Health  Sciences, Universiti Putra Malaysia,   Serdang, Selangor, MalaysiaAbstract:  This study involves adaptation of bulk or sequential technique to load multiple  flavonoids in a single phytosome, which can be termed as “flavonosome”.",Non-OADS,/arxiv_data1/oa_pdf/7f/f6/ijn-11-3417.PMC4968855.pdf
"Flavonoids were reported Correspondence: Sharida Fakurazi Department of Human Anatomy,  Faculty of Medicine and Health Sciences,  Universiti Putra Malaysia, 43400 Serdang,  Selangor, Malaysia Tel +60 3 8947 2331 Fax +60 3 8942 2341 email sharida@upm.edu.m y Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Karthivashan et al Running head recto: Optimization, formulation, and characterization of flavonosome DOI: http://dx.doi.org/10.2147/IJN.S112045",Non-OADS,/arxiv_data1/oa_pdf/7f/f6/ijn-11-3417.PMC4968855.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7f/f6/ijn-11-3417.PMC4968855.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/f6/ijn-11-3417.PMC4968855.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a4/7a/dmso-9-225.PMC4968856.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/a4/7a/dmso-9-225.PMC4968856.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Effects of vildagliptin relative to sulfonylureas  in Muslim patients with type 2 diabetes fasting  during Ramadan: influence of age and treatment  with/without metformin in the VIRTUE study Ahmed AK Hassoun1 Md Faruque Pathan2 Rita C Medlej3,4 Monira Alarouj5 Inass Shaltout6 Manoj S Chawla7 Ditte Knap8 Julius A Vaz9 1Dubai Diabetes Centre, Dubai,   UAE; 2Department of Endocrinology,  BIRDEM Hospital, Dhaka, Bangladesh;   3Department of Endocrinology, Hotel  Dieu de France Hospital, 4Chronic  Care Centre, Saint Joseph University,   Beirut, Lebanon; 5Dasman Diabetes  Institute, Dasman, Kuwait; 6Faculty  of Medicine, Cairo University,   Cairo, Egypt; 7Lina Diabetes Care  Centre, Mumbai, India; 8Novartis  Pharma AG, Basel, Switzerland;   9Novartis Healthcare Private Limited,   Hyderabad, India Correspondence: Ahmed AK Hassoun   Dubai Diabetes Center,  Al Hudaiba  Awards Buildings, Near the Union House,  Southern end of 2nd of December  Street,Block C, First Floor, Dubai,   PO Box 213480, UAE   T el +971 4 3819 6012   Fax +971 4 354 6669   Email AAHassoun@dha.gov.a eBackground:  VIRTUE was a prospective, observational study assessing the effectiveness  and safety of vildagliptin vs sulfonylureas (SUs) (both as monotherapy and in combination  with metformin) in patients with type 2 diabetes mellitus who fasted during Ramadan.",Non-OADS,/arxiv_data1/oa_pdf/a4/7a/dmso-9-225.PMC4968856.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/a4/7a/dmso-9-225.PMC4968856.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/7a/dmso-9-225.PMC4968856.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/05/db/ndt-12-1887.PMC4968857.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1887–1891Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1887OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11040 0 clinical characteristics of patients with benign  nonlesional temporal lobe epilepsy Jiyeon Kim1 seong hoon Kim2 sung chul lim2 Woojun Kim2 Y oung-Min shon3 1Department of Neurology, Korea  University ansan hospital, college  of Medicine, Korea University, ansan,   2Department of Neurology, catholic  Neuroscience institute, college of  Medicine, The catholic University of  Korea, seocho-gu, 3Department of  Neurology, samsung Medical center,   sungkyunkwan University school of  Medicine, seoul, KoreaPurpose:  To evaluate the evolution of nonlesional temporal lobe epilepsy (TLE-NL) in patients  treated exclusively with antiepileptic drugs and to elucidate clinical phenotypes related to the  prognosis of these patients.",Non-OADS,/arxiv_data1/oa_pdf/05/db/ndt-12-1887.PMC4968857.pdf
"There are no detectable structural lesions, even using correspondence: Young-Min shon Department of Neurology, samsung  Medical center, sungkyunkwan University  school of Medicine, 81 irwonro,  gangnam-gu, seoul 135-710, Korea Tel +82 2 3410 2701 Fax +82 2 3410 0052 email sonogung@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Kim et al Running head recto: Clinical characteristics of patients with benign TLE-NL DOI: http://dx.doi.org/10.2147/NDT.S110400",Non-OADS,/arxiv_data1/oa_pdf/05/db/ndt-12-1887.PMC4968857.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/05/db/ndt-12-1887.PMC4968857.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/db/ndt-12-1887.PMC4968857.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1423–1433Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1423Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10590 2 Visualization of a hyaluronan network on the  surface of silicone-hydrogel materials Katarzyna a Wygladacz Daniel J hook Vision Care, Bausch & lomb  incorporated, rochester, nY, UsaAbstract:  Biotrue multipurpose solution (MPS) is a bioinspired disinfecting and condition - ing solution that includes hyaluronic acid (HA) as a natural wetting agent.",Non-OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
"These include hydroxypropyl methylcellulose (eg, Complete MoisturePlus  MPS; Abbott Medical Optics Inc, Santa Ana, CA, USA),4 carboxymethyl cellulose  (eg, Refresh Optive lubricating and rewetting drops; Allergan, Irvine, CA, USA),5 Correspondence: Daniel J hook Vision Care, Bausch & lomb  incorporated, 1400 north goodman  street, rochester, nY 14609, Usa Tel +1 585 338 6580 email d aniel.hook@bausch.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Wygladacz and Hook Running head recto: Hyaluronan on silicone-hydrogel lenses DOI: http://dx.doi.org/10.2147/OPTH.S105902",Non-OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
Available from: http://www.accessdata.fda.gov/ cdrh_docs/pdf3/k030092.pdf .,OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
"Available from: http://www.accessdata.fda.gov/cdrh_ docs/pdf12/K121201.pd f. Accessed May 25, 2016.",OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
Available from: http://spie.org/ Publications/Proceedings/Paper/10.1117/12.64479 0.,Non-OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
"Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf12/ K122575.pd f. Accessed May 25, 2016.",OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
Available from: https://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
Avail - able from: http://www.accessdata.fda.gov/cdrh_docs/pdf4/k042275.,Non-OADS,/arxiv_data1/oa_pdf/07/2d/opth-10-1423.PMC4968858.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/09/ott-9-4629.PMC4968859.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4629–4637OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4629Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9605 3 miR-203  is involved in the laryngeal carcinoma  pathogenesis via targeting VegF a and cox-2 lin Xu1  Bin shen2 Tingting chen3 Pin Dong2 1Department of Otolaryngology,   second affiliated hospital of Zhejiang  University Medical college, hangzhou,   2Department of Otolaryngology- head & neck surgery, shanghai  Jiaotong University affiliated  First People’s hospital, shanghai,   3lishui central hospital, lishui,   Zhejiang Province, People’s republic  of chinaAbstract:  The development of laryngeal squamous cell carcinoma (LSCC) is a multistep  process involving multiple factors.",Non-OADS,/arxiv_data1/oa_pdf/44/09/ott-9-4629.PMC4968859.pdf
"Alterations in MiRNA expres - sion are involved in the initiation, progression, and metastasis of human cancer, and  it is believed that miRNAs function both as tumor suppressors and as oncogenes in  cancer development.3,4 Accumulating studies have shown that disturbed expression correspondence: Bin shen Department of Otolaryngology – head &  neck surgery, shanghai Jiao Tong  University Affiliated First People’s  hospital, 100 haining road, shanghai  200080, People’s republic of china email binshen1982@sohu.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xu et al Running head recto: miR-203  represses the expression of VEGFA and Cox-2 in laryngeal carcinoma DOI: http://dx.doi.org/10.2147/OTT.S96053",Non-OADS,/arxiv_data1/oa_pdf/44/09/ott-9-4629.PMC4968859.pdf
"miR-203  suppresses the expression of  VegF a and cox-2 by targeting 3 ′-UTr To understand the roles of reduced miR-203  in the patho - genesis of LSCC, we first predicted the target genes of  miR-203  by using online bioinformatics tool: TargetScan  (http://www.targetscan.or g).10 To our surprise, VEGFA  and Cox-2, the overexpression of whom has been found to  be positively correlated with the malignancy of LSCC, are  the direct feasible targets of miR-203  (Figures 2 and 3).10–13   To examine whether these two genes are the real target of  miR-203 , we employed the dual-luciferase reporter system.",Non-OADS,/arxiv_data1/oa_pdf/44/09/ott-9-4629.PMC4968859.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/44/09/ott-9-4629.PMC4968859.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/09/ott-9-4629.PMC4968859.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/85/ott-9-4681.PMC4968860.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4681–4686OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4681Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10649 6 Potential predictive role of chemotherapy-induced  changes of soluble cD40 ligand in untreated  advanced pancreatic ductal adenocarcinoma amalia azzariti1,* Oronzo Brunetti2,* letizia Porcelli1 giusi graziano3 rosa Maria iacobazzi1 Michele signorile2 aldo scarpa4 Vito lorusso2 nicola silvestris2 1Preclinical and clinical Pharmacology  Unit, 2Medical Oncology Unit,   3scientific Direction, national cancer  research centre, istituto T umouri  “giovanni Paolo ii”, Bari, 4arc-neT  research centre, University of  Verona, Verona, italy *These authors contributed equally  to this workAbstract:  Pancreas ductal adenocarcinoma lacks predictive biomarkers.",Non-OADS,/arxiv_data1/oa_pdf/62/85/ott-9-4681.PMC4968860.pdf
"In locally advanced, metastatic, and relapsed settings,  FOLFIRINOX (fluorouracil, leucovorin, irinotecan, and oxaliplatin) and gemcitabine  plus nab-paclitaxel chemotherapy regimens increase OS, even if prognosis still remains  unfavorable.4,5 In particular, the four-drug combination regimen FOLFIRINOX has been  shown to be superior to gemcitabine alone in patients with metastatic PDAC, in terms  of median OS of 11.1  months in the FOLFIRINOX group as compared to 6.8  months in correspondence: nicola silvestris Medical Oncology Unit, national cancer  research centre, istituto Tumouri  “giovanni Paolo ii”, Viale Orazio Flacco,  65, 70124 Bari, italy Tel/fax +39 80 555 5419 email n.silvestris@oncologico.bari.i t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Azzariti et al Running head recto: Soluble CD40 ligand in metastatic pancreatic ductal adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S106496",Non-OADS,/arxiv_data1/oa_pdf/62/85/ott-9-4681.PMC4968860.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/62/85/ott-9-4681.PMC4968860.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/85/ott-9-4681.PMC4968860.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/92/b6/ott-9-4645.PMC4968861.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4645–4652OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4645Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10337 6 clinical implication of long noncoding RNA 91H   expression profile in osteosarcoma patients Wen-Kai Xia1 Qing-Feng lin2 Dong shen2 Zhi-li liu2 Jun su2 Wei-Dong Mao2 1Department of n ephrology,   2Department of Oncology, The  affiliated Jiangyin hospital, school  of Medicine, southeast University,   Jiangyin, Jiangsu, People’s republic  of chinaAbstract:  Long noncoding RNAs have been documented as having widespread roles in  carcinogenesis and cancer progression.",Non-OADS,/arxiv_data1/oa_pdf/92/b6/ott-9-4645.PMC4968861.pdf
"Intriguingly, lncRNAs are also  commonly expressed in serum, plasma, and other bodily fluids.9–11 Changes in lncRNAs  expression levels have been increasingly verified in a variety of cancer types, indicating  that they are potentially new targets for cancer diagnostics and treatments.12correspondence: Wei-Dong Mao Department of Oncology, The Affiliated  Jiangyin hospital, school of Medicine,  southeast University, 163 shoushan  road, Jiangyin, Jiangsu 214400, People’s  republic of china email maowdjy@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xia et al Running head recto: lncRNA expression in osteosarcoma patients’ for clarity  DOI: http://dx.doi.org/10.2147/OTT.S103376",Non-OADS,/arxiv_data1/oa_pdf/92/b6/ott-9-4645.PMC4968861.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/92/b6/ott-9-4645.PMC4968861.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/b6/ott-9-4645.PMC4968861.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/0b/ijn-11-3461.PMC4968862.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3461–3473International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3461OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10815 2 Photothermal effects of laser-activated surface  plasmonic gold nanoparticles on the apoptosis  and osteogenesis of osteoblast-like cells lih-rou rau1 Wan-Yu huang1 Jiunn-Woei liaw2–5 shiao-Wen Tsai1,3,6 1graduate Institute of Biochemical  and Biomedical engineering,   2Department of Mechanical  engineering, 3center for Biomedical  engineering, chang gung University,   4Institute for radiological research,   chang gung Memorial hospital,   chang gung University, Taoyuan,   5center for advanced Molecular  Imaging and Translation, 6Department  of Orthopaedic surgery, chang gung  Memorial hospital, linkou, Taiwan,   republic of chinaAbstract:  The specific properties of gold nanoparticles (AuNPs) make them a novel class of  photothermal agents that can induce cancer cell damage and even death through the conversion of  optical energy to thermal energy.",Non-OADS,/arxiv_data1/oa_pdf/ce/0b/ijn-11-3461.PMC4968862.pdf
"Localized surface plasmon resonance (LSPR) is a unique optical property of  nanosized metallic particles that allows collective oscillation of free electrons in correspondence: shiao-Wen Tsai graduate Institute of Biochemical and  Biomedical engineering, chang gung  University, No 259, Wenhua 1st rd,  guishan District, Taoyuan city 33302,  Taiwan, republic of china Tel +886 3 211 8800 ext 5984 Fax +886 3 211 8668 email swtsai@mail.cgu.edu.t w  Jiunn-Woei liaw Department of Mechanical engineering,  chang gung University, No 259, Wenhua  1st rd, guishan District, Taoyuan city  33302, Taiwan, republic of china email markliaw@mail.cgu.edu.t wJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Rau et al Running head recto: Photothermal effects of AuNPs on apoptosis and osteogenesis of MG63 DOI: http://dx.doi.org/10.2147/IJN.S108152",Non-OADS,/arxiv_data1/oa_pdf/ce/0b/ijn-11-3461.PMC4968862.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ce/0b/ijn-11-3461.PMC4968862.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/0b/ijn-11-3461.PMC4968862.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/58/ott-9-4549.PMC4968863.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4549–4559OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4549Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9596 2green synthesis, characterization, and anticancer  activity of hyaluronan/zinc oxide nanocomposite Farideh namvar1,2 susan azizi3 heshu sulaiman rahman4–6 rosfarizan Mohamad1,3 abdullah rasedee4 Mozhgan soltani2 raha abdul rahim7 1institute of Tropical Forestry  and Forest Products (in TrOP),   Universiti Putra Malaysia, UPM  serdang, selangor, Malaysia; 2research  center for animal Development  applied Biology, Mashhad Branch,   islamic azad University, Mashhad,   iran; 3Department of Bioprocess  Technology, Faculty of Biotechnology  and Biomolecular sciences,   4Department of Veterinary laboratory  Diagnosis, Faculty of Veterinary  Medicine, Universiti Putra Malaysia,   UPM serdang, selangor, Malaysia;   5Department of clinic and internal  Medicine, college of Veterinary  Medicine, University of sulaimani,   6Department of laboratory Medical  sciences, Komar University of science  and T echnology, sulaimani city,   Kurdistan region, northern iraq;   7Department of cell and Molecular  Biology, Faculty of Biotechnology and  Biomolecular sciences, Universiti  Putra Malaysia, UPM serdang, selangor,   MalaysiaAbstract:  The study describes an in situ green biosynthesis of zinc oxide nanocomposite using  the seaweed Sargassum muticum  water extract and hyaluronan biopolymer.",Non-OADS,/arxiv_data1/oa_pdf/a0/58/ott-9-4549.PMC4968863.pdf
"It is one correspondence: rosfarizan Mohamad;   susan azizi Department of Bioprocess Technology,  Faculty of Biotechnology and  Biomolecular sciences, University Putra  Malaysia, 43400 UPM serdang, selangor,  Malaysia Tel +60 3 8946 3455 Fax +60 3 8946 1071 email farizanmohd@gmail.co m;   azisusan@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Namvar et al Running head recto: Green synthesis of nanocomposite for cancer therapy DOI: http://dx.doi.org/10.2147/OTT.S95962",Non-OADS,/arxiv_data1/oa_pdf/a0/58/ott-9-4549.PMC4968863.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a0/58/ott-9-4549.PMC4968863.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/58/ott-9-4549.PMC4968863.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/03/64/ott-9-4695.PMC4968864.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4695–4703OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4695Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10289 1 Mutational analysis of primary and metastatic  colorectal cancer samples underlying the  resistance to cetuximab-based therapy radim nemecek1 Jitka Berkovcova2 lenka radova3 T omas Kazda4 Jitka Mlcochova3 Petra Vychytilova- Faltejskova1,3 Ondrej slaby1,3 Marek svoboda1 1Department of comprehensive  cancer care, Masaryk Memorial  cancer institute, Masaryk University,   Brno, czech republic; 2Department  of Oncological and experimental  Pathology, Masaryk Memorial cancer  institute, Brno, czech republic;   3central european institute of  T echnology, Masaryk University,   Brno, czech republic; 4Department  of radiation Oncology, Masaryk  Memorial cancer institute, Masaryk  University, Brno, czech republicPurpose:  Although several molecular markers predicting resistance to cetuximab- or  panitumumab-based therapy of metastatic colorectal cancer were described, mutations in RAS  proto-oncogenes remain the only predictors being used in daily clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/03/64/ott-9-4695.PMC4968864.pdf
"Additional 25%–40% of patients develop metastases after the primary surgical and  oncological treatment.2 Most of the metastatic patients are treated with systemic pal - liative chemotherapy in combination with monoclonal antibodies (moAbs) against correspondence: Marek svoboda Department of comprehensive cancer  care, Masaryk Memorial cancer institute,  Masaryk University, Zluty kopec 7,  656 53 Brno, czech republic Tel +420 5 4313 4231 Fax +420 5 4321 1169 email msvoboda@mou.c z Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Nemecek et al Running head recto: Gene mutations and prediction of response to anti-EGFR therapy DOI: http://dx.doi.org/10.2147/OTT.S102891",Non-OADS,/arxiv_data1/oa_pdf/03/64/ott-9-4695.PMC4968864.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/03/64/ott-9-4695.PMC4968864.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/64/ott-9-4695.PMC4968864.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/20/96/dddt-10-2401.PMC4968865.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2401–2419Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2401Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10931 8 Flurbiprofen–antioxidant mutual prodrugs as safer  nonsteroidal anti-inflammatory drugs: synthesis,  pharmacological investigation, and computational  molecular modeling Zaman ashraf1,2 alamgeer3 Munazza Kanwal1 Mubashir hassan2 sahar abdullah3 Mamuna Waheed3 haseeb ahsan3 song Ja Kim2 1Department of chemistry, allama  iqbal Open University, islamabad,   Pakistan; 2Department of Biological  sciences, college of natural sciences,   Kongju national University, gongju,   republic of Korea; 3Department of  Pharmacology, Faculty of Pharmacy,   University of sargodha, sargodha,   PakistanAbstract:  Flurbiprofen–antioxidant mutual prodrugs were synthesized to reduce the  gastrointestinal (GI) effects associated with flurbiprofen.",Non-OADS,/arxiv_data1/oa_pdf/20/96/dddt-10-2401.PMC4968865.pdf
"These adverse effects of NSAIDs are believed to embrace two different correspondence: song Ja Kim Department of Biological sciences,  college of natural sciences, Kongju  national University, 56 gongju  Daehak-ro gongju-si, chungnam 32588,  republic of Korea email ksj85@kongju.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ashraf et al Running head recto: Flurbiprofen–antioxidant mutual prodrugs as safer NSAIDs DOI: http://dx.doi.org/10.2147/DDDT.S109318",Non-OADS,/arxiv_data1/oa_pdf/20/96/dddt-10-2401.PMC4968865.pdf
The amino acid sequences  of COX-1 and COX-2 in FASTA format having accession  numbers (P23219 and P35354) were obtained from Uniprot  Knowledge database ( http://www.uniprot.org /).,OADS,/arxiv_data1/oa_pdf/20/96/dddt-10-2401.PMC4968865.pdf
The  Osiris Property Explorer ( http://www.organic-chemistry.org/ prog/peo /) an online tool was used to evaluate the possible  tumorigenic or mutagenic risks and to estimate the drug-like  properties.,OADS,/arxiv_data1/oa_pdf/20/96/dddt-10-2401.PMC4968865.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/20/96/dddt-10-2401.PMC4968865.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/96/dddt-10-2401.PMC4968865.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/20/be/opth-10-1385.PMC4968866.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1385–1396Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1385CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10966 3 The sustained effect (12 months) of a single-dose  vectored thermal pulsation procedure for  meibomian gland dysfunction and evaporative  dry eye Caroline a Blackie1 Christy a Coleman1 edward J Holland2 On behalf of the lipiFlow  Study Group 1T earScience inc., Morrisville, nC,   2Cincinnati eye institute, edgewood,   KY, USaPurpose:  To evaluate the sustained effect (up to 1 year) of a single, 12-minute vectored thermal  pulsation (VTP) treatment in improving meibomian gland function and dry eye symptoms in  patients with meibomian gland dysfunction and evaporative dry eye.",Non-OADS,/arxiv_data1/oa_pdf/20/be/opth-10-1385.PMC4968866.pdf
"Despite the limitations of the current definition of dry eye, there is strong Correspondence: Caroline a Blackie TearScience inc., 400 Commonwealth  ave, Unit #2, Boston, Ma 02215, USa Tel +1 617 423 6370 Fax +1 617 426 4924 email cblackie@tearscience.co m Journal name: Clinical Ophthalmology Article Designation: Clinical Trial Report Y ear: 2016 Volume: 10 Running head verso: Blackie et al Running head recto: VTP procedure for MGD and evaporative dry eye DOI: http://dx.doi.org/10.2147/OPTH.S109663",Non-OADS,/arxiv_data1/oa_pdf/20/be/opth-10-1385.PMC4968866.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/20/be/opth-10-1385.PMC4968866.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/be/opth-10-1385.PMC4968866.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/64/ijn-11-3475.PMC4968867.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3475–3485International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3475OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10607 3 effects of surface charges of gold nanoclusters  on long-term in vivo biodistribution, toxicity, and  cancer radiation therapy Jun-Ying Wang1 Jie chen1 Jiang Yang2 hao Wang1 Xiu shen1 Yuan-Ming sun1 Meili guo3 Xiao-Dong Zhang4 1Tianjin Key laboratory of  radiation Medicine and Molecular  Nuclear Medicine, Institute of  radiation Medicine, chinese academy  of Medical sciences and Peking Union  Medical college, Tianjin, 2environment,   energy and Natural resources center,   Department of environmental science  and engineering, Fudan University,   shanghai, 3Department of Physics,   school of science, Tianjin chengjian  University, 4Department of Physics,   school of science, Tianjin University,   Tianjin, People’s republic of chinaAbstract:  Gold nanoclusters (Au NCs) have exhibited great advantages in medical diagnostics  and therapies due to their efficient renal clearance and high tumor uptake.",Non-OADS,/arxiv_data1/oa_pdf/f7/64/ijn-11-3475.PMC4968867.pdf
"Furthermore, correspondence: Xiao-Dong Zhang Department of Physics, school of  science, Tianjin University, 135 Yaguan  road, Tianjin 300350, People’s republic  of china Tel/fax +86 22 8568 3041 email xiaodongzhang@tju.edu.c n  Yuan-Ming sun Tianjin Key laboratory of radiation  Medicine and Molecular Nuclear  Medicine, Institute of radiation Medicine,  chinese academy of Medical sciences  and Peking Union Medical college,  No 238, Baidi road, Tianjin 300350,  People’s republic of china email sunyuanming@irm-cams.ac.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wang et al Running head recto: Effects of surface charges of Au NCs on cancer radiation therapy DOI: http://dx.doi.org/10.2147/IJN.S106073",Non-OADS,/arxiv_data1/oa_pdf/f7/64/ijn-11-3475.PMC4968867.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f7/64/ijn-11-3475.PMC4968867.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/64/ijn-11-3475.PMC4968867.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e3/c1/ott-9-4569.PMC4968868.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4569–4581OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4569Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10848 5 network analysis reveals potential markers for  pediatric adrenocortical carcinoma anurag Kulshrestha1 shikha suman2 rakesh ranjan1 1Bioinformatics Division, national  Bureau of animal genetic resources,   Karnal, 2Division of applied sciences,   indian institute of information  T echnology, allahabad, indiaAbstract:  Pediatric adrenocortical carcinoma (ACC) is a rare malignancy with a poor outcome.",Non-OADS,/arxiv_data1/oa_pdf/e3/c1/ott-9-4569.PMC4968868.pdf
"Moreover, leukemogenesis may develop on  treatment with topoisomerase inhibitors such as etoposide and doxorubicin.3 Surgery  and exhaustive chemotherapy have shown poor outcomes in children with locally  advanced or metastasis disease.4correspondence: anurag Kulshrestha Bioinformatics Division, national Bureau  of animal genetic resources, Karnal,  haryana 132001, india Tel +91 896 029 8856 email anurag.kulshrestha23@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Kulshrestha et al Running head recto: Markers of pediatric ACC DOI: http://dx.doi.org/10.2147/OTT.S108485",Non-OADS,/arxiv_data1/oa_pdf/e3/c1/ott-9-4569.PMC4968868.pdf
The entire  workflow representing the procedure employed for the study  is shown in Figure 1. raw biological data The raw DNA microarray data were obtained from Gene  Expression Omnibus ( http://www.ncbi.nlm.nih.gov/ge o) for  healthy children and children suffering from ACC.,OADS,/arxiv_data1/oa_pdf/e3/c1/ott-9-4569.PMC4968868.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e3/c1/ott-9-4569.PMC4968868.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/c1/ott-9-4569.PMC4968868.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/32/42/opth-10-1405.PMC4968869.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1405–1410Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1405CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10979 7 effect of pupillary dilation on Haigis formula- calculated intraocular lens power measurement  by using optical biometry Bharkbhum Khambhiphant1 Suganlaya Sasiwilasagorn2 nattida Chatbunchachai3 Krit pongpirul2,4 1Department of Ophthalmology,   King Chulalongkorn Memorial  Hospital, Thai red Cross Society,   2Department of Ophthalmology,   Faculty of Medicine, Chulalongkorn  University, Bangkok, 3Department  of Ophthalmology, Samut prakan  Hospital, Samut prakan, Thailand;   4Department of international Health,   Johns Hopkins Bloomberg School of  public Health, Baltimore, MD, USaPurpose:  The purpose of this study was to evaluate the effect of pupillary dilation on the  Haigis formula-calculated intraocular lens (IOL) power and ocular biometry measurements  by using IOLMaster®.",Non-OADS,/arxiv_data1/oa_pdf/32/42/opth-10-1405.PMC4968869.pdf
"Our previous study showed that pupil dilation does not have an effect on the IOL  power measurement using the IOLMaster® (Carl Zeiss Meditec AG, Jena, Germany).6  However, the study was conducted based on the SRK-T formula and the anterior  chamber depth (ACD) was significantly increased postdilation, which was comparable  to other reports.6–10Correspondence: Bharkbhum  Khambhiphant Department of Ophthalmology,  King Chulalongkorn Memorial  Hospital, Thai red Cross Society,  Bangkok 10330, Thailand Tel +66 8 9811 1573 Fax +66 2 252 8290 email bharkbhum@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Clinical Trial Report Y ear: 2016 Volume: 10 Running head verso: Khambhiphant et al Running head recto: Effect of pupillary dilation on IOL power calculation DOI: http://dx.doi.org/10.2147/OPTH.S109797",Non-OADS,/arxiv_data1/oa_pdf/32/42/opth-10-1405.PMC4968869.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/32/42/opth-10-1405.PMC4968869.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/42/opth-10-1405.PMC4968869.pdf
Available at: http://www.optovue.com/products/ivue/.,Non-OADS,/arxiv_data1/oa_pdf/9a/3a/i1552-5783-57-9-OCT37.PMC4968921.pdf
Available at: http://www.zeiss.com/meditec/en_us/products—solutions/ophthalmology-optometry/glaucoma/diagnostics/optical-coherence-thomography/oct-optical-coherence-tomography/cirrus-hd-oct.html#speciﬁcations.,Non-OADS,/arxiv_data1/oa_pdf/9a/3a/i1552-5783-57-9-OCT37.PMC4968921.pdf
Available at: http://www.zeiss.com/meditec/en_us/products—solutions/ophthalmology-optometry/glaucoma/therapy/surgical-microscopes/opmi-lumera-700.html#technical-data.,Non-OADS,/arxiv_data1/oa_pdf/9a/3a/i1552-5783-57-9-OCT37.PMC4968921.pdf
Available at: http://www.haag-streit-surgical.com/products/ophthalmology/ioctr.html.,Non-OADS,/arxiv_data1/oa_pdf/9a/3a/i1552-5783-57-9-OCT37.PMC4968921.pdf
Available at: http://www.leica-microsystems.com/products/optical-coherence-tomography-oct/details/product/enfocus/.,Non-OADS,/arxiv_data1/oa_pdf/9a/3a/i1552-5783-57-9-OCT37.PMC4968921.pdf
"The African Descent and Glaucoma Evaluation Study and DIGS are registered as cohort clinical trials (http://www.clinicaltrials.gov, identiﬁers NCT00221923and NCT00221897, September 14, 2005).",Non-OADS,/arxiv_data1/oa_pdf/5b/f9/i1552-5783-57-9-OCT511.PMC4968923.pdf
"The visual ﬁelds were scanned at high resolution, and ImageJ software (http://rsbweb.nih.gov/ ij; provided in the public domain by the National Institutes ofHealth, Bethesda, MD, USA) and a touchscreen device were usedto trace and calculate the area of each isopter minus anyscotomata.",OADS,/arxiv_data1/oa_pdf/68/9e/i1552-5783-57-9-OCT429.PMC4968926.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/4e/50/tom106.PMC4968944.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2016.00136 106 TOMOGRAPHY.ORG |VOLUME 2 NUMBER 2 |JUNE 2016,Non-OADS,/arxiv_data1/oa_pdf/4e/50/tom106.PMC4968944.pdf
Supplemental Materials Table 1: http://dx.doi.org/10.18383/j.tom.2016.00136.sup.01 Figure S1: http://dx.doi.org/10.18383/j.tom.2016.00136.sup.02Video 1: http://dx.doi.org/10.18383/j.tom.2016.00136.vid.01 ACKNOWLEDGMENTS This work was supported by the National Institute of Health grant U01CA172027 (HKS/JJO/HS) and a predoctoral fellowship F31CA180319 (JSC).,Non-OADS,/arxiv_data1/oa_pdf/4e/50/tom106.PMC4968944.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Correspondence to: George A Kelley, FACSM, Professor, Director, Meta-Analytic Research Group, Department of Biostatistics,  School of Public Health, Robert C. Byrd Health Sciences Center, PO Box 9190, West Virginia University, Morgantown, WV  26506-9190, United States.",Non-OADS,/arxiv_data1/oa_pdf/13/64/nihms772216.PMC4968945.pdf
"All data were analyzed using version 3.0 of P-curve ( http://www.p-curve.com/app3/ ),  version 3.0 of Comprehensive Meta-Analysis (Englewood, New Jersey, 2015) and Microsoft  Excel 2010.Kelley and Kelley Page 4 World J Rheumatol .",OADS,/arxiv_data1/oa_pdf/13/64/nihms772216.PMC4968945.pdf
Available from: http://health.gov/paguidelines/report/pdf/ committeereport.pdf 47.,Non-OADS,/arxiv_data1/oa_pdf/13/64/nihms772216.PMC4968945.pdf
Available from: http://www.cdc.gov/arthritis/pa_factsheet.htmKelley and Kelley Page 10 World J Rheumatol .,Non-OADS,/arxiv_data1/oa_pdf/13/64/nihms772216.PMC4968945.pdf
"15, 2066 –2076 http://dx.doi.org/10.1080/15384101.2016.1198863",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
Ribbon diagrams were generated using the program CCP4MG ( http://www.ccp4.ac.uk/MG/ ).,OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"51 Protein sequences were obtained from http://www.uniprot.org/ ,52and sequence alignment was performed using MUSCLE (http://www.ebi.ac.uk/Tools/msa/muscle/ ).53 Statistical analysis Differences in mitotic indices were analyzed by both the Krus- kal-Wallis test and Student ’s t-test.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Nat Rev Mol Cell Biol 2009;10:478-87; PMID:19546858; http://dx.doi.org/10.1038/nrm2718 [2] Fung MK, Cheung HW, Wong H-L, Yuen H-F, Ling M-T, Chan K- W, Wong Y-C, Cheung AL, Wang X. MAD2 expression and its sig- niﬁcance in mitotic checkpoint control in testicular germ cell tumour.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Biochim Biophys Acta 2007; 1773:821-32; PMID:17467818;http://dx.doi.org/10.1016/j.bbamcr.2007.03.014 [3] Doak SH, Jenkins GJ, Parry EM, Grif ﬁths AP, Baxter JN, Parry JM.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"JPathol 2012; 226:746-55; PMID:22069160; http://dx.doi.org/10.1002/path.3035 [5] Li G-Q, Li H, Zhang H-F. Mad2 and p53 expression pro ﬁles in colo- rectal cancer and its clinical signi ﬁcance.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"World J Gastroenterol 2003; 9:1972-5; PMID:12970887; http://dx.doi.org/10.3748/wjg.v9.i9.1972 [6] Sumi T, Morishita M, Nakano Y, Teramae M, Fukuda T, Nobeyama H, Yoshida H, Matsumoto Y, Yasui T, Ishiko O.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Exp Ther Med 2012; 3:341-6; PMID:22969893; http://dx.doi.org/10.3892/ etm.2011.407 [7] Scintu M, Vitale R, Prencipe M, Gallo AP, Bonghi L, Valori VM, Maiello E, Rinaldi M, Signori E, Rabitti C, et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Cancer Lett 2007; 254:298-307; PMID:17498870;http://dx.doi.org/10.1016/j.canlet.2007.03.021 [8] Tanaka K, Nishioka J, Kato K, Nakamura A, Mouri T, Miki C, Kusu- noki M, Nobori T. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Jpn J CancerRes 2001; 92:952-8; PMID:11572763; http://dx.doi.org/10.1111/ j.1349-7006.2001.tb01186.x [9] Manchado E, Guillamot M, Malumbres M. Killing cells by targeting mitosis.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Cell Death Differ 2012; 19: 369-77; PMID:22223105; http://dx.doi.org/10.1038/cdd.2011.197 [10] Mikhailov A, Cole RW, Rieder CL.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Curr Biol 2002; 12:1797-806;PMID:12419179; http://dx.doi.org/10.1016/S0960-9822(02)01226-5 [11] Jackson JR, Patrick DR, Dar MM, Huang PS.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Nat Rev Cancer 2007;7:107-17; PMID:17251917; http://dx.doi.org/10.1038/nrc2049[12] Kasai T, Iwanaga Y, Iha H, Jeang K-T.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
J Biol Chem 2002; 277:5187-93; PMID:11729202;http://dx.doi.org/10.1074/jbc.M110295200 [13] Tao W. The mitotic checkpoint in cancer therapy.,Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Cell Cycle 2005; 4:1495-9; PMID:16258280; http://dx.doi.org/10.4161/cc.4.11.2130 [14] Nitta M, Kobayashi O, Honda S, Hirota T, Kuninaka S, Marumoto T, Ushio Y, Saya H. Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Oncogene 2004; 23:6548-58; PMID:15221012; http://dx.doi.org/10.1038/sj.onc.1207873 [15] Cheung HW, Jin D-Y, Ling M-T, Wong Y-C, Wang Q, Tsao SW, Wang X. Mitotic arrest de ﬁcient 2 expression induces chemosensiti- zation to a DNA-damaging agent, cisplatin, in nasopharyngeal carci-noma cells.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Cancer Res 2005; 65:1450-8; PMID:15735033; http://dx.doi.org/10.1158/0008-5472.CAN-04-0567 [16] Fung MK, Cheung H-W, Ling M-T, Cheung AL, Wong Y-C, Wang X.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Br J Cancer 2006; 95:475-84; PMID:16880791; http://dx.doi.org/10.1038/sj.bjc.6603284 [17] Fung MK, Han H-Y, Leung SC, Cheung HW, Cheung AL, Wong Y-C, Ling M-T, Wang X. MAD2 interacts with DNA repair proteins andnegatively regulates DNA damage repair.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"J Mol Biol 2008; 381:24-34; PMID:18597777; http://dx.doi.org/10.1016/j.jmb.2008.05.080 [18] Dotiwala F, Harrison JC, Jain S, Sugawara N, Haber JE.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Curr Biol 2010; 20:328-32; PMID:20096585; http://dx.doi.org/10.1016/j.cub.2009.12.033 [19] Wang L, Yin F, Du Y, Chen B, Liang S, Zhang Y, Du W, Wu K, Ding J, Fan D. Depression of MAD2 inhibits apoptosis and increases pro-liferation and multidrug resistance in gastric cancer cells by regulat- ing the activation of phosphorylated survivin.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Tumour Biol 2010; 31:225-32; PMID:20440596; http://dx.doi.org/10.1007/s13277-010-0036-6 [20] Yin F, Du Y, Hu W, Qiao T, Ding J, Wu K, Liu Z, Fan D. Mad2beta, an alternative variant of Mad2 reducing mitotic arrest and apoptosisinduced by adriamycin in gastric cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Life Sci 2006; 78:1277-86; PMID:16214181; http://dx.doi.org/10.1016/j.lfs.2005.06.034 [21] Li Y, Benezra R. Identi ﬁcation of a human mitotic checkpoint gene: hsMAD2.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Science 1996; 274:246-8; PMID:8824189; http://dx.doi.org/10.1126/science.274.5285.246 [22] Gemma A, Hosoya Y, Seike M, Uematsu K, Kurimoto F, Hibino S, Yoshimura A, Shibuya M, Kudoh S, Emi M. Genomic structure of the human MAD2 gene and mutation analysis in human lung andbreast cancers.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Lung Cancer 2001; 32:289-95; PMID:11390010; http://dx.doi.org/10.1016/S0169-5002(00)00223-3 [23] Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R. MAD2 haplo-insuf-ﬁciency causes premature anaphase and chromosome instability in mammalian cells.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
Nature 1997; 386:623-7; PMID:9121588; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"J Cell Biol 2008; 180:665-72;PMID:18283116; http://dx.doi.org/10.1083/jcb.200712029 [26] Luo X, Fang G, Coldiron M, Lin Y, Yu H, Kirschner MW, Wagner G. Structure of the Mad2 spindle assembly checkpoint protein and itsinteraction with Cdc20.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Nat Struct Biol 2000; 7: 224-9; PMID:10700282; http://dx.doi.org/10.1038/73338 [27] Sironi L, Mapelli M, Knapp S, De Antoni A, Jeang K-T, Musacchio A.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
Plos Biol 2008; 6:e50PMID:18318601; http://dx.doi.org/10.1371/journal.pbio.0060050CELL CYCLE 2075,Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Cell2007; 131:744-55; PMID:18022368; http://dx.doi.org/10.1016/j.cell.2007.08.048 [30] Tipton AR, Wang K, Link L, Bellizzi JJ, Huang H, Yen T, Liu S-T. BUBR1 and closed MAD2 (C-MAD2) interact directly to assemble afunctional mitotic checkpoint complex.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"J Biol Chem 2011; 286:21173- 9; PMID:21525009; http://dx.doi.org/10.1074/jbc.M111.238543 [31] Hara M, €Ozkan E, Sun H, Yu H, Luo X.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Proc Natl AcadSci U S A 2015; 112:11252-7; PMID:26305957; http://dx.doi.org/ 10.1073/pnas.1512197112 [32] Luo X, Tang Z, Rizo J, Yu H. The Mad2 spindle checkpoint protein undergoes similar major conformational changes upon binding toeither Mad1 or Cdc20.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Mol Cell 2002; 9:59-71; PMID:11804586; http://dx.doi.org/10.1016/S1097-2765(01)00435-X [33] Orth M, Mayer B, Rehm K, Rothweiler U, Heidmann D, Holak TA, Stemmann O. Shugoshin is a Mad1/Cdc20-like interactor of Mad2.EMBO J 2011; 30:2868-80; PMID:21666598; http://dx.doi.org/ 10.1038/emboj.2011.187 [34] Ryan SD, Britigan EM, Zasadil LM, Witte K, Audhya A, Roopra A, Weaver BA.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Am J Clin Pathol2009; 131:793-801; PMID:19461085; http://dx.doi.org/10.1309/AJCPBMHHD0HFCY8W [36] Burum-Auensen E, Skotheim RI, Schjølberg AR, Røislien J, Lothe RA, Clausen OP.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"J Carcinog 2010; 9:1; PMID:20411023; http://dx.doi.org/10.4103/1477-3163.60358 [37] Quimby BB, Arnaoutov A, Dasso M. Ran GTPase regulates Mad2 localization to the nuclear pore complex.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Eukaryot Cell 2005; 4:274-80; PMID:15701789; http://dx.doi.org/10.1128/EC.4.2.274-280.2005 [38] Lee SH, Sterling H, Burlingame A, McCormick F. Tpr directly binds to Mad1 and Mad2 and is important for the Mad1-Mad2-mediatedmitotic spindle checkpoint.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Genes Dev 2008; 22:2926-31;PMID:18981471; http://dx.doi.org/10.1101/gad.1677208 [39] Rodriguez-Bravo V, Maciejowski J, Corona J, Buch HK, Collin P, Kanemaki MT, Shah JV, Jallepalli PV.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
Cell 2014; 156: 1017-31; PMID:24581499; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"AnnOncol 2004; 15:1377-99; PMID:15319245; http://dx.doi.org/10.1093/annonc/mdh301 [41] Mendoza J, Mart /C19ınez J, Hern /C19andez C, P /C19erez-Montiel D, Castro C, Fabi/C19an-Morales E, Santib /C19a~nez M, Gonz /C19alez-Barrios R, D /C19ıaz-Ch /C19avez J, Andonegui MA, et al.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Br J Cancer 2013; 109:68-75; PMID:23807173; http://dx.doi.org/10.1038/bjc.2013.303 [42] Stoilov P, Daoud R, Nayler O, Stamm S. Human tra2-beta1 autoregu- lates its protein concentration by in ﬂuencing alternative splicing ofits pre-mRNA.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Hum Mol Genet 2004; 13:509-24; PMID:14709600; http://dx.doi.org/10.1093/hmg/ddh051 [43] Sureau A, Gattoni R, Dooghe Y, St /C19evenin J, Soret J. SC35 autoregu- lates its expression by promoting splicing events that destabilize its mRNAs.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
EMBO J 2001; 20:1785-96; PMID:11285241; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Cancer Res 2008; 68:9194-201; PMID:19010891;http://dx.doi.org/10.1158/0008-5472.CAN-08-2600 [45] Masuda A, Maeno K, Nakagawa T, Saito H, Takahashi T. Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in humanlung cancers.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Am J Pathol 2003; 163:1109-16; PMID:12937152;http://dx.doi.org/10.1016/S0002-9440(10)63470-0 [46] Schweizer N, Ferr /C19as C, Kern DM, Logarinho E, Cheeseman IM, Maiato H. Spindle assembly checkpoint robust ness requires Tpr-mediated regu- lation of Mad1/Mad2 proteostasis.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"J Cell Biol 2013; 203:883-93;PMID:24344181; http://dx.doi.org/10.1083/jcb.201309076 [47] Filippov V, Schmidt EL, Filippova M, Duerksen-Hughes PJ.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Gene 2008; 420:34-41; PMID:18571879; http://dx.doi.org/10.1016/j.gene.2008.05.008 [48] Mu R, Wang Y-B, Wu M, Yang Y, Song W, Li T, Zhang W-N, Tan B, Li A-L, Wang N, et al.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Cell Death Dis 2014; 5:e1151; PMID:24675469; http://dx.doi.org/10.1038/ cddis.2014.117 [49] Wassmann K, Liberal V, Benezra R. Mad2 phosphorylation regulates its association with Mad1 and the APC/C EMBO J 2003; 22:797-806; PMID:12574116; http://dx.doi.org/10.1093/emboj/cdg071 [50] Voigt W. Sulforhodamine B assay and chemosensitivity.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Methods Mol Med 2005; 110:39-48; PMID:15901925; http://dx.doi.org/ 10.1385/1-59259-869-2:039 [51] McNicholas S, Potterton E, Wilson KS, Noble ME.",Non-OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Nucleic Acids Research 2015; 43(D1):D204 –D212; http://dx.doi.org/ 10.1093/nar/gku989 [53] Li W, Cowley A, Uludag M, Gur T, McWilliam H, Squizzato S, Park YM, Buso N, Lopez R. The EMBL-EBI bioinformatics web and pro-grammatic tools framework.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Nucleic Acids Res 2015; 43:W580-4; PMID:25845596; http://dx.doi.org/10.1093/nar/gkv279 [54] Zou KH, Hall WJ, Shapiro DE.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
"Stat Med 1997; 16:2143-56; PMID:9330425; http://dx.doi.org/ 10.1002/(SICI)1097-0258(19971015)16:19%3c2143::AID-SIM655%3 e3.0.CO;2-3 [55] Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples.",OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
Nutr Metab (Lond) 2010; 7: 26; PMID:20374655; http://dx.doi.org/10.1186/1743-7075-7-262076 A. L/C19OPEZ-SAAVEDRA ET AL.,OADS,/arxiv_data1/oa_pdf/d4/51/kccy-15-15-1198863.PMC4968973.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/39/96/imcrj-9-219.PMC4968977.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/39/96/imcrj-9-219.PMC4968977.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Idiopathic horseshoe-like macular tear: a case  report Masaomi Kubota1 T omohiro Shibata1 Hisato Gunji1 Hiroshi Tsuneoka2 1Department of Ophthalmology, The  Jikei University School of Medicine  Kashiwa Hospital, Chiba, 2Department  of Ophthalmology, The Jikei University  School of Medicine, T okyo, Japan Correspondence: Masaomi Kubota   Department of Ophthalmology,   The Jikei University School of Medicine  Kashiwa Hospital,   163-1 Kashiwashita, Kashiwa City, Chiba  227-8567, Japan   T el +81 4 7164 1111 (ext.",Non-OADS,/arxiv_data1/oa_pdf/39/96/imcrj-9-219.PMC4968977.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/39/96/imcrj-9-219.PMC4968977.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/96/imcrj-9-219.PMC4968977.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/3e/fc/tacg-9-121.PMC4968978.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3e/fc/tacg-9-121.PMC4968978.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3e/fc/tacg-9-121.PMC4968978.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).The Application of Clinical Genetics 2016:9 121–129The Application of Clinical Genetics Dovepress submit your manuscript | www.dovepress.com Dovepress 121 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S112712 Examining genotypic variation in autism spectrum  disorder and its relationship to parental age  and phenotype David A Geier1,2 Janet K Kern1,3 Lisa K Sykes2 Mark R Geier1,2 1Research Department, The Institute  of Chronic Illnesses, Inc, 2Research  Department, CoMeD, Inc, Silver  Spring, MD, 3Research Department,   CONEM US Autism Research Group,  Allen, TX, USABackground: Previous studies on genetic testing of chromosomal abnormalities in individu- als diagnosed with autism spectrum disorder (ASD) found that ~80% have negative genetic  test results (NGTRs) and ~20% have positive genetic test results (PGTRs), of which ~7% were  probable de novo mutations (PDNMs).",Non-OADS,/arxiv_data1/oa_pdf/3e/fc/tacg-9-121.PMC4968978.pdf
"1Correspondence: Janet K Kern Research Department, The Institute of Chronic Illnesses, Inc, 14 Redgate Court, Silver Spring, MD 20905, USATel +1 301 989 0548Fax +1 301 989 1543Email jkern@dfwair.netJournal name: The Application of Clinical Genetics Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Geier et alRunning head recto: Genotypic variation in autism spectrum disorderDOI: http://dx.doi.org/10.2147/TACG.S112712",Non-OADS,/arxiv_data1/oa_pdf/3e/fc/tacg-9-121.PMC4968978.pdf
"The Application of Clinical Genetics 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/the-application-of-clinical-genetics-journalThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/3e/fc/tacg-9-121.PMC4968978.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes   from published authors.Dovepress 129 Genotypic variation in autism spectrum disorder,Non-OADS,/arxiv_data1/oa_pdf/3e/fc/tacg-9-121.PMC4968978.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 367–376ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  367 ORiginal REsEaRCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S112006Work intensity in sacroiliac joint fusion and  lumbar microdiscectomy Clay Frank1 Dimitriy Kondrashov2 s Craig Meyer3 gary Dix4 Morgan lorio5 Don Kovalsky6 Daniel Cher7 1integrated spine Care, Wawautosa,   Wi, 2st Mary’s spine Center, san  Francisco, C a, 3Columbia Orthopedic  group, Columbia, MO, 4Maryland  Brain spine and Pain, annapolis, MD,   5neurospine solutions, Bristol, Tn ,   6Orthopaedic Center of southern  illinois, Mt Vernon, il, 7si-BOn E, inc.,   san Jose, C a, UsaBackground: The evidence base supporting minimally invasive sacroiliac (SI) joint fusion  (SIJF) surgery is increasing.",Non-OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
"Although the sacroiliac (SI) joint has been recognized as a pain generator since  the 1800s, and despite the fact that the first SI joint fusion (SIJF) was performed in Correspondence: Daniel Cher si-BOnE, inc., 3055 Olin avenue, suite 2200, san Jose, Ca, Usa 95128Email dcher@si-bone.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: Original ResearchY ear: 2016V olume: 8Running head verso: Frank et alRunning head recto: Work intensity in SIJF and LMDDOI: http://dx.doi.org/10.2147/CEOR.S112006",Non-OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
"Mean OR in/out times were also lower for minimally invasive Table 1 spine surgical procedures and associated coding and  current RVU Procedures CPT code 2016 work RVUs* Posterior lumbar microdiscectomy 63030 13.18 Percutaneous discectomy 62287 9.03  Minimally invasive  sacroiliac joint   fusion 27279 9.03 Notes: *Data from https://www.cms.gov/Medicare/Medicare-Fee-for-service-Payment/ PhysicianFeesched/PFs-Federal-Regulation-notices-items/CMs-1631-FC.html.54 Abbreviations:  CPT, current procedural technology; RVU, relative value unit.Table 2  nasa TlX rating system Components Questions Rating scale Mental demand how mentally demanding was  the task?Very low–very high Physical demand how physically demanding was the task?Very low–very high Temporal demand how hurried or rushed was the pace of the task?Very low–very high Performance how successful were you in accomplishing what you were asked to do?Perfect–failure Effort how hard did you have to   work to accomplish your level   of performance?Very low–very high Frustration how insecure, discouraged, irritated, stressed, and annoyed were you?Very low–very high Abbreviation:  nasa, national aeronautics and space administration; TlX, task  load index.",Non-OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
Available from: http://well.blogs.nytimes.com/2011/09/22/how-one-small-group-sets-doctors-pay/.,Non-OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
Available from: http://www.citizen.org/public-citizen-inside-job-ama-self-regulation-medicare-report.,Non-OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/PFS-Federal-Regulation-Notices-Items/CMS-1631-FC.html.,Non-OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 376 Frank et al,Non-OADS,/arxiv_data1/oa_pdf/e2/eb/ceor-8-367.PMC4968979.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/hmer-8-081.PMC4968980.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/hmer-8-081.PMC4968980.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cd/2b/hmer-8-081.PMC4968980.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hepatic Medicine: Evidence and Research 2016:8 81–88Hepatic Medicine: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  81 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HMER.S85544Idiopathic noncirrhotic portal hypertension:  current perspectives Oliviero Riggio1 Stefania Gioia1 Ilaria Pentassuglio1 Valeria Nicoletti1 Michele Valente2 Giulia d’Amati2 1Department of Clinical Medicine,   Center for the Diagnosis and  Treatment of Portal Hypertension,   2Department of Radiological,   Oncological, and Pathological Sciences, Sapienza University of Rome,  Rome, ItalyAbstract:  The term idiopathic noncirrhotic portal hypertension (INCPH) has been recently  proposed to replace terms, such as hepatoportal sclerosis, idiopathic portal hypertension,  incomplete septal cirrhosis, and nodular regenerative hyperplasia, used to describe patients  with a hepatic presinusoidal cause of portal hypertension of unknown etiology, characterized  by features of portal hypertension (esophageal varices, nonmalignant ascites, porto-venous col- laterals), splenomegaly, patent portal, and hepatic veins and no clinical and histological signs  of cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/cd/2b/hmer-8-081.PMC4968980.pdf
"6Correspondence: Oliviero Riggio Department of Gastroenterology, Centro di Riferimento per l’Ipertensione Portale., II Gastroenterologia, Dipartimento di Medicina Clinica, “Sapienza” Università di Roma, Viale dell’Università 37, 00185 Rome, ItalyTel +39 6 4997 2001Fax +39 6 4453 319Email oliviero.riggio@uniroma1.itJournal name: Hepatic Medicine: Evidence and Research Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Riggio et alRunning head recto: Idiopathic noncirrhotic portal hypertensionDOI: http://dx.doi.org/10.2147/HMER.S85544",Non-OADS,/arxiv_data1/oa_pdf/cd/2b/hmer-8-081.PMC4968980.pdf
"Hepatic Medicine: Evidence and Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hepatic-medicine-evidence-and-research-journalThe Open Access Journal of Hepatology is an international, peer- reviewed, open access journal covering all aspects of adult and pediatric hepatology in the clinic and laboratory including the following topics: Pathology, pathophysiology of hepatic disease; Investigation and treat-ment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/cd/2b/hmer-8-081.PMC4968980.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 88 Riggio et al  34.,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/hmer-8-081.PMC4968980.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2016:8 105–111Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  105 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S109450Minimally invasive prostate cancer detection test  using FISH probes Rima Tinawi-Aljundi1 Shannon T Knuth2 Michael Gildea2 Joshua Khal2 Jason Hafron1 Kenneth Kernen1 Robert Di Loreto1 Joan Aurich-Costa2 1Pathology and Research Department,   Michigan Institute of Urology,   St Clair Shores, MI, USA;   2Research and Development, Cellay,   Inc., Cambridge, MA, USAPurpose: The ability to test for and detect prostate cancer with minimal invasiveness has the  potential to reduce unnecessary prostate biopsies.",Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
"1 Approximately 2.9 million American men  are living with prostate cancer.2 Lifetime risk of developing prostate cancer is 14%  (2010–2012 data1), while lifetime risk of dying from the disease is 2.8% or 1 in 38.3  Risk factors include age (>75% of prostate cancer diagnosed in men >65); African-American and Caribbean-African ancestry (1.6 times more likely to develop prostate cancer; 2.4 times more likely to die compared to Caucasians); geography; positive family history for prostate cancer; mutations of BRCA1 or BRCA2 genes and pres-ence of hereditary nonpolyposis colorectal cancer, or HNPCC/Lynd Syndrome; high Correspondence: Joan Aurich-Costa Cellay, Inc., 100 Inman Street, Cambridge, MA 02139, USATel +1 617 995 1300 Ext 336Fax +1 617 995 1304Email joan.aurich@cellayinc.comJournal name: Research and Reports in Urology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Tinawi-Aljundi et alRunning head recto: Minimally invasive prostate cancer testDOI: http://dx.doi.org/10.2147/RRU.S109450",Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
Available from: http://seer.cancer.gov/statfacts/html/prost.html.,Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
Available from: http://www.cdc.gov/cancer/prostate/statistics/race.htm.,Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
Available from: http://www.cancer.org/cancer/cancerbasics/lifetime-probability-of-developing-or-dying-from-cancer.,Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
Available from: http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-risk-factors.,Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
Avail-able from: http://www.pcf.org/site/c.leJRIROrEpH/b.8368629/k.D6C1/   African_Americans_At_Higher_Risk_for_Prostate_Cancer.htm.,Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
"Available from: https://www.auanet.org/education/guidelines/prostate-cancer-detection.cfm; Accessed February 5, 2016.",Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
Available  from: http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/prostate-cancer-screening.,Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
Available from: http://www.cancer.gov/news-events/press releases/2011/CostCancer2020.,Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
"Research and Reports in Urology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 111 Minimally invasive prostate cancer test  15.,Non-OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
"Available from: http://cgap.nci.nih.gov/Chromo-somes/Mitelman, 2011.",OADS,/arxiv_data1/oa_pdf/df/98/rru-8-105.PMC4968981.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/87/8d/ppa-10-1359.PMC4968982.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1359–1372Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1359OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10560 5 Modeling the hospital safety partnership  preferences of patients and their families:  a discrete choice conjoint experiment charles e cunningham1 Tracy hutchings2 Jennifer henderson2 heather rimas1 Yvonne chen1 1Department of Psychiatry and  Behavioural neurosciences, Faculty of  health sciences, Michael g Degroote  school of Medicine, McMaster  University,  2Department of Quality  and Performance, hamilton health  sciences, hamilton, On , canadaBackground:  Patients and their families play an important role in efforts to improve health  service safety.",Non-OADS,/arxiv_data1/oa_pdf/87/8d/ppa-10-1359.PMC4968982.pdf
"Keywords:  hospital safety, patients, partnerships, preferences, discrete choice conjoint  experiment Introduction The social and economic costs associated with medical errors are staggering.1 Reducing  accidents and errors is a major focus of hospital quality programs and an international  policy imperative.2 Engaging patients is increasingly recognized to be an important  component of safety initiatives3–5 and a logical extension of efforts to involve patients  in the health care process.6 Patients are present at the point of care where errors may  occur, able to detect medically relevant incidents,7 concerned about their safety,8–10 and correspondence: charles e cunningham ron Joyce children’s health centre,  child and Youth Mental health Program,  237 Barton street east, hamilton,  On l8l 2X2, canada Tel +1 905 521 2100 ext 77307 Fax +1 905 577 8453 email cunnic@hhsc.c a Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Cunningham et al Running head recto: Patient safety partnership preferences DOI: http://dx.doi.org/10.2147/PPA.S105605",Non-OADS,/arxiv_data1/oa_pdf/87/8d/ppa-10-1359.PMC4968982.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/87/8d/ppa-10-1359.PMC4968982.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/e6/2c/ceor-8-361.PMC4968983.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e6/2c/ceor-8-361.PMC4968983.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e6/2c/ceor-8-361.PMC4968983.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 361–366ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  361 ORiginal REsEaRCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S105402Characterizing individual painDETECT symptoms  by average pain severity alesia sadosky1 Vijaya Koduru2 E Jay Bienen3 Joseph C Cappelleri4 1Pfizer inc, new Y ork, nY, 2Eliassen  group, n ew london, CT, 3Outcomes  Research Consultant, new Y ork, nY,  4Pfizer inc, groton, CT, Usa  Background: painDETECT is a screening measure for neuropathic pain.",Non-OADS,/arxiv_data1/oa_pdf/e6/2c/ceor-8-361.PMC4968983.pdf
"2,3 Adding to this challenge is the heterogeneity of NeP , arising from  the multiplicity of conditions that may result not only in such pain but also in the phe-notypic presentation of sensory symptoms, 4–7 which may result from differences in the  underlying pathophysiologic mechanisms.8,9 Thus, accurate identification of NeP has Correspondence: alesia sadosky Pfizer Inc, 235 East 42nd Street, New York, nY 10017, UsaTel +1 212 733 9491Fax +1 212 309 5294Email alesia.sadosky@pfizer.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: Original ResearchY ear: 2016V olume: 8Running head verso: Sadosky et alRunning head recto: Mapping painDETECT symptom severityDOI: http://dx.doi.org/10.2147/CEOR.S105402",Non-OADS,/arxiv_data1/oa_pdf/e6/2c/ceor-8-361.PMC4968983.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/e6/2c/ceor-8-361.PMC4968983.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 366 sadosky et al References  1. International Association for the Study of Pain.,Non-OADS,/arxiv_data1/oa_pdf/e6/2c/ceor-8-361.PMC4968983.pdf
Avail- able from: https://www.iasp-pain.org/Education/Content.aspx?Item   Number=1698.,Non-OADS,/arxiv_data1/oa_pdf/e6/2c/ceor-8-361.PMC4968983.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d9/64/ijn-11-3451.PMC4968984.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3451–3459International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3451OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10542 0 cabazitaxel-loaded human serum albumin  nanoparticles as a therapeutic agent against  prostate cancer Na Qu1 robert J lee1,2 Yating sun1 guangsheng cai1 Junyang Wang1 Mengqiao Wang1 Jiahui lu1 Qingfan Meng1 lirong T eng1 Di Wang1 lesheng T eng1,3 1school of life sciences, Jilin  University, changchun, People’s  republic of china; 2Division of  Pharmaceutics, college of Pharmacy,   The Ohio state University, columbus,   Oh, Usa; 3state Key laboratory  of long-acting and Targeting Drug  Delivery system, Yantai, People’s  republic of chinaAbstract:  Cabazitaxel-loaded human serum albumin nanoparticles (Cbz-NPs) were synthesized  to overcome vehicle-related toxicity of current clinical formulation of the drug based on Tween-80  (Cbz-Tween).",Non-OADS,/arxiv_data1/oa_pdf/d9/64/ijn-11-3451.PMC4968984.pdf
"The NPs were then evaluated correspondence: lesheng Teng;   Di Wang school of life sciences, Jilin University,  No 2699, Qianjin street, changchun,  130012, People’s republic of china Tel +86 431 8516 8646 email tenglesheng@jlu.edu.c n;  jluwangdi@outlook.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Qu et al Running head recto: Cabazitaxel-loaded human serum albumin nanoparticles for cancer DOI: http://dx.doi.org/10.2147/IJN.S105420",Non-OADS,/arxiv_data1/oa_pdf/d9/64/ijn-11-3451.PMC4968984.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d9/64/ijn-11-3451.PMC4968984.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/64/ijn-11-3451.PMC4968984.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/2c/4e/jmdh-9-311.PMC4968985.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2c/4e/jmdh-9-311.PMC4968985.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2c/4e/jmdh-9-311.PMC4968985.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 311–322Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 311 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S105000A simple dietary assessment tool to monitor food  intake of hospitalized adult patients  Dwi Budiningsari1,2 Suzana Shahar1 Zahara Abdul Manaf1 Susetyowati Susetyowati2  1Dietetic Programme, School of  Healthcare Sciences, Faculty of Health  Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia;   2Department of Health Nutrition,   Faculty of Medicine, Gadjah Mada University, Y ogyakarta, Indonesia Background/objectives: Monitoring food intake of patients during hospitalization using  simple methods and minimal training is an ongoing problem in hospitals.",Non-OADS,/arxiv_data1/oa_pdf/2c/4e/jmdh-9-311.PMC4968985.pdf
"There were no differences in energy, protein,  carbohydrate, and fat intake estimated among health care staff (P=0.967; P=0.951; P=0.888;  P=0.847, respectively).Conclusion: In conclusion, PDAT provides a valid estimation of macronutrient consumption  among hospitalized adult patients.Keywords:  validation, dietary assessment tool, nutrient intake, plate waste, hospitalized patients Introduction Inadequate food intake among hospitalized patients is a common problem1-4 that can lead  to malnutrition which is associated with an increased risk of complications, longer hospital  stay leading to increased cost, frequent readmission, and mortality.5,6  Globally, malnutrition  affects up to 40% of hospitalized patients,1 with higher prevalence in developing countries Correspondence: Suzana Shahar Dietetic Programme, School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Azis, 50300 Kuala Lumpur, Malaysia Tel +60 3 9289 7194  Fax +60 3 2693 8717 Email suzana.shahar@ukm.edu.myJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Budiningsari et alRunning head recto: Simple dietary assessment tool for food intake of hospitalized patientsDOI: http://dx.doi.org/10.2147/JMDH.S105000",Non-OADS,/arxiv_data1/oa_pdf/2c/4e/jmdh-9-311.PMC4968985.pdf
Available from: http://gizi.depkes.go.id/download/Pedoman%20Gizi/COVER%20 PGRS_PGRS%20Final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/4e/jmdh-9-311.PMC4968985.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/2c/4e/jmdh-9-311.PMC4968985.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 322 Budiningsari et al,Non-OADS,/arxiv_data1/oa_pdf/2c/4e/jmdh-9-311.PMC4968985.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c4/cb/ijn-11-3435.PMC4968986.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3435–3449International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3435OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10564 5 Degradability, biocompatibility, and osteogenesis  of biocomposite scaffolds containing nano  magnesium phosphate and wheat protein both  in vitro and in vivo for bone regeneration Yan Xia1 Panyu Zhou1,* Fei Wang2 chao Qiu2 Panfeng Wang1 Yuntong Zhang1 liming Zhao3 shuogui Xu1,2 1Department of emergency,   2Department of Orthopedics,   changhai hospital, second Military  Medical University, 3state Key  laboratory of Bioreactor engineering,   east china University of science  and Technology, shanghai, People’s  republic of china *These authors contributed equally  to this workAbstract:  In this study, bioactive scaffold of nano magnesium phosphate (nMP)/wheat  protein  (WP) composite (MWC) was fabricated.",Non-OADS,/arxiv_data1/oa_pdf/c4/cb/ijn-11-3435.PMC4968986.pdf
"Keywords:  nano magnesium phosphate, wheat protein, composite scaffolds, degradation,  bone regeneration Introduction Divalent cation of Mg plays critical roles in bone remodeling and skeletal tissue  development of the human body, and in calcified tissues, Mg is involved in the cal - cification process.1,2 Mg may improve bone mineral density and affect bone fragility,  and lack of magnesium can affect all the stages of skeletal metabolism, leading to  decreased bone growth and osteoporosis.3,4 Over the past few years, Mg-containing  bioactive materials have received increased attention for bone tissue repair, and  several magnesium-based biomaterials were reported, such as Mg and its alloys,  magnesium-containing bioactive glasses and coatings, and Mg-substituted calcium  phosphate bioceramics/biocements, and so on.5–8 These studies have shown that Mg  as an important element in the bioactive materials can have some special effects on  the material properties.9–11 Natural polymers (such as collagen, chitosan, plant protein, etc) are the most  important raw materials for the development of biomedical materials.12 Wheat correspondence: shuogui Xu Department of emergency, changhai  hospital, second Military Medical  University, No 168, changhai road,  Yangpu District, shanghai 200433,  People’s republic of china email xiayan20162@sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Xia et al Running head recto: Biocomposite scaffolds for bone regeneration DOI: http://dx.doi.org/10.2147/IJN.S105645",Non-OADS,/arxiv_data1/oa_pdf/c4/cb/ijn-11-3435.PMC4968986.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c4/cb/ijn-11-3435.PMC4968986.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/cb/ijn-11-3435.PMC4968986.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/ac/tcrm-12-1139.PMC4968987.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1139–1143Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1139Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10742 3 a bypass case due to an acute inferior myocardial  infarction caused by vascular occlusion of the left  subclavian artery and left anterior descending  artery Yakup altas ali Veysel Ulug g Department of Cardiology, Diyarbakir  Gazi Yasargil education and Research  Hospital, Diyarbakir, T urkeyAbstract:  ST segment elevation is the most common electrocardiographic finding in acute  myocardial infarction.",Non-OADS,/arxiv_data1/oa_pdf/ad/ac/tcrm-12-1139.PMC4968987.pdf
"The patient described a Correspondence: Yakup altas Department of Cardiology, Diyarbakir  Gazi Yasargil education and Research  Hospital, Diyarbakir, Turkey Tel +90 505 451 8108 email drfrtykp@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Altas and Ulu g Running head recto: Inferior AMI and occluded LAD DOI: http://dx.doi.org/10.2147/TCRM.S107423",Non-OADS,/arxiv_data1/oa_pdf/ad/ac/tcrm-12-1139.PMC4968987.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ad/ac/tcrm-12-1139.PMC4968987.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/ac/tcrm-12-1139.PMC4968987.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/87/de/nss-8-259.PMC4968988.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/87/de/nss-8-259.PMC4968988.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/87/de/nss-8-259.PMC4968988.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2016:8 259–266Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  259 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S110032Clinical predictors of central sleep apnea evoked  by positive airway pressure titration Marilyn Moro1 Karen Gannon1 Kathy Lovell1 Margaret Merlino1 James Mojica2 Matt T Bianchi1,3 1Neurology Department, 2Pulmonary  and Critical Care Medicine,   Massachusetts General Hospital,  Boston, MA, USA;  3Division of Sleep  Medicine, Harvard Medical School,  Boston, MA, USAPurpose: Treatment-emergent central sleep apnea (TECSA), also called complex apnea,  occurs in 5%–15% of sleep apnea patients during positive airway pressure (PAP) therapy, but  the clinical predictors are not well understood.",Non-OADS,/arxiv_data1/oa_pdf/87/de/nss-8-259.PMC4968988.pdf
"1 The natural history of TECSA remains uncertain, although a  recent randomized trial of CPAP versus adaptive servoventilation suggested that it may resolve spontaneously in about half the PAP-treated patients, 2 consistent with  prior retrospective and prospective studies.2–5 In addition to mechanistic questions Correspondence: Matt T Bianchi Neurology Department, Massachusetts General Hospital, Wang 720, 55 Fruit Street, Boston, MA 02114, USATel +1 617 724 7426Fax +1 617 724 6513Email mtbianchi@partners.orgJournal name: Nature and Science of Sleep Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Moro et alRunning head recto: Clinical predictors of emergent central apneaDOI: http://dx.doi.org/10.2147/NSS.S110032",Non-OADS,/arxiv_data1/oa_pdf/87/de/nss-8-259.PMC4968988.pdf
"Nature and Science of Sleep 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/87/de/nss-8-259.PMC4968988.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/53/d9/tcrm-12-1145.PMC4968989.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1145–1150Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1145Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11265 6 Repeated adjacent segment diseases and fractures  in osteoporotic patients: a case report Hsin-Yao Chen1 Chiu-Liang Chen1,2 Wei-Liang Chen3 1Department of orthopedic  surgery, Changhua Christian  Hospital, Changhua City, 2Liberal  arts Center of Da Yeh University,   Dacun T ownship, Changhua County,   Taiwan; 3Department of Clinical  Image, Changhua Christian Hospital,   Changhua City, Changhua County,   TaiwanBackground:  Pedicle screw instrumentation for treating spinal disorder is becoming increasingly  widespread.",Non-OADS,/arxiv_data1/oa_pdf/53/d9/tcrm-12-1145.PMC4968989.pdf
"Cement augmentation for the uppermost  instrumented vertebra (UIV) and the adjacent unfused vertebral bodies had been  reported.2,3 However, long instrumentations would transit the forces to the adjacent  cephalad levels, leading to disc degeneration, failure of facet, and finally vertebral  subluxation with neurologic complication.2 This study presents an unusual case of an 81-year-old Taiwanese woman who has  been left with various spinal complications caused by repeated instrumented fusions for Correspondence: Chiu-Liang Chen Department of orthopedic surgery,  Changhua Christian Hospital, 135  Nanxiao street, Changhua City,  Changhua County 500, Taiwan Tel +886 47 116 128 Fax +886 47 116 129 email 111111@cch.org.t w Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Chen et al Running head recto: Repeated ASD in osteoporotic patients DOI: http://dx.doi.org/10.2147/TCRM.S112656",Non-OADS,/arxiv_data1/oa_pdf/53/d9/tcrm-12-1145.PMC4968989.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/53/d9/tcrm-12-1145.PMC4968989.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/d9/tcrm-12-1145.PMC4968989.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ff/20/ppa-10-1349.PMC4968990.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1349–1357Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1349OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10743 7 Patients’ empowerment, physicians’ perceptions,  and achievement of therapeutic goals in patients  with type 1 and type 2 diabetes mellitus in Mexico Fernando J lavalle- gonzález1 erwin chiquete2 On behalf of the iDMP s-3W  collaborative group  (Mexico) 1Department of endocrinology,   hospital Universitario Dr José  eleuterio gonzález, Monterrey, nl,   2Department of neurology and  Psychiatry, instituto nacional de  ciencias Médicas y nutrición salvador  Zubirán, Mexico city, MexicoBackground:  Physicians’ perception may not parallel objective measures of therapeutic  targets in patients with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/ff/20/ppa-10-1349.PMC4968990.pdf
"Keywords:  A1c, care, diabetes, HbA1c, goal, IDMPS, insulin, management, Mexico, opinion,  self-monitoring, treat to target Introduction According to the National Health and Nutrition Survey 2006 (ENSANUT 2006), 14%  of adults live with diabetes in Mexico, with half of the cases being newly diagnosed  patients identified during population screening.1 This epidemiological profile repre - sents a doubling in the frequency of diabetes since 1993.2 Hence, diabetes-related  late complications are also increasing in Mexico, so that by the year 2014, diabetes  was considered the leading cause of general mortality, with more than 80,000 deaths  attributed to its related acute and chronic complications.3 This changing paradigm in  public health has been explained by the steep rise in the frequency of overweight, in the correspondence: erwin chiquete Department of neurology and Psychiatry,  instituto nacional de ciencias Médicas y  nutrición salvador Zubirán, Vasco de  Quiroga 15, Tlapan, ciudad de México,  código Postal 14000, México Tel +52 54 87 0900 ext 5052 Fax +52 56 55 1076 email erwinchiquete@hotmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Lavalle-González and Chiquete Running head recto: Physician’s perceptions and control of patients with diabetes DOI: http://dx.doi.org/10.2147/PPA.S107437",Non-OADS,/arxiv_data1/oa_pdf/ff/20/ppa-10-1349.PMC4968990.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ff/20/ppa-10-1349.PMC4968990.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/b3/b5/jmdh-9-323.PMC4968991.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b3/b5/jmdh-9-323.PMC4968991.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b3/b5/jmdh-9-323.PMC4968991.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 323–333Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 323 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S84900Alpers–Huttenlocher syndrome: the role of a  multidisciplinary health care team Russell P Saneto1,2 1Department of Neurology, University  of Washington, 2Division of Pediatric  Neurology, Seattle Children’s Hospital,   Seattle, WA, USAAbstract: Alpers–Huttenlocher syndrome (AHS) is a mitochondrial DNA-depletion syn- drome.",Non-OADS,/arxiv_data1/oa_pdf/b3/b5/jmdh-9-323.PMC4968991.pdf
"1–3 In the Blackwood et al report, two siblings of the five reported cases also  had liver cirrhosis with episodes of epilepsia partialis continua (EPC).1,3 In a larger series  of neuropathological and clinical findings reported by Harding, the close homogeneity Correspondence: Russell P Saneto Division of Pediatric Neurology, Seattle Children’s Hospital, 4800 Sand Point Way Northeast, Seattle, WA 98105, USATel +1 206 987 2078Fax +1 206 987 2649Email russ.saneto@seattlechildrens.orgJournal name: Journal of Multidisciplinary Healthcare Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: SanetoRunning head recto: Alpers–Huttenlocher syndrome and health careDOI: http://dx.doi.org/10.2147/JMDH.S84900",Non-OADS,/arxiv_data1/oa_pdf/b3/b5/jmdh-9-323.PMC4968991.pdf
Available from: http://tools.niehs.nih.gov/polg.,OADS,/arxiv_data1/oa_pdf/b3/b5/jmdh-9-323.PMC4968991.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/b3/b5/jmdh-9-323.PMC4968991.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 333 Alpers–Huttenlocher syndrome and health care  51.,Non-OADS,/arxiv_data1/oa_pdf/b3/b5/jmdh-9-323.PMC4968991.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/59/ibpc-9-079.PMC4968992.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).integrated Blood Pressure Control 2016:9 79–94submit your manuscript | www.dovepress.co m Dove press  79 http: //dx.doi.org/10.2147/IBPC.S7734 4Current best practice in the management   of hypertensive disorders in pregnancy Rosemary T ownsend1 Patrick O’Brien2 Asma Khalil1 1Fetal Medicine Unit, St George’s  University of London, London, UK;    2institute for women’s Health,   University College London, London,   UK Correspondence: Asma Khalil   Fetal Medicine Unit, St George’s  University of London, Blackshaw Road,  London Sw17 0QT, UK   Tel +44 20 8725 0080   Fax +44 20 8725 0079   email akhalil@sgul.ac.u k; asmakhalil79@ googlemail.co mAbstract:  Preeclampsia is a potentially serious complication of pregnancy with increasing  significance worldwide.",Non-OADS,/arxiv_data1/oa_pdf/9a/59/ibpc-9-079.PMC4968992.pdf
"Integrated Blood Pressure Control Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/integrated-blood-pressure-control-journa lIntegrated Blood Pressure Control is an international, peer-reviewed  open-access journal focusing on the integrated approach to managing  hypertension and risk reduction.",Non-OADS,/arxiv_data1/oa_pdf/9a/59/ibpc-9-079.PMC4968992.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/59/ibpc-9-079.PMC4968992.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 257–266International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 257 OrIGInal research open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S111337Does a medical history of hypertension influence  disclosing genetic testing results of the risk for  salt-sensitive hypertension, in primary care?",Non-OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
"1,2 A study using ambulatory blood pressure moni- toring suggested that genetic factors account for 30%–60% of the  variation in blood correspondence: Masanobu Okayama Division of community Medicine and Medical education, Kobe University Graduate school of Medicine, arata-cho 2-1-5, hyogo-ku, Kobe, hyogo 652-0032, JapanTel +81 78 382 6732Fax +81 78 382 6283email okayama@jichi.ac.jpJournal name: International Journal of General Medicine Article Designation: Original ResearchY ear: 2016V olume: 9Running head verso: Okayama et alRunning head recto: Influence of hypertension on disclosing genetic testing resultsDOI: http://dx.doi.org/10.2147/IJGM.S111337",Non-OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
Available from: http://www.uptodate.com/contents/overview-of-hypertension-in-adults?source=search_result&search=hypertension&selectedTitle=1~150.,Non-OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
Available from: https://www.genome.gov/GWAStudies/.,OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
Available from: http://www.mhlw.go.jp/bunya/kenkou/seikatsu/pdf/03-c-06.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
Available from: http://gen-en.net/news.html.,Non-OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 266 Okayama et al,Non-OADS,/arxiv_data1/oa_pdf/ae/43/ijgm-9-257.PMC4968993.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/32/26/rru-8-113.PMC4968994.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/32/26/rru-8-113.PMC4968994.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/32/26/rru-8-113.PMC4968994.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2016:8 113–122Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  113 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S93636Evaluation and management of overactive bladder:  strategies for optimizing care Marcella G Willis-Gray   Alexis A Dieter   Elizabeth J Geller Division of Female Pelvic Medicine  and Reconstructive Surgery,  Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill,  NC, USAAbstract:  Overactive bladder (OAB) is a common condition affecting millions of men and  women worldwide.",Non-OADS,/arxiv_data1/oa_pdf/32/26/rru-8-113.PMC4968994.pdf
"6 There are  also consequences with job performance, including decreased productivity at work due to frequent bathroom trips, lost time at work due to related illnesses, physician visits and hospitalization, and even loss of employment due to the detrimental effect on job performance.Correspondence: Elizabeth J Geller  Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Old Clinic Building, Campus Box 7570, Chapel Hill, NC 27599, USA Tel +1 919 966 4717   Email egeller@med.unc.eduJournal name: Research and Reports in Urology Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Willis-Gray et alRunning head recto: Evaluation and management of overactive bladderDOI: http://dx.doi.org/10.2147/RRU.S93636",Non-OADS,/arxiv_data1/oa_pdf/32/26/rru-8-113.PMC4968994.pdf
Available from: https://www.auanet.org/common/pdf/education/clinical-guidance/Overactive-Bladder-Algorithm.pdf.,Non-OADS,/arxiv_data1/oa_pdf/32/26/rru-8-113.PMC4968994.pdf
"Research and Reports in Urology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/32/26/rru-8-113.PMC4968994.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 122 Willis-Gray et al  50.,Non-OADS,/arxiv_data1/oa_pdf/32/26/rru-8-113.PMC4968994.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/19/ec/jpr-9-535.PMC4968995.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/19/ec/jpr-9-535.PMC4968995.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/19/ec/jpr-9-535.PMC4968995.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 535–542Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  535 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S110161Efficacy of stereotactic gamma knife surgery and  microvascular decompression in the treatment of  primary trigeminal neuralgia: a retrospective study  of 220 cases from a single center Zi-Feng Dai Qi-Lin Huang Hai-Peng Liu Wei Zhang Department of Neurosurgery, Xinqiao  Hospital, The Third Military Medical University, Chongqing, People’s Republic of ChinaObjectives: A retrospective study was undertaken to compare the efficacy of stereotactic  gamma knife surgery (GKS) and microvascular decompression (MVD) in the treatment of pri- mary trigeminal neuralgia (TN) at a single center.",Non-OADS,/arxiv_data1/oa_pdf/19/ec/jpr-9-535.PMC4968995.pdf
"6–9Correspondence: Qi-Lin Huang Department of Neurosurgery, Xinqiao Hospital, The Third Military Medical University, Xinqiao Street, Chongqing 400037, People’s Republic of ChinaEmail hqlxqyy@sina.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Dai et alRunning head recto: Gamma knife surgery for trigeminal neuralgiaDOI: http://dx.doi.org/10.2147/JPR.S110161",Non-OADS,/arxiv_data1/oa_pdf/19/ec/jpr-9-535.PMC4968995.pdf
Available from: https://www.nice.org.uk/guidance/ipg85/documents/systematic-review-of-the-clinical-efficacy-and-safety-of-stereotactic-radiosurgery-gamma-knife-in-the-treatment-of-trigeminal-neuralgia2.,Non-OADS,/arxiv_data1/oa_pdf/19/ec/jpr-9-535.PMC4968995.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/19/ec/jpr-9-535.PMC4968995.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 542 Dai et al,Non-OADS,/arxiv_data1/oa_pdf/19/ec/jpr-9-535.PMC4968995.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Medicine reclassification processes and  regulations for proper use of over-the-counter  self-care medicines in Japan Kaori Nomura1 Yuki Kitagawa2 Yasukatsu Yuda2 Hiromi Takano-Ohmuro2 1Division of Molecular Epidemiology,   Jikei University School of Medicine,   2Faculty of Pharmacy, Musashino  University, Shinmachi, T okyo, Japan Correspondence: Hiromi Takano-Ohmuro   Faculty of Pharmacy, Musashino  University, 1-1-20 Shinmachi,   Nishitokyo-shi, T okyo 202-8585, Japan   T el +81 3 424 688 654   Fax +81 3 424 688 608   Email h_ohmuro@musashino-u.ac.j p;  hiromiohmuro@gmail.co mObjectives:  Japan has actively reclassified substances ranging from prescription drugs to  over-the-counter (OTC) drugs in recent years.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Health Education Service,  HED/84.1 Page 1., Copyright (1983), Available from http://apps.who.int/iris/bitstream/10665/70092/1/HED_84.1.pd f (Accessed June 20 2016);3 Adapted from The Role of the  Pharmacists in Self-Care and Self-Medication: Report of the 4th WHO Consultative Group on the Role of the Pharmacist .",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from:  http://apps.who.int/iris/bitstream/10665/65860/1/WHO_DAP_98.13.pd f. Accessed June 20 2016.;4 Adapted from Self-Care – A Real Choice , the UK Department of Health.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from: http://webarchive.nationalarchives.gov.uk/20130107105354/http:// www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/ digitalasset/dh_4101702.pd f. Accessed 20 June 2016.;5 Adapted from  Joining Up Self- Care in the NHS , Steering Group for the Joining Up Self Care Project, 2006.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from:  http://www.selfcareforum.org/wp-content/uploads/2011/07/JUSCFullReport.pd f. Accessed December 20, 2015;6 reprinted from Self-Care in the Context of Primary Health Care:  Report of the Regional Consultation Bangkok, Thailand, January 7–9, 2009 ; World Health Organization Regional Office for South-East Asia.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available  from: http://apps.searo.who.int/PDS_DOCS/B4301.pd f. Accessed June 20 2016;7 Adapted from the World Self Medication Industry (WSMI).,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.wsmi.org/wp-content/data/pdf/storyofselfcare_brochure.pd f. Accessed December 201 2015.8 Risk Management and Healthcare Policy 2016:9submit your manuscript | www.dovepress.co m Dove press Dove press 174Nomura et al,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: https://www.gov.uk/guidance/medicines-reclassify-your-produc t;29 adapted from  the Ministry of Internal Affairs and Communications.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from http://law.e-gov.go.jp/htmldata/ S35/S35HO145.htm l.32 Risk Management and Healthcare Policy 2016:9submit your manuscript | www.dovepress.co m Dove press Dove press 176Nomura et al,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from: http://www.mhra.gov.uk/home/groups/comms-ic/documents/publication/con213177.pd f. Accessed 5 July, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from: http://www.mhlw.go.jp/file/05-Shingikai-11121000-Iyakushokuhinkyoku-Soumuka/0000090067.pd f. Accessed July 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from:  http://www.mhlw.go.jp/file/05-Shingikai-11121000-Iyakushokuhinkyoku-Soumuka/0000090067.pd f. Accessed December 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from: https://d2cauhfh6h4x0p.cloudfront.net/ s3fs-public/global_health_and_aging.pd f. Accessed December 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from: https://www.kantei.go.jp/jp/ singi/keizaisaisei/pdf/en_saikou_jpn_hon.pd f. Accessed December 20,   2015.",OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from: http://apps.who.int/iris/ bitstream /10665/65860/1/WHO_DAP_98.13.pd f. Accessed July 5, 2015.",OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available  from: http://webarchive.nationalarchives.gov.uk/20130107105354/http:// www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/ documents/digitalasset/dh_4101702.pd f. Accessed 20 June 2016.,OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from: http://www.selfcareforum.org/ wp-content/uploads/2011/07/JUSCFullReport.pd f. Accessed December  20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Avail - able from: http://apps.searo.who.int/PDS_DOCS/B4301.pd f. Accessed  December 20, 2015.",OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from:  http://www.wsmi.org/wp-content/data/pdf/storyofselfcare_brochure.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available  from: http://www5.cao.go.jp/keizai-shimon/kaigi/cabinet/2014/2014_ basicpolicies_02.pd f. Accessed December 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.mhlw.go.jp/wp/hakusyo/ kousei/14 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
A vailable from:  http://apps.who.int/medicinedocs/en/d/Js2218e /.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available  from: http://www.mhlw.go.jp/english/wp/wp-hw4/dl/honbun/2_2_10.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/  kenkou_iryou/iyakuhin/ippanyou/index.html.,OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.mhlw.go.jp/shingi/2007/03/ txt/s0322-6.txt.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.mhlw.go.jp/stf/ shingi2/0000097160.html.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.jmari.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.plosone.org/article/ fetchObject.action?uri =info:doi/10.1371/journal.pone.0107726&   representation =PDF.,OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.mhlw.go.jp/stf/seisakunitsuite/ bunya/0000092787.html.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://wwwhourei.mhlw.go.jp/hourei /.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from: http://www.kegg.jp/kegg-bin/get_htext?br08312.ke g.  Accessed July 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available  from: http://www.kegg.jp/kegg/drug/br08314.html.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.pagb.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Available from:  https://www.gov.uk/government/uploads/system/uploads/ attachment_ data/file/277307/Legal_classification_changes.pd f. Accessed July  5,  2015.",OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.it-asso.com/gxp/eudralex_v27/  contents/vol-2/c/switchguide_160106.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.pharmacyregulation.org/ sites/default/files/guidance_for_registered_pharmacies_on_distance_ and_internet_services_.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from  http://law.e-gov.go.jp/htmldata/S35/S35HO145.htm l. Accessed 5 May  2016.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.mhlw.go.jp/file/06-Seisakujouhou- 11120000-Iyakushokuhinkyoku/sinseido.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.mhlw.go.jp/file/05-Shingikai- 11121000-Iyakushokuhinkyoku-Soumuka/0000089801.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.med.or.jp/ nichinews/n250120e.html.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: https://www.gov.uk/drug-safety-update/domperidone- no-longer-available-without-prescription.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: https://www.gov.uk/government/news/diclofenac- tablets-now-only-available-as-a-prescription-medicine.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Avail - able from: http://news.bbc.co.uk/2/hi/health/4072314.stm.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from:  http://www.takeda.co.jp/news/2011/20110221_4752.html.,OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.who.int/healthpromotion/ areas/gphpe/en /.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available  from: http://www.who.int/hia/evidence/doh/en /.,OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://www.mhlw.go.jp/seisakunitsuite/ bunya/kenkou_iryou/iryou/shinkou/dl/vision_2013b.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: https://www.yano.co.jp/ press/pdf/1312.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from:  http://www.oecd.org/els/health-systems/ReviewofHealthCareQuality - JAPAN_ExecutiveSummary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Available from: http://webarchive.nationalarchives.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
gov.uk/20141205150130/http://www.mhra.gov.uk/Howweregulate/ Medicines/ Licensingofmedicines/Legalstatusandreclassification/ Listsofsubstances/ index.htm.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/e0/rmhp-9-173.PMC4968996.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b8/39/ijn-11-3385.PMC4968997.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3385–3395International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3385OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10213 8 augmenting regional and targeted delivery in the  pulmonary acinus using magnetic particles  Yan Ostrovski Philipp hofemeier Josué sznitman Department of Biomedical  engineering, Technion – Israel Institute  of T echnology, haifa, IsraelBackground:  It has been hypothesized that by coupling magnetic particles to inhaled  therapeutics, the ability to target specific lung regions (eg, only acinar deposition), or even more  so specific points in the lung (eg, tumor targeting), can be substantially improved.",Non-OADS,/arxiv_data1/oa_pdf/b8/39/ijn-11-3385.PMC4968997.pdf
"Moreover, from a systemic delivery  perspective, it is the only available noninvasive delivery method for many drugs that  cannot be orally administered due to their degradation in the digestive system (eg,  proteins such as insulin).5–7 In past decades, there has been substantial progress in understanding respiratory  fluid dynamics and the transport of inhaled therapeutic aerosols,8 including the physical  (eg, aerodynamic) determinants affecting lung deposition outcomes.9 Nevertheless, the  ability to target either a specific pulmonary region (eg, alveolar region) or a localized  point within the airway tree (eg, lung tumors in the context of bronchogenic carci - noma) remains generally poor.10 Such a drawback leads to higher risks of side effects  and lower bioavailability, which translates into inexact delivered doses to the target correspondence: Josué sznitman Department of Biomedical engineering,  Technion – Israel Institute of Technology,  Julius Silver Building, Office 254, Haifa  32000, Israel Tel/fax +972 4 829 5678 email sznitman@bm.technion.ac.i l Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ostrovski et al Running head recto: Targeting the pulmonary acinus with magnetic particles DOI: http://dx.doi.org/10.2147/IJN.S102138",Non-OADS,/arxiv_data1/oa_pdf/b8/39/ijn-11-3385.PMC4968997.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b8/39/ijn-11-3385.PMC4968997.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/39/ijn-11-3385.PMC4968997.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/41/9b/opth-10-1351.PMC4969041.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1351–1356Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1351Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10845 6 intraocular pressure dynamics with prostaglandin  analogs: a clinical application of the water- drinking test Pelin Özyol1 erhan Özyol1 ercan Baldemir2 1Ophthalmology Department,   2Biostatistics Department, Faculty  of Medicine, Mugla sitki Kocman  University, Mugla, T urkeyAim:  To evaluate the clinical applicability of the water-drinking test in treatment-naive primary  open-angle glaucoma patients.",Non-OADS,/arxiv_data1/oa_pdf/41/9b/opth-10-1351.PMC4969041.pdf
"The ability of the eye to recover from a transient rise of IOP Correspondence: Pelin Özyol Mug ˘la Sıtkı Koçman Üniversitesi Eg ˘itim  ve Araştırma Hastanesi Göz Hastalıkları  Klinig ˘i, 48000, Menteşe, Mugla, Turkey Tel +90 506 397 6465 email pelingesoglu@yahoo.com.t r Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Özyol et al Running head recto: Clinical application of the water-drinking test DOI: http://dx.doi.org/10.2147/OPTH.S108456",Non-OADS,/arxiv_data1/oa_pdf/41/9b/opth-10-1351.PMC4969041.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/41/9b/opth-10-1351.PMC4969041.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/9b/opth-10-1351.PMC4969041.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/42/e3/opth-10-1357.PMC4969042.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1357–1364Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1357Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10824 3 Comparative evaluation of femtosecond laser- assisted cataract surgery and conventional  phacoemulsification in white cataract Jeewan s Titiyal Manpreet Kaur archita singh Tarun arora namrata sharma Cornea, Cataract & refractive  surgery services, Dr rajendra  Prasad  Centre for Ophthalmic  sciences, all india institute of  Medical sciences, new Delhi, indiaPurpose:  To compare femtosecond laser-assisted capsulotomy with conventional manual  capsulorhexis in cases of white cataract.",Non-OADS,/arxiv_data1/oa_pdf/42/e3/opth-10-1357.PMC4969042.pdf
"Keywords:  femtosecond laser-assisted cataract surgery, white cataract, conventional  phacoemulsification, capsulorhexis Introduction Femtosecond laser-assisted cataract surgery (FLACS) is superior to conventional  phacoemulsification in terms of precise wound construction, capsulotomy, intraocular  lens (IOL) centration, and decreased effective phacoemulsification time.1–4 FLACS is  comparable to traditional cataract surgery in terms of intraoperative complications,  although further research is needed to evaluate its long-term safety aspects.5–7 It may  be especially advantageous in white cataracts, where achieving an adequately sized  continuous curvilinear capsulorhexis is the major surgical challenge.Correspondence: Jeewan s Titiyal Cornea, Cataract and refractive surgery  services, Dr rajendra Prasad Centre for  Ophthalmic sciences, all india institute  of Medical sciences, ansari nagar,  new Delhi 110029, india Tel +91 11 2659 3146 email titiyal@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Titiyal et al Running head recto: FLACS in white cataract DOI: http://dx.doi.org/10.2147/OPTH.S108243",Non-OADS,/arxiv_data1/oa_pdf/42/e3/opth-10-1357.PMC4969042.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/42/e3/opth-10-1357.PMC4969042.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/e3/opth-10-1357.PMC4969042.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/68/opth-10-1365.PMC4969043.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1365–1373Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1365Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S9371 4 Advantages, limitations, and diagnostic accuracy of  photoscreeners in early detection of amblyopia:  a review irene Sanchez1,2 Sara Ortiz-T oquero1,2 Raul Martin2,3 victoria de Juan2,4 1Department of Theoretical Physics,   Atomic and Optics, School of  Optometry, 2Optometry Research  Group, iOBA-eye institute, University  of valladolid, valladolid, Spain; 3Faculty  of Health and Human Sciences,   Plymouth University, Plymouth, UK;   4Department of Ophthalmology,   Hospital Ramón y Cajal, Madrid, SpainAbstract:  Amblyopia detection is important to ensure proper visual development and avoid  permanent decrease of visual acuity.",Non-OADS,/arxiv_data1/oa_pdf/7e/68/opth-10-1365.PMC4969043.pdf
"However, small strabismus or micro-strabismus  is not easily detected by non-health care professionals (family, parents, or teachers  at the kindergarten).Correspondence: victoria de Juan Department of Ophthalmology, Hospital  Ramón y Cajal, Carretera de Colmenar  viejo, km 9.100, 28034 Madrid, Spain Tel +34 983 18 4853 email victoriadejuanryc@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Sanchez et al Running head recto: Advantages and limitations of photoscreeners in amblyopia screening DOI: http://dx.doi.org/10.2147/OPTH.S93714",Non-OADS,/arxiv_data1/oa_pdf/7e/68/opth-10-1365.PMC4969043.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7e/68/opth-10-1365.PMC4969043.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/68/opth-10-1365.PMC4969043.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/55/42/opth-10-1343.PMC4969044.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1343–1349Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1343Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10661 1 a mathematical approach to human pterygium  shape Bojan Pajic1–4 iraklis Vastardis1 Predrag rajkovic5 Brigitte Pajic-eggspuehler1 Daniel M aebersold6 Zeljka Cvejic2 1eye Clinic Orasis, swiss eye  research Foundation, reinach ag,   switzerland; 2Department of Physics,   Faculty of sciences, University of novi  sad, novi sad,3Faculty of Medicine  of the Military Medical academy,   University of Defence, Belgrade,   serbia; 4Division of Ophthalmology,   Department of Clinical  neurosciences, geneva University  hospitals, geneva, switzerland;   5Department of Mathematics, Faculty  of Mechanical engineering, University  of niš, niš, serbia; 6Department of  radiation Oncology, inselspital, Bern  University hospital, Bern, switzerlandPurpose:  Pterygium is a common lesion affecting the population in countries with high levels  of ultraviolet exposure.",Non-OADS,/arxiv_data1/oa_pdf/55/42/opth-10-1343.PMC4969044.pdf
"They are also smaller Correspondence: Bojan Pajic swiss eye research Foundation,  eye Clinic Orasis, Titlisstrasse 44,  5734 reinach, switzerland Tel +41 627 656 080 email bpajic@datacomm.c h Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Pajic et al Running head recto: Mathematical calculation of human pterygium shape DOI: http://dx.doi.org/10.2147/OPTH.S106611",Non-OADS,/arxiv_data1/oa_pdf/55/42/opth-10-1343.PMC4969044.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/55/42/opth-10-1343.PMC4969044.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/42/opth-10-1343.PMC4969044.pdf
Available at: http://apps.who.int/iris/bitstream/10665/70904/1/WHO_HIV_2012.12_eng.pdf.,OADS,/arxiv_data1/oa_pdf/04/85/qai-72-s207.PMC4969053.pdf
"METHODS Counts of Visible Injuries in Crashes We used crash data from 1995 to 2012 from 43 states  to obtain counts of injuries (et able, http://links.lww.com/ eDe/B55, which presents crash data year and graduated driver licensing status by state).",OADS,/arxiv_data1/oa_pdf/04/a1/ede-27-620.PMC4969054.pdf
"two  states (indiana and Wyoming) did not adopt graduated driver licensing during the study period (et able, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/04/a1/ede-27-620.PMC4969054.pdf
"of   InjuriescRate Per 100,000  Person-yeardCrude Rate Ratio Per   Quarter-person-year (95% CI)Adjusted Rate Ratio Per   Quarter-person-year (95% CI)e passenger 16 Absent 79,721 531 present 111,898 291 0.55 (0.54, 0.55) 0.93 (0.89, 0.97) 17 Absent 73,309 514 present 118,796 308 0.60 (0.59, 0.60) 1.02 (0.97, 1.07) Bus rider 16 Absent 682 5 present 1,251 3 0.72 (0.65, 0.79) 0.99 (0.75, 1.32) 17 Absent 550 4 present 1,043 3 0.74 (0.67, 0.82) 1.03 (0.77, 1.37) Bicyclist 16 Absent 4,019 27 present 9,599 25 0.93 (0.90, 0.97) 0.97 (0.90, 1.04) 17 Absent 3,229 22 present 7,961 21 0.96 (0.92, 1.00) 0.99 (0.92, 1.07) pedestrian 16 Absent 5,217 35 present 13,029 34 0.97 (0.94, 1.01) 0.99 (0.92, 1.06) 17 Absent 4,701 31 present 12,056 31 1.00 (0.97, 1.03) 1.01 (0.96, 1.07) Driver 16 Absent 105,139 700 present 136,486 355 0.51 (0.50, 0.51) 0.87 (0.83, 0.92) 17 Absent 126,720 843 present 197,257 511 0.61 (0.60, 0.61) 1.05 (0.98, 1.12) All 16 Absent 194,778 1,298 present 272,263 707 0.54 (0.54, 0.55) 0.90 (0.87, 0.93) 17 Absent 212,509 1,414 present 337,113 874 0.62 (0.61, 0.62) 1.03 (0.98, 1.08) aData from the p olice Crash reports from 1995 to 2012 from 43 states (see et able, http://links.lww.com/eDe/B55, which presents crash data year and graduated driver licensing  status by state).",Non-OADS,/arxiv_data1/oa_pdf/04/a1/ede-27-620.PMC4969054.pdf
Available at: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/04/a1/ede-27-620.PMC4969054.pdf
Available at: http://www.iihs.org/media/028244c2-87b1-4108-8122-c055877ea5da/-1425338212/Laws/gdl_effective_dates.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/a1/ede-27-620.PMC4969054.pdf
Available  at: http://www.nhtsa.gov/Data/State+Data+programs/SDS+overview.,OADS,/arxiv_data1/oa_pdf/04/a1/ede-27-620.PMC4969054.pdf
Available at: http://www.census.,OADS,/arxiv_data1/oa_pdf/04/a1/ede-27-620.PMC4969054.pdf
Available at: http://www.bea.gov/it able/it able.cfm?reqid=70&step=1 &isuri=1&acrdn=3#reqid=70&step=1&isuri=1.,OADS,/arxiv_data1/oa_pdf/04/a1/ede-27-620.PMC4969054.pdf
Available at:  http://www.bls.gov/cpi/#tables.,OADS,/arxiv_data1/oa_pdf/04/a1/ede-27-620.PMC4969054.pdf
Available  at: http://www.eia.gov/state/seds/seds-data-complete.cfm?sid=AL%20 -%20pricesexpenditures.,OADS,/arxiv_data1/oa_pdf/04/a1/ede-27-620.PMC4969054.pdf
"Khush et al.15figure 2B prospective  cohortfecal indicator bacteria in  drinking waterreported diarrhea exposure measured  concurrently with outcome could be influenced by the outcome itselfoutcome (N Y) Cough, congestion/coryza the eAppendix (http://links.lww.com/eDe/B56) includes a more detailed discussion of each example.",Non-OADS,/arxiv_data1/oa_pdf/55/b9/ede-27-637.PMC4969055.pdf
"Negative controls often lack specific-ity in the type of bias that they detect—many examples in the table illustrate this limitation (Discussion in the eAppendix, http://links.lww.com/eDe/B56).",Non-OADS,/arxiv_data1/oa_pdf/55/b9/ede-27-637.PMC4969055.pdf
The Gene Set Enrichment Analysis ( http://www.broadinstitute.org/tools/software.html .,Non-OADS,/arxiv_data1/oa_pdf/f7/17/cad-27-756.PMC4969056.pdf
"western blotting methods (Supplementary material 1, Supplemental digital content 1, http://links.lww.com/ACD/ A163 ).",Non-OADS,/arxiv_data1/oa_pdf/f7/17/cad-27-756.PMC4969056.pdf
Available at: http://www.cdc.gov/hiv/group/gender/ transgender/.,Non-OADS,/arxiv_data1/oa_pdf/c4/b9/qai-72-s220.PMC4969058.pdf
"Gender Variance in the UK: Prevalence, Incidence, Growth, and Geographic Distribution ; Available at: http://www.gires.",Non-OADS,/arxiv_data1/oa_pdf/3b/8b/qai-72-s210.PMC4969059.pdf
"Available at: http://hab.hrsa.gov/data/servicesdelivered/2014RWHAPDataReport.pdf.Accessed 20 March, 2016.11.",OADS,/arxiv_data1/oa_pdf/3b/8b/qai-72-s210.PMC4969059.pdf
"Richmond, Virgina:Virginia department of health; Avail able at: https://www.vdh.virginia.",Non-OADS,/arxiv_data1/oa_pdf/3b/8b/qai-72-s210.PMC4969059.pdf
Available at: http://www.theguardian.com/world/2015/mar/24/sweden-adds-gender-neutral-pronoun-to-dictionary.,Non-OADS,/arxiv_data1/oa_pdf/5f/8d/qai-72-s235.PMC4969060.pdf
Available at: http://www.californiaaidsresearch.org/ ﬁles/chrp-press-releases/prep-for-transgender- persons-april-2016.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/5a/qai-72-s226.PMC4969062.pdf
Available at: http://www.fa ﬁch.ufmg.br/ nuh/index.php/item/163-preparadas-mulheres-transexuais-e-travestis-sao- alvo-de-pesquisa-sobre-prep-no-brasil/163-preparadas-mulheres-transex- uais-e-travestis-sao-alvo-de-pesquisa-sobre-prep-no-brasil.,Non-OADS,/arxiv_data1/oa_pdf/af/5a/qai-72-s226.PMC4969062.pdf
"For details of the search strategies devel-oped for each database, see eAppendix 1 (http://links.lww.com/eDe/B6).",OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
"Data were extracted in a summary table (see eAppendices 2 and 3; http://links.lww.com/eDe/B6) which included publication details (year, authors, location); flight characteristics (flight origin and destination, flight duration,  aircraft type, ground delays, information on ventilation sys- tem); details on the index case(s) (number, age, gender, coun-try of residence or nationality, seating, symptoms during the flight, pathogen/strain found, laboratory confirmation of diag- nosis); study type and details on contact tracing (definition  of contact, contact tracing strategy, methods used to identify contacts, methods used for contacting contacts, total number of contacts identified, total number of successfully traced con- tacts, seating of contacts in relation to index case); exposure  of primary and secondary cases (before, during, and after flight); conclusion on disease transmission (number of cases/number of contacted passengers, and/or crew excluding index cases), and intervention.",OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
"9–11,23–35 An  overview of the extracted data and a summary of the main  characteristics and limitations of each study are presented in  eAppendices 2 and 3 (http://links.lww.com/eDe/B6).",Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
"Flights Details the total number of flights investigated (n = 23) exceeded  the number of articles reviewed, because five studies referred  to multiple or stop-over flights (eAppendix 2; http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
Study Types and Contact Tracing All investigations described retrospective follow-up  of passengers after identifying one or more index cases with influenza or symptoms of influenza-like illness aboard aircraft (eAppendices 2 and 3; http://links.lww.com/eDe/B6).,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
"Cases in   2 Rows Shankar23a277 43 16 1 5 12 1 20 1 5 1 20 Y oung24a278 239 86 6 10 4 5 50 Zhang26, flight 1 274 82 30 1 9 11 8 89 1 9 8 89 Zhang26, flight 2 144 140 97 1 0 0 0 na 1 0 0 na Neatherlin27265 159 60 1 8 5 Neatherlin27167 133 80 1 7 5 3 43 catala28165 74 45 6 4 5 4 100 6 4 4 100 Foxwell29, flight 1 445 188 42 10 24 13 9 38 4 2 2 100 Foxwell29, flight 2 293 131 45 3 6 5 4 67 0 1 1 100 Ooi30596 26 4 1 5 19 2 40 1 5 2 40 Kim31338 199 59 1 1 1 0 0 1 1 0 0 Baker32379 121 32 11 2 2 2 100 9 2 2 100 Han33, flight 1 91 91 100 1 0 0 0 na 1 0 0 na Han33, flight 2 87 87 100 1 0 0 0 na 1 0 0 na Han33, flight 3 87 87 100 2 1 1 1 100 2 1 1 100 Bin35141 141 100 1 0 0 0 na 1 0 0 na Marsden1075 75 100 1 20 27 9 45 Klontz11, flight 1 44 44 100 8 18 41 18 100 Klontz11, flight 2 46 46 100 3 5 11 2 40 Moser960 59 98 1 38 64 total 4,252 2,165 51 61 163 8 68 42 27 30 21 70 For details, see eAppendix 2 (http://links.lww.com/eDe/B6).",Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
10 Different index case definitions were applied in the  studies based on (1) influenza-like illness or respiratory symp-toms; (2) clinical (respiratory) symptoms and PcR confirma-tion; (3) clinical (respiratory) symptoms and positive culture;  or (4) symptoms and positive serology (eAppendix 3; http://links.lww.com/eDe/B6).,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
"11,24,28,29,32 On Board Transmission, Seating Proximity, and  Attack Rate Four studies did not clearly describe the number of  infected passengers and attack rates, mixing symptomatic  and confirmed secondary cases.10,24,27,29 two studies reported  evidence that transmission of influenza did not occur during flight (eAppendix 2; http://links.lww.com/eDe/B6).",Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
"Intervention After Contact Tracing Nine of the 14 studies described an intervention following  contact tracing (eAppendix 3; http://links.lww.com/eDe/B6): antiviral treatment and isolation (n = 5), only isolation of symp- tomatic cases or all passengers (n = 3), and assessment of the  need for antiviral medication (n = 1).",Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
Available at: http://epp.eurostat.ec.europa.eu/portal/page/ portal/transport/data/main_tables.,OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
Available  at: https://www.faa.gov/data_research/aviation/taf/media/taf_summary_ fy2014-2040.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
Available at: http://www.ecdc.europa.eu/en/publications/Publications/ influenza-RAGiDA-2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
Available at: http://ecdc.europa.eu/en/publications/Publications/0911_GUi_Risk_Assessment_Guidelines_for_Diseases_ transmitted_on_Aircraft.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
Available at: http://www.who.int/tb/publications/2008/ wHO_HtM_tB_2008.399_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
Available at: http://www.who.int/ith/mode_of_travel/tcd_air - craft/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/ede-27-743.PMC4969063.pdf
Available at: http://www.unaids.org/ sites/default/ ﬁles/media_asset/UNAIDS_Gap_report_en.pdf.,OADS,/arxiv_data1/oa_pdf/9d/81/qai-72-s252.PMC4969064.pdf
Available at: http://www.esrc.ac.uk/ ﬁles/funding/guidance-for-applicants/esrc-framework-for-research-ethics- 2015/.,Non-OADS,/arxiv_data1/oa_pdf/9d/81/qai-72-s252.PMC4969064.pdf
Available at: http://www.wma.net/en/30publications/10policies/b3/.,Non-OADS,/arxiv_data1/oa_pdf/9d/81/qai-72-s252.PMC4969064.pdf
Available at: http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/81/qai-72-s252.PMC4969064.pdf
Available at: http://digitalcommons.law.yale.,Non-OADS,/arxiv_data1/oa_pdf/9d/81/qai-72-s252.PMC4969064.pdf
"1a –h, Supple- mental digital content 1, http://links.lww.com/MCA/A74 ).",Non-OADS,/arxiv_data1/oa_pdf/32/4f/mca-27-449.PMC4969065.pdf
Available at: https://www.nap.edu/read/13128/chapter/1.,Non-OADS,/arxiv_data1/oa_pdf/21/2c/qai-72-s243.PMC4969066.pdf
Available at: http://transhealth.ucsf.edu/pdf/data-recommendation.pdf.,Non-OADS,/arxiv_data1/oa_pdf/21/2c/qai-72-s243.PMC4969066.pdf
Available at: http://www.avac.,Non-OADS,/arxiv_data1/oa_pdf/21/2c/qai-72-s243.PMC4969066.pdf
Available at: https://www.atnonline.org/public/TransYouthRes.asp.,Non-OADS,/arxiv_data1/oa_pdf/21/2c/qai-72-s243.PMC4969066.pdf
Available at: https://www.atnonline.org/public/default.asp.,Non-OADS,/arxiv_data1/oa_pdf/21/2c/qai-72-s243.PMC4969066.pdf
doi:  http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/be/gastnu-39-287.PMC4969068.pdf
Retrieved from   http://www.danskepatienter.dk/sites/danskepatienter.dk/ﬁ  les/ patientrepr%C3%A6sentation%20021109.pdf    Limitations   This study is limited by its retrospective design.,Non-OADS,/arxiv_data1/oa_pdf/31/be/gastnu-39-287.PMC4969068.pdf
"Retrieved  from  http://www.sykepleien.no/Content/337889/SSNs%20 etiske%20retningslinjer.pdf         Olsen  ,   P. R.  ,     &   Harder  ,   I.",OADS,/arxiv_data1/oa_pdf/31/be/gastnu-39-287.PMC4969068.pdf
"Retrieved from   http://www.internationalproject-ipc.com/_downloads/Focus_ on_Qualitative_Methods_Interviewing_Children.pdf         Fallon  ,   S.  ,     Smith  ,   J.  ,     Morgan  ,   S.  ,     Stoner  ,   M.  ,     &   Austin  ,   C.    ( 2008 ).",Non-OADS,/arxiv_data1/oa_pdf/31/be/gastnu-39-287.PMC4969068.pdf
"Retrieved from  http://ww2.lakartidningen.se/store/articlepdf/1/ 18102/LKT1216s817_820.pdf         van der Zaag-Loonen  ,   H. J.  ,     Grootenhuis  ,   M. A.  ,     Last  ,   B. F.  ,     &    Derkx  ,   H. H.    ( 2004 ).",Non-OADS,/arxiv_data1/oa_pdf/31/be/gastnu-39-287.PMC4969068.pdf
"Retrieved from  http://www.rch.org.au/uploadedFiles/ Main/Content/cah/2012%20Adolscent%20Report.pdf         Stern  ,   D.    ( 2004 ).",OADS,/arxiv_data1/oa_pdf/31/be/gastnu-39-287.PMC4969068.pdf
"Nursing Assessment Tool for People With Liver Cirrhosis 272 Copyright © 2016 Society of Gastroenterology Nurses and Associates Gastroenterology Nursing2014, from  http://revistas.um.es/eglobal/article/viewFile/eglobal .11.3.155221/136401         Horta  ,   W. A.",Non-OADS,/arxiv_data1/oa_pdf/df/20/gastnu-39-264.PMC4969069.pdf
"Retrieved  October 3, 2013, from  http://www.nursingworld.org/EspeciallyFor You/What-is-Nursing/Tools-You-Need/Thenursingprocess.html         Werner  ,   K. T.  ,     &   Perez  ,   S. T.    ( 2012 ).",Non-OADS,/arxiv_data1/oa_pdf/df/20/gastnu-39-264.PMC4969069.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/f6/main.PMC4969086.pdf
http://dx.doi.org/10.1016/j.idcr.2016.07.003 2214-2509/ ã2016 The Authors.,OADS,/arxiv_data1/oa_pdf/b3/f6/main.PMC4969086.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases 5 (2016) 46 –48 Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/b3/f6/main.PMC4969086.pdf
"Int J Infect Dis IJID Off Publ Int Soc Infect Dis 2016, doi:http://dx.doi.org/10.1016/j.ijid.2016.02.014 .",OADS,/arxiv_data1/oa_pdf/b3/f6/main.PMC4969086.pdf
"Handchir Mikrochir Plast Chir Organ Deutschsprachigen Arbeitsgemeinschaft Handchir Organ Deutschsprachigen Arbeitsgemeinschaft Mikrochir Peripher Nerven Gefasse Organ V 2015, doi:http://dx.doi.org/10.1055/s-0035-1549942 .",Non-OADS,/arxiv_data1/oa_pdf/b3/f6/main.PMC4969086.pdf
"J Med Microbiol 2011;60:492 –9, doi:http://dx.doi.org/10.1099/ jmm.0.020768-0 .",Non-OADS,/arxiv_data1/oa_pdf/b3/f6/main.PMC4969086.pdf
"Ann Saudi Med 2011;31:93 – 4, doi:http://dx.doi.org/10.4103/0256-4947.75794 .",Non-OADS,/arxiv_data1/oa_pdf/b3/f6/main.PMC4969086.pdf
"Am J Infect Control 2012;40:854 –9, doi: http://dx.doi.org/10.1016/j.ajic.2011.10.009 .",OADS,/arxiv_data1/oa_pdf/b3/f6/main.PMC4969086.pdf
This  is  an  open access article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/09/main.PMC4969087.pdf
"In  our  case,  the http://dx.doi.org/10.1016/j.ijscr.2016.07.024 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/35/09/main.PMC4969087.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/2f/main.PMC4969088.pdf
A  primary  diagnosis  of  MO  was  made  based on  the  clinical  history  and  imaging  ﬁndings  and  after  a  discussion http://dx.doi.org/10.1016/j.ijscr.2016.07.005 2210-2612/© 2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/41/2f/main.PMC4969088.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/f9/main.PMC4969089.pdf
"Case  report We  decided  to  adopt  this  technique  in  order  to  early  detect  and treat  an  intestinal  ischemia  in  a  68-year-old  patient,  previously http://dx.doi.org/10.1016/j.ijscr.2016.07.016 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/d7/f9/main.PMC4969089.pdf
"Acknowledgement Prof. Maria  Rosaria  Buri,  Professional  Translator/Aiic  Confer- ence  Interpreter,  University  of  Salento,  for  English  language  editing (http://www.mariarosariaburi.it ).",Non-OADS,/arxiv_data1/oa_pdf/d7/f9/main.PMC4969089.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 681–689 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.07.002 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/2b/ed/main.PMC4969090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/ed/main.PMC4969090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/ed/main.PMC4969090.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.jare.2016.",OADS,/arxiv_data1/oa_pdf/2b/ed/main.PMC4969090.pdf
"The 10 leading causes of death in the world, 2000 and 2012. http://www.who.int/mediacentre/ factsheets/fs310/en/ 2.",Non-OADS,/arxiv_data1/oa_pdf/a9/f8/nihms796170.PMC4969105.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.06.011,Non-OADS,/arxiv_data1/oa_pdf/da/ee/main.PMC4969209.pdf
MALDI-TOF MS spectrum accession number The MALDI-TOF MS spectrum of “Varibaculum massiliense ”strain Marseille-P2802Tis available online ( http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/da/ee/main.PMC4969209.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,13,7 5 –76 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/da/ee/main.PMC4969209.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Wolf –Hirschhorn syndrome EpilepsyWest syndrome Spasm Lamotrigine 1.,Non-OADS,/arxiv_data1/oa_pdf/29/a9/main.PMC4969236.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.07.001 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/29/a9/main.PMC4969236.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/a9/main.PMC4969236.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/a1/main.PMC4969238.pdf
http://dx.doi.org/10.1016/j.ejro.2016.05.006 2352-0477/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/88/a1/main.PMC4969238.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/a1/main.PMC4969238.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c7/28/main.PMC4969240.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.05.008 287,OADS,/arxiv_data1/oa_pdf/c7/28/main.PMC4969240.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 671–679 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.07.001 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/05/7e/main.PMC4969241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/7e/main.PMC4969241.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/05/7e/main.PMC4969241.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Pseudo-LennoxESES Focal epilepsy SCN9ACPA6SCNM1 1.,Non-OADS,/arxiv_data1/oa_pdf/f0/19/main.PMC4969243.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.04.003 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/19/main.PMC4969243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/19/main.PMC4969243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/98/02/main.PMC4969256.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.06.002 294,OADS,/arxiv_data1/oa_pdf/98/02/main.PMC4969256.pdf
BMJ Case Rep. 2015; http://dx.doi.org/10.1136/bcr-2014 e209020 .,Non-OADS,/arxiv_data1/oa_pdf/98/02/main.PMC4969256.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/8b/main.PMC4969257.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.06.004 290,OADS,/arxiv_data1/oa_pdf/1e/8b/main.PMC4969257.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Metabolomic pro ﬁling ADSL de ﬁciency Intellectual disabilitySuccinyladenosine 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/a0/main.PMC4969260.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: www.elsevier.com/locate/ymgmr http://dx.doi.org/10.1016/j.ymgmr.2016.07.007 2214-4269/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/6b/a0/main.PMC4969260.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/a0/main.PMC4969260.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/da/main.PMC4969261.pdf
"This activated form of Notch translocates to the nucleus where it binds to the CSL protein (also known as RBPJ, an important nuclear mediator ofNotch signaling that is similar to the DNA-binding protein found inContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/rinimResults in Immunology http://dx.doi.org/10.1016/j.rinim.2016.04.001 2211-2839/ &2016 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/06/da/main.PMC4969261.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/da/main.PMC4969261.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/32/main.PMC4969262.pdf
"In animal cells, miRNAs regulate their targets by translational inhibition and mRNA destabilization [18], and may also play a role in the stressContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/rinimResults in Immunology http://dx.doi.org/10.1016/j.rinim.2016.03.001 2211-2839/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/68/32/main.PMC4969262.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/32/main.PMC4969262.pdf
"All assembled transcripts were compared with publicly avail- able databases including Nr (NCBI non-redundant protein sequences), KOG/COG (Clusters of Orthologous Groups of proteins)[29], Swiss-Prot (a manually annotated and reviewed protein sequence database) [30], KO (KEGG ortholog database) [31], Pfam (protein family) [32] and GO (Gene Ontology) ( http://www.gen eontology.",OADS,/arxiv_data1/oa_pdf/68/32/main.PMC4969262.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.rinim.2016.03.001 .,OADS,/arxiv_data1/oa_pdf/68/32/main.PMC4969262.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ca/aa/main.PMC4969263.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.05.017 284,OADS,/arxiv_data1/oa_pdf/ca/aa/main.PMC4969263.pdf
Available online 28 February 2016; http://dx.doi.org/10.1016/j.simyco.2016.02.001 .,OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 83: 1 –18.,Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"1Studies in Mycology Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
De novo assembly was carried out with the Trinity short reads assembling program ( http://trinityrnaseq.sourceforge.net/ )LIET AL .,OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"2 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
The KEGG data- base contains a systematic analysis of intracellular metabolic pathways and functions and enhances pathway annotation of unigenes (Path- ﬁnder; http://www.genome.jp/ )(Kanehisa et al.,OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"The hyper-geometric tests used for signi ﬁcantly enriched GO terms in DEGs comparing to the genome background (D), Nis the number of all genes with GO annotation, nis the number of DEGs in N,Mis the number of all genes that are annotated to the certain GO terms, and mis the number of DEGs in M.MELANIN PATHWAYS IN FONSECAEA www.studiesinmycology.org 3 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"4 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"Distinct singletons represents the Unigenes come from a single gene.MELANIN PATHWAYS IN FONSECAEA www.studiesinmycology.org 5 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"6 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"Most consensus sequences were grouped into three major functional categories, namely biological process, cellular component, and molecular function.MELANIN PATHWAYS IN FONSECAEA www.studiesinmycology.org 7 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"8 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"The type strain of F. monophora (CBS 269.37) was used as the control.MELANIN PATHWAYS IN FONSECAEA www.studiesinmycology.org 9 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"10 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"The X-axis is the selected unigenes, Y-axis is the va lue of log2 ratio; positive value means up-regulation in albino strain compare with parent strain.MELANIN PATHWAYS IN FONSECAEA www.studiesinmycology.org 11 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"12 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"DOPA melanin production of both strains cultured on PDA medium contained DOPA (25 mg/L) and L-tyrosine (25 mg/L), respectively (D).MELANIN PATHWAYS IN FONSECAEA www.studiesinmycology.org 13 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"14 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"The exposure of the glycoprotein lay er (β-1,3-glucan) on the albino cell wall promote the host immunological response, while the melanin, α-1,3-glucan probably hides the β-1,3-glucan antigens, and results in chronic immune response of host cell.MELANIN PATHWAYS IN FONSECAEA www.studiesinmycology.org 15 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"16 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"FEMS Microbiology Letters 232: 203 –209.MELANIN PATHWAYS IN FONSECAEA www.studiesinmycology.org 17 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
"18 Please cite this article in press as: Li XQ, et al., The role of melanin pathways in extremotolerance and virulence of Fonsecaea revealed by de novo assembly transcriptomics using illumina paired-end sequencing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.02.001",Non-OADS,/arxiv_data1/oa_pdf/22/63/main.PMC4969264.pdf
Available online 1 July 2016; http://dx.doi.org/10.1016/j.simyco.2016.06.002 .,OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
This is an open access article under the CC BY-NC-ND li cense ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 83: 19 –48.,Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"19Studies in Mycology Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"20 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"graminis CPC 26068, CBS 141379T USA Oryza sativa KX306562 KX306492 KX306627 KX306694 (continued on next page )TAKE-ALL OR NOTHING www.studiesinmycology.org 21 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"22 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"tritici CPC 26277 UK Elymus repens (couch grass) KX306607 KX306537 KX306665 KX306740 (continued on next page )TAKE-ALL OR NOTHING www.studiesinmycology.org 23 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"24 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"The identity of some isolates could not be resolved in theTAKE-ALL OR NOTHING www.studiesinmycology.org 25 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"26 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"The tree was rooted with Pyricularia grisea (BR0029 and CR0024).TAKE-ALL OR NOTHING www.studiesinmycology.org 27 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"28 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"The tree was rooted with Falciphora oryzae (CBS 125863) and Pseudophialophora eragrostis (CM19M9).TAKE-ALL OR NOTHING www.studiesinmycology.org 29 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"30 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"Scale bars: A –H=1 0 μm.TAKE-ALL OR NOTHING www.studiesinmycology.org 31 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"32 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"On OA reaching 90 mm diam, cottony-funiculose,moderate, colourless.TAKE-ALL OR NOTHING www.studiesinmycology.org 33 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"34 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"Scale bars: A –L=1 0 μm.TAKE-ALL OR NOTHING www.studiesinmycology.org 35 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"36 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"Scale bars: A –E=1 0 μm.TAKE-ALL OR NOTHING www.studiesinmycology.org 37 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"38 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"Scale bars: A –D=1 0 μm.TAKE-ALL OR NOTHING www.studiesinmycology.org 39 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"40 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"Hyphopodia if present lobed, brown, 19 –45 × 15.5 –36μm diam.TAKE-ALL OR NOTHING www.studiesinmycology.org 41 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"42 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"Scale bars: A –C=5 0 μm; D –I=2 0 μm, J –V=1 0 μm.TAKE-ALL OR NOTHING www.studiesinmycology.org 43 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"44 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"Scale bars: A –E=1 0 μm.TAKE-ALL OR NOTHING www.studiesinmycology.org 45 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"46 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"Persoonia 36:5 7 –82.TAKE-ALL OR NOTHING www.studiesinmycology.org 47 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
"48 Please cite this article in press as: Hern /C19andez-Restrepo M, et al., Take-all or nothing, Studies in Mycology (2016), http://dx.doi.org/10.1016/j.simyco.2016.06.002",Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC4969266.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/e6/main.PMC4969268.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.11.003 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/c1/e6/main.PMC4969268.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 124 e131,Non-OADS,/arxiv_data1/oa_pdf/c1/e6/main.PMC4969268.pdf
Available from: http://mohfw.nic.in/ WriteReadData/l892s/18048892912105179110National%20Health%20policy-2002.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c1/e6/main.PMC4969268.pdf
Available from: http://www.mohfw.nic.in/ [accessed 24.09.15].,Non-OADS,/arxiv_data1/oa_pdf/c1/e6/main.PMC4969268.pdf
"Ministry of Health and Family Welfare, Available from: http://www.nrhm.gov.",Non-OADS,/arxiv_data1/oa_pdf/c1/e6/main.PMC4969268.pdf
Available from: https://www.nrhm-mis.nic.in/hmisreports/frmstandard_reports.aspx [accessed 04.10.15].,OADS,/arxiv_data1/oa_pdf/c1/e6/main.PMC4969268.pdf
Available from: http://www.indianmedicine.nic.in/ writereaddata/linkimages/1997031657-Orissa.pdf [accessed 24.09.15].,Non-OADS,/arxiv_data1/oa_pdf/c1/e6/main.PMC4969268.pdf
Available from: http://www.indianmedicine.nic.,Non-OADS,/arxiv_data1/oa_pdf/c1/e6/main.PMC4969268.pdf
Available from: http://www.planningcommission.nic.in/reports/ wrkpapers/wrkp_1_09.pdf [accessed 24.09.15].,Non-OADS,/arxiv_data1/oa_pdf/c1/e6/main.PMC4969268.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: fMRIResting stateFunctional connectivityObesityAdolescents 1.,Non-OADS,/arxiv_data1/oa_pdf/97/90/main.PMC4969269.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.005 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/97/90/main.PMC4969269.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/90/main.PMC4969269.pdf
Psychiatry http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/97/90/main.PMC4969269.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/79/main.PMC4969270.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.06.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/e0/79/main.PMC4969270.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 76 e77,Non-OADS,/arxiv_data1/oa_pdf/e0/79/main.PMC4969270.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/1e/main.PMC4969271.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.05.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/87/1e/main.PMC4969271.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 119 e123,Non-OADS,/arxiv_data1/oa_pdf/87/1e/main.PMC4969271.pdf
"Available from:, http://www.r-project.org/ .",Non-OADS,/arxiv_data1/oa_pdf/87/1e/main.PMC4969271.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/3f/main.PMC4969272.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.08.003 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/62/3f/main.PMC4969272.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 100 e108,Non-OADS,/arxiv_data1/oa_pdf/62/3f/main.PMC4969272.pdf
101 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHSpecial article Introduction The group A Streptococcus  (GAS) bacterium—is one of the top-10 infectious causes of  deaths in the world [1].,Non-OADS,/arxiv_data1/oa_pdf/b1/a9/cevr-5-101.PMC4969273.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:101-107 http://dx.doi.org/10.7774/cevr.2016.5.2.101 pISSN 2287-3651 • eISSN 2287-366X  Jean-Louis Excler, Jerome H. Kim International Vaccine Institute, Seoul, Korea Received: May 24, 2016 Revised: June 14, 2016 Accepted: June 20, 2016 Corresponding author: Jean-Louis Excler, MD International Vaccine Institute, SNU Research  Park, 1 Gwanak-ro, Gwanak-gu, Seoul 08826,  Korea  Tel: +82-2-881-1176, Fax: +82-2-881-1164 E-mail: JeanLouis.Excler@ivi.int No potential conflict of interest relevant to this  article was reported.Group A Streptococcus  (GAS) infections cause substantial worldwide morbidity and mortal - ity, mostly associated with suppurative complications such as pharyngitis, impetigo, and non- suppurative immune syndromes such as acute rheumatic fever, rheumatic heart disease, and  acute post-streptococcal glomerulonephritis.",Non-OADS,/arxiv_data1/oa_pdf/b1/a9/cevr-5-101.PMC4969273.pdf
"Jean-Louis Excler et al • Accelerating the development of a group A Streptococcus  vaccine 102 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.101syndromes (acute rheumatic fever [ARF], RHD, and acute  post-streptococcal glomerulonephritis), and toxin-mediated  diseases such as scarlet fever and streptococcal toxic shock  syndrome.",Non-OADS,/arxiv_data1/oa_pdf/b1/a9/cevr-5-101.PMC4969273.pdf
" Jean-Louis Excler et al • Accelerating the development of a group A Streptococcus  vaccine 103 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.101M protein–based vaccines The M protein is a coiled-coil protein consisting of 3 domains:  an A-repeat of the N-terminal domain, which is highly vari - able and used for epidemiologic molecular typing (emm typ - ing); a B-repeat domain (antibodies against this region are  not opsonic and some are cross-reactive with human tissues);  and a conserved C-repeat domain.",Non-OADS,/arxiv_data1/oa_pdf/b1/a9/cevr-5-101.PMC4969273.pdf
"Jean-Louis Excler et al • Accelerating the development of a group A Streptococcus  vaccine 104 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.101strains, another approach involves the use of conserved non- M protein GAS antigens for vaccine design by reverse vaccin - ology technology.",Non-OADS,/arxiv_data1/oa_pdf/b1/a9/cevr-5-101.PMC4969273.pdf
" Jean-Louis Excler et al • Accelerating the development of a group A Streptococcus  vaccine 105 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.101tire world [24,25].",Non-OADS,/arxiv_data1/oa_pdf/b1/a9/cevr-5-101.PMC4969273.pdf
ORCID Jean-Louis Excler http://orcid.org/0000-0002-6462-5101 Jerome H. Kim http://orcid.org/0000-0003-0461-6438 References 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/a9/cevr-5-101.PMC4969273.pdf
Jean-Louis Excler et al • Accelerating the development of a group A Streptococcus  vaccine 106 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.1012005;91:3-4.,Non-OADS,/arxiv_data1/oa_pdf/b1/a9/cevr-5-101.PMC4969273.pdf
 Jean-Louis Excler et al • Accelerating the development of a group A Streptococcus  vaccine 107 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.101didates: the Group A Streptococcus case.,Non-OADS,/arxiv_data1/oa_pdf/b1/a9/cevr-5-101.PMC4969273.pdf
Available from: http://who.int/immuni - zation/research/meetings_workshops/pdvac/en.,OADS,/arxiv_data1/oa_pdf/b1/a9/cevr-5-101.PMC4969273.pdf
108 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Mycobacterium avium  subsp.,Non-OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:108-116 http://dx.doi.org/10.7774/cevr.2016.5.2.108 pISSN 2287-3651 • eISSN 2287-366X  Hong-Tae Park1, Han Sang Yoo1,2 1Department of Infectious Diseases, College  of Veterinary Medicine, Seoul National  University, Seoul; 2Institute of Green Bio Science  and Technology, Seoul National University,  Pyeongchang, Korea Received: April 21, 2016 Revised: May 10, 2016 Accepted: May 20, 2016 Corresponding author: Han Sang Yoo, DVM, PhD Department of Infectious Diseases, College of  Veterinary Medicine, Seoul National University,   1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea Tel: +82-2-880-1263, Fax: +82-2-874-2738 E-mail: yoohs@snu.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
" Hong-Tae Park et al • MAP vaccine development 109 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.108MAP infection can be divided into four categories according  to severity of clinical signs, the potential for shedding organ - isms, and the possibility of detection using current diagnostic  methods [3].",Non-OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
"Hong-Tae Park et al • MAP vaccine development 110 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.108 In the later stages of infection, increasing antibodies are  frequently observed with increasing bacterial shedding [32].",Non-OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
 Hong-Tae Park et al • MAP vaccine development 111 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.108on previous studies.,OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
Hong-Tae Park et al • MAP vaccine development 112 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.108only Mycopar is approved for use in the United States [17].,Non-OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
ORCID Hong-Tae Park http://orcid.org/0000-0003-3415-2339 Han Sang Yoo http://orcid.org/0000-0003-0548-0835 References 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
 Hong-Tae Park et al • MAP vaccine development 113 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.108associated with Johne’s disease on US dairy operations.,OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
Hong-Tae Park et al • MAP vaccine development 114 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.108ity in J774 macrophages compared with other mycobac - teria.,OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
 Hong-Tae Park et al • MAP vaccine development 115 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.10853.,OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
Hong-Tae Park et al • MAP vaccine development 116 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.10877.,OADS,/arxiv_data1/oa_pdf/e1/b1/cevr-5-108.PMC4969274.pdf
"117 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Introduction Equine influenza virus (EIV) causes common respiratory diseases in horses, donkeys,  and mules.",Non-OADS,/arxiv_data1/oa_pdf/b7/cd/cevr-5-117.PMC4969275.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:117-124 http://dx.doi.org/10.7774/cevr.2016.5.2.117 pISSN 2287-3651 • eISSN 2287-366X  Woonsung Na1*, Minjoo Yeom1*,  Huijoon Yuk1, Hyoungjoon Moon2,  Bokyu Kang2, Daesub Song1 1College of Pharmacy, Korea University, Sejong;  2Research Unit, Green Cross Veterinary Products,  Yongin, Korea *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/b7/cd/cevr-5-117.PMC4969275.pdf
"Woonsung Na et al • Current vaccine research and epidemiology of influenza virus in neglected hosts (horses and dogs)   118 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.117 Dogs were not considered a natural host of the influenza  virus until H3N8 canine influenza, which originated from  equine influenza, and was identified in racing greyhounds in  2004 [9].",Non-OADS,/arxiv_data1/oa_pdf/b7/cd/cevr-5-117.PMC4969275.pdf
" Woonsung Na et al • Current vaccine research and epidemiology of influenza virus in neglected hosts (horses and dogs)  119 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.117ondary bacterial complications such as pneumonia, pleuro - pneumonia, chronic bronchitis, recrudescence of fever, dys - pnea, and cough with sputum, which signals the onset of bac - terial pneumonia [25].",Non-OADS,/arxiv_data1/oa_pdf/b7/cd/cevr-5-117.PMC4969275.pdf
Woonsung Na et al • Current vaccine research and epidemiology of influenza virus in neglected hosts (horses and dogs)   120 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.117Fig.,OADS,/arxiv_data1/oa_pdf/b7/cd/cevr-5-117.PMC4969275.pdf
 Woonsung Na et al • Current vaccine research and epidemiology of influenza virus in neglected hosts (horses and dogs)  121 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.117sity of Pittsburgh is concentrating on applying for an EIV vac - cine patent.,Non-OADS,/arxiv_data1/oa_pdf/b7/cd/cevr-5-117.PMC4969275.pdf
"Woonsung Na et al • Current vaccine research and epidemiology of influenza virus in neglected hosts (horses and dogs)   122 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.117against heterologous H3N2 CIV; however, trials demonstrat - ed that it reduced the severity and duration of clinical illness,  and abbreviated the shedding viral load [45,46].",Non-OADS,/arxiv_data1/oa_pdf/b7/cd/cevr-5-117.PMC4969275.pdf
ORCID Woonsung Na http://orcid.org/0000-0002-7254-5240 Minjoo Yeom http://orcid.org/0000-0001-8949-6361 Huijoon Yuk http://orcid.org/0000-0002-9076-0155 Hyoungjoon Moon http://orcid.org/0000-0001-6211-8758 Bokyu Kang  http://orcid.org/0000-0001-5840-468X Daesub Song http://orcid.org/0000-0002-2759-1061 References 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/cd/cevr-5-117.PMC4969275.pdf
 Woonsung Na et al • Current vaccine research and epidemiology of influenza virus in neglected hosts (horses and dogs)  123 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.11771.,OADS,/arxiv_data1/oa_pdf/b7/cd/cevr-5-117.PMC4969275.pdf
Woonsung Na et al • Current vaccine research and epidemiology of influenza virus in neglected hosts (horses and dogs)   124 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.117infection in dogs in southern China.,Non-OADS,/arxiv_data1/oa_pdf/b7/cd/cevr-5-117.PMC4969275.pdf
"125 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHReview article Current Information on Immunization in Organ T ransplant   Recipients Organ transplantation is one of the most effective therapeutic modalities for patients  with acute or chronic end-stage liver or kidney disease, but infectious complications  significantly impact the morbidity and mortality among organ transplant recipients.",Non-OADS,/arxiv_data1/oa_pdf/01/62/cevr-5-125.PMC4969276.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:125-131 http://dx.doi.org/10.7774/cevr.2016.5.2.125 pISSN 2287-3651 • eISSN 2287-366X  Youn Jeong Kim, Sang Il Kim Division of Infectious Disease, Department of  Internal Medicine, Seoul St. Mary’s Hospital,  College of Medicine, The Catholic University of  Korea, Seoul, Korea Received: June 7, 2016 Revised: June 20, 2016 Accepted: June 25, 2016 Corresponding author: Sang Il Kim, MD Division of Infectious Disease, Department of  Internal Medicine, Seoul St. Mary’s Hospital,  College of Medicine, The Catholic University of  Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591,  Korea Tel: +82-2-2258-6002, Fax: +82-2-2258-1254 E-mail: drksi@catholic.ac.kr No potential conflict of interest relevant to this  article was reported.Solid organ transplant recipients need emphases on immunization that result in certainly de- crease the risk of vaccine preventable diseases.",Non-OADS,/arxiv_data1/oa_pdf/01/62/cevr-5-125.PMC4969276.pdf
"Youn Jeong Kim et al • Vaccination strategies in patients with solid organ transplant 126 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.125thermore, influenza infection was related to graft rejection in  19.5% of kidney transplant recipients [8].",OADS,/arxiv_data1/oa_pdf/01/62/cevr-5-125.PMC4969276.pdf
" Youn Jeong Kim et al • Vaccination strategies in patients with solid organ transplant 127 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.125over time [34,35].",Non-OADS,/arxiv_data1/oa_pdf/01/62/cevr-5-125.PMC4969276.pdf
Youn Jeong Kim et al • Vaccination strategies in patients with solid organ transplant 128 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.125with persons at high risk for serious complications of varicel - la [57].,Non-OADS,/arxiv_data1/oa_pdf/01/62/cevr-5-125.PMC4969276.pdf
 Youn Jeong Kim et al • Vaccination strategies in patients with solid organ transplant 129 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.125Immunization for Healthcare Workers and  Close Contacts of T ransplant Recipients Healthcare workers and close contacts of transplant recipi - ents should be immunized against all vaccine preventable  diseases to provide the transplant recipient with additional  protection from these diseases [4].,Non-OADS,/arxiv_data1/oa_pdf/01/62/cevr-5-125.PMC4969276.pdf
ORCID Youn Jeong Kim http://orcid.org/0000-0001-5870-1801 Sang Il Kim http://orcid.org/0000-0001-9361-7381 References 1.,Non-OADS,/arxiv_data1/oa_pdf/01/62/cevr-5-125.PMC4969276.pdf
Youn Jeong Kim et al • Vaccination strategies in patients with solid organ transplant 130 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.12516.,Non-OADS,/arxiv_data1/oa_pdf/01/62/cevr-5-125.PMC4969276.pdf
 Youn Jeong Kim et al • Vaccination strategies in patients with solid organ transplant 131 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.125er transplantation.,Non-OADS,/arxiv_data1/oa_pdf/01/62/cevr-5-125.PMC4969276.pdf
"132 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Aujeszky’s disease (AD), also known as pseudorabies, is caused by Aujeszky’s disease  virus (ADV), an alpha-herpesvirus of the family Herpesviridae  with a positive double- stranded DNA genome about 145 kb in length [1].",Non-OADS,/arxiv_data1/oa_pdf/35/7d/cevr-5-132.PMC4969277.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:132-137 http://dx.doi.org/10.7774/cevr.2016.5.2.132 pISSN 2287-3651 • eISSN 2287-366X  Dong-Kun Yang, Ha-Hyun Kim,  Sung-Suk Choi, Bang-Hun Hyun,  Jae-Young Song Viral Disease Division, Animal and Plant  Quarantine Agency, MAFRA, Gimcheon, Korea Received: December 24, 2015 Revised: February 24, 2016 Accepted: March 5, 2016 Corresponding author: Dong-Kun Yang, PhD, DVM Viral Disease Division, Animal and Plant   Quarantine Agency, MAFRA, 177 Hyeoksin 8-ro,  Gimcheon 39660, Korea Tel: +82-54-912-0785, Fax: +82-54-912-0812 E-mail: yangdk@korea.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/35/7d/cevr-5-132.PMC4969277.pdf
" Dong-Kun Yang et al • Oral administration of YS-400 induces VN antibodies 133 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.132failures, including abortion, stillbirth, and weak piglets [2].",Non-OADS,/arxiv_data1/oa_pdf/35/7d/cevr-5-132.PMC4969277.pdf
Dong-Kun Yang et al • Oral administration of YS-400 induces VN antibodies 134 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.132Experimental design Experiment 1 Young pigs (11 weeks of age) seronegative for ADV were hous - ed in a compartment.,Non-OADS,/arxiv_data1/oa_pdf/35/7d/cevr-5-132.PMC4969277.pdf
 Dong-Kun Yang et al • Oral administration of YS-400 induces VN antibodies 135 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.132anti-gB antibodies.,OADS,/arxiv_data1/oa_pdf/35/7d/cevr-5-132.PMC4969277.pdf
"Dong-Kun Yang et al • Oral administration of YS-400 induces VN antibodies 136 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.132TK genes are partly deleted and the IL2 and beta-galactosi - dase genes inserted, served as both the orally administered  and bait vaccine.",Non-OADS,/arxiv_data1/oa_pdf/35/7d/cevr-5-132.PMC4969277.pdf
ORCID Dong-Kun Yang http://orcid.org/0000-0001-5765-3043 Ha-Hyun Kim http://orcid.org/0000-0001-6473-0035Sung-Suk Choi http://orcid.org/0000-0001-5124-9736 Bang-Hun Hyun http://orcid.org/0000-0002-3429-3425 Jae-Young Song http://orcid.org/0000-0002-9554-9252 References 1.,Non-OADS,/arxiv_data1/oa_pdf/35/7d/cevr-5-132.PMC4969277.pdf
 Dong-Kun Yang et al • Oral administration of YS-400 induces VN antibodies 137 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.13212.,OADS,/arxiv_data1/oa_pdf/35/7d/cevr-5-132.PMC4969277.pdf
138 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Foot-and-mouth disease (FMD) is one of the most important animal diseases in the  world.,Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:138-147 http://dx.doi.org/10.7774/cevr.2016.5.2.138 pISSN 2287-3651 • eISSN 2287-366X  Can Çokçalı şkan1, Tunçer Türko ğlu1,  Beyhan Sareyyüpo ğlu1,   Ergün Uzunlu1, Ayca Babak2,   Banu B. Özbilge1, Veli Gülyaz1 1Republic of Turkey, Ministry of Food, Agriculture  and Livestock, Institute of Foot and Mouth  Disease (SAP), Ankara; 2Republic of Turkey,  Ministry of Food, Agriculture and Livestock,  Directorate-General for Agriculture and Rural  Development, Ankara,Turkey  Received: December 30, 2015 Revised: February 25, 2016 Accepted: March 5, 2016 Corresponding author: Can Çokçalı şkan, DVM, PhD Quality Control Department, Foot-and-Mouth  Disease (SAP) Institute, Dumlupinar Bulvari No.",Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
 Can Çokçalı şkan et al • QS-21 enhances the early antibody response to oil adjuvant FMD vaccine in cattle 139 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.138intramuscular injection [5].,Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
Can Çokçalı şkan et al • QS-21 enhances the early antibody response to oil adjuvant FMD vaccine in cattle 140 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.138OIE manual [18].,Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
 Can Çokçalı şkan et al • QS-21 enhances the early antibody response to oil adjuvant FMD vaccine in cattle 141 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.138Fig.,Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
Can Çokçalı şkan et al • QS-21 enhances the early antibody response to oil adjuvant FMD vaccine in cattle 142 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.13828 were significant.,Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
" Can Çokçalı şkan et al • QS-21 enhances the early antibody response to oil adjuvant FMD vaccine in cattle 143 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.138adjuvant control group, the response began on day 8 but rea- ched a peak on 45 dpv.",Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
Can Çokçalı şkan et al • QS-21 enhances the early antibody response to oil adjuvant FMD vaccine in cattle 144 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.138Fig.,Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
" Can Çokçalı şkan et al • QS-21 enhances the early antibody response to oil adjuvant FMD vaccine in cattle 145 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.138that Cochinchina momordica  seed extracts, a possible sapo - nin source [30], increased FMD-VP-1 antibodies in an oil ad - juvanted vaccine in a guinea pig model.",Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
ORCID Can Çokçalı şkan http://orcid.org/0000-0002-3839-0986 Tunçer Türko ğlu http://orcid.org/0000-0002-6780-6186 Beyhan Sareyyüpo ğlu http://orcid.org/0000-0002-0279-1673 Ergün Uzunlu http://orcid.org/0000-0002-0509-7257 Ayca Babak http://orcid.org/0000-0001-6084-4537 Banu B. Özbilge http://orcid.org/0000-0002-9187-1543 Veli Gülyaz http://orcid.org/0000-0002-9089-919X References 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
Can Çokçalı şkan et al • QS-21 enhances the early antibody response to oil adjuvant FMD vaccine in cattle 146 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.138and-mouth disease vaccines.,Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
 Can Çokçalı şkan et al • QS-21 enhances the early antibody response to oil adjuvant FMD vaccine in cattle 147 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.138disease vaccine.,Non-OADS,/arxiv_data1/oa_pdf/e1/bf/cevr-5-138.PMC4969278.pdf
"148 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Salmonella enterica  serovar Gallinarum (SG), an intracellular gram-negative bacteri - um, is a causative agent for a well-recognized septicemic disease of poultry called as  fowl typhoid (FT) in many areas, including Latin America, the Middle East, the Pacific  Rim, Africa, and Asia.",Non-OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:148-158 http://dx.doi.org/10.7774/cevr.2016.5.2.148 pISSN 2287-3651 • eISSN 2287-366X  Gayeon Won, Atul A. Chaudhari,  John Hwa Lee College of Veterinary Medicine, Chonbuk National  University, Iksan, Korea Received: May 2, 2016 Revised: May 22, 2016 Accepted: June 30, 2016 Corresponding author:   John Hwa Lee, DVM, PhD College of Veterinary Medicine, Chonbuk National  University, 79 Gobong-ro, Iksan 54596, Korea Tel: +82-63-850-0940, Fax: +82-63-850-0910 E-mail: johnhlee@jbnu.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
" Gayeon Won et al • Salmonella  Gallinarum vaccine candidate 149 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.148the major safety threats to animal as well as external environ - ment, through the use of live vaccines still remains inexplica - ble [11,12].",Non-OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
"Gayeon Won et al • Salmonella  Gallinarum vaccine candidate 150 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.148liminary experiment to determine the appropriate dose for  inoculation, the oral and intramuscular immunizations with  the SG ghost were performed at a concentration of 1×1010  and 1×108 cells/100 μL per chicken, respectively.",Non-OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
" Gayeon Won et al • Salmonella  Gallinarum vaccine candidate 151 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.148PBS, and analyzed with a flow cytometer (BD Biosciences,  Franklin Lakes, NJ, USA).",OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
"Gayeon Won et al • Salmonella  Gallinarum vaccine candidate 152 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.148ma IgG concentrations were significantly higher than the  control group A at second, third, and fourth week post-prime  immunization.",Non-OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
" Gayeon Won et al • Salmonella  Gallinarum vaccine candidate 153 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.148route offered optimized protection against the virulent chal - lenge and induced considerable amount of serum antibody  levels in chickens, we further evaluated the immune poten - tial of the ghost vaccine candidate after prime and booster  dose of immunization by intramuscular route.",Non-OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
"Gayeon Won et al • Salmonella  Gallinarum vaccine candidate 154 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.148Booster immunization and cellular immune responses in  chickens Similarly, the splenic populations of M/M and CD4+ and CD8+  T cells were investigated after booster immunization for the  immunized and un-immunized chickens.",Non-OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
 Gayeon Won et al • Salmonella  Gallinarum vaccine candidate 155 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.148trol).,OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
Gayeon Won et al • Salmonella  Gallinarum vaccine candidate 156 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.148population and mRNA levels of IFN- γ compared to non-im - munized groups (Fig.,OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
The results described presently suggests  that prime-boost immunization with the candidate via intra - muscular route is an optimized immunization strategy and is  capable of inducing a potent Th1 and Th2 type immune re - sponses in the immunized host.ORCID Gayeon Won http://orcid.org/0000-0003-4832-7937 Atul A. Chaudhari http://orcid.org/0000-0002-5281-3252 John Hwa Lee http://orcid.org/0000-0002-2028-2207 References 1.,Non-OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
 Gayeon Won et al • Salmonella  Gallinarum vaccine candidate 157 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.148cination with Edwardsiella tarda ghosts.,OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
Gayeon Won et al • Salmonella  Gallinarum vaccine candidate 158 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.14839.,OADS,/arxiv_data1/oa_pdf/8c/07/cevr-5-148.PMC4969279.pdf
"159 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Rabies is an important zoonosis that results in more than 60,000 human deaths around  the world every year.",Non-OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:159-168 http://dx.doi.org/10.7774/cevr.2016.5.2.159 pISSN 2287-3651 • eISSN 2287-366X  Dong-Kun Yang1, Ha-Hyun Kim1,  Sung-Suk Choi1, Jong-Tack Kim2,  Kang-Bok Lee3, Seong Heon Lee1,  In-Soo Cho1 1Viral Disease Division, Animal and Plant  Quarantine Agency, MAFRA, Gimcheon; 2College  of Veterinary Medicine, Kangwon National  University, Chuncheon; 3Jeonnam Wildlife  Management Center, Suncheon, Korea Received: May 11, 2016 Revised: June 15, 2016 Accepted: June 30, 2016 Corresponding author: Dong-Kun Yang, PhD, DVM Viral Disease Division, Animal and Plant Quaran - tine Agency, 177 Hyeoksin 8-ro, Gimcheon 39660,  Korea  Tel: +82-54-912-0785, Fax: +82-54-912-0812  E-mail: yangdk@korea.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
"Dong-Kun Yang et al • Recombinant rabies virus (ERAGS) induces complete protection 160 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.159or other domestic species [6,7].",Non-OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
 Dong-Kun Yang et al • Recombinant rabies virus (ERAGS) induces complete protection 161 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.159in a 24-well tissue culture plate.,OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
"Dong-Kun Yang et al • Recombinant rabies virus (ERAGS) induces complete protection 162 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.159mL), groups 4 and 5 received IC inoculations with the ERAGS  strain (105.0 and 107.0 FAID 50/mL, respectively), group 6 recei- ved an IC inoculation with the ERA strain (107.0 FAID 50/mL),  and group 7 was the control group and did not receive an in - oculation.",Non-OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
" Dong-Kun Yang et al • Recombinant rabies virus (ERAGS) induces complete protection 163 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.159the highest titer at 96-hour post-inoculation, which indicated  that the mutations at positions 194 and 333 in the G protein  of the ERA strain did not influence the growth properties.",OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
Dong-Kun Yang et al • Recombinant rabies virus (ERAGS) induces complete protection 164 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.159istration.,OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
 Dong-Kun Yang et al • Recombinant rabies virus (ERAGS) induces complete protection 165 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.159Fig.,OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
Dong-Kun Yang et al • Recombinant rabies virus (ERAGS) induces complete protection 166 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.159the absence of adverse clinical signs and salivary excretion in  animals [18-20].,Non-OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
" Dong-Kun Yang et al • Recombinant rabies virus (ERAGS) induces complete protection 167 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.159Therefore, the ERAGS strain may be sufficiently safe and ef - fective for use as a live vaccine or oral bait vaccine in raccoon  dogs.",Non-OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
ORCID Dong-Kun Yang http://orcid.org/0000-0001-5765-3043 Ha-Hyun Kim http://orcid.org/0000-0001-6473-0035 Sung-Suk Choi http://orcid.org/0000-0001-5124-9736 Jong-Tack Kim http://orcid.org/0000-0002-6388-550X Kang-Bok Lee http://orcid.org/0000-0002-6215-326X Seong Heon Lee http://orcid.org/0000-0002-6024-3798 In-Soo Cho http://orcid.org/0000-0002-2692-3191 References 1.,Non-OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
Dong-Kun Yang et al • Recombinant rabies virus (ERAGS) induces complete protection 168 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.159Vaccine 2004;23:518-24.,OADS,/arxiv_data1/oa_pdf/a4/47/cevr-5-159.PMC4969280.pdf
"169 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHOriginal article Introduction Rabies causes death in many mammals, including pigs.",Non-OADS,/arxiv_data1/oa_pdf/7d/54/cevr-5-169.PMC4969281.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:169-174 http://dx.doi.org/10.7774/cevr.2016.5.2.169 pISSN 2287-3651 • eISSN 2287-366X  Dong-Kun Yang, Ha-Hyun Kim,  Sung-Suk Choi, Seong Heon Lee,  In-Soo Cho Viral Disease Division, Animal and Plant  Quarantine Agency, MAFRA, Gimcheon, Korea  Received: June 2, 2016 Revised: June 25, 2016 Accepted: June 30, 2016 Corresponding author: Dong-Kun Yang, PhD, DVM Viral Disease Division, Animal and Plant   Quarantine Agency, 177 Hyeoksin 8-ro,   Gimcheon 39660, Korea Tel: +82-54-912-0785, Fax: +82-54-912-0812 E-mail: yangdk@korea.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/7d/54/cevr-5-169.PMC4969281.pdf
Dong-Kun Yang et al • Safe and immunogenicity of recombinant rabies virus (ERAGS) in swine  170 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.169public health concern.,Non-OADS,/arxiv_data1/oa_pdf/7d/54/cevr-5-169.PMC4969281.pdf
" Dong-Kun Yang et al • Safe and immunogenicity of recombinant rabies virus (ERAGS) in swine  171 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.169pH 7.2), the cells were reacted with a specific monoclonal an - tibody (Median Diagnostics, Chuncheon, Korea) against the  rabies N protein for 45 minutes at 37°C; they were then stained  with fluorescein isothiocyanate−conjugated goat-anti mouse  IgG+IgM (KPL, Gaithersburg, MD, USA).",Non-OADS,/arxiv_data1/oa_pdf/7d/54/cevr-5-169.PMC4969281.pdf
Dong-Kun Yang et al • Safe and immunogenicity of recombinant rabies virus (ERAGS) in swine  172 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.169Fig.,OADS,/arxiv_data1/oa_pdf/7d/54/cevr-5-169.PMC4969281.pdf
 Dong-Kun Yang et al • Safe and immunogenicity of recombinant rabies virus (ERAGS) in swine  173 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.169because an outbreak of pig rabies caused by a rabid dog was  reported in China [4].,Non-OADS,/arxiv_data1/oa_pdf/7d/54/cevr-5-169.PMC4969281.pdf
"Dong-Kun Yang et al • Safe and immunogenicity of recombinant rabies virus (ERAGS) in swine  174 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.169significant VNA titers against RABV , indicating that the ERAGS  strain may be immunogenic in swine.",Non-OADS,/arxiv_data1/oa_pdf/7d/54/cevr-5-169.PMC4969281.pdf
ORCID  Dong-Kun Yang http://orcid.org/0000-0001-5765-3043 Ha-Hyun Kim http://orcid.org/0000-0001-6473-0035 Sung-Suk Choi http://orcid.org/0000-0001-5124-9736 Seong Heon Lee http://orcid.org/0000-0002-6024-3798 In-Soo Cho http://orcid.org/0000-0002-2692-3191 References 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/54/cevr-5-169.PMC4969281.pdf
"175 http://www.ecevr.org/A Bordetella pertussis   proteoliposome induces protection  in mice without affecting the  immunogenicity of diphtheria  and tetanus toxoids in a trivalent  formulationCLINICAL   EXPERIMENTAL VACCINE RESEARCHBrief communication Whooping cough, an acute respiratory disease caused by Bordetella pertussis , still is an  important cause of public health concern worldwide even in countries with high vac - cination coverage [1].",Non-OADS,/arxiv_data1/oa_pdf/2b/58/cevr-5-175.PMC4969282.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:175-178 http://dx.doi.org/10.7774/cevr.2016.5.2.175 pISSN 2287-3651 • eISSN 2287-366X  Sonsire Fernández Castillo1,   Mario Landys Chovel1,   Niurka Gutiérrez Hernández1,  Lorena Corcho González1,   Amaya Blanco2,   Daily Serrano Hernández1,   Mildrey Fariñas Medina1,   Maydelis Álvarez Tito1,   José Luis Pérez Quiñoy1 1Finlay Institute, Havana; 2Medical Faculty and  Institute of Basic and Preclinical Science “Victoria  de Girón”, University of Medical Sciences of  Havana, Havana, Cuba Received: December 29, 2015 Revised: February 15, 2016 Accepted: March 25, 2016 Corresponding author:   Sonsire Fernández Castillo, MS Finlay Institute, 27 Street, No.",Non-OADS,/arxiv_data1/oa_pdf/2b/58/cevr-5-175.PMC4969282.pdf
"Sonsire Fernández Castillo, et al • DT-PLBp formulation induces protection in mice 176 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.175intranasal challenge models [7].",Non-OADS,/arxiv_data1/oa_pdf/2b/58/cevr-5-175.PMC4969282.pdf
" Sonsire Fernández Castillo, et al • DT-PLBp formulation induces protection in mice 177 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.175pressed as the arithmetic means±standard deviation of log10  of the CFU/g of lung for each group of mice at each extraction  time after challenge.",Non-OADS,/arxiv_data1/oa_pdf/2b/58/cevr-5-175.PMC4969282.pdf
ORCID Sonsire Fernández Castillo  http://orcid.org/0000-0001-5329- 5971 Mario Landys Chovel http://orcid.org/0000-0002-6991-7007 Niurka Gutiérrez Hernández  http://orcid.org/0000-0002- 3896-9648 Lorena Corcho González  http://orcid.org/0000-0002-0084- 281X Amaya Blanco http://orcid.org/0000-0002-5049-4024 Daily Serrano Hernández  http://orcid.org/0000-0001-9233- 2376 Mildrey Fariñas Medina  http://orcid.org/0000-0001-6530- 9904 Maydelis Álvarez Tito http://orcid.org/0000-0002-7507-6013 José Luis Pérez Quiñoy http://orcid.org/0000-0001-8325-2120 References 1.,Non-OADS,/arxiv_data1/oa_pdf/2b/58/cevr-5-175.PMC4969282.pdf
"Sonsire Fernández Castillo, et al • DT-PLBp formulation induces protection in mice 178 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.1753.",Non-OADS,/arxiv_data1/oa_pdf/2b/58/cevr-5-175.PMC4969282.pdf
"89 http://www.ecevr.org/CLINICAL   EXPERIMENTAL VACCINE RESEARCHSpecial article Introduction Dengue virus (DENV) is a single-stranded, enveloped RNA flavivirus, which is endem - ic in most tropical and subtropical regions of the world [1].",Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial  use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV SClin Exp Vaccine Res 2016;5:89-100 http://dx.doi.org/10.7774/cevr.2016.5.2.89 pISSN 2287-3651 • eISSN 2287-366X  Sl-Ki Lim, Yong Seok Lee,   Suk Namkung, Jacqueline K Lim,   In-Kyu Yoon International Vaccine Institute, Seoul, Korea Received: May 25, 2016 Revised: June 14, 2016 Accepted: June 20, 2016 Corresponding author: In-Kyu Yoon, MD  International Vaccine Institute, 1 Gwanak-ro,  Gwanak-gu, Seoul 08826, Korea Tel: +82-2-881-1105, Fax: +82-2-881-1215 E-mail: inkyu.yoon@ivi.int No potential conflict of interest relevant to this  article was reported.Travel-acquired dengue cases have been increasing as the overall global dengue burden has  expanded.",Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 90 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.89 Fig.,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
" Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 91 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.89ized cases, respectively [9].",Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
"Available  from: http://kto.visitkorea.or.kr/kor/notice/data/statis/profit/board/view.kto?id=426547&isNotice=false& instanceId=294&rnum=2 .05,00010,00015,00020,000 2010 2011 2012 2013 2014The number of outbound travelers (Thousands) YearSE Asia NE Asia China S.Asia Oceania Africa Europe Other American Countries Canada,USA20,000 15,000 10,000 5,000 0  2010 2011 2012 2013 2014 YearNo.",Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Available from:  http://is.cdc.go.kr/dstat/jsp/stat/stat0001.jsp050100150200250300 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 201 1 2012 2013 2014 2015 201 6Number of reporte cases Year300 250 200 150 100 50 0 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 YearNo.,OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
"Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 92 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.89laysia, and Cambodia [23,25,26], and most were between 20  and 39 years of age [25-27].",Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
 Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 93 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.89already been exposed to DENV may benefit more from den - gue vaccination than first time travelers.,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 94 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.89travel vaccination [44].,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
" Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 95 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.89uals aged 9 years and older was 65.6% (95% confidence inter - val [CI], 60.7 to 69.9), substantially higher than the efficacy of  44.6% (95% CI, 31.6 to 55.0) in younger children.",Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 96 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.89ssed in a DENV-2 backbone [64].,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
 Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 97 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.89ber of imported dengue cases during the first four months of  2016 was three times higher than in the same period the pre - vious year.,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
ORCID Sl-Ki Lim http://orcid.org/0000-0003-2246-6824 Yong Seok Lee http://orcid.org/0000-0002-9633-654X Suk Namkung http://orcid.org/0000-0002-2220-6785 Jacqueline K Lim http://orcid.org/0000-0001-6744-7825 In-Kyu Yoon http://orcid.org/0000-0001-5077-6470 References 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Available from: http://www.who.int/me - diacentre/factsheets/fs117/en/.,OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Avail - able from: http://www.who.int/denguecontrol/en/.,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
http://dx.doi.org/  10.1016/S1473-3099(16)00146-8.,OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Available from: http://data.world - bank.org/indicator/ST.INT.DPRT.,OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
"Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 98 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.89Web Statistics System, 2016 [Internet].",OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Available from: http://is.cdc.go.kr/dstat/jsp/ stat/stat0001.jsp.,OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Available from: http://travelinfo.cdc.go.kr/trav - elinfo/jsp_travelinfo/home/main/main.jsp#.,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Available from: http://wwwnc.cdc.gov/trav - el/yellowbook/2016/the-pre-travel-consultation/protec - tion-against-mosquitoes-ticks-other-arthropods.,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Available from: http://www.who.int/ denguecontrol/mosquito/en/.,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Available  from: http://www.tourism.go.th/home/listcontent/11/  222/91.,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
" Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 99 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.89healthy children in Asia: a phase 3, randomised, observer- masked, placebo-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Available from: http://www.doh.gov.ph/node/5842.,OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
Sl-Ki Lim et al • Prospects for dengue vaccines for travelers 100 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2016.5.2.8975.,Non-OADS,/arxiv_data1/oa_pdf/ab/60/cevr-5-89.PMC4969283.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2016.07.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/cc/ca/main.PMC4969307.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 132 e133,Non-OADS,/arxiv_data1/oa_pdf/cc/ca/main.PMC4969307.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/4a/main.PMC4969308.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2016.06.001 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/main.PMC4969308.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 113 e118,Non-OADS,/arxiv_data1/oa_pdf/97/4a/main.PMC4969308.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/c7/main.PMC4969309.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2016.06.002 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/8e/c7/main.PMC4969309.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 109 e112,Non-OADS,/arxiv_data1/oa_pdf/8e/c7/main.PMC4969309.pdf
Fact sheets; cancer fact sheets [updated 2015] Available from: http://globocan.iarc.fr/Pages/fact_sheets_ cancer.aspx .,Non-OADS,/arxiv_data1/oa_pdf/8e/c7/main.PMC4969309.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim Journal of Ayurveda and Integrative Medicine 7 (2016) 73 e75 http://dx.doi.org/10.1016/j.jaim.2016.07.002 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/97/c0/main.PMC4969310.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/c0/main.PMC4969310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/72/main.PMC4969311.pdf
"Peer review under responsibility of Transdisciplinary University, Bangalore Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2016.06.003 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/fa/72/main.PMC4969311.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 78 e82,Non-OADS,/arxiv_data1/oa_pdf/fa/72/main.PMC4969311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/99/main.PMC4969312.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.09.004 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/71/99/main.PMC4969312.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 83 e87,Non-OADS,/arxiv_data1/oa_pdf/71/99/main.PMC4969312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/39/main.PMC4969313.pdf
"Contents lists available at ScienceDirect Journal of Ayurveda and Integrative Medicine journal homepage: http://elsevier.com/locate/jaim http://dx.doi.org/10.1016/j.jaim.2015.11.004 0975-9476/ ©2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation.",Non-OADS,/arxiv_data1/oa_pdf/20/39/main.PMC4969313.pdf
This is an open access article un der the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Ayurveda and Integrative Medicine 7 (2016) 88 e99,Non-OADS,/arxiv_data1/oa_pdf/20/39/main.PMC4969313.pdf
The differences compared to ETN and ADA wereEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/FED4 F060197B5A08 .,Non-OADS,/arxiv_data1/oa_pdf/6a/2e/12325_2016_Article_372.PMC4969317.pdf
"zThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/6a/2e/12325_2016_Article_372.PMC4969317.pdf
"London, UK: NICE; 2009. http://guidance.nice.org.",Non-OADS,/arxiv_data1/oa_pdf/6a/2e/12325_2016_Article_372.PMC4969317.pdf
http://www.nice.org.uk/guidance/ta375 (2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/2e/12325_2016_Article_372.PMC4969317.pdf
2013. http://www.nice.org.uk/about nice/howwework/devnicetech/guidetothemethod softechnologyappraisal.jsp .,Non-OADS,/arxiv_data1/oa_pdf/6a/2e/12325_2016_Article_372.PMC4969317.pdf
Patients who received Acthar prescriptions were similarEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ AAD4F06050B69811 .,Non-OADS,/arxiv_data1/oa_pdf/f6/c1/12325_2016_Article_363.PMC4969319.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f6/c1/12325_2016_Article_363.PMC4969319.pdf
"Multiple Sclerosis International Federation, 2013. http://www.msif.",Non-OADS,/arxiv_data1/oa_pdf/f6/c1/12325_2016_Article_363.PMC4969319.pdf
Patients who switched had higher mean DAS28 before starting TNFi therapy than patients with single orEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/9ED 4F0604E25CD16 .,Non-OADS,/arxiv_data1/oa_pdf/54/ab/12325_2016_Article_371.PMC4969320.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/54/ab/12325_2016_Article_371.PMC4969320.pdf
2013. http://www.virec.research.va.gov/ DSS-NDEs/NDEs.htm .,OADS,/arxiv_data1/oa_pdf/54/ab/12325_2016_Article_371.PMC4969320.pdf
2013. http://www.pbm.va.,Non-OADS,/arxiv_data1/oa_pdf/54/ab/12325_2016_Article_371.PMC4969320.pdf
"The mean age was 4.0 ±3.8 years, the female/male ratio was 1/1.7, and the majority ofEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/98D4 F06077358131 .",Non-OADS,/arxiv_data1/oa_pdf/78/88/12325_2016_Article_358.PMC4969321.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/78/88/12325_2016_Article_358.PMC4969321.pdf
Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/BCD 4F0600F321DB3 .,Non-OADS,/arxiv_data1/oa_pdf/68/a0/12325_2016_Article_369.PMC4969324.pdf
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/Adv Ther (2016) 33:1440–1451 1449,Non-OADS,/arxiv_data1/oa_pdf/68/a0/12325_2016_Article_369.PMC4969324.pdf
The analyses also suggest that change in OIC status is a key driver of the impact of OIC treatment on health state utility.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 0BD4F0605E3DE0E1 .,Non-OADS,/arxiv_data1/oa_pdf/f1/57/12325_2016_Article_365.PMC4969326.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f1/57/12325_2016_Article_365.PMC4969326.pdf
http://paincommunity.org/blog/wp- content/uploads/Managing_Opioid-Induced_Con stipation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f1/57/12325_2016_Article_365.PMC4969326.pdf
London: NICE; 2013. http://www.nice.org.uk/article/pmg9/1344 Adv Ther (2016) 33:1331–1346,Non-OADS,/arxiv_data1/oa_pdf/f1/57/12325_2016_Article_365.PMC4969326.pdf
Rotterdam: EuroQol Research Foundation; 2014. http://www.euroqol.,Non-OADS,/arxiv_data1/oa_pdf/f1/57/12325_2016_Article_365.PMC4969326.pdf
2016. http://www.who.int/ cancer/palliative/painladder/en/ .,Non-OADS,/arxiv_data1/oa_pdf/f1/57/12325_2016_Article_365.PMC4969326.pdf
2013. http://www.who.int/ healthinfo/statistics/Gl obalDALYmethods_2000_ 2011.pdf .,OADS,/arxiv_data1/oa_pdf/f1/57/12325_2016_Article_365.PMC4969326.pdf
"We did not ﬁnd signiﬁcant associations between early prescriptions for Acthar and number of hospitalizations, emergency room visits,Enhanced content To view enhanced content for this article, go to http://www.medengine.com/Redeem/7AD 4F0607A27667B .",Non-OADS,/arxiv_data1/oa_pdf/a3/ae/12325_2016_Article_361.PMC4969327.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a3/ae/12325_2016_Article_361.PMC4969327.pdf
Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures: U.S. Food and Drug Administration; 2009. http://www.fda.gov/News Events/Newsroom/Press Announcements/ucm179855.htm .,Non-OADS,/arxiv_data1/oa_pdf/a3/ae/12325_2016_Article_361.PMC4969327.pdf
Acthar gel (repository corticotropin)injection 2010. http://www.accessdata.fda.gov/ drugsatfda_docs/nda/2010/022432_hp_acthar_gel_ toc.cfm .,Non-OADS,/arxiv_data1/oa_pdf/a3/ae/12325_2016_Article_361.PMC4969327.pdf
Acthar gel package insert 2015. http://www.acthar.com/pdf/ Acthar-PI.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a3/ae/12325_2016_Article_361.PMC4969327.pdf
Retrospective information on symptoms and previous medical history was collected via face-to-face interviews; patients also completedEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/8BD4 F060730340E1 .,Non-OADS,/arxiv_data1/oa_pdf/aa/a2/12325_2016_Article_366.PMC4969328.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/aa/a2/12325_2016_Article_366.PMC4969328.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d8/d6/12325_2016_Article_364.PMC4969329.pdf
http://www.hhs.gov/ohrp/regulations-and-policy/decisiontrees/index.html#c2 .,Non-OADS,/arxiv_data1/oa_pdf/d8/d6/12325_2016_Article_364.PMC4969329.pdf
"Global Initiative for Asthma (GINA); 2014 (revised), available  from: http://www.ginasthma.org.",Non-OADS,/arxiv_data1/oa_pdf/64/aa/PDIA-33-25424.PMC4969408.pdf
37. http://alergiaweb.es; Available at: 14.07.2014.38.,Non-OADS,/arxiv_data1/oa_pdf/0e/ea/PDIA-33-27765.PMC4969411.pdf
48. http://ihcp.jrc.ec.europa.eu/our_labs/eurl-ecvam/validation-regulatory-acceptance/topical-toxicity/skin-corrosion; Avail- able at: 14.07.2014.,Non-OADS,/arxiv_data1/oa_pdf/0e/ea/PDIA-33-27765.PMC4969411.pdf
57. http://kosmetyka.farmacom.com.pl/pdf/Prezentacjalabora-toriumHamilton.pdf; Available at: 15.07.2014.,Non-OADS,/arxiv_data1/oa_pdf/0e/ea/PDIA-33-27765.PMC4969411.pdf
Dyrektywa 2001/20/WE Parlamentu Europejskiego i Rady z dnia 4 kwietnia 2001 r. http://ec.europa.eu/health/files/ eudralex/vol-1/dir_2001_20/dir_2001_20_pl.pdf; Available at: 14.07.2014.,Non-OADS,/arxiv_data1/oa_pdf/0e/ea/PDIA-33-27765.PMC4969411.pdf
489 ) http://isap.sejm.gov.pl/DetailsServlet?id=WDU20120000489; Available at: 14.07.2014.,OADS,/arxiv_data1/oa_pdf/0e/ea/PDIA-33-27765.PMC4969411.pdf
665) p http://isap.sejm.gov.pl/Download?id=WDU20130000665&type=2.,OADS,/arxiv_data1/oa_pdf/0e/ea/PDIA-33-27765.PMC4969411.pdf
"Available at: http://drug.fda.moph.go.th/zone_search/files/1C_22_54_B_Tetavax.Pdf, 2016.",Non-OADS,/arxiv_data1/oa_pdf/25/c0/PDIA-33-27777.PMC4969423.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.417 ORIGINAL ARTICLE Clinical Characteristics of Odontogenic Cutaneous  Fistulas Eun-Young Lee* , Ji-Yeon Kang1,*, Kyung-Won Kim, Ki Hwa Choi2, Tae Young Yoon2, Ji Yeoun Lee2 Department of Oral and Maxillofacial Surgery, Chungbuk  National University College of Medicine, Cheongju, 1Department of Oral and  Maxillofacial Surgery, Dongtan Sacred Heart Hospital, Hallym University, Hwaseong, 2Department of Dermatology, Chungbuk National  University College of Medicine, Cheongju, Korea Background:  Odontogenic cutaneous fistula appears as dim- pling or a nodule with purulent discharge, usually in the chin or jaw.",Non-OADS,/arxiv_data1/oa_pdf/bf/fa/ad-28-417.PMC4969468.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.422 ORIGINAL ARTICLE Relation between the Peripherofacial Psoriasis and Scalp  Psoriasis Kyung Ho Kim, Ji Young Ahn, Mi Youn Park, Jai Il Youn Department of Dermatology, National Medical Center, Seoul, Korea Background:  Facial involvement of ps oriasis is known to be  one of the clinical manifestatio ns that indicate the severity of  the psoriasis and thought to be more closely associated with  certain distribution.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/ad-28-422.PMC4969469.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.427 ORIGINAL ARTICLE Histopathological Differential Diagnosis of Psoriasis and  Seborrheic Dermatitis of the Scalp Ji-Hye Park, Young Joon Park, Sue Kyoung Kim, Ji Eun Kwon1, Hee Young Kang, Eun-So Lee,  Jee Ho Choi2, You Chan Kim Departments of Dermatology and 1Pathology, Ajou University School of Medicine, Suwon, 2Department of Dermatology, Asan Medical  Center, University of Ulsan Coll ege of Medicine, Seoul, Korea Background:  The differential diagnosis of psoriasis and se- borrheic dermatitis can be difficult when both conditions are localized to the scalp without the involvement of other skin  sites.",Non-OADS,/arxiv_data1/oa_pdf/27/50/ad-28-427.PMC4969470.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.433 ORIGINAL ARTICLE Single Low-Dose Radiation Induced Regulation  of Keratinocyte Differentiation in Calcium-Induced HaCaT Cells Hyung Jin Hahn, Hae Jeong Youn1, Hwa Jun Cha2, Karam Kim2, Sungkwan An2,*, Kyu Joong Ahn1,* Department of Dermatology, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu,  1Department of Dermatology, Konkuk University School of Medicine, 2Korea Institute for Skin and Clinical Sciences and  Molecular-Targeted Drug Research Cent er, Konkuk University, Seoul, Korea Background:  We are continually exposed to low-dose radia- tion (LDR) in the range 0.1 Gy from natural sources, medical devices, nuclear energy plants , and other industrial sources  of ionizing radiation.",Non-OADS,/arxiv_data1/oa_pdf/88/ca/ad-28-433.PMC4969471.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.438 ORIGINAL ARTICLE Efficacy of a Complex of 5-Aminolevulinic Acid and  Glycyl-Histidyl-Lysine Peptide on Hair Growth  Weon Ju Lee, Hyun Bo Sim, Yong Hyun Jang, Seok-Jong Lee, Do Won Kim, Soon-Ho Yim1 Department of Dermatology, Kyungpook National University School of Medicine, Daegu, 1Department of Pharmaceutical Engimeering,  College of Public Health and Welfare, Dongshin University, Naju, Korea Background:  Pattern hair loss is a very common problem.",Non-OADS,/arxiv_data1/oa_pdf/1d/2a/ad-28-438.PMC4969472.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.444 ORIGINAL ARTICLE Safety and Tolerability of the Dual 5-Alpha Reductase  Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia Gwang Seong Choi, Joon Hyung Kim1, Shin-Young Oh1, Jung-Min Park1, Ji-Soo Hong1,  Yil-Seob Lee1, Won-Soo Lee2 Department of Dermatology, Inha University College of Medicine, Incheon, 1GlaxoSmithKline, Seoul, 2Department of Dermatology and  Institute of Hair & Cosmetic Medicine, Yonsei Un iversity Wonju College of Medicine, Wonju, Korea Background:  After the approval of du tastride for androgenic  alopecia (AGA) in 2009, Korean authority required a post-marketing surveillance to obtain further data on its safe- ty profile.",Non-OADS,/arxiv_data1/oa_pdf/3c/8f/ad-28-444.PMC4969473.pdf
Available from: https://www.drugsafe.or.kr/iwt/ds/ko/bbs/  EgovBbs.do?bbsId=BBSMSTR_000000000041&nttId=536.,Non-OADS,/arxiv_data1/oa_pdf/3c/8f/ad-28-444.PMC4969473.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.451 ORIGINAL ARTICLE Immunohistochemical Comparison of IL-36 and the  IL-23/Th17 Axis of Generalized Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis Hyo Sang Song, Sang Jin Kim, Tae-In Park1, Yong Hyun Jang2, Eun-So Lee Department of Dermatology, Ajou University School of Medicine, Suwon, Departments of 1Pathology and 2Dermatology, Kyungpook  National University School of Medicine, Daegu, Korea Background:  Cutaneous pustular di sorders incl ude general- ized pustular psoriasis (GPP) and acute generalized ex-anthematous pustulosis (AGEP).",Non-OADS,/arxiv_data1/oa_pdf/d3/fe/ad-28-451.PMC4969474.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.457 ORIGINAL ARTICLE Expression of Epidermal c-Kit+ of Vitiligo Lesions Is  Related to Responses to Excimer Laser Oun Jae Park*, Ji Su Han*, Sang Hyung Lee, Chan-Sik Park1, Chong Hyun Won, Mi Woo Lee,  Jee Ho Choi, Sung Eun Chang Departments of Dermatology and 1Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Background:  The survival and growth of melanocytes are  controlled by the binding of stem cell factor to its cell surface receptor c-kit+ (CD117).",Non-OADS,/arxiv_data1/oa_pdf/59/d6/ad-28-457.PMC4969475.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.464 ORIGINAL ARTICLE Stressful Events and Serum Concentration of Substance  P in Acne Patients Anita Rokowska-Waluch, Mariola Pawlaczyk, Marcin Cybulski1, Jakub Żurawski2, Mariusz Kaczmarek3,  Michał Michalak4, Ewa Mojs1 Division of Skin Disease Prophylaxis, Department of Geriatric Medicine and Gerontology, Departments of 1Clinical Psychology, 2Biology  and Environmental Study, 3Clinical Immunology, and 4Computer Science and Statistics, Poznan University of Medical Sciences, Poznan,  Poland Background:  Psychological stress is an important factor of  acne pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/aa/58/ad-28-464.PMC4969476.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.470 ORIGINAL ARTICLE Change in Antimicrobial Susceptibility of Skin-Colonizing  Staphylococcus aureus  in Korean Patients with Atopic  Dermatitis during T en-Year Period Jung-Min Park1, Ju-Hyun Jo2, Hyunju Jin1, Hyun-Chang Ko1,3, Moon-Bum Kim1,3, Jung-Min Kim4,  Do-Won Kim5, Ho-Sun Jang6, Byung-Soo Kim1,3 1Department of Dermatology, Pusan National University School of Medicine, 2Bon Dermatologic Clinic, 3Biomedical Research Institute,  Pusan National University Hospital, Busan, Departments of 4Microbiology and 5Dermatology, Kyungpook National University School of  Medicine, Deagu, 6Jang Ho Sun Dermatologic Clinic, Busan, Korea  Background:  A small subset of adolescents atopic dermatitis   (AD) tends to persist.",Non-OADS,/arxiv_data1/oa_pdf/0a/d7/ad-28-470.PMC4969477.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.479 ORIGINAL ARTICLE Immunohistochemistry and Polymerase Chain Reaction  for Detection Human Papilloma Virus in Warts: A Comparative Study Hong Sun Lee1, Ji Hyun Lee2, Ji Yoon Choo2, Hee Jin Byun3-5, Jin Hyun Jun6, Jun Young Lee1,2 1Department of Dermatology, College of Medicine, The Catholic University of Korea, 2Department of Dermatology, Seoul St. Mary’s  Hospital, College of Medicine, The Catholic University of Korea, 3Department of Dermatology, Seoul National University College of  Medicine, 4Institute of Dermatological Science, Medical Research Center, Seoul National University, 5Laboratory of Cutaneous Aging  Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, 6Department of Bio-Medical Laboratory Science, Eulji  Medi-Bio Research Institute, Eulji University, Seongnam, Korea Background:  Immunohistochemistry and polymerase chain  reaction (PCR) are the most widely used methods for the de-tection of viruses.",Non-OADS,/arxiv_data1/oa_pdf/82/c5/ad-28-479.PMC4969478.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.486 CASE REPORT Increased Infiltration of CD8+ T Cells by Dacarbazine  in a Patient with Mucosal Penile Melanoma Refractory to Nivolumab Masato Funazumi, Takeshi Namiki, Yumi Arima, Kohei Kato, Kohei Nojima, Kentaro Tanaka1,  Keiko Miura2, Hiroo Yokozeki Departments of Dermatology, 1Plastic Surgery, and 2Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and  Dental University, Tokyo, Japan Primary penile melanomas are rare tumors that represent less  than 0.1% of all melanomas.",Non-OADS,/arxiv_data1/oa_pdf/c1/d7/ad-28-486.PMC4969479.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.491 CASE REPORT Fig.",Non-OADS,/arxiv_data1/oa_pdf/9e/04/ad-28-491.PMC4969480.pdf
"4, 2016 http://dx.doi.org/10.5021/ad.2016.28.4.495 BRIEF REPORT Fig.",Non-OADS,/arxiv_data1/oa_pdf/3e/0c/ad-28-495.PMC4969481.pdf
"http://dx.doi.org/10.5021/ad.2016.28.4.497 Extramammary Paget’s Disease Combined with  Squamous Cell Carcinoma In Situ  of the Vulva:  A Case Report and Differential Diagnosis  Eun Jeong Jang, Young Kyung Bae, Dong Hoon Shin1, Doo Jin Lee2 Departments of Pathology, 1Dermatology, and 2Gynecology, Yeungnam University College of Medicine, Daegu, Korea Dear Editor: A 68-year-old woman presented with itching sensation of  the vulva.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/ad-28-497.PMC4969482.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.4.499 A Unique Cutaneous Presentation of Breast Cancer:  A Red Apple Stuck in the Breast  Hyun-Joo Lee1, Jeong-Min Kim1, Gun-Wook Kim1, Je-Ho Mun1,3, Hoon-Soo Kim1,2,  Hyun-Chang Ko1,3, Byung-Soo Kim1,2, Moon-Bum Kim1,2, Margaret Song1,2 1Department of Dermatology, Pusan National University School of Medicine, 2Bio-Medical Research Institute, Pusan National University  Hospital, Busan, 3Research Institute for Convergence of Biomedical Science an d Technology, Pusan National University Yangsan Hospital,  Yangsan, Korea Dear Editor: Cutaneous involvement of brea st cancer is an uncommon  occurrence for a dermatologis t although breast cancer is  the most common source of cutaneous metastasis in  women.",Non-OADS,/arxiv_data1/oa_pdf/5a/13/ad-28-499.PMC4969483.pdf
"South Med J 2003;96:164-167. http://dx.doi.org/10.5021/ad.2016.28.4.501 Transepidermal Elimination of Gold Metals after  Face-Lifting Acupuncture Dong In Keum, Hana Bak, Sung Ku Ahn Department of Dermatology, Yonsei Universi ty Wonju College of Medicine, Wonju, Korea Dear Editor: Numerous interventions are offered for skin rejuvenation  and anti-skin aging including treatments for facial wrin- kles, facial muscle tone, and elasticity1.",Non-OADS,/arxiv_data1/oa_pdf/5a/13/ad-28-499.PMC4969483.pdf
"South Med J 2003;96:164-167. http://dx.doi.org/10.5021/ad.2016.28.4.501 Transepidermal Elimination of Gold Metals after  Face-Lifting Acupuncture Dong In Keum, Hana Bak, Sung Ku Ahn Department of Dermatology, Yonsei Universi ty Wonju College of Medicine, Wonju, Korea Dear Editor: Numerous interventions are offered for skin rejuvenation  and anti-skin aging including treatments for facial wrin- kles, facial muscle tone, and elasticity1.",Non-OADS,/arxiv_data1/oa_pdf/be/ec/ad-28-501.PMC4969484.pdf
"(D) Skin atrophy with resolving blisters on the leg.http://dx.doi.org/10.5021/ad.2016.28.4.503 Homozygous Deletion Mutation of the FERMT1  Gene  in a Chinese Patient with Kindler Syndrome Seung Joon Oh, Song-Ee Kim, Sang Eun Lee, Soo-Chan Kim Department of Dermatology and Cutaneous Biology Research Institute, Gangnam Severance Hospital, Yonsei University College of  Medicine, Seoul, Korea Dear Editor: Kindler syndrome (KS, OMIM173650) is a rare autosomal  recessive genodermatosis characterized by trauma-in-duced skin blistering, cutaneous atrophy, progressive poi- kiloderma and ph otosensitivity 1.",Non-OADS,/arxiv_data1/oa_pdf/a0/70/ad-28-503.PMC4969485.pdf
"To date, more than 60 FERMT1  gene mutations and 150  KS patients have been reported and one Chinese and 4  Japanese patients have been reported in Eastern Asia5  (https://grenada.lumc.nl/L OVD2/mendelian_genes/home.p hp?select_db=FERMT1).",Non-OADS,/arxiv_data1/oa_pdf/a0/70/ad-28-503.PMC4969485.pdf
"http://dx.doi.org/10.5021/ad.2016.28.4.505 A Case of Facial Sarcoptes scabiei  in a Female Child Joon Seok, Kui Young Park, Kapsok Li, Beom Joon Kim, Seong Jun Seo, Myeung Nam Kim,  Chang Kwun Hong Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea  Dear Editor: Scabies in infants and young children differs from adult  scabies infection and is frequently misdiagnosed1.",Non-OADS,/arxiv_data1/oa_pdf/a0/70/ad-28-503.PMC4969485.pdf
"http://dx.doi.org/10.5021/ad.2016.28.4.505 A Case of Facial Sarcoptes scabiei  in a Female Child Joon Seok, Kui Young Park, Kapsok Li, Beom Joon Kim, Seong Jun Seo, Myeung Nam Kim,  Chang Kwun Hong Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea  Dear Editor: Scabies in infants and young children differs from adult  scabies infection and is frequently misdiagnosed1.",Non-OADS,/arxiv_data1/oa_pdf/10/af/ad-28-505.PMC4969486.pdf
"(B) Skin lesions  showing completely cured after six  months of treatment.http://dx.doi.org/10.5021/ad.2016.28.4.507 Cutaneous Sporotrichosis Presenting as Clinical Feature  of Facial Cellulitis in an Adult Jun Gyu Song, You Bum Song, Sang Youl  Yun, Moo Kyu Suh, Gyoung Yim Ha1, Jung Ran Kim2,  Jong Soo Choi3 Departments of Dermatology, Laboratory Medicine1, and Pathology2, Dongguk University College of Medicine, Gyeongju, 3Department of  Dermatology, Yeungnam University College of Medicine, Daegu, Korea Dear Editor: Sporotrichosis is subcutane ous mycosis due to the dimor- phic fungus Sporothrix schenckii  complex1-3.",Non-OADS,/arxiv_data1/oa_pdf/61/94/ad-28-507.PMC4969487.pdf
"Erythematous plaque on the left cheek with a white  atrophic area in the lower part of the lesion as the trace of an  old scar.http://dx.doi.org/10.5021/ad.2016.28.4.509 Scar Sarcoidosis Induced by Pulsed Dye Laser Treatment Hyeong-Rae Kim, Sue-Jeong Kim, Myung Im, Yo ung Lee, Young-Joon Seo, Jeung-Hoon Lee Department of Dermatology, Chungnam National University School of Medicine, Daejeon, Korea Dear Editor: Sarcoidosis is a multi-systemic disease of unknown etiology.",Non-OADS,/arxiv_data1/oa_pdf/b8/b5/ad-28-509.PMC4969488.pdf
"A solitary asymptomatic 6-mm sized, flesh-colored,  dome-shaped nodule on the left postauricular area.http://dx.doi.org/10.5021/ad.2016.28.4.511 A Case of Late Stage Sebaceous Trichofolliculoma  Showing Overlapping Features with Folliculosebaceous Cystic Hamartoma Eun-Jae Shin, Ki-Heon Jeong, Min-Kyung Shin Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, Korea Dear Editor: Sebaceous trichofolliculoma (ST) is a rare benign tumor  and represents a variant of tr ichofolliculoma (TF).",Non-OADS,/arxiv_data1/oa_pdf/26/01/ad-28-511.PMC4969489.pdf
"Physical examination re- vealed asymptomatic, four, firm, skin-colored tumors with longitu- dinal grooves of subjacent nails on  both great toes.http://dx.doi.org/10.5021/ad.2016.28.4.513 Multiple Acquired Periungual Fibrokeratoma Yoon Seob Kim, Ji Hyun Lee, Young Min Park, Jun Young Lee Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Dear Editor: Acquired periungual fib rokeratoma (APF) is a rare and be- nign tumor that usually presents as a solitary, fibrous, and hyperkeratotic lesion 1.",Non-OADS,/arxiv_data1/oa_pdf/46/0a/ad-28-513.PMC4969490.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.4.515 Donut Ablation Method as an Alternative to Surgical  Excision or T otal Ablational Laser Treatment Joon Min Jung, Seung Seog Han1, Chong Hyun Won, Sung Eun Chang Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, 1I Dermatology Clinic, Seoul, Korea Dear Editor: We read with interest the article entitled ‘‘Effective  Treatment of Congenital Melanocytic Nevus and Nevus Sebaceous Using the Pinhole Method with the Er- bium-Doped Yttrium Alum inium Garnet Laser’’ 1.",Non-OADS,/arxiv_data1/oa_pdf/86/88/ad-28-515.PMC4969491.pdf
"Lasers Surg Med 1999;24:122-127. http://dx.doi.org/10.5021/ad.2016.28.4.517 Acral Persistent Papular Mucinosis with Partial  Response to T acrolimus Ointment Ji-Young Jun, Seung Hwan Oh, Joon Ho Shim, Jun-Hwan Kim, Ji-Hye Park, Dong-Youn Lee Department of Dermatology, Samsung Medical Center, Sung kyunkwan University School of Medicine, Seoul, Korea Dear Editor: Acral persistent papular muci nosis (APPM) is a rare sub- type of localized lichen myxedematosus (LM)1 with un- known etiology.",Non-OADS,/arxiv_data1/oa_pdf/86/88/ad-28-515.PMC4969491.pdf
"Lasers Surg Med 1999;24:122-127. http://dx.doi.org/10.5021/ad.2016.28.4.517 Acral Persistent Papular Mucinosis with Partial  Response to T acrolimus Ointment Ji-Young Jun, Seung Hwan Oh, Joon Ho Shim, Jun-Hwan Kim, Ji-Hye Park, Dong-Youn Lee Department of Dermatology, Samsung Medical Center, Sung kyunkwan University School of Medicine, Seoul, Korea Dear Editor: Acral persistent papular muci nosis (APPM) is a rare sub- type of localized lichen myxedematosus (LM)1 with un- known etiology.",Non-OADS,/arxiv_data1/oa_pdf/c8/88/ad-28-517.PMC4969492.pdf
"J Am Acad Dermatol 2008;58:530-532. http://dx.doi.org/10.5021/ad.2016.28.4.519 Cutaneous Metastasis of Rhabdomyosarcoma Originated  from Maxillary Sinus in a Young Adult Female Jun-Hwan Kim, Seunghwan Oh, Ji-Young Jun, Joon Ho Shim, Ji-Hye Park, Dong-Youn Lee Department of Dermatology, Samsung Medical Center, Sung kyunkwan University School of Medicine, Seoul, Korea Dear Editor: Rhabdomyosarcoma (RMS) is a malignant mesenchymal  neoplasm showing skeletal myogenic differentiation that  usually arises on the head an d neck, genitourinary tract, or  soft tissue of the extremities1.",Non-OADS,/arxiv_data1/oa_pdf/c8/88/ad-28-517.PMC4969492.pdf
"J Am Acad Dermatol 2008;58:530-532. http://dx.doi.org/10.5021/ad.2016.28.4.519 Cutaneous Metastasis of Rhabdomyosarcoma Originated  from Maxillary Sinus in a Young Adult Female Jun-Hwan Kim, Seunghwan Oh, Ji-Young Jun, Joon Ho Shim, Ji-Hye Park, Dong-Youn Lee Department of Dermatology, Samsung Medical Center, Sung kyunkwan University School of Medicine, Seoul, Korea Dear Editor: Rhabdomyosarcoma (RMS) is a malignant mesenchymal  neoplasm showing skeletal myogenic differentiation that  usually arises on the head an d neck, genitourinary tract, or  soft tissue of the extremities1.",Non-OADS,/arxiv_data1/oa_pdf/12/db/ad-28-519.PMC4969493.pdf
"http://dx.doi.org/10.5021/ad.2016.28.4.522 Palmoplantar Pustulosis Induced by both Adalimumab  and Golimumab for Treatment of Ankylosing Spondylitis Jung Eun Seol, In Ho Park, Wonkyung Lee, Hyojin Kim, So Young Jung1, Han Young Wang1 Department of Dermatology, Inje University Busan Paik Hospital, 1Department of Dermatology, Inje University Haeundae Paik Hospital,  Busan, Korea Dear Editor: Adalimumab is a fully humanized monoclonal tumor ne- crosis factor (TNF)- α antibody used to treat various in- flammatory diseases, including ankylosing spondylitis,  rheumatoid arthritis, and psoriasis1.",Non-OADS,/arxiv_data1/oa_pdf/89/6e/ad-28-522.PMC4969494.pdf
"Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatologyhttp://dx.doi.org/10.5021/ad.2016.28.4.524 The Epidemiology of Dermatophyte Infection  in Southeastern Korea (1979 ∼2013) Sang Lim Kim, Kyou Chae Lee, Yong Hyun Jang, Seok-Jong Lee, Do Won Kim, Weon Ju Lee,  Yong Jun Bang1, Jae Bok Jun1 Department of Dermatology, Kyungpook National University School of Medicine, 1Institute of Medical Mycology, Catholic Skin Clinic,  Daegu, Korea Dear Editor: Dermatophytosis is common worldwide and is believed to  affect more than 20% ∼25% of the world’s population1.",Non-OADS,/arxiv_data1/oa_pdf/db/32/ad-28-524.PMC4969495.pdf
"(B) One week after incision and drainage with antibiotics treatment, the  abscess cleared only leaving mild skin excoriation, trachionychia  and Beau’s line, which all releaved afterwards.http://dx.doi.org/10.5021/ad.2016.28.4.528 Periungual Abscess Caused by Citrobacter braakii   in a Patient with Chronic Paronychia Soo Hyeon Bae, Seong-Jin Kim Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea  Dear Editor: Citrobacter  species, aerobic, gram-negative bacilli in the  Enterobacteriaceae  family, are normally present in the en- vironment and do not usually cause disease in immu- nocompetent hosts1.",Non-OADS,/arxiv_data1/oa_pdf/48/13/ad-28-528.PMC4969496.pdf
"World Appl Sci J 2012;19:1234-1243. http://dx.doi.org/10.5021/ad.2016.28.4.529 A Rare Cutaneous Adverse Reaction after Intra-Articular  Injection of Hyaluronic Acid Hee-Chul Chung, Hana Bak, Jin Wook Lee, Sung Ku Ahn Department of Dermatology, Yonsei Universi ty Wonju College of Medicine, Wonju, Korea Dear Editor: Hyaluronic acid (HA) is a high-molecular-weight poly- saccharide found throughout the extracellular matrix and  is one of the major components of articular joints.",Non-OADS,/arxiv_data1/oa_pdf/48/13/ad-28-528.PMC4969496.pdf
"World Appl Sci J 2012;19:1234-1243. http://dx.doi.org/10.5021/ad.2016.28.4.529 A Rare Cutaneous Adverse Reaction after Intra-Articular  Injection of Hyaluronic Acid Hee-Chul Chung, Hana Bak, Jin Wook Lee, Sung Ku Ahn Department of Dermatology, Yonsei Universi ty Wonju College of Medicine, Wonju, Korea Dear Editor: Hyaluronic acid (HA) is a high-molecular-weight poly- saccharide found throughout the extracellular matrix and  is one of the major components of articular joints.",Non-OADS,/arxiv_data1/oa_pdf/02/e4/ad-28-529.PMC4969497.pdf
Avail - able at: http://www.pewresearch.org/fact-tank/2013/06/06/cell-phone- ownership-hits-91-of-adults/.,Non-OADS,/arxiv_data1/oa_pdf/90/32/DialoguesClinNeurosci-18-127.PMC4969699.pdf
Available at: http://www.gsma - mobileeconomy.com/GSMA_Global_Mobile_Economy_Report_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/90/32/DialoguesClinNeurosci-18-127.PMC4969699.pdf
Available at: http://apps.who.int/iris/bitst ream/10665/44508/1/9789241501019_eng.pdf.,OADS,/arxiv_data1/oa_pdf/90/32/DialoguesClinNeurosci-18-127.PMC4969699.pdf
Available at https://rockhealth.com/reports/the-future-of-biosensing- wearables.,Non-OADS,/arxiv_data1/oa_pdf/90/32/DialoguesClinNeurosci-18-127.PMC4969699.pdf
Available at: http://www.forbes.com/sites/ ptc/2013/11/05/how-google-glass-is-now-being-used-during-surgery/#271 5e4857a0b2633e9ca1413.,Non-OADS,/arxiv_data1/oa_pdf/90/32/DialoguesClinNeurosci-18-127.PMC4969699.pdf
Available at: http://www.healthcareitnews.com/news/drchronos- bright-ideas-google-glass.,Non-OADS,/arxiv_data1/oa_pdf/90/32/DialoguesClinNeurosci-18-127.PMC4969699.pdf
Available at:  http://www.newyorker.com/magazine/2015/02/09/r-u.,Non-OADS,/arxiv_data1/oa_pdf/90/32/DialoguesClinNeurosci-18-127.PMC4969699.pdf
Available at: https://www.clinicaltrials.gov/ ct2/show/study/NCT01568229.,Non-OADS,/arxiv_data1/oa_pdf/e8/ae/DialoguesClinNeurosci-18-135.PMC4969700.pdf
Avail - able at: http://www.allen-cognitive-network.org/index.php/allen-model/ routine-task-inventory-expanded-rti-e. Accessed February 2016.,OADS,/arxiv_data1/oa_pdf/61/56/DialoguesClinNeurosci-18-145.PMC4969701.pdf
Available at:  http://www.occu - pationalinfo.org.,Non-OADS,/arxiv_data1/oa_pdf/61/56/DialoguesClinNeurosci-18-145.PMC4969701.pdf
Available at: http://d-scholarship.pitt.edu/80 00/.,Non-OADS,/arxiv_data1/oa_pdf/61/56/DialoguesClinNeurosci-18-145.PMC4969701.pdf
Available at:  http://d-scholarship.pitt.edu/9697/.,Non-OADS,/arxiv_data1/oa_pdf/61/56/DialoguesClinNeurosci-18-145.PMC4969701.pdf
Available at: http://www.digitaltrends.com/ mobile/us-smartphone-users-now-over-100-million-android-increases- market-share/.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/DialoguesClinNeurosci-18-163.PMC4969703.pdf
http://www.emarketer.com/Article/2-Billion-Consum - ers-Worldwide-Smartphones-by-2016/1011694.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/DialoguesClinNeurosci-18-163.PMC4969703.pdf
Available at: http://www.csmoni - tor.com/USA/Society/2011/0210/Cellphones-helping-minorities-close-gap- on-Internet-access.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/DialoguesClinNeurosci-18-163.PMC4969703.pdf
Available at: http://www.dmwmedia.com/news/2012/05/07/ research-ethnic-minorities-quickest-to-adopt-smartphones-with-charts.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/DialoguesClinNeurosci-18-163.PMC4969703.pdf
Available at: http://www.pewinternet.org/2015/04/01/us-smartphone-use- in-2015/.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/DialoguesClinNeurosci-18-163.PMC4969703.pdf
Available at: http://www.statista.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/DialoguesClinNeurosci-18-163.PMC4969703.pdf
Available at: http://www.medscape.com/view - article/851226.,Non-OADS,/arxiv_data1/oa_pdf/c2/8f/DialoguesClinNeurosci-18-163.PMC4969703.pdf
"In the intervention region Szolnok, a significant reduc - tion in completed suicides was observed both compared  with a control region and with changes in national sui - cide rates.27 In the meantime, the European Commis - sion’s Green Paper on mental health (http://ec.europa.",Non-OADS,/arxiv_data1/oa_pdf/d9/b5/DialoguesClinNeurosci-18-183.PMC4969705.pdf
Available at: http://www.itu.int/en/ITU-D/Statistics/ Documents/facts/ICTFactsFigures2015.pdf.,OADS,/arxiv_data1/oa_pdf/cb/e0/DialoguesClinNeurosci-18-191.PMC4969706.pdf
Available  from: http://www.timesofindia.indiatimes.com/india/ Should‑celebrities‑endorse‑with‑care/articleshow/51860894.cms.,Non-OADS,/arxiv_data1/oa_pdf/33/f5/IJU-32-171.PMC4970384.pdf
Available from: http://www.mohanfoundation.org/ THO‑amendment‑act‑2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c2/d8/IJU-32-173.PMC4970385.pdf
Available from: http://www.mohanfoundation.org/newsletters/itns/ details.asp?id=93.,Non-OADS,/arxiv_data1/oa_pdf/c2/d8/IJU-32-173.PMC4970385.pdf
"[3] The ESRD  risk is small for well-screened donors, and it  can be calculated for individuals by using an  online risk tool (http://www.transplantmodels.",Non-OADS,/arxiv_data1/oa_pdf/0b/a4/IJU-32-175.PMC4970386.pdf
Available from:  http://www.nephron.org/cgi‑bin/rpa_sdm.cgi.,Non-OADS,/arxiv_data1/oa_pdf/0b/a4/IJU-32-175.PMC4970386.pdf
Available from: https://www.unos.org/wp‑content/uploads/unos/ Appendix_B_AttachI_XIII.pdf.,Non-OADS,/arxiv_data1/oa_pdf/92/3f/IJU-32-192.PMC4970389.pdf
Available from: http://www.micromedexsolutions.com.,Non-OADS,/arxiv_data1/oa_pdf/92/3f/IJU-32-192.PMC4970389.pdf
Available from: http://www.sciencedirect.com/science/article/pii/ S1110570412001075 [Last accessed on 2016 Jan 26].,Non-OADS,/arxiv_data1/oa_pdf/18/a0/IJU-32-229.PMC4970396.pdf
Available from: http://www.foxnews.com/us/2013/06/16/ap- impact-bite-marks-long-accepted-as-criminal-evidence-face- doubts-about/.,Non-OADS,/arxiv_data1/oa_pdf/c0/d7/JFDS-8-103.PMC4970404.pdf
Available from: http://www.nlm.nih.gov/medlineplus/ency/ article/002498.htm.,Non-OADS,/arxiv_data1/oa_pdf/c0/d7/JFDS-8-103.PMC4970404.pdf
Marcus  S. Available from: http://emedicine.medscape.com/ article/815399-overview.,Non-OADS,/arxiv_data1/oa_pdf/c0/d7/JFDS-8-103.PMC4970404.pdf
Available from:  http://www.oxforddictionaries.com/definition/english/ eunuch?q=eunuchs and searchDictCode=all.,Non-OADS,/arxiv_data1/oa_pdf/82/27/JFDS-8-108.PMC4970405.pdf
Available from: http://www.merriam‑webster.com/dictionary/ transgender [Last accessed on 2015 Jul 01].,OADS,/arxiv_data1/oa_pdf/82/27/JFDS-8-108.PMC4970405.pdf
Available from: http://www.acf.hhs.gov/programs/cb/ research‑data‑technology/statistics‑research/child‑maltreatment.,Non-OADS,/arxiv_data1/oa_pdf/b9/03/JFDS-8-113b.PMC4970412.pdf
Available from: http://www.teethremoval.com/ dental_deaths.html.,Non-OADS,/arxiv_data1/oa_pdf/85/a4/JFDS-8-61.PMC4970415.pdf
Available from: http://www.imaindia.org/ downloads/Supreme%20Court%20Judgement%20regarding%20arrest%20of%20doctors%20for%20criminal%20negligence.pdf.,Non-OADS,/arxiv_data1/oa_pdf/85/a4/JFDS-8-61.PMC4970415.pdf
Available from: http://www.cricklaw.com/docs/Death_in_ the_Chair_Article.pdf.,Non-OADS,/arxiv_data1/oa_pdf/85/a4/JFDS-8-61.PMC4970415.pdf
Available  from: http://www.dciindia.org.in/Rule_Regulation/Gazette_ Notification_reg_DCI_Revised_Dentists_Code_of_Ethics_ Regulations_2014_27.07.2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/85/a4/JFDS-8-61.PMC4970415.pdf
Available from: http://www.icf.indianrailways.gov.in/uploads/ files/CrPC.pdf.,Non-OADS,/arxiv_data1/oa_pdf/85/a4/JFDS-8-61.PMC4970415.pdf
Available from: http://www.icf.indianrailways.,Non-OADS,/arxiv_data1/oa_pdf/85/a4/JFDS-8-61.PMC4970415.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (http://creativecommons.org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distribution, and reproduc- tion in any medium, provided the same Creative Commons licence is included and the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/42/S0007114516002786a.PMC4970443.pdf
"Higher Education for England (2015) Policy for open access in the post-2014 Research Excellence Framework: UpdatedJuly 2015. http://www.hefce.ac.uk/media/HEFCE,2014/Content/ Pubs/2014/201407/HEFCE2014_07_updated%20July%202015.",Non-OADS,/arxiv_data1/oa_pdf/9c/42/S0007114516002786a.PMC4970443.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/0e/ijn-11-3533.PMC4970448.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3533–3544International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3533OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11048 8 aptamer-hybrid nanoparticle bioconjugate  efficiently delivers miRNA-29b to non-small-cell  lung cancer cells and inhibits growth by  downregulating essential oncoproteins Maryna Perepelyuk christina Maher ashakumary  lakshmikuttyamma sunday a shoyele Department of Pharmaceutical  science, college of Pharmacy, Thomas  Jefferson University, Philadelphia,   Pa, UsaAbstract:  MicroRNAs (miRNAs) are potentially attractive candidates for cancer therapy.",Non-OADS,/arxiv_data1/oa_pdf/9f/0e/ijn-11-3533.PMC4970448.pdf
"Members of miRNA-29 family have been known to play an important role  in cancer by regulating cell differentiation, proliferation, apoptosis, invasion, and  migration.4,5 However, clinical application of this relatively novel therapeutic faces  many challenges, including degradation in serum, rapid blood clearance, stimula - tion of immune response, off-target effects, and poor cellular uptake.6 Recently,  our group developed a novel targeted hybrid nanoparticle delivery system.7–9 This  delivery system demonstrated its ability to protect loaded oligonucleotide against  serum nuclease, reduce rate of blood clearance, efficient cellular uptake, and selective correspondence: sunday a shoyele Department of Pharmaceutical science,  college of Pharmacy, Thomas Jefferson  University, Ninth Floor, 901 Walnut  Street, Philadelphia, PA 19107, USA Tel +1 215 503 3407 email sunday.shoyele@jefferson.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Perepelyuk et al Running head recto: Aptamer-nanoparticle bioconjugates in lung cancer DOI: http://dx.doi.org/10.2147/IJN.S110488",Non-OADS,/arxiv_data1/oa_pdf/9f/0e/ijn-11-3533.PMC4970448.pdf
Available from: http://seer.cancer.gov/csr/1975_2009_ pops09 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/0e/ijn-11-3533.PMC4970448.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9f/0e/ijn-11-3533.PMC4970448.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/0e/ijn-11-3533.PMC4970448.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/fe/ijn-11-3545.PMC4970449.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3545–3555International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3545OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9706 3 Degradability, cytocompatibility, and osteogenesis  of porous scaffolds of nanobredigite and  Pcl–Peg–Pcl composite Jun hou1 Donghui Fan2 lingming Zhao2 Baoqin Yu3 Jiacan su3 Jie Wei2 Jung-Woog shin4 1The First affiliated hospital of anhui  Medical University, Department  of Oral and Maxillofacial surgery,   hefei, 2Key laboratory for Ultrafine  Materials of Ministry of education  and The state Key laboratory  of Bioreactor engineering, east  china University of science and  T echnology, shanghai, 3Department  of Orthopaedics Trauma, changhai  hospital, second Military Medical  University, shanghai, People's republic  of china; 4Department of Biomedical  engineering, Inje University, gimhae,   republic of KoreaAbstract:  Biocomposite scaffolds were fabricated by incorporation of nanobredigite (n-BD)  into the polymer of poly( ε-caprolactone)–poly(ethyleneglycol)–poly( ε-caprolactone) (PCL– PEG–PCL).",Non-OADS,/arxiv_data1/oa_pdf/c8/fe/ijn-11-3545.PMC4970449.pdf
"Degradable polymers of poly( ε-caprolactone)–poly(ethyleneglycol)–poly  (ε-caprolactone) (PCL–PEG–PCL) have been reported to possess good biocompatibility, correspondence: Donghui Fan Key Laboratory for Ultrafine Materials  of Ministry of education, east china  University of science and Technology,  shanghai 200237, People’s republic of  china email dyt901208@163.co m  Jiacan su Department of Orthopedics Trauma,  changhai hospital, second Military  Medical University, shanghai 200433,  People’s republic of china Tel +86 21 8187 3400 Fax +86 21 8187 3398 email jiacansu@sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hou et al Running head recto: Degradability, cytocompatibility, and osteogenesis of porous scaffolds DOI: http://dx.doi.org/10.2147/IJN.S97063",Non-OADS,/arxiv_data1/oa_pdf/c8/fe/ijn-11-3545.PMC4970449.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c8/fe/ijn-11-3545.PMC4970449.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/fe/ijn-11-3545.PMC4970449.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/5a/ijn-11-3501.PMC4970450.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3501–3516International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3501OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10869 4 Nanostructured lipid carriers loaded with  resveratrol modulate human dendritic cells João P Barbosa1–3,* ana r Neves3,* andreia M silva1,2,4 Mário a Barbosa1,2,4 M salette reis3 susana g santos1,2 1Instituto de Investigação e Inovação  em saúde, Universidade do Porto,   Portugal; 2INeB - Instituto de  engenharia Biomédica, Universidade  do Porto, Portugal; 3UcIBIO,   reQUIMT e, chemical sciences  Department, Faculty of Pharmacy,   University of Porto, Portugal;   4Instituto de ciências Biomédicas  abel salazar, Universidade do Porto,   Porto, Portugal *These authors contributed equally  to this workAbstract:  Dendritic cells (DCs) are promising targets for drug delivery, as they can induce  immunity or tolerance.",Non-OADS,/arxiv_data1/oa_pdf/9f/5a/ijn-11-3501.PMC4970450.pdf
"Thus,  DC labeling could be an important tool in evaluating the efficacy of immunotherapy.1 The natural antioxidant and anti-inflammatory compound resveratrol (rsv) is found  in a variety of plants and fruits that constitute our normal diet, such as grapes and also correspondence: susana g santos Instituto de Investigação e Inovação  em saúde, rua alfredo allen 208,  4200-135 Porto, Portugal Tel +351 22 040 8800 ext 6075 email susana.santos@ineb.up.p t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Barbosa et al Running head recto: Nanostructured lipid carriers for dendritic cells DOI: http://dx.doi.org/10.2147/IJN.S108694",Non-OADS,/arxiv_data1/oa_pdf/9f/5a/ijn-11-3501.PMC4970450.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9f/5a/ijn-11-3501.PMC4970450.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/5a/ijn-11-3501.PMC4970450.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a3/64/ijn-11-3487.PMC4970452.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3487–3500International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3487OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11092 0 a nano-sandwich construct built with graphene  nanosheets and carbon nanotubes enhances  mechanical properties of hydroxyapatite– polyetheretherketone scaffolds Pei Feng1,* shuping Peng2,3,* Ping Wu4 chengde gao1 Wei huang1 Y ouwen Deng5 Tao Xiao5 cijun shuai1 1state Key laboratory of  high Performance complex  Manufacturing, 2The Key laboratory  of carcinogenesis and cancer  Invasion of the chinese Ministry  of education, 3The Key laboratory  of carcinogenesis of the chinese  Ministry of health and cancer  research Institute, Xiangya hospital,   central south University, changsha,   4college of chemistry, Xiangtan  University, Xiangtan, 5Department  of Orthopedics, The second Xiangya  hospital, central south University,   changsha, People’s republic of china *These authors contributed equally  to this workAbstract:  A nano-sandwich construct was built by combining two-dimensional graphene  nanosheets (GNSs) and one-dimensional carbon nanotubes (CNTs) to improve the mechanical  properties of hydroxyapatite–polyetheretherketone (HAP–PEEK) scaffolds for bone tissue  engineering.",Non-OADS,/arxiv_data1/oa_pdf/a3/64/ijn-11-3487.PMC4970452.pdf
"However, GNSs  are prone to aggregate and stack due to the strong π–π interactions and large van der  Waals forces, which lead to poor dispersion in matrix, and then this largely hampers  the reinforcement efficiency.7–9 Carbon nanotubes (CNTs), one-dimensional carbon nanomaterials, possess the  unique long and tubular structures of nanosized diameter and large length/diameter  ratio.10–12 A sandwich construct can be built by introducing the one-dimensional CNTs correspondence: cijun shuai state Key laboratory of high Performance  complex Manufacturing, central south  University, Qingshui road, changsha  410083, People’s republic of china Tel +86 731 8887 9351 Fax +86 731 8887 9044 email shuai@csu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Feng et al Running head recto: A nano-sandwich construct built with GNSs and CNTs DOI: http://dx.doi.org/10.2147/IJN.S110920",Non-OADS,/arxiv_data1/oa_pdf/a3/64/ijn-11-3487.PMC4970452.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a3/64/ijn-11-3487.PMC4970452.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/64/ijn-11-3487.PMC4970452.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d9/63/ijn-11-3517.PMC4970453.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3517–3531International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3517OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10534 8 The synergistic radiosensitizing effect of  tirapazamine-conjugated gold nanoparticles on   human hepatoma hepg2 cells under  X-ray irradiation Xi liu1–4 Yan liu1–4 Pengcheng Zhang1–4 Xiaodong Jin1–3 Xiaogang Zheng1–4 Fei Ye1–4 Weiqiang chen1–3 Qiang li1–3 1Institute of Modern Physics, 2Key  laboratory of heavy Ion radiation  Biology and Medicine, chinese  academy of sciences, 3Key laboratory  of Basic research on heavy Ion  radiation application in Medicine,   gansu Province, lanzhou, 4school of  life science, University of chinese  academy of sciences, Beijing, People’s  republic of chinaAbstract:  Reductive drug-functionalized gold nanoparticles (AuNPs) have been proposed  to enhance the damage of X-rays to cells through improving hydroxyl radical production by  secondary electrons.",Non-OADS,/arxiv_data1/oa_pdf/d9/63/ijn-11-3517.PMC4970453.pdf
"Radiation therapy is one of the primary  modalities of cancer treatment, which provide relieve from symptoms of advanced or  metastatic diseases, and is the need of .50% of cancer patients.2 The major challenge  of radiation therapy is maximizing the radiation dose delivered to malignant tissues  while minimizing damage to the surrounding normal tissues.3–5 Improving the efficacy  of radiation therapy, like enhancing the radiation effects by increasing the dose specifi - cally to the tumor cells, can benefit a significant number of patients.6,7 One way of improving the efficacy of radiation therapy is by expanding photon/ Auger electron induction in the physical/chemical stage during irradiation, which will  lead to enhancement in reactive oxygen species (ROS) production and subsequently  the radiobiological response.8 The interaction of ionizing radiation with high- Z correspondence: Weiqiang chen;  Qiang li Institute of Modern Physics, chinese  academy of sciences, No 509 Nanchang  road, chengguan District, lanzhou,  gansu Province, People’s republic of  china Tel +86 931 496 9316 email chenwq7315@impcas.ac.c n;  liqiang@impcas.ac.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: Radiosensitization by gold nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S105348",Non-OADS,/arxiv_data1/oa_pdf/d9/63/ijn-11-3517.PMC4970453.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d9/63/ijn-11-3517.PMC4970453.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/63/ijn-11-3517.PMC4970453.pdf
Keywords Contraception; Failure rates; Unintended pregnancy; International; Life tables This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd// ).,Non-OADS,/arxiv_data1/oa_pdf/a9/db/nihms797097.PMC4970461.pdf
"The complete report and accompanying tables can be found at http://www.guttmacher.org/ report/contraceptive-failure-rates-in-developing-world  (available after March 24, 2016).",Non-OADS,/arxiv_data1/oa_pdf/a9/db/nihms797097.PMC4970461.pdf
"Accepted for publication: 17 June 2016 To cite this article: Lopatiene K, Borisovaite M, Lapenaite E. Prevention and Treatment of White Spot Lesions During and After Treatment with Fixed Orthodontic Appliances: a Systematic  Literature Review J Oral Maxillofac Res 2016;7(2):e1 URL: http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1.pdf doi: 10.5037/jomr.2016.7201 http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.",Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
[URL: http://www.academicjournals.org/journal/JDOH/article-abstract/4AEC3755437 ] 23.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
[URL: http://handbook.cochrane.org/index.htm#chapter_8/8_assessing_risk_of_bias_in_included_studies.htm ] 27.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
"To cite this article: Lopatiene K, Borisovaite M, Lapenaite E. Prevention and Treatment of White Spot Lesions During and After Treatment with Fixed Orthodontic Appliances: a Systematic  Literature Review J Oral Maxillofac Res 2016;7(2):e1 URL: http://www.ejomr.org/JOMR/archives/2016/2/e1/v7n2e1.pdf doi: 10.5037/jomr.2016.7201 Copyright ©  Lopatiene K, Borisovaite M, Lapenaite E. Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 30 June 2016.",Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/9c/2a/jomr-07-e1.PMC4970501.pdf
Inflammatory Cytokines Interleukin-1β and Tumour Necrosis Factor-α - Novel Biomarkers for the Detection of Periodontal  Diseases: a Literature Review J Oral Maxillofac Res 2016;7(2):e2 URL: http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2.pdf doi: 10.5037/jomr.2016.7202 http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
The protocol can be accessed at: http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42016035729 Focus question The focus question of this review is whether or not  the salivary levels of the inflammatory cytokines  IL-1β and TNF-α could be associated with clinical  evidence of periodontal tissue breakdown so that they  could be used as biological markers of periodontal   diseases.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
[URL: http://www.cochrane.org/ cochrane-interventions-handbook ] 13.,OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
"Inflammatory Cytokines Interleukin-1β and Tumour Necrosis Factor-α - Novel Biomarkers for the Detection of Periodontal  Diseases: a Literature Review J Oral Maxillofac Res 2016;7(2):e2 URL: http://www.ejomr.org/JOMR/archives/2016/2/e2/v7n2e2.pdf doi: 10.5037/jomr.2016.7202 Copyright ©  Gomes FI, Aragão MG, Barbosa FC, Bezerra MM, de Paulo Teixeira Pinto V , Chaves HV .",Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
"Published in the  JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 30 June 2016.",Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.23.",Non-OADS,/arxiv_data1/oa_pdf/d2/17/jomr-07-e2.PMC4970502.pdf
Designing for Safety: Implications of a Fifteen Year Review of Swallowed and Aspirated Dentures J Oral Maxillofac Res 2016;7(2):e3 URL: http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3.pdf doi: 10.5037/jomr.2016.7203 http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
[URL: http://www.hscic.gov.uk/catalogue/PUB01086/adul-dent-heal-surv-summ-them-exec- 2009-rep2.pdf ] 2.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
[URL: http://hrcak.srce.hr/69096 ] 16.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
[URL: http://www.ajol.info/index.php/jmbr/article/view/81348 ] 40.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
[URL: http://periodicos.pucminas.br/index.php/Arquivobrasileirodontologia/issue/view/122/showToc ] 51.,OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
[URL: http://ispub.com/IJORL/8/2/8363 ] 72.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
[URL: http://www.consultant360.com/articles/what-you-don-t-see-may-be-problem ] 78.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
Designing for Safety: Implications of a Fifteen Year Review of Swallowed and Aspirated Dentures J Oral Maxillofac Res 2016;7(2):e3 URL: http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3.pdf doi: 10.5037/jomr.2016.7203,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e3/v7n2e3ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL   RESEARCH ( http://www.ejomr.org ), 30 June 2016.",Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/82/b9/jomr-07-e3.PMC4970503.pdf
"Micro-CT Analysis of Bone Healing in Rabbit Calvarial Critical-Sized Defects with Solid Bioactive Glass, Tricalcium  Phosphate Granules or Autogenous Bone J Oral Maxillofac Res 2016;7(2):e4 URL: http://www.ejomr.org/JOMR/archives/2016/2/e4/v7n2e4.pdf doi: 10.5037/jomr.2016.7204 http://www.ejomr.org/JOMR/archives/2016/2/e4/v7n2e4ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.",Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e4/v7n2e4ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e4/v7n2e4ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e4/v7n2e4ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e4/v7n2e4ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e4/v7n2e4ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e4/v7n2e4ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e4/v7n2e4ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
"Micro-CT Analysis of Bone Healing in Rabbit Calvarial Critical-Sized Defects with Solid Bioactive Glass, Tricalcium  Phosphate Granules or Autogenous Bone J Oral Maxillofac Res 2016;7(2):e4 URL: http://www.ejomr.org/JOMR/archives/2016/2/e4/v7n2e4.pdf doi: 10.5037/jomr.2016.7204 Copyright ©  Lappalainen OP, Karhula SS, Haapea M, Kauppinen S, Finnilä M, Saarakkala S, Serlo W, Sándor GK.",Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 30 June 2016.",Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/ed/80/jomr-07-e4.PMC4970504.pdf
"Accepted for publication: 16 June 2016 To cite this article: Schwartz K, Rodrigo-Domingo M, Jensen T. Skeletal Stability after Large Mandibular Advancement (> 10 mm) with Bilateral Sagittal Split Osteotomy and Skeletal Elastic  Intermaxillary Fixation  J Oral Maxillofac Res 2016;7(2):e5 URL: http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5.pdf doi: 10.5037/jomr.2016.7205 http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
"[Medline: 2019890 ]  [doi: 10.1016/0278-2391(91)90166-J ] To cite this article: Schwartz K, Rodrigo-Domingo M, Jensen T. Skeletal Stability after Large Mandibular Advancement (> 10 mm) with Bilateral Sagittal Split Osteotomy and Skeletal Elastic  Intermaxillary Fixation  J Oral Maxillofac Res 2016;7(2):e5 URL: http://www.ejomr.org/JOMR/archives/2016/2/e5/v7n2e5.pdf doi: 10.5037/jomr.2016.7205 Copyright ©  Schwartz K, Rodrigo-Domingo M, Jensen T. Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 30 June 2016.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/1f/67/jomr-07-e5.PMC4970505.pdf
Vertical Craniofacial Morphology and its Relation to Temporomandibular Disorders J Oral Maxillofac Res 2016;7(2):e6 URL: http://www.ejomr.org/JOMR/archives/2016/2/e6/v7n2e6.pdf doi: 10.5037/jomr.2016.7206 http://www.ejomr.org/JOMR/archives/2016/2/e6/v7n2e6ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e6/v7n2e6ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e6/v7n2e6ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e6/v7n2e6ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e6/v7n2e6ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e6/v7n2e6ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e6/v7n2e6ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
http://www.ejomr.org/JOMR/archives/2016/2/e6/v7n2e6ht.htm J Oral Maxillofac Res 2016 (Apr-Jun) | vol.,Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
"Vertical Craniofacial Morphology and its Relation to Temporomandibular Disorders J Oral Maxillofac Res 2016;7(2):e6 URL: http://www.ejomr.org/JOMR/archives/2016/2/e6/v7n2e6.pdf doi: 10.5037/jomr.2016.7206 Copyright ©  Bavia PF, Rodrigues Garcia RC.",Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH  (http://www.ejomr.org ), 30 June 2016.",Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/59/25/jomr-07-e6.PMC4970506.pdf
"3, 108 –114 http://dx.doi.org/10.1080/19336934.2016.1182268",Non-OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Prog Lipid Res 2008; 47:333-9; PMID:18439916;http://dx.doi.org/10.1016/j.plipres.2008.03.004 [4] Ozier-Kalogeropoulos O, Adeline MT, Yang WL, Car- man GM, Lacroute F. Use of synthetic lethal mutants to clone and characterize a novel CTP synthetase gene in Saccharomyces cerevisiae.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Mol Gen Genet 1994; 242:431-9; PMID:8121398; http://dx.doi.org/10.1007/BF00281793 [5] von der Saal W, Anderson PM, Villafranca JJ.",Non-OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Biochemistry 1971; 10:3365-71; PMID:4940761;http://dx.doi.org/10.1021/bi00794a008 [8] Long CW, Pardee AB.",Non-OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Role of glutamine in the biosynthesis of cytidine nucleotides in Escherichia coli.Biochim Biophys Acta 1961; 47:607-9; PMID:13692169;http://dx.doi.org/10.1016/0006-3002(61)90563-7 [10] Ozier-Kalogeropoulos O, Fasiolo F, Adeline MT, Collin J, Lacroute F. Cloning, sequencing and characterization of the Saccharomyces cerevisiae URA7 gene encoding CTP syn- thetase.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Mol Gen Genet 1991; 231:7-16; PMID:1753946;http://dx.doi.org/10.1007/BF00293815 [11] Kursula P, Flodin S, Ehn M, Hammarstrom M, Schuler H, Nordlund P, Stenmark P. Structure of the synthetasedomain of human CTP synthetase, a target for anticancertherapy.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Acta Crystallogr Sect F Struct Biol Cryst Com-mun 2006; 62:613-7; PMID:16820675; http://dx.doi.org/ 10.1107/S1744309106018136 [12] Goto M, Omi R, Nakagawa N, Miyahara I, Hirotsu K. Crys- tal structures of CTP synthetase reveal ATP, UTP, and glu-tamine binding sites.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
Structure 2004; 12:1413-23; PMID:15296735; http://dx.doi.org/10.1016/j.str.2004.05.013[13] Anderson PM.,OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Biochemistry 1983; 22:3285-92; PMID:6349684;http://dx.doi.org/10.1021/bi00282a038 [14] Levitzki A, Koshland DE, Jr.",Non-OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Biochemistry 1972; 11:241-6; PMID:4550559;http://dx.doi.org/10.1021/bi00752a015 [16] Aronow B, Ullman B.",Non-OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"J Genet Genomics 2010; 37:281-96;PMID:20513629; http://dx.doi.org/10.1016/S1673-8527(09)60046-1 [18] Ingerson-Mahar M, Briegel A, Werner JN, Jensen GJ, Gitai Z.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Nat Cell Biol 2010; 12:739-46; PMID:20639870; http://dx.doi.org/10.1038/ncb2087 [19] Noree C, Sato BK, Broyer RM, Wilhelm JE.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"J Cell Biol 2010;190:541-51; PMID:20713603; http://dx.doi.org/10.1083/jcb.201003001 [20] Carcamo WC, Satoh M, Kasahara H, Terada N, Hamazaki T, Chan JY, Yao B, Tamayo S, Covini G, von Muhlen CA,et al.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"PLoS One 2011; 6:e29690; PMID:22220215;http://dx.doi.org/10.137 1/journal.pone.0029690 [21] Barry RM, Bitbol AF, Lorestani A, Charles EJ, Habrian CH, Hansen JM, Li HJ, Baldwin EP, Wingreen NS, Kollman JM,et al.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
EMBO Rep 2014; 15:1184-91; PMID:25223282; http://dx.doi.org/10.15252/embr.201438688FLY 113,Non-OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Cell Mol Life Sci2014; 71:2963-73; PMID:24477477; http://dx.doi.org/10.1007/s00018-014-1567-6 [26] Gou KM, Chang CC, Shen QJ, Sung LY, Liu JL.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"J Genet Genomics2011; 38:391-402; PMID:21930098; http://dx.doi.org/10.1016/j.jgg.2011.08.004 [28] Meredith MJ, Lane MD.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Phosphorylation and regulation of choline kinase from Saccharomyces cerevisiae by protein kinase A. J Biol Chem 1999; 274:9531-8; PMID:10092638; http://dx.doi.org/10.1074/jbc.274.14.9531 [31] Park TS, O ’Brien DJ, Carman GM.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"J Biol Chem2003; 278:20785-94; PMID:12670958; http://dx.doi.org/10.1074/jbc.M301394200 [32] Chang YF, Martin SS, Baldwin EP, Carman GM.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"J Biol Chem 2007; 282:17613-22; PMID: 17463002; http://dx.doi.org/10.1074/jbc.M702799200 [33] Higgins MJ, Graves PR, Graves LM.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"J Biol Chem 2007; 282:29493-503; PMID:17681942; http://dx.doi.org/10.1074/jbc.M703948200 [34] Noree C, Monfort E, Shiau AK, Wilhelm JE.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Mol Biol Cell 2014; 25:2282-90; PMID:24920825; http://dx.doi.org/10.1091/mbc.E14-04-0912 [35] Sadowski M, Suryadinata R, Tan AR, Roesley SN, Sar- cevic B.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"IUBMB Life 2012; 64:136-42;PMID:22131221; http://dx.doi.org/10.1002/iub.589 [36] Peng J, Schwartz D, Elias JE, Thoreen CC, Cheng D, Mar- sischky G, Roelofs J, Finley D, Gygi SP.",OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
NatBiotechnol 2003; 21:921-6; PMID:12872131; http://dx.doi.org/10.1038/nbt849114 L.-M. PAI ET AL.,OADS,/arxiv_data1/oa_pdf/22/79/kfly-10-03-1182268.PMC4970526.pdf
"Published with license by Taylor & FrancisThis is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"3, 142 –148 http://dx.doi.org/10.1080/19336934.2016.1193657",Non-OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
Sci- ence 1910; 32:183-5; PMID:17839276; http://dx.doi.org/10.1126/science.32.814.183 [7] Sturtevant AH.,OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Psyche J Entomol 1919; 26:153-5;http://dx.doi.org/10.1155/1919/97402 [8] Schultz J, Dobzhansky T. Triploid hybrids between Dro- sophila melanogaster and Drosophila simulans.",Non-OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"J ExpZool 1933; 65:73-82; http://dx.doi.org/10.1002/jez.1400650105 [9] Muller HJ, Pontecorvo G. Recombinants between Drosoph- ila Species the F1 Hybrids of which are Sterile [Internet].1940 [cited 2016 Mar 10]; Available from: http://www.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
J Genet 1943; 45:51-66; http://dx.doi.org/10.1007/BF02982774 [11] Watanabe TK.,Non-OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Science 2006;314:1292-5; PMID:17124320; http://dx.doi.org/10.1126/science.1133953 [15] Bolkan BJ, Booker R, Goldberg ML, Barbash DA.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Genetics 2007; 177:2233-41; PMID:17947412; http://dx.doi.org/10.153 4/genetics.107.079939 [16] Thomae AW, Schade GOM, Padeken J, Borath M, Vetter I, Kremmer E, Heun P, Imhof A.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Dev Cell 2013; 27:412-24; PMID:24239514;http://dx.doi.org/10.1016/j.devcel.2013.10.001 [17] Ferree PM, Gomez K, Rominger P, Howard D, Kornfeld H, Barbash DA.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Genetics 2014;196:1001-5; PMID:24478337; http://dx.doi.org/10.1534/genetics.113.161075 [18] Phadnis N, Baker EP, Cooper JC, Frizzell KA, Hsieh E, Cruz AFA de la, Shendure J, Kitzman JO, Malik HS.",Non-OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
Science 2015; 350:1552-5; PMID:26680200; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Gene 2004; 342:49-56; PMID:15527965;http://dx.doi.org/10.1016/j.gene.2004.07.043 [20] Pr ovost E, Hersperger G, Timmons L, Ho WQ, Her- sperger E, Alcazar R, Shearn A. Loss-of-Function Mutations in a Glutathione S-Transferase Suppressthe prune-Killer of prune Lethal Interaction.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Genetics2006; 172:207-19; PMID:16143620; http://dx.doi.org/10.1534/genetics.105.044669 [21] Kondo S, Perrimon N. A Genome-Wide RNAi Screen Identi ﬁes Core Components of the G2-M DNA Damage Checkpoint.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Sci Signal 2011; 4:rs1-rs1; PMID:21205937; http://dx.doi.org/10.1126/scisignal.2001350 [22] Ambrus AM, Rasheva VI, Nicolay BN, Frolov MV.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"PLoS Biol 2014; 12:e1001809; PMID:24643257; http://dx.doi.org/10.1371/journal.pbio.1001809 [24] S /C19anchez L, D €ubendorfer A.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Wilhelm RouxsArch Dev Biol 1983; 192:48-50; http://dx.doi.org/ 10.1007/BF00848770 [25] Gatti M, Baker BS.",Non-OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
Genes Dev 1989;3:438-53; PMID:2498166; http://dx.doi.org/10.1101/gad.3.4.438 [26] Sturtevant AH.,OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Nature 1991; 353:437-40;PMID:1654526; http://dx.doi.org/10.1038/353437a0 [28] Biggs J, Tripoulas N, Hersperger E, Dearolf C, Shearn A.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Genes Dev1988; 2:1333-43; PMID:2849580; http://dx.doi.org/ 10.1101/gad.2.10.1333 [29] Biggs J, Hersperger E, Steeg PS, Liotta LA, Shearn A.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Cell 1990; 63:933-40;PMID:2175255; http://dx.doi.org/10.1016/0092-8674(90)90496-2 [30] Dearolf CR, Hersperger E, Shearn A. Developmental con- sequences of awdb3, a cell-autonomous lethal mutation of Drosophila induced by hybrid dysgenesis.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Dev Biol1988; 129:159-68; PMID:3137111; http://dx.doi.org/10.1016/0012-1606(88)90170-4 [31] Lascu I, Chaffotte A, Limbourg-Bouchon B, V /C19eron M. A Pro/Ser substitution in nucleoside diphosphate kinase ofDrosophila melanogaster (mutation killer of prune)affects stability but not catalytic ef ﬁciency of the enzyme.",Non-OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Cell 2005; 123:555-68;PMID:16286005; http://dx.doi.org/10.1016/j.cell.2005.08.043 [33] Babu MM, Iyer LM, Balaji S, Aravind L. The natural history of the WRKY –GCM1 zinc ﬁngers and the relationship between transcription factors and transposons.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Nucleic Acids Res 2006; 34:6505-20; PMID:17130173; http://dx.doi.org/10.1093/nar/gkl888 [34] Marquez CP, Pritham EJ.",OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"Genetics 2010; 185:1507-17; PMID:20457878; http://dx.doi.org/10.1534/genetics.110.116673 [35] Ow MC, Martinez NJ, Olsen PH, Silverman HS, Barrasa MI, Conradt B, Walhout AJM, Ambros V. The FLYWCHtranscription factors FLH-1, FLH-2, and FLH-3 repressembryonic expression of microRNA genes in C. elegans.Genes Dev 2008; 22:2520-34; PMID:18794349; http://dx.doi.org/10.1101/gad.1678808 [36] Satyaki PRV, Cuykendall TN, Wei KHC, Brideau NJ, Kwak H, Aruna S, Ferree PM, Ji S, Barbash DA.",Non-OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"PLoS Genet2014; 10:e1004240; PMID:24651406; http://dx.doi.org/10.1371/journal.pgen.1004240 [37] Cuykendall TN, Satyaki P, Ji S, Clay DM, Edelman NB, K i m c h yA ,L iL H ,N u z z oE A ,P a r e k hN ,P a r kS ,e ta l .AScreen for F1 Hybrid male rescue reveals no major-effecthybrid lethality Loci in the Drosophila melanogaster autoso- mal genome.",Non-OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
Science 2009; 323:376-9; PMID:19074311; http://dx.doi.org/10.1126/science.1163934148 J. C. COOPER AND N. PHADNIS,OADS,/arxiv_data1/oa_pdf/7a/86/kfly-10-03-1193657.PMC4970527.pdf
"3, 115 –122 http://dx.doi.org/10.1080/19336934.2016.1182269",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Curr Opin Immunol 2003; 15:12-9; PMID:12495727;http://dx.doi.org/10.1016/S0952-7915(02)00005-5 [2] Lemaitre B, Hoffmann J.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Annu Rev Immunol 2007;25:697-743; PMID:17201680; http://dx.doi.org/10.1146 /annurev.immunol.25.022106.141615 [3] Kleino A, Silverman N. The Drosophila IMD pathway in the activation of the humoral immune response.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"DevComp Immunol 2014; 42:25-35; PMID:23721820;http://dx.doi.org/10.1016/j.dci.2013.05.014 [4] Lindsay SA, Wasserman SA.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Dev Comp Immunol 2014; 42:16-24; PMID:23632253; http://dx.doi.org/10.1016/j.dci.2013.04.011 [5] Sorrentino RP, Melk JP, Govind S. Genetic analysis of contributions of dorsal group and JAK-Stat92E pathwaygenes to larval hemocyte concentration and the eggencapsulation response in Drosophila.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Genetics 2004;166:1343-56; PMID:15082553; http://dx.doi.org/10.1534/ genetics.166.3.1343 [6] Luo H, Hanratty WP, Dearolf CR.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"EMBO Rep 2015; 16:1664-72; PMID:26412855; http://dx.doi.org/10.15252/embr.201540277 [13] Schmid MR, Anderl I, Vesala L, Vanha-aho L-M, Deng X-J, R €amet M, Hultmark D. Control of Drosophila blood cell activation via Toll signaling in the fat body.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"PLoSOne 2014; 9:e102568; PMID:25102059; http://dx.doi.org/10.1371/journal.pone.0102568 [14] Arbouzova NI, Zeidler MP.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
Development 2006; 133:2605-16; PMID:16794031; http://dx.doi.org/10.1242/dev.02411120 H. YANG AND D. HULTMARK,OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Scand J Immunol 2014; 79:377-85; http://dx.doi.org/10.1111/sji.12170 [17] Bach EA, Ekas LA, Ayala-Camargo A, Flaherty MS, Lee H, Perrimon N, Baeg G-H. GFP reporters detect the acti- vation of the Drosophila JAK/STAT pathway in vivo .",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
Gene Expr Patterns 2007; 7:323-31; PMID:17008134;http://dx.doi.org/10.1016/j.modgep.2006.08.003 [18] Williams MJ.,OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"J Immunol 2007; 178:4711-6; PMID:17404248;http://dx.doi.org/10.4049/jimmunol.178.8.4711 [19] Honti V, Csord /C19as G, Kurucz E, M /C19arkus R, And /C19o I.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Dev Comp Immunol 2014; 42:47-56; PMID:23800719; http://dx.doi.org/10.1016/j.dci.2013.06.005 [20] Makhijani K, Bruckner K. Of blood cells and the nervous sys- tem: Hematopoiesis in the Drosophila larva.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Fly (Austin) 2012; 6:254-60; PMID:23022764; http://dx.doi.org/10.4161/ ﬂy.22267 [21] Pastor-Pareja JC, Wu M, Xu T. An innate response of blood cells to tumors and tissue damage in Drosophila .",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Dis Models Mech 2008; 1:144-54; discussion 53; http://dx.doi.org/10.1242/dmm.000950 [22] Parisi F, Stefanatos RK, Strathdee K, Yu Y, Vidal M. Transformed epithelia trigger non-tissue-autonomoustumor suppressor response by adipocytes via activation of Toll and Eiger/TNF signaling.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Cell Rep 2014; 6:855-67; PMID:24582964; http://dx.doi.org/10.1016/j.celrep.2014.01.039 [23] Agaisse H, Petersen U-M, Boutros M, Mathey-Prevot B, Perrimon N. Signaling role of hemocytes in Drosophila JAK/STAT-dependent response to septic injury.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Dev Cell2003; 5:441-50; PMID:12967563; http://dx.doi.org/10.1016/S1534-5807(03)00244-2 [24] Ekengren S, Tryselius Y, Dushay MS, Liu G, Steiner H, Hult- mark D. A humoral stress response in Drosophila .C u r rB i o l 2001; 11:714-8 (Addendum on p. 1479); PMID:11369236;http://dx.doi.org/10.1016/S0960-9822(01)00203-2 [25] Osman D, Buchon N, Chakrabarti S, Huang YT, Su WC, Poidevin M, Tsai YC, Lemaitre B. Autocrine and para-crine unpaired signalling regulate intestinal stem cellmaintenance and division.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"J Cell Sci 2012; 125:5944-9; PMID:23038775; http://dx.doi.org/10.1242/jcs.113100 [26] Buchon N, Broderick NA, Kuraishi T, Lemaitre B. Drosophila EGFR pathway coordinates stem cell prolifer- ation and gut remodeling following infection.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"BMC Biol2010; 8:152; PMID:21176204; http://dx.doi.org/10.1186/1741-7007-8-152 [27] Kemp C, Mueller S, Goto A, Barbier V, Paro S, Bonnay F, Dostert C, Troxler L, Hetru C, Meignin C, et al.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"PLoS One 2015; 10:e0136593; PMID:26322507; http://dx.doi.org/10.1371/journal.pone.0136593 [30] Lin G, Xu N, Xi R. Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Nature 2008; 455:1119-23; PMID:18806781; http://dx.doi.org/ 10.1038/nature07329 [31] Cordero JB, Stefanatos RK, Scopelliti A, Vidal M, Sansom OJ.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"EMBO J 2012; 31:3901-17; PMID:22948071; http://dx.doi.org/10.1038/emboj.2012.248 [32] Jiang H, Grenley MO, Bravo MJ, Blumhagen RZ, Edgar BA.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Cell Stem Cell 2011; 8:84-95; PMID:21167805; http://dx.doi.org/10.1016/j.stem.2010.11.026 [33] Biteau B, Jasper H. EGF signaling regulates the prolifera- tion of intestinal stem cells in Drosophila .",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Development 2011; 138:1045-55; PMID:21307097; http://dx.doi.org/10.1242/dev.056671 [34] Xu N, Wang SQ, Tan D, Gao Y, Lin G, Xi R. EGFR, Wingless and JAK/STAT signaling cooperatively main- tain Drosophila intestinal stem cells.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Dev Biol 2011; 354:31-43; PMID:21440535; http://dx.doi.org/10.1016/j.ydbio.2011.03.018 [35] Zhou F, Rasmussen A, Lee S, Agaisse H. The UPD3 cyto- kine couples environmental challenge and intestinal stemcell division through modulation of JAK/STAT signalingin the stem cell microenvironment.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
Dev Biol 2013; 373:383-93; PMID:23110761; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"EMBO Rep 2010; 11:201-7; PMID:20168330; http://dx.doi.org/10.1038/embor.2010.1 [37] Pedersen BK, Febbraio MA.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Nat Rev Endocrinol 2012; 8:457-65; PMID:22473333; http://dx.doi.org/10.1038/nrendo.2012.49 [38] Droujinine IA, Perrimon N. De ﬁning the interorgan com- munication network: systemic coordination of organismalcellular processes under homeostasis and localized stress.Front Cell Infect Microbiol 2013; 3:82; PMID:24312902;http://dx.doi.org/10.3389/fcimb.2013.00082 [39] Rai M, Demontis F. Systemic nutrient and stress signal- ing via myokines and myometabolites.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"2016; 78:85-107; PMID:26527185; http://dx.doi.org/ 10.1146/annurev-physiol-021115-105305 [40] Demontis F, Perrimon N. Integration of Insulin r eceptor/ Foxo signaling and dMyc activity during muscle growth reg-ulates body size in Drosophila.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Development 2009; 136:983-93; PMID:19211682; http://dx.doi.org/10.1242/dev.027466 [41] Demontis F, Perrimon N. FOXO/4E-BP signaling in Dro- sophila muscles regulates organism-wide proteostasis during aging.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Cell 2010; 143:813-25; PMID:21111239;http://dx.doi.org/10.1016/j.cell.2010.10.007 [42] Bai H, Kang P, Hernandez AM, Tatar M. Activin signal- ing targeted by insulin/dFOXO regulates aging and mus-cle proteostasis in Drosophila .",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"PLoS Genet 2013; 9: e1003941; PMID:24244197; http://dx.doi.org/10.1371/journal.pgen.1003941 [43] Demontis F, Patel VK, Swindell WR, Perrimon N. Intertissue control of the nucleolus via a myokine-dependent longevitypathway.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Cell Rep 2014; 7:1481-94; PMID:24882005; http://dx.doi.org/10.1016/j.celrep.2014.05.001 [44] Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Klarlund Pedersen B.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
J Physiol 2000; 529 (Pt 1):237-42; PMID:11080265; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"J Physiol 1998; 508(Pt 3):949-53; PMID:9518745; http://dx.doi.org/10.1111/j.1469-7793.1998.949bp.x [46] Frost RA, Nystrom GJ, Lang CH.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Am J Physiol Regul IntegrComp Physiol 2002; 283:R698-709; PMID:12185005;http://dx.doi.org/10.1152/ajpregu.00039.2002 [47] Frost RA, Nystrom GJ, Lang CH.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Am J Physiol Regul Integr Comp Physiol 2003; 285:R1153-64; PMID:12842862; http://dx.doi.org/ 10.1152/ajpregu.00164.2003 [48] Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, Roussos C. Production of interleukin-6by skeletal myotubes: Role of reactive oxygen species.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Am JRespir Cell Mol Biol 2002; 26:587-93; PMID:11970911;http://dx.doi.org/10.1165/ajrcmb.26.5.4598 [49] Luo G, Hershko DD, Robb BW, Wray CJ, Hasselgren PO.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Am J Physiol Regul Integr Comp Physiol 2003; 284:R1249-54; PMID:12676746; http://dx.doi.org/10.1152/ajpregu.00490.2002 [50] Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I, Jedrychowski MP, Ruas JL, Wrann CD, Lo JC, et al.Meteorin-like is a hormone that regulates immune-adi- pose interactions to increase beige fat thermogenesis.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
Cell2014; 157:1279-91; PMID:24906147; http://dx.doi.org/10.1016/j.cell.2014.03.065 [51] Rizki TM.,OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Biochem Biophys Res Commun 1995; 209:111-6;PMID:7726823; http://dx.doi.org/10.1006/bbrc.1995.1477 [53] Lemaitre B, Nicolas E, Michaut L, Reichhart J-M, Hoffmann JA.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
Cell 1996; 86:973-83; PMID:8808632; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"J Immunol 2011; 186:649-56; PMID:21209287;http://dx.doi.org/10.4049/jimmunol.1002302 [55] Shia AK, Glittenberg M, Thompson G, Weber AN, Reich- hart J-M, Ligoxygakis P. Toll-dependent antimicrobialresponses in Drosophila larval fat body require Sp €atzle secreted by haemocytes.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"J Cell Sci 2009; 122:4505-15; PMID:19934223; http://dx.doi.org/10.1242/jcs.049155 [56] Weber AN, Tauszig-Delamasure S, Hoffmann JA, Lelievre E, G a s c a nH ,R a yK P ,M o r s eM A ,I m l e rJ L ,G a yN J .B i n d i n go ftheDrosophila cytokine Sp €atzle to Toll is direct and estab- lishes signaling.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Nat Immunol 2003; 4:794-800; PMID:12872120; http://dx.doi.org/10.1038/ni955 [57] Vanha-aho L-M, Valanne S, R €amet M. Cytokines in Drosophila immunity.",OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Immunol Lett 2016; 170:42-51; PMID:26730849; http://dx.doi.o rg/10.1016/j.imlet.2015.12 .005 [58] Vanha-aho L-M, Anderl I, Vesala L, Hultmark D, Valanne S, R€amet M. Edin expression in the fat body is required in the defense against parasitic wasps in Drosophila melanogaster .",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"PLoS Pathog 2015; 11:e1004895; PMID:25965263; http://dx.doi.org/10.1371/journal.ppat.1004895 [59] Makhijani K, Alexander B, Tanaka T, Rulifson E, Br€uckner K. The peripheral nervous system supports blood cell homing and survival in the Drosophila larva.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"Development 2011; 138:5379-91; PMID:22071105;http://dx.doi.org/10.1242/dev.067322 [60] Rajan A, Perrimon N. Drosophila cytokine unpaired 2 regu- lates physiological homeostasis by remotely controlling insu-lin secretion.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
Immunity 2015; 42:133-44; PMID:25601202; http://dx.doi.org/10.1016/j.immuni.2014.12.023122 H. YANG AND D. HULTMARK,OADS,/arxiv_data1/oa_pdf/63/f6/kfly-10-03-1182269.PMC4970531.pdf
"3, 123 –127 http://dx.doi.org/10.1080/19336934.2016.1182273",Non-OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Cell Tissue Res 2000; 300:239-49;PMID:10867820; http://dx.doi.org/10.1007/s004410000195 [2] Chen J, Call GB, Beyer E, Bui C, Cespedes A, Chan A, Chan J, Chan S, Chhabra A, Dang P, et al.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Dev Biol 2011; 351:128-34; PMID:21215264; http://dx.doi.org/10 .1016/j.ydbio.2010.12.040 [5] Satoh T, Inagaki T, Liu Z, Watanabe R, Satoh AK.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
GPI biosynthesis is essential for rhodopsin sorting at thetrans-Golgi network in Drosophila photoreceptors.Development 2013; 140:385-94; PMID:23250212; http://dx.doi.org/10.1242/dev.083683.,Non-OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Int Rev Cell Mol Biol 2015; 315:1-22; PMID:25708460;http://dx.doi.org/10.101 6/bs.ircmb.2014.12.002 [9] Girod A, Storrie B, Simpson JC, Johannes L, Goud B, Roberts LM, Lord JM, Nilsson T, Pepperkok R. Evidence for a COP-I-independent transport route from the Golgicomplex to the endoplasmic reticulum.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Nat Cell Biol1999; 1:423-30; PMID:10559986; http://dx.doi.org/10.1038/15658 [10] White J, Johannes L, Mallard F, Girod A, Grill S, Reinsch S, Keller P, Tzschaschel B, Echard A, Goud B, et al.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"J Cell Biol 1999; 147:743-60; PMID:10562278; http://dx.doi.org/10.1083/jcb.147.4.743 [11] Mallard F, Tang BL, Galli T, Tenza D, Saint-Pol A, Yue X, Antony C, Hong W, Goud B, Johannes L. Early/recyclingendosomes-to-TGN transport involves two SNARE com-plexes and a Rab6 isoform.",Non-OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"J Cell Biol 2002; 156:653-64;PMID:11839770; http://dx.doi.org/10.1083/jcb.200110081 [12] Utskarpen A, Slagsvold HH, Iversen TG, W €alchli S, Sandvig K. Transport of ricin from endosomes to the Golgi apparatus is regulated by Rab6A and Rab6A ’.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Traf- ﬁc 2006; 7:663-72; PMID:16683916; http://dx.doi.org/ 10.1111/j.1600-0854.2006.00418.x [13] Storrie B, Micaroni M, Morgan GP, Jones N, Kamy- kowski JA, Wilkins N, Pan TH, Marsh BJ.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Traf ﬁc 2012; 13:727-44; PMID:22335553; http://dx.doi.org/10.1111/j.1600-0854.2012.01343.x [14] Johns HL, Gonzalez-Lopez C, Sayers CL, Hollinshead M, Elliott G. Rab6 dependent post-Golgi traf ﬁcking of HSV1 envelope proteins to sites of virus envelopment.",Non-OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Traf ﬁc2014; 15:157-78; PMID:24152084; http://dx.doi.org/ 10.1111/tra.12134 [15] Miserey-Lenkei S, Chalancon G, Bardin S, Formstecher E, Goud B, Echard A. Rab and actomyosin-dependent ﬁs- sion of transport vesicles at the Golgi complex.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Nat CellBiol 2010; 12:645-54; PMID:20562865; http://dx.doi.org/10.1038/ncb2067 [16] Iwanami N, Nakamura Y, Satoh T, Liu Z, Satoh AK.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Dev Cell 2006; 11:483-93; PMID:17011488; http://dx.doi.org/10.1016/j.devcel.2006.08.012 [18] Zelhof AC, Hardy RW, Becker A, Zuker CS.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Nature 2006;443:696-9; PMID:17036004; http://dx.doi.org/10.1038/nature05128 [19] Satoh AK, O ’Tousa JE, Ozaki K, Ready DF.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"Rab11 medi- ates post-Golgi traf ﬁcking of rhodopsin to the photosen- sitive apical membrane of Drosophila photoreceptors.Development 2005; 132:1487-97; PMID:15728675;http://dx.doi.org/10.1242/dev.01704 [20] Satoh A, Tokunaga F, Kawamura S, Ozaki K. In situ inhi- bition of vesicle transport and protein processing in thedominant negative Rab1 mutant of Drosophila.",OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
Neuron 1993; 10:1113-9;PMID:8318232; http://dx.doi.org/10.1016/0896-6273(93)90059-Z [22] Bonifacino JS.,OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
Curr Biol 2005;15:1722-33; PMID:16213818; http://dx.doi.org/10.1016/j.cub.2005.08.064FLY 127,OADS,/arxiv_data1/oa_pdf/d4/ed/kfly-10-03-1182273.PMC4970535.pdf
"7, 723 –726 http://dx.doi.org/10.1080/15384047.2016.1178427",Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
N Engl J Med 2011; 364:1046-60; PMID:21410373; http://dx.doi.org/10.1056/NEJMra1011442 2.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Blood 2008; 111(5):2516-20; PMID:17975015; http://dx.doi.org/10.1182/blood-2007-10-116129 5.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Clin Lymphoma Myeloma Leuk 2014; 14(3):211-4;PMID:24373936; http://dx.doi.org/10.1016/j.clml.2013.11.004 6.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Br J Haematol 2013; 162:483-8;PMID:23772701; http://dx.doi.org/10.1111/bjh.12414 7.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
J. Hematol 1999; 62:228-33;PMID:10589078; http://dx.doi.org/10.1002/(SICI)1096-8652(199912)62:4%3c228::AID-AJH5%3e3.0.CO;2-3 8.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Cell Ther 1997; 39:327-30; PMID:9497892; http://dx.doi.org/10.1007/s00282- 997-0327-6 9.,OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
World J Methodol 2014; 4(2):73-90; PMID:25332907; http://dx.doi.org/10.5662/wjm.v4.i2.73 10.,OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Blood 2008;111: 2521-26; PMID:17901246; http://dx.doi.org/10.1182/blood-2007- 08-104984 11.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Leu- kemia 2012; 26(4):595-608; PMID:22193964; http://dx.doi.org/ 10.1038/leu.2011.346 12.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Leuk Lym- phoma 2010; 51(7):1178-87; PMID:20497001; http://dx.doi.org/10.3109/10428194.2010.48330313.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Leuk Res 2010; 34(4):471-4; PMID:19674790; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Leuk Lymphoma 2004; 45:291-300; PMID:15101714;http://dx.doi.org/10.1080/10428190310001597964 15.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
BrJ Haematol 2002; 117:103-8; PMID:11918539; http://dx.doi.org/ 10.1046/j.1365-2141.2002.03401.x 17.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Ann Hem-atol 2015; 94:2033-42; PMID:26420061; http://dx.doi.org/10.1007/s00277-015-2484-y 19.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
New drugs and novel mechanisms of action in multiple myeloma in 2013: areport from the International Myeloma Working Group (IMWG).Leukemia 2014; 28(3):525-42; PMID:24253022; http://dx.doi.org/ 10.1038/leu.2013.350 21.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Leuk Lymphoma 2013; 54:864-6;PMID:22880953; http://dx.doi.org/10.3109/10428194.2012.718343 22.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Curr Cancer Drug Targets 2011; 11: 254-84; PMID:21247382; http://dx.doi.org/10.2174/156800911794519716 23.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Leukemia 2011; 25: 906-08; PMID:21350560; http://dx.doi.org/10.1038/leu.2011.29 24.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
PLoS One2013; 8(8):e71754; PMID:23940785; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Hematol Oncol 2012; 30(4):170-4; PMID:22144117; http://dx.doi.org/10.1002/hon.1021 27.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
Br J Haematol 2013; 162(3): 371-5; PMID:23718539;http://dx.doi.org/10.1111/bjh.12404726 M. B. ABID ET AL.,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/kcbt-17-07-1178427.PMC4970536.pdf
"7, 732 –740 http://dx.doi.org/10.1080/15384047.2016.1177683",Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
CA Cancer J Clin 2015; 65:5-29; PMID:25559415; http://dx.doi.org/10.3322/ caac.212542.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Clin Cancer Res 2012; 18:4266-76; PMID:22896693; http://dx.doi.org/10.1158/1078-0432.CCR-11-3114 3.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
J Hepatobiliary Pancreat Sci 2014; 21:105-12; PMID:23798470; http://dx.doi.org/10.1002/jhbp.6 4.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Sci TranslMed 2014; 6:249ra111; PMID:25122639; http://dx.doi.org/10.1126/scitranslmed.3008982 6.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Gut 2008; 57:483-91; PMID:18025068; http://dx.doi.org/10.1136/gut.2007.125419 7.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Nat Rev Cancer; 10:785-94; PMID:20944664; http://dx.doi.org/10.1038/nrc2934 8.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Oncotarget 2014; 5:12346-57; PMID:25402324; http://dx.doi.org/10.18632/oncotarget.2641 9.,OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Clin Cancer Res 2005; 11:4827-34;PMID:16000580; http://dx.doi.org/10.1158/1078-0432.CCR-04-2510 12.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Oncol Res 2001; 12:501-8; PMID:11939414; http://dx.doi.org/10.3727/096504001108747512 14.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Cancer Biol Ther 2014; 15:1068-76;PMID:24842165; http://dx.doi.org/10.4161/cbt.29185 15.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
J Clin Oncol 2002; 20:142-52;PMID:11773163; http://dx.doi.org/10.1200/JCO.20.1.142 16.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
26:179-80; PMID:12616110; http://dx.doi.org/10.1097/00002371- 200303000-00011 17.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Mol Imaging Biol 2015; 17:811-8;PMID:25902968; http://dx.doi.org/10.1007/s11307-015-0853-5 19.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Nat Biotechnol 2004; 22:313-20; PMID:14990953; http://dx.doi.org/10.1038/nbt937 20.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Photonic detection of bacterial pathogens in living hosts.Mol Microbiol 1995; 18:593-603; PMID:8817482; http://dx.doi.org/10.1111/j.1365-2958.1995.mmi_18040593.x 21.,OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
JPathol 2010; 220:317-27; PMID:19967724; http://dx.doi.org/10.1002/ path.2656 22.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Biochem J 2009; 418:567-74; PMID:19143658; http://dx.doi.org/ 10.1042/BJ20081949 23.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Mol Therapy 2013; 21:1985-95; PMID:23922014; http://dx.doi.org/10.1038/mt.2013.183 24.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Cancer Gene Ther 2003; 10:737-44; PMID:14502226; http://dx.doi.org/10.1038/sj.cgt.7700634 25.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Oncotarget 2015; 6:14625-31; PMID:25714030; http://dx.doi.org/10.18632/ oncotarget.3342 26.,OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Mol CellProteomics 2011; 10:M111 009399; PMID:21474796; http://dx.doi.org/10.1074/mcp.M111.00939927.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
J Cell Biochem 2014;115:1254-61; PMID:24435915; http://dx.doi.org/10.1002/jcb.24769 30.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Hypoxia-induced endoplasmic reticu- lum stress characterizes a necrotic phenotype of pancreatic cancer.Oncotarget 2015; 6:32154-60; PMID:26452217; http://dx.doi.org/10.18632/oncotarget.5168 31.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Sci Rep 2012; 2:436; PMID:22666539; http://dx.doi.org/10.1038/srep00436 33.,OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
"Avogadri F, Martinoli C, Petrovska L, Chiodoni C, Transidico P, Bronte V, Longhi R, Colombo MP, Dougan G, Rescigno M. Cancer immunotherapy based on killing of Salmonella-infected tumor cells.Cancer research 2005; 65:3920-7; PMID:15867392; http://dx.doi.org/ 10.1158/0008-5472.CAN-04-3002 34.",Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
Sci Rep 2015; 5:14958; PMID:26468779; http://dx.doi.org/10.1038/srep14958 36.,Non-OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
"Methods Mol Biol (Clifton, NJ) 2007;394:323-54; PMID:18363243; http://dx.doi.org/10.1007/978-1-59745-512-1_16740 S. ZHOU ET AL.",OADS,/arxiv_data1/oa_pdf/38/9d/kcbt-17-07-1177683.PMC4970537.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Serous carcinoma of endometrium Neuroendocrine small-cellPrognosisTreatmentCase reportLiterature review 1.,Non-OADS,/arxiv_data1/oa_pdf/80/e9/main.PMC4970543.pdf
http://dx.doi.org/10.1016/j.gore.2016.07.004 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/80/e9/main.PMC4970543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/e9/main.PMC4970543.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/75/fiw157.PMC4970567.pdf
"R package 2.0-10 ,2013.http://CRAN.R-project.org/ package =vegan.",Non-OADS,/arxiv_data1/oa_pdf/c4/75/fiw157.PMC4970567.pdf
"Vienna, Austria: R Foundation for Statistical Computing, 2013;http://www.R-project.org .",Non-OADS,/arxiv_data1/oa_pdf/c4/75/fiw157.PMC4970567.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/e6/pcw089.PMC4970613.pdf
Results and Discussion NPP2 and NPP6 have a plastidial localization Computer-assisted analyses using the SignalP (http://www.cbs.dtu.dk/services/SignalP/) and PSORT (http://psort.ims.u-tokyo.,OADS,/arxiv_data1/oa_pdf/d3/e6/pcw089.PMC4970613.pdf
2009)(http://gene64.dna.affrc.go.jp/RPD/main_en.html; http://ppdb.tc.cornell.edu/subproteome.aspx).,OADS,/arxiv_data1/oa_pdf/d3/e6/pcw089.PMC4970613.pdf
"A typical DDA cycle consistedof an MS scan within m/z 350–1,600 performed under the target mass reso- lution of 60,000 followed by MS/MS fragmentation of the three most intense precursor ions under the normalized collision energy of 35% in the linear trap.Singly charged ions were excluded from MS/MS experiments, and m/z values of fragmented precursor ions were dynamically excluded for a further 60 s. Protein identiﬁcation was carried out by Proteome Discoverer version 1.3 and SEQUESTsearch engine (Thermo Fisher Scientiﬁc) using the O. sativa database (63,539 entries) of Uniprot (http://www.uniprot.org).",OADS,/arxiv_data1/oa_pdf/d3/e6/pcw089.PMC4970613.pdf
expasy.org/tools/glycomod/) and GlycoSuite website (https://glycosuite.pro-teomesystems.com/glycosuite/glycodb).,OADS,/arxiv_data1/oa_pdf/d3/e6/pcw089.PMC4970613.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
The intensities of signals due to MBP–PATL2 were determined with ImageJ (http://imagej.nih.gov/ij/) after immunochemical detection.,OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
"To obtain a fraction enriched for phosphorylated pro-teins, the extracted proteins were treated with a PhosphoProtein Puriﬁcation kit (Qiagen; http://www.qiagen.com/).",Non-OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
2D-DIGE Proteins in phosphoprotein-enriched fractions were precipitated with a 2-DClean-Up kit (GE Healthcare; http://www.gelifesciences.com/).,Non-OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
"Spots of interest were excised with an Ettan Spot Picker (GE Healthcare), digested with trypsin in situ, and then analyzed by MALDI-TOF/ MS with a Voyager system (Applied Biosystems; http://www.appliedbiosystems.",OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
"Production of antibodies and immunodetection of proteins Antibodies against PATL2 were raised by immunizing rabbits with the synthetic peptide CDDLVSEDLEGSEFC (residues 399–411 of PALT2), which was synthe-sized and afﬁnity-puriﬁed by MBL (http://www.mbl.co.jp/).",Non-OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
"Signalswere detected with SuperSignal TMWest Femto Maximum Sensitivity Substrate (Thermo Scientiﬁc, http://www.thermoscientiﬁc.com/) and LAS- 4000 mini (GE Healthcare).",OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
"TotalRNA was isolated with the High Pure RNA Tissue kit (Roche, http://roche-biochem.com/).",OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
"For the analysis of levels of RNAs by real-time PCR, we prepared 50 ng of total RNA for conversion to cDNA using ReverTra Ace /C213(Toyobo, http://www.toyobo.co.jp/).",OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
"PCR was performed using a SYBR/C213Green II kit (TAKARA, http://www.takara-bio.co.jp/) with primer pairs as follows: for PATL2, 50-CCAGAGTTTGTCGCTAAAGAGC-30and 50-TGTCCTTGGCGATGT AATGA-30; and for eIF5A, 50-CGTGTTGATTACCAGTTGATTGA-30and 50-TGG GAAGCTTGAGATCATCC-30.",Non-OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
"zeiss.com/) and FV1000 (Olympus, http://www.olympus.co.jp/) confocalmicroscope.",Non-OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
"After a 30 min incubation at 25/C14C, MBP–PATL2 was puriﬁed with amylose resin (New England BioLabs, http://www.neb.com/).",Non-OADS,/arxiv_data1/oa_pdf/0e/88/pcw098.PMC4970614.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/a5/itt-5-009.PMC4970629.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).ImmunoTargets and Therapy 2016:5 9–20ImmunoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  9RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/ITT .S4067 5Current and emerging treatment options in   the management of lupus Natasha Jordan1 David D’Cruz2 1Department of Rheumatology,   Cambridge University Hospitals  NHS Foundation Trust, Cambridge,   2Louise Coote Lupus Unit, Guy’s and  St Thomas’ Hospital NHS Foundation  Trust, London, UK Correspondence: Natasha Jordan   Department of Rheumatology,  Cambridge University Hospitals   NHS Foundation Trust, Hills Road,  Cambridge CB2 0QQ, UK   Tel +44 1223 216 217   Fax +44 1223 586 931   email natasha.jordan@addenbrookes.",Non-OADS,/arxiv_data1/oa_pdf/c3/a5/itt-5-009.PMC4970629.pdf
"ImmunoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/immunotargets-and-therapy-journa lImmunoTargets and Therapy is an international, peer-reviewed open access journal  focusing on the immunological basis of diseases, potential targets for immune  based therapy and treatment protocols employed to improve patient management.",Non-OADS,/arxiv_data1/oa_pdf/c3/a5/itt-5-009.PMC4970629.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/18/itt-5-037.PMC4970630.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).ImmunoTargets and Therapy ImmunoTargets and Therapy 2016:5 37–45Dove press submit your manuscript | www.dovepress.co m Dove press  RevIewopen access to scientific and medical research Open Access Full T ext Article 37 http: //dx.doi.org/10.2147/ITT .S8189 2Immunotherapy for tuberculosis: future prospects Getahun Abate1 Daniel F Hoft1,2 1Department of Internal Medicine,   Division of Infectious Diseases,   Allergy and Immunology, 2Department  of Molecular Microbiology and  Immunology, Saint Louis University,   St. Louis, MO, USA Correspondence: Getahun Abate   Department of Internal Medicine,  Division of Infectious Diseases, Allergy  and Immunology, Saint Louis University,  Doisy Research Center, 8th floor, 1100  S. Grand Blvd, St. Louis, MO 63104, USA   T el +1 314 977 5500   email abateg@slu.ed u    Daniel F Hoft   Department of Internal Medicine,  Division of Infectious Diseases, Allergy  and Immunology, Saint Louis University,  Doisy Research Center, 8th floor, 1100 S.  Grand Blvd, St. Louis, MO 63104, USA   T el +1 314 977 5500   Fax +1 314 771 3816   email hoftdf@slu.ed uAbstract:  Tuberculosis (TB) is still a major global health problem.",Non-OADS,/arxiv_data1/oa_pdf/98/18/itt-5-037.PMC4970630.pdf
"Available from:  http://www.newtbdrugs.org/pipeline.ph p. Accessed January 25, 2016.",OADS,/arxiv_data1/oa_pdf/98/18/itt-5-037.PMC4970630.pdf
"ImmunoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/immunotargets-and-therapy-journa lImmunoTargets and Therapy is an international, peer-reviewed open access journal  focusing on the immunological basis of diseases, potential targets for immune  based therapy and treatment protocols employed to improve patient management.",Non-OADS,/arxiv_data1/oa_pdf/98/18/itt-5-037.PMC4970630.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cd/b5/itt-5-001.PMC4970631.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).ImmunoTargets and Therapy ImmunoTargets and Therapy 2016:5 1–7Dove press submit your manuscript | www.dovepress.co m Dove press  RevIewopen access to scientific and medical research Open Access Full T ext Article 1 http: //dx.doi.org/10.2147/ITT .S8064 8Role of romiplostim in splenectomized and  nonsplenectomized patients with immune  thrombocytopenia Jose Perdomo Hematology Research Unit, St George  and Sutherland Clinical School,   University of New South wales,   Kogarah, NSw , Australia Correspondence: Jose Perdomo   Hematology Research Unit, St George  and Sutherland Clinical School,  University of New South wales, Level 3   Research and education Centre,  4–10 South Street, Kogarah, 2217,  NSw 2217, Australia   T el +61 2 9113 1915   Fax +61 2 9113 2058   email j.perdomo@unsw.edu.a uAbstract:  Romiplostim is a thrombopoietin receptor agonist (TPO-RA) used for the treatment  of adult primary immune thrombocytopenia (ITP).",Non-OADS,/arxiv_data1/oa_pdf/cd/b5/itt-5-001.PMC4970631.pdf
Available from: http://www.ema.europa.eu/ema/ index.jsp?curl =pages/medicines/human/medicines/000942/human_ med_000938.jsp&mid =WC0b01ac058001d12 4.,Non-OADS,/arxiv_data1/oa_pdf/cd/b5/itt-5-001.PMC4970631.pdf
"ImmunoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/immunotargets-and-therapy-journa lImmunoTargets and Therapy is an international, peer-reviewed open access journal  focusing on the immunological basis of diseases, potential targets for immune  based therapy and treatment protocols employed to improve patient management.",Non-OADS,/arxiv_data1/oa_pdf/cd/b5/itt-5-001.PMC4970631.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cc/d2/ppa-10-1373.PMC4970632.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1373–1384Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1373Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9255 0 Patient considerations in the management of  chronic constipation: focus on prucalopride Andrea Shin Department of Medicine, Division of  Gastroenterology and Hepatology,   indiana University School of Medicine,   indianapolis, iN, USAAbstract:  Chronic constipation is a common condition that significantly impacts health care  utilization, productivity, and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/cc/d2/ppa-10-1373.PMC4970632.pdf
"Criteria should be fulfilled for at least the  last 3 months with symptom onset at least 6 months prior to diagnosis.2 The Rome  criteria include patients with “functional constipation;” however, this term has been  avoided in the last two American Gastroenterological Association technical reviews  on constipation in consideration of the fact that there exists a subset of patients with  slow-transit constipation that is not considered to be truly “functional”.1 In North America, the reported prevalence of constipation ranges from 2% to 27%,  although most estimates report rates ranging from 12% to 19%.3 A prior systematic  review investigating epidemiology of constipation reported worldwide prevalence  rates ranging from 0.7% to 79% with an overall median of 16% and a median of Correspondence: Andrea Shin Department of Medicine, Division of  Gastroenterology and Hepatology,  indiana University School of Medicine,  702 Rotary Circle Suite 225,  indianapolis, iN 46202, USA Tel +1 317 274 3505 email ashin@iu.ed u Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Shin Running head recto: Prucalopride in chronic constipation DOI: http://dx.doi.org/10.2147/PPA.S92550",Non-OADS,/arxiv_data1/oa_pdf/cc/d2/ppa-10-1373.PMC4970632.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/cc/d2/ppa-10-1373.PMC4970632.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/23/ppa-10-1385.PMC4970633.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1385–1399Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1385Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10182 1Preference for pharmaceutical formulation and  treatment process attributes Katie D Stewart1 Joseph A Johnston2 Louis S Matza1 Sarah e Curtis2 Henry A Havel3 Stephanie A Sweetana3 Heather L Gelhorn1 1Outcomes Research, evidera,   Bethesda, MD, USA; 2Global Patient  Outcomes & Real world evidence,   3Small Molecule Design and  Development, eli Lilly & Company,   indianapolis, iN, USAPurpose:  Pharmaceutical formulation and treatment process attributes, such as dose frequency  and route of administration, can have an impact on quality of life, treatment adherence, and  disease outcomes.",Non-OADS,/arxiv_data1/oa_pdf/3c/23/ppa-10-1385.PMC4970633.pdf
"Furthermore, treat - ment regimens can vary in terms of dose frequency and dose flexibility, including Correspondence: Katie D Stewart Outcomes Research, evidera, 7101  wisconsin Avenue, Suite 1400, Bethesda,  MD 20814, USA Tel +1 240 235 2493 Fax +1 301 654 9864 email katie.stewart@evidera.co m Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Stewart et al Running head recto: Preference for treatment process attributes DOI: http://dx.doi.org/10.2147/PPA.S101821",Non-OADS,/arxiv_data1/oa_pdf/3c/23/ppa-10-1385.PMC4970633.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/3c/23/ppa-10-1385.PMC4970633.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/49/dddt-10-2379.PMC4970634.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2379–2386Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2379Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11094 6 Ceftazidime/avibactam: a novel cephalosporin/ nonbeta-lactam beta-lactamase inhibitor for the  treatment of complicated urinary tract infections  and complicated intra-abdominal infectionsJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Hidalgo et al Running head recto: Ceftazidime/avibactam for the treatment of cUTIs and cIAIs DOI: http://dx.doi.org/10.2147/DDDT.S110946 Jose A Hidalgo1,2 Celeste M vinluan1–3 Nishaal Antony3 1UTeP/UT Austin Cooperative  Pharmacy Program, College of  Health Sciences, University of T exas  at el Paso, el Paso, 2Department of  Pharmacy, College of Pharmacy, The  University of T exas at Austin, Austin,   3Department of internal Medicine,   T exas T ech University Health Sciences  Center, el Paso, TX, USAAbstract:  There has been greater interest in developing additional antimicrobial agents due  to the increasing health care costs and resistance resulting from bacterial pathogens to cur - rently available treatment options.",Non-OADS,/arxiv_data1/oa_pdf/08/49/dddt-10-2379.PMC4970634.pdf
Available from:  http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.,OADS,/arxiv_data1/oa_pdf/08/49/dddt-10-2379.PMC4970634.pdf
"Avail - able from: http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ ar-threats-2013-508.pd f. Accessed February 3, 2016.",OADS,/arxiv_data1/oa_pdf/08/49/dddt-10-2379.PMC4970634.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/08/49/dddt-10-2379.PMC4970634.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/49/dddt-10-2379.PMC4970634.pdf
Available from: http://clinicaltrials.gov/ show/NCT0247573 3.,Non-OADS,/arxiv_data1/oa_pdf/08/49/dddt-10-2379.PMC4970634.pdf
Available from:  http://clinicaltrials.gov/show/NCT0180809 2.,Non-OADS,/arxiv_data1/oa_pdf/08/49/dddt-10-2379.PMC4970634.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ef/1e/ppa-10-1401.PMC4970636.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1401–1407Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1401OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11063 2 long-term antidepressant use: patient  perspectives of benefits and adverse effects claire cartwright1 Kerry gibson1 John read2 Ondria cowan1 Tamsin Dehar1 1school of Psychology, University of  Auckland, new Zealand; 2Psychology  Department, University of east   london, stratford campus,   london, UKAbstract:  Long-term antidepressant treatment has increased and there is evidence of adverse  effects; however, little is known about patients’ experiences and views of this form of treat - ment.",Non-OADS,/arxiv_data1/oa_pdf/ef/1e/ppa-10-1401.PMC4970636.pdf
"A recent international review of 13 sets of prescribing  guidelines revealed that recommendations for duration of continuation treatment varied  from 4 to 12 months and maintenance treatment from 1 year to lifelong or indefinite.7 While there is evidence for continuation of antidepressant treatment after remis - sion, there is less evidence for maintenance or longer term treatment.8 While most  cases of depression are managed through primary care,9 a recent review revealed  that no randomized clinical trials have been conducted to evaluate the efficacy of correspondence: claire cartwright school of Psychology, University of  Auckland, Private Bag 90219, Auckland,  new Zealand Tel +64 9 373 7599 ext 86269 Fax +64 9 373 7450 email c.cartwright@auckland.ac.n z Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Cartwright et al Running head recto: Patient perspectives of long-term antidepressant use DOI: http://dx.doi.org/10.2147/PPA.S110632",Non-OADS,/arxiv_data1/oa_pdf/ef/1e/ppa-10-1401.PMC4970636.pdf
Available from: http://dx.doi.org/10.1787/health_glance-2013-e n  4.,Non-OADS,/arxiv_data1/oa_pdf/ef/1e/ppa-10-1401.PMC4970636.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ef/1e/ppa-10-1401.PMC4970636.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/fa/itt-5-047.PMC4970637.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).immunoTargets and Therapy 2016:5 47–56submit your manuscript | www.dovepress.co m Dove press  47 http: //dx.doi.org/10.2147/ITT .S7322 3The role of adipokines in chronic inflammation Peter Mancuso Department of Nutritional Sciences,   School of Public Health, University of  Michigan, Ann Arbor, M i, USA Correspondence: Peter Mancuso   Department of Nutritional Sciences,  School of Public Health, University of  Michigan, Room 1846 SPH i,   1415 washington Heights,  Ann Arbor,   Mi 48109-2029, USA   email pmancuso@umich.ed uAbstract:  Adipose tissue has traditionally been defined as connective tissue that stores excess  calories in the form of triacylglycerol.",Non-OADS,/arxiv_data1/oa_pdf/12/fa/itt-5-047.PMC4970637.pdf
"ImmunoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/immunotargets-and-therapy-journa lImmunoTargets and Therapy is an international, peer-reviewed open access journal  focusing on the immunological basis of diseases, potential targets for immune  based therapy and treatment protocols employed to improve patient management.",Non-OADS,/arxiv_data1/oa_pdf/12/fa/itt-5-047.PMC4970637.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/63/dddt-10-2369.PMC4970638.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2369–2378Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2369Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11220 8 A review of omalizumab for the management  of severe asthma Ching-Hsiung Lin1–3 Shih-Lung Cheng4,5 1Division of Chest Medicine,   Department of internal Medicine,   Changhua Christian Hospital,   Changhua, Taiwan, Republic of China;   2Department of Respiratory Care,   College of Health Sciences, Chang  Jung Christian University, Tainan,   Taiwan, Republic of China; 3School  of Medicine, Chung Shan Medical  University, Taichung, Taiwan, Republic  of China; 4Department of internal  Medicine, Far eastern Memorial  Hospital, Taipei, Taiwan, Republic of  China; 5Department of Chemical  engineering and Materials Science,   Yuan Ze University, Zhongli  City, Taoyuan County, Taiwan,   Republic of ChinaAbstract:  Despite the expansion of the understanding in asthma pathophysiology and the  continual advances in disease management, a small subgroup of patients remain partially  controlled or refractory to standard treatments.",Non-OADS,/arxiv_data1/oa_pdf/c5/63/dddt-10-2369.PMC4970638.pdf
"The latest Global Asthma Report in 2014  showed a marked increase in asthma prevalence and estimated that as many as  334 million people worldwide are affected, highlighting the presence of a profound  socioeconomic burden.5 According to the latest Global Strategy for Asthma Management and Prevention  from Global Initiative for Asthma (GINA), asthma severity is assessed based on the  level of treatment required to achieve and maintain symptom control.6 While most  asthma could be controlled with low-intensity treatment, a minority of patients,  likely constituting 5% of the total asthma population, could only achieve subop - timal symptom control with optimized treatment.2,7,8 Severe asthma is defined as  to patients whose symptoms or exacerbations require the use of high-dose inhaled  corticosteroid (ICS) plus a second controller or in whom disease persists despite  the use of this treatment, and those of whom only partially respond to treatment of  comorbidities.6Correspondence: Shih-Lung Cheng Department of internal Medicine,  Far eastern Memorial Hospital, No 21,  Sec 2, Nan-Ya SR, Pan-Chiao, New Taipei  City, Taiwan, Republic of China Tel +886 2 8966 7000 Fax +886 2 7738 0708 email chest5415@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Lin and Cheng Running head recto: Omalizumab for severe asthma management DOI: http://dx.doi.org/10.2147/DDDT.S112208",Non-OADS,/arxiv_data1/oa_pdf/c5/63/dddt-10-2369.PMC4970638.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c5/63/dddt-10-2369.PMC4970638.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/63/dddt-10-2369.PMC4970638.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ba/14/itt-5-021.PMC4970639.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).ImmunoTargets and Therapy 2016:5 21–35ImmunoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  21RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/ITT .S8203 7Current perspectives on the immunopathogenesis  of systemic sclerosis Patrizia Fuschiotti Division of Rheumatology and Clinical  Immunology, Department of Medicine,   University of Pittsburgh School of  Medicine, Pittsburgh, PA, USA Correspondence: Patrizia Fuschiotti   Division of Rheumatology and Clinical  Immunology, Department of Medicine,  University of Pittsburgh School of  Medicine, S709 BST, 200 Lothrop Street,  Pittsburgh, PA 15261, USA   T el +1 412 648 9385   Fax +1 412 383 8864   email paf23@pitt.ed uAbstract:  Systemic sclerosis (SSc or scleroderma) is a progressive and highly debilitating  autoimmune disorder characterized by inflammation, vasculopathy, and extensive fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/ba/14/itt-5-021.PMC4970639.pdf
"ImmunoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/immunotargets-and-therapy-journa lImmunoTargets and Therapy is an international, peer-reviewed open access journal  focusing on the immunological basis of diseases, potential targets for immune  based therapy and treatment protocols employed to improve patient management.",Non-OADS,/arxiv_data1/oa_pdf/ba/14/itt-5-021.PMC4970639.pdf
Visit http://www.dovepress.com/testimonials.php to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/14/itt-5-021.PMC4970639.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a3/28/itt-5-057.PMC4970640.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a3/28/itt-5-057.PMC4970640.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Prion diseases: immunotargets and therapy Jennifer T Burchell Peter K Panegyres Neurodegenerative Disorders  Research Pty Ltd, West Perth,   Western Australia, Australia Correspondence: Peter K Panegyres   Neurodegenerative Disorders Research  Pty Ltd, 4 Lawrence Avenue, West Perth,  Western Australia 6005, Australia   T el +61 8 9481 6293   Fax +61 8 9481 6294   Email research@ndr.org.a uAbstract:  Transmissible spongiform encephathalopathies or prion diseases are a group of  neurological disorders characterized by neuronal loss, spongiform degeneration, and activation of  astrocytes or microglia.",Non-OADS,/arxiv_data1/oa_pdf/a3/28/itt-5-057.PMC4970640.pdf
Or use: http://youtu.be/e1O0lRXAyq 4,Non-OADS,/arxiv_data1/oa_pdf/a3/28/itt-5-057.PMC4970640.pdf
"ImmunoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/immunotargets-and-therapy-journa lImmunoTargets and Therapy is an international, peer-reviewed open access journal  focusing on the immunological basis of diseases, potential targets for immune  based therapy and treatment protocols employed to improve patient management.",Non-OADS,/arxiv_data1/oa_pdf/a3/28/itt-5-057.PMC4970640.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/dddt-10-2387.PMC4970641.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2387–2399Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2387Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6144 3 Tafenoquine and its potential in the treatment  and relapse prevention of Plasmodium vivax   malaria: the evidence to date Yehenew A ebstie1,* Solomon M Abay2,* wondmagegn T Tadesse3 Dawit A ejigu4 1Department of Microbiology,   immunology and Parasitology,   2Department of Pharmacology,   3Department of Pharmacology and  Clinical Pharmacy, School of Medicine,   College of Health Sciences, Addis  Ababa University, 4Department of  Pharmacology, St Paul’s Hospital  Millennium Medical College, Addis  Ababa, ethiopia *These authors contributed equally  to this workAbstract:  Despite declining global malaria incidence, the disease continues to be a threat to  people living in endemic regions.",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/dddt-10-2387.PMC4970641.pdf
"Some factors that explain underestimation of vivax malaria incidence  include microscopic misreading as falciparum in co-endemic areas and presence of  undetectable parasitemia among symptomatic patients and liver hypnozoites among  asymptomatic patients.2,4–11Correspondence: Yehenew A ebstie Department of Microbiology,  immunology and Parasitology, School  of Medicine, College of Health Sciences,  Addis Ababa University, Zambia Street,  PO Box 9086, Addis Ababa, ethiopia Tel +251 9 1304 9270 email yeh_kiam@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Ebstie et al Running head recto: Tafenoquine and its potential in treatment and relapse DOI: http://dx.doi.org/10.2147/DDDT.S61443",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/dddt-10-2387.PMC4970641.pdf
Available from: https://us.gsk.com/en-us/media/ press-releases/2014/gsk-and-mmv-announce-start-of-phase-iii- programme-of-tafenoquine-for-plasmodium-vivax-malaria/.,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/dddt-10-2387.PMC4970641.pdf
Available from:  http://gtr.rcuk.ac.uk/projects?ref =MR/L000644/ 1.,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/dddt-10-2387.PMC4970641.pdf
Available from: http://www.malarianexus.co m/news/ tafenoquine-gets-u-s-food-and-drug-administration- fda-breakth rough /.,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/dddt-10-2387.PMC4970641.pdf
"Available from: http://www.brookings.edu/events/2015/04/24-fd a-  breakthrough-therapy-criteri a. Accessed May 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/dddt-10-2387.PMC4970641.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/dddt-10-2387.PMC4970641.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/dddt-10-2387.PMC4970641.pdf
"Available from: https://pubchem.ncbi.nlm.nih.gov/ compound/primaquin e. Accessed May 23, 2016.",OADS,/arxiv_data1/oa_pdf/4a/6f/dddt-10-2387.PMC4970641.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/85/03/rmhp-9-185.PMC4970651.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/85/03/rmhp-9-185.PMC4970651.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/85/03/rmhp-9-185.PMC4970651.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2016:9 185–191Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 185 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S107721 Occupational management in the workplace and  impact on Workers’ Compensation Board claims,  duration, and cost: a prospective longitudinal cohort Mark E Lemstra Alliance Health Medical Clinic, Moose  Jaw, SK, CanadaAbstract: Few workplaces have prospectively reviewed workplace and worker issues simultane- ously and assessed their impact on Workers’ Compensation Board (WCB) claims.",Non-OADS,/arxiv_data1/oa_pdf/85/03/rmhp-9-185.PMC4970651.pdf
"No intervention had high levels of evidence for reducing claim Correspondence: Mark E Lemstra Alliance Health Medical Clinic, 890 A Lillooet St W, Moose Jaw, SK S6H 8B4, CanadaTel +1 306 230 3911Email marklemstra@shaw.caJournal name: Risk Management and Healthcare Policy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: LemstraRunning head recto: Occupational management in the workplaceDOI: http://dx.doi.org/10.2147/RMHP .S107721",Non-OADS,/arxiv_data1/oa_pdf/85/03/rmhp-9-185.PMC4970651.pdf
"Risk Management and Healthcare Policy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/85/03/rmhp-9-185.PMC4970651.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 191 Occupational management in the workplace 14.,Non-OADS,/arxiv_data1/oa_pdf/85/03/rmhp-9-185.PMC4970651.pdf
BRCA1/2 variant data has been submitted to Leiden Open SourceDatabase at http://databases.lovd.nl/shared/individuals/PatientID (PatientID:00051505 –00051521).,OADS,/arxiv_data1/oa_pdf/68/25/ejhg2015268a.PMC4970683.pdf
BRCA1/2 variant data have been submitted to Leiden Open Source Database at http://databases.lovd.nl/shared/individuals/PatientID (PatientID: 00051505 –00051521).,OADS,/arxiv_data1/oa_pdf/68/25/ejhg2015268a.PMC4970683.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/4.0/Germline BRCA testing in FFPE tissue from deceased AH Petersen et al 1111 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/68/25/ejhg2015268a.PMC4970683.pdf
Available at: http://www.bodytrace.com/medical/faq.html.,Non-OADS,/arxiv_data1/oa_pdf/1a/f9/OSP4-2-224.PMC4970749.pdf
"Inclusion criteria were as follows: EDI-OCT scan obtained within 2 weeks ofinitial acute presentation, minimum follow-up of 3 months, refractive error not higher than /C03.00 diopters (as patients with higher myopia may have a thinnerchoroid and can be a confounder for CT assessment).Local ethics board approval was obtained to analyze the images using public domain software (available in the public domain at Fiji; http://imagej.nih.gov/ij ,version 2.0.0-rc.15/1.49j, date: 2014-10-06).",Non-OADS,/arxiv_data1/oa_pdf/97/0f/i2164-2591-5-4-7.PMC4970799.pdf
Available from URL: http://www.nccn.org.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/CAS-107-653.PMC4970832.pdf
US available from URL: http://www.revlimid.com/wp-content/uploads/full-prescribing-information.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/CAS-107-653.PMC4970832.pdf
[Cited 27 December 2015] available from URL: http://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/380809_4 291024M1024_1_21.,OADS,/arxiv_data1/oa_pdf/ae/b8/CAS-107-653.PMC4970832.pdf
Cell migration area was deﬁned as the advanced area from the scratched border at 0 h after scratching; the area was measured using the NIH ImageJ software (http://rsb.info.nih.-gov/ij/).,OADS,/arxiv_data1/oa_pdf/26/01/CAS-107-666.PMC4970834.pdf
Available from URL: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/26/01/CAS-107-666.PMC4970834.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(2): 107-114, 2014 http://dx.doi.org/10.5371/hp.2014.26.2.107 Copyright ⓒ2014 by Korean Hip Society 107Print ISSN 2287-3260 Online ISSN 2287-3279 Copyright ⓒ2014 by Korean Hip Society 107INTRODUCTION Femoral subtrochanteric fractures, which account for 10-34% of total hip fractures, are occurring withincreasing frequency due to traffic accidents as well as atrend towards an aging population 1-3).",Non-OADS,/arxiv_data1/oa_pdf/f3/71/hp-26-107.PMC4971114.pdf
"Key Words : Subtrochanteric fractures, Intramedullary nailing, Ununited fracture Submitted: April 26, 2014  1st revision: May 15, 2014 2nd revision: June 9, 2014 Final acceptance: June 13, 2014 Address reprint request to Yerl-Bo Sung, MD, PhDDepartment of Orthopedic Surgery, Inje University Sanggye PaikHospital, 1342 Dongil-ro, Nowon-gu, Seoul 139-707, KoreaTEL: +82-2-950-1032  FAX: +82-2-934-6342 E-mail: ybs58@paik.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/71/hp-26-107.PMC4971114.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(2): 115-123, 2014 http://dx.doi.org/10.5371/hp.2014.26.2.115 Copyright ⓒ2014 by Korean Hip Society 115Print ISSN 2287-3260 Online ISSN 2287-3279 Copyright ⓒ2014 by Korean Hip Society 115 115Print ISSN 2287-3260 Online ISSN 2287-3279 Correlation of Structural Bony Abnormalities and Mechanical Symptoms of Hip Joints Sung-Hwa Lyu, MD, Yoon-Ho Kwak, MD*, Young-Kyun Lee, MD, Yong-Chan Ha, MD*, Kyung-Hoi Koo, MD Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea, Department of Orthopaedic Surgery, Chung-Ang University College of Medicine*, Seoul, Korea Purpose : The purpose of this study is to determine structural bony abnormalities predisposing for femoroacetabular impingement by comparison of patients with and without mechanical symptoms.Materials and Methods :  We conducted this comparative study on 151 patients (151 hips; mean age 44.8 years; range 16-73 years) with mechanical symptoms with results of multi-detector computed tomography (MDCT)arthrography (the symptomatic group).",Non-OADS,/arxiv_data1/oa_pdf/26/a3/hp-26-115.PMC4971115.pdf
"Key Words : Femoroacetabular impingement, Multidetector computed tomography, Arthrography Submitted: March 24, 2014  1st revision: April 8, 2014 Final acceptance: May 22, 2014 Address reprint request to Yong-Chan Ha, MDDepartment of Orthopaedic Surgery, Chung-Ang University Collegeof Medicine, 102 Heukseok-ro, Dongjak-ku, Seoul 156-755, KoreaTEL: +82-2-6299-1577  FAX: +82-2-822-1710 E-mail: hayongch@naver.comThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/a3/hp-26-115.PMC4971115.pdf
"CASE REPORT Hip Pelvis 26(2): 124-127, 2014 http://dx.doi.org/10.5371/hp.2014.26.2.124 Copyright ⓒ2014 by Korean Hip Society 124Print ISSN 2287-3260 Online ISSN 2287-3279 Due to similar clinical signs and symptoms, it is often difficult to make an accurate diagnosis in cases wherepatients with a medical history of polycythemia vera presentwith a deep vein thrombosis following hip surgery.",Non-OADS,/arxiv_data1/oa_pdf/5c/f2/hp-26-124.PMC4971116.pdf
"Key Words : Polycythemia vera, Deep vein thrombosis, Postoperative infection Submitted: February 16, 2014  1st revision: March 14, 2014 2nd revision: April 14, 2014 Final acceptance: April 25, 2014 Address reprint request to Byung Ho Seo, MDDepartment of Orthopedic Surgery, Pohang Sunlin MedicalCenter, 43 Daeshin-ro, Buk-gu, Pohang 791-704, KoreaTEL: +82-54-245-5482  FAX: +82-54-245-5345 E-mail: gog5005@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/f2/hp-26-124.PMC4971116.pdf
"EDITORIAL Hip Pelvis 26(2): 63-64, 2014 http://dx.doi.org/10.5371/hp.2014.26.2.63 Copyright ⓒ2014 by Korean Hip Society 63Print ISSN 2287-3260 Online ISSN 2287-3279 The Journal of the Korean Hip Society was first published in 1989 and it has been a quarterly publicationsince the year 2000.",Non-OADS,/arxiv_data1/oa_pdf/8f/b9/hp-26-63.PMC4971117.pdf
"Further, we need an international editorial boardOn the Occasion of the Publication of the English Version of “ Hip & Pelvis ” Youn-Soo Park, MD Department of Orthopedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Submitted: June 9, 2014  Final acceptance: June 16, 2014 Address reprint request toYoun-Soo Park, MDDepartment of Orthopedic Surgery, Samsung Medical Center, 81Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTEL: +82-2-3410-3504  FAX: +82-2-3410-0061 E-mail: ysp3504@skku.edu This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/b9/hp-26-63.PMC4971117.pdf
"REVIEW ARTICLE Hip Pelvis 26(2): 65-73, 2014 http://dx.doi.org/10.5371/hp.2014.26.2.65 Copyright ⓒ2014 by Korean Hip Society 65Print ISSN 2287-3260 Online ISSN 2287-3279 Copyright ⓒ2014 by Korean Hip Society 65INTRODUCTION Total hip arthroplasty (THA) is extensively performed on a considerable number of patients with advancedstages of osteonecrosis of femoral head (ONFH) inKorea.",Non-OADS,/arxiv_data1/oa_pdf/9d/6a/hp-26-65.PMC4971118.pdf
"Key Words : Hip joint, Osteonecrosis of the femoral head, Arthroplasty Submitted: January 29, 2014  1st revision: February 26, 2014 Final acceptance: March 17, 2014 Address reprint request to Yoon Je Cho, MDDepartment of Orthopedic Surgery, Kyung Hee University MedicalCenter, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-872, KoreaTEL: +82-2-958-8372  FAX: +82-2-958-8346 E-mail: yjcho@khmc.or.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/6a/hp-26-65.PMC4971118.pdf
"REVIEW ARTICLE Hip Pelvis 26(2): 74-78, 2014 http://dx.doi.org/10.5371/hp.2014.26.2.74 Copyright ⓒ2014 by Korean Hip Society 74Print ISSN 2287-3260 Online ISSN 2287-3279 NEUROVASCULAR INJURY IN HIP ARTHROPLASTY Although neurovascular injury is not a very common complication, once it occurs it can have seriousconsequences for both patients and doctors.",Non-OADS,/arxiv_data1/oa_pdf/a0/85/hp-26-74.PMC4971119.pdf
"Key Words : Hip, Neurovascular injury, Hip arthroplasty Submitted: February 10, 2014  1st revision: March 6, 2014 2nd revision: March 31, 2014  Final acceptance: April 2, 2014 Address reprint request to Ick-Hwan Yang, MDDepartment of Orthopaedic Surgery, Sinchon Severance Hospital,Yonsei University College of Medicine, 50-1 Yonsei-Ro,Seodaemun-gu, Seoul 120-752, KoreaTEL: +82-2-2228-2180  FAX: +82-2-363-1139 E-mail: ihyang@yumc.yonsei.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/85/hp-26-74.PMC4971119.pdf
"REVIEW ARTICLE Hip Pelvis 26(2): 79-83, 2014 http://dx.doi.org/10.5371/hp.2014.26.2.79 Copyright ⓒ2014 by Korean Hip Society 79Print ISSN 2287-3260 Online ISSN 2287-3279 Copyright ⓒ2014 by Korean Hip Society 79INTRODUCTION Pelvic fractures are mainly divided into unstable fractures resulting in pelvic ring deformity, and stablefractures, which include pubic ramus, iliac wing andavulsion fractures 1-6).",Non-OADS,/arxiv_data1/oa_pdf/16/a3/hp-26-79.PMC4971120.pdf
"Key Words : Pelvis, Pelvic bones, Therapeutics, Clinical protocols, Review literature as topic Submitted: July 11, 2013  1st revision: October 2, 2013 2nd revision: November 27, 2013  3rd revision: December 11, 2013 4rd revision: January 6, 2014  5rd revision: January 27, 2014 6rd revision: February 1, 2014  7rd revision: March 24, 2014 Final acceptance: April 8, 2014 Address reprint request to Weon-Yoo Kim, MDDepartment of Orthopedic Surgery, Daejeon St. Mary’s Hospital,The Catholic University of Korea, 64 Daeheung-ro, Jung-gu,Daejeon 301-723, KoreaTEL: +82-42-220-9530  FAX: +82-42-221-0429 E-mail: weonkim@hotmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/a3/hp-26-79.PMC4971120.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(2): 84-91, 2014 http://dx.doi.org/10.5371/hp.2014.26.2.84 Copyright ⓒ2014 by Korean Hip Society 84Print ISSN 2287-3260 Online ISSN 2287-3279 Print ISSN 2287-3260 Online ISSN 2287-3279 Primary Total Hip Arthroplasty Using Third Generation Ceramic-Ceramic Articulation: Results after a Minimum of Three-years of Follow-up Dong Woo Lee, MD, Sung Kwan Hwang, MD Department of Orthopedics, Yonsei University Wonju College of Medicine, Wonju, Korea Purpose : This study assessed the short term clinicoradiological results of primary total hip arthroplasty using third generation ceramic-ceramic articulation Accolade TMZF femoral stems.Materials and Methods : Two hundred and seventy two patients (294 hips) with primary total hip arthroplasty using third generation ceramic-ceramic articulation Accolade TMZF femoral stems who had been followed-upfor a minimum of 3 years were included.",Non-OADS,/arxiv_data1/oa_pdf/b6/e4/hp-26-84.PMC4971121.pdf
"Key Words : Third generation ceramic-ceramic articulation, Primary total hip arthroplasty, Harris hip score Submitted: April 23, 2014  1st revision: May 15, 2014 2nd revision: June 12, 2014  Final acceptance: June 16, 2014 Address reprint request to Sung Kwan Hwang, MDDepartment of Orthopedics, Yonsei University Wonju College ofMedicine, 20 Ilsan-ro, Wonju 220-701, KoreaTEL: +82-33-741-1351  FAX: +82-33-741-1365 E-mail: hwtonlka@wonju.yonsei.ac.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/e4/hp-26-84.PMC4971121.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(2): 92-98, 2014 http://dx.doi.org/10.5371/hp.2014.26.2.92 Copyright ⓒ2014 by Korean Hip Society 92Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Total hip arthroplasty (THA) using ceramic-on-ceramic bearings is characterized by a low wearing rate, no release of metal ions, resistance to scratches, andhydrophilic properties, and thus has a better clinicalprognosis than metal-on-polyethylene bearing surfaces 1).",Non-OADS,/arxiv_data1/oa_pdf/ad/9d/hp-26-92.PMC4971122.pdf
"Key Words : Total hip arthroplasty, Ceramic-on-ceramic bearing, Squeaking, Noise, Meta-analysis Submitted: April 15, 2014  1st revision: May 8, 2014 Final acceptance: May 30, 2014 Address reprint request to Youn-Soo Park, MDDepartment of Orthopedic Surgery, Samsung Medical Center, 81Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTEL: +82-2-3410-3504  FAX: +82-2-3410-0061 E-mail: ysp3504@skku.edu This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/9d/hp-26-92.PMC4971122.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(2): 99-106, 2014 http://dx.doi.org/10.5371/hp.2014.26.2.99 Copyright ⓒ2014 by Korean Hip Society 99Print ISSN 2287-3260 Online ISSN 2287-3279 99Print ISSN 2287-3260 Online ISSN 2287-3279 The Comparison of Compression Hip Screw and Bipolar Hemiarthroplasty for the Treatment of AO Type A2 Intertrochanteric Fractures Yee-Suk Kim, MD, Jae-Seung Hur, MD, Kyu-Tae Hwang, MD, Il-Yong Choi, MD, Young-Ho Kim, MD* Department of Orthopedic Surgery, Hanyang University Hostpial, Hanyang University Department of Orthopedic Surgery, Hanyang University Guri Hostpial, Hanyang University* Purpose : The purpose of this study was to compare the outcomes of osteosynthesis using compression hip screw fixation versus bipolar hemiarthroplasty in AO type A2 intertrochanteric fractures.Materials and Methods : From March 2003 to December 2009, 89 patients were included in this study.",Non-OADS,/arxiv_data1/oa_pdf/7e/14/hp-26-99.PMC4971123.pdf
"Key Words : Femur, Intertrochanteric fracture, Compression hip screw, Bipolar hemiarthroplasty Submitted: December 7, 2013  1st revision: January 27, 2014 2nd revision: March 11, 2014 Final acceptance: March 25, 2014 Address reprint request to Young-Ho Kim, MDDepartment of Orthopaedic Surgery, Guri Hospital, College ofMedicine, Hanyang University, 249-1 Gyomoon-dong, Guri 471-701, KoreaTEL: +82-31-560-2316  FAX: +82-31-557-8781 E-mail: kimyh1@hanyang.ac.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/14/hp-26-99.PMC4971123.pdf
The mean surface area of the fetal-maternal interface of the placental villi (syncytiotrophoblast) was 12.59 M 2.Received: 25 May 2016 Revised: 12 July 2016 Accepted: 25 July 2016 Heliyon 2 (2016) e00135 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
"Morphometric parameters reported in the literature for the placenta of non-Sudanese women are the volume densities and absolutevolumes of the placental villi, intervillus space, fetal blood vessels and surface area Article No~e00135 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
Article No~e00135 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
Article No~e00135 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
"For the determination of the surface density of the syncytiotrophoblast (Svt ), which forms the fetal maternal interface, the fields were photographed at a magnification Article No~e00135 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
Article No~e00135 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
Parameter Percentage volume Absolute values Mean ± SD Volume of intervillus space34.7% 169.34 ± 20 (cm3) Volume of placental villi 65.3% 318.66 ± 20 (cm3) Volume of fetal blood capillaries13% 41.42 ± 14.47 (cm3) Volume of fetal connective tissue and blood vessels larger than capillaries 87% 277.23 ± 16.7 (cm3) Surface area of trophoblast (villus surface area)- 12.59 ± 1.02 (M2) Article No~e00135 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
(2003) BolivianMean value Placental volume (cm3)488 488 540 476 - 488 487.69 Volume of intervillus space (cm3)144 110 210 180 276 184 169.34 Volume of villi (cm3) 224 204 239 253 259 235.8 318.66 Volume of fetal blood capillaries(cm 3)45 36 74 36 48 47.8 41.42 Surface area of villi M211 16.7 13.3 12.6 11 12.9 12.59 Article No~e00135 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
"Furthermore, roughly 40% of total placental volume in European women was occupied by the Article No~e00135 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
The remarkable difference in volumes of fetal and maternal blood volumes in theplacenta favors the process of exchange of substances for the benefit of the fetus Article No~e00135 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
Article No~e00135 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
Article No~e00135 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
Article No~e00135 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
Article No~e00135 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00135 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/cd/main.PMC4971126.pdf
Maximum room temperature conductivity of 7 :4×1 0 /C05Sc m−1was achieved with 22.5 wt.%Received: 3 June 2016 Revised: 13 July 2016 Accepted: 15 July 2016 Heliyon 2 (2016) e00134 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
The amorphous phase of PVdF-HFP Article No~e00134 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Thermal analysis was carried out for Article No~e00134 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Sample code PVdF-HFP (wt.%) PMMA (wt.%) LiTf (wt.%) BL1 67.5 7.5 25 BL2 60 15 25BL3 52.5 22.5 25 BL4 45 30 25 BL5 37.5 37.5 25 Article No~e00134 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Article No~e00134 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Article No~e00134 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Article No~e00134 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Article No~e00134 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Article No~e00134 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Sample code Conductivity ( ×10/C05Scm−1)t i BL1 6.6 0.84 BL2 6.8 0.88BL3 7.4 0.86 BL4 4.9 0.86 BL5 4.2 0.85 Article No~e00134 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Article No~e00134 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Article No~e00134 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Article No~e00134 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Article No~e00134 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
Article No~e00134 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00134 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/63/main.PMC4971127.pdf
"To examine the expression of pro-inflammatory cytokines and cellular signaling pathways, semi-quantitative RT-PCR and Western blotting were also used in this study.Received: 10 March 2016 Revised: 3 June 2016 Accepted: 12 July 2016 Heliyon 2 (2016) e00132 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
"1 F) synthesized the appropriated 2-alkylamino-DMNQs, Article No~e00132 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Primers for iNOS forward:5'-CCC TTC CGA AGT TTC TGG CAG CAG C-3'; reverse:5'- GGC TGT CAG AGC CTC GTG GCT TTG G −3'; for IL-1 βforward 5'-ATG GCA ACT GTT CCT GAA CTC AAC T-3'; reverse 5'-CAG GAC AGG TATAGA TTC TTT CCT TT-3'; for TNF- αforward 5'-CTC AAA TGG GCT TTC Article No~e00132 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
4 (A and Article No~e00132 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
It was reported that DMNQ derivatives Article No~e00132 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
Article No~e00132 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00132 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/7b/main.PMC4971128.pdf
"Furthermore, molecular marker labeling and morphological examinations characterized several other distinct DiI-Ac-LDL+multi-cellular modules and a VEGFR3+sprouting structure in the balloon cultures that likely represented intermediate structures of balloon-formation.Received: 7 May 2016 Revised: 21 June 2016 Accepted: 15 July 2016 Heliyon 2 (2016) e00133 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
A diameter of around 0.5 mm was commonly seen for spherical structures; the largest of these structures could grow to > 1 mm Article No~e00133 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
"Fluorescent-activated cell sorting (FACS) analysis also showed that the expressions of endothelial markers VE-cadherin, CD31, CD34, KDR, CXCR4, and Article No~e00133 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
"5 A, bottom row, green gate and arrows), indicating the existence of a VE-cadherin+CD31+ Article No~e00133 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
"Therefore, this article focuses only on Article No~e00133 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
"H9 and H1 hESCswere cultured on irradiated MEFs in media containing DMEM/F12, 20% knockout Article No~e00133 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
"Western blotting Cultured cells were lysed directly by 2 × Laemmli buffer (Bio-Rad), boiled for 5 min, and analyzed using SDS-PAGE electrophoresis followed by wet-transfer Article No~e00133 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Primer Name Forward Primer (5'-3') Reverse Primer (5'-3') ACTB agagctacgagctgcctgac cgtggatgccacaggact VE-cadherin gttcacgcatcggttgttcaa cgcttccaccacgatctcata FLT1 gtcacagaagaggatgaaggtgtc cacagtccggcacgtaggtgatt KDR tttttgcccttgttctgtcc tcattgttcccagcatttca TIE1 agaacctagcctccaagatt actgtagttcagggactcaaTIE2 tccaaggatgtctctgctctc ttggggtcatcctcggtat Endoglin ttcctggagttcccaacg aggtgccattttgcttgg Calponin1 ctgtcagccgaggttaagaac gaggccgtccatgaagttgtt Article No~e00133 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
doi.org/10.1016/j.heliyon.2016.e00133 Article No~e00133 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Article No~e00133 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00133 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/cb/main.PMC4971129.pdf
Keywords: Cell biologyReceived: 11 May 2016 Revised: 30 May 2016 Accepted: 6 July 2016 Heliyon 2 (2016) e00131 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This complex functions in the canonical Hippo signaling Article No~e00131 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
"Therefore, it is unlikely that Article No~e00131 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
( C) Proposed model for the influence of phosphorylation of neighboring Article No~e00131 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Immunoprecipitation with anti-Myc antibody revealed that Article No~e00131 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
The replacement rate of Article No~e00131 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Data represent the Article No~e00131 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Data represent the average of ∼240 cells from three independent Article No~e00131 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
"To inhibit the kinase activity of Aurora-B, cells were treatedwith 100 nM Hesperadin (Millipore, Billerica, MA, USA) for 2 h. Article No~e00131 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 27 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
"Generation of LATS2 -knockout HeLa-S3 cells by TALEN The LATS2 gene was disrupted in HeLa-S3 cell lines using TALEN system, and single clones were isolated (LATS2-KO/HeLa-S3, Torigata and Nojima, Article No~e00131 28 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 29 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 30 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 31 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 32 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
Article No~e00131 33 http://dx.doi.org/10.1016/j.heliyon.2016.e00131 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/59/main.PMC4971130.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/f4/b3/jpts-28-2084.PMC4971131.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Original Article  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/5c/20/jpts-28-2132.PMC4971132.pdf
9) http://www.who.int.,Non-OADS,/arxiv_data1/oa_pdf/5c/20/jpts-28-2132.PMC4971132.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.Review  The Journal of Physical Therapy Science,Non-OADS,/arxiv_data1/oa_pdf/b5/b7/jpts-28-2171.PMC4971133.pdf
"http://www.sciencedirect.com.proxy.cuk.ac.kr:8080 See comment in PubMed Commons below/science/article/pii/S0031940615038080 (Ac - cessed Feb. 15, 2016) 2) Michalsen A, Traitteur H, Lüdtke R, et al.",OADS,/arxiv_data1/oa_pdf/b5/b7/jpts-28-2171.PMC4971133.pdf
"http://www.sciencedirect.com.proxy.cuk.ac.kr:8080/science/article/pii/S1356689X15002313 (Accessed Feb. 12, 2016) 7) Sharma M: Yoga as an alternative and complementary approach for stress management: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/b5/b7/jpts-28-2171.PMC4971133.pdf
"http://onlinelibrary.wiley.com.proxy.cuk.ac.kr:8080/doi/10.1002/14651858.CD010664.pub2/abstract;jsessionid=8ACE27B704BEF96967F3CA00A8ECAE0F.f04t03 (Accessed Feb. 12, 2016) 11) Cramer H, Lauche R, Haller H, et al.",OADS,/arxiv_data1/oa_pdf/b5/b7/jpts-28-2171.PMC4971133.pdf
http://bmcmusculoskeletdisord.biomedcentral.com/arti - cles/10.1186/1471–2474-15–91 (Accessed Mar.,Non-OADS,/arxiv_data1/oa_pdf/b5/b7/jpts-28-2171.PMC4971133.pdf
"REVIEW ARTICLE Hip Pelvis 26(3): 129-135, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.129 Copyright ⓒ2014 by Korean Hip Society 129Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Ankylosing spondylitis is a chronic disease that involves sacroiliac joints as well as spine/pelvic limbjoints and eventually causes deformity and ankylosis ofthe spine and joints 1).",Non-OADS,/arxiv_data1/oa_pdf/72/c9/hp-26-129.PMC4971137.pdf
"Key Words : Ankylosing spondylitis, Medical treatment, TNF- αinhibitors Submitted: July 5, 2014 1st revision: July 28, 2014 2nd revision: August 28, 2014 Final acceptance: September 3, 2014 Address reprint request to Kyoung-Ho Moon, MD, PhDDepartment of Orthopedic Surgery, Inha University Hospital,7-206, 27 Inhang-ro, Jung-gu, Incheon 400-711, KoreaTEL: +82-32-890-3663  FAX: +82-32-890-3047 E-mail: moon@inha.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/c9/hp-26-129.PMC4971137.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(3): 136-142, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.136 Copyright ⓒ2014 by Korean Hip Society 136Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION World Health Organization reports that the number ofpatients who were diagnosed with diabetes mellitus had increased to 366 million in 2011 from 151 million in 2000.This number is expected to increase another 50.7% by2030, which would be 552 million patients.",Non-OADS,/arxiv_data1/oa_pdf/b0/6c/hp-26-136.PMC4971138.pdf
"Key Words : Diabetes mellitus, Total hip arthroplasty, Infection, Complications Submitted: July 2, 2014  1st revision: July 28, 2014 2nd revision: August 8, 2014 Final acceptance: August 13, 2014 Address reprint request to Kee Hyung Rhyu, MDDepartment of Orthopaedic Surgery, Kyung Hee UniversityHospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul134-727, KoreaTEL: +82-2-440-7497  FAX: +82-2-440-7498 E-mail: khrhyu@empas.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/6c/hp-26-136.PMC4971138.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(3): 143-149, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.143 Copyright ⓒ2014 by Korean Hip Society 143Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Cementless total hip arthroplasty (THA) has been associated with favorable results at both mid- and long-term follow-ups 1,2).",Non-OADS,/arxiv_data1/oa_pdf/3f/46/hp-26-143.PMC4971139.pdf
"Key Words : Total hip arthroplasty, Hydroxyapatite coating, Anatomical femoral stem Submitted: June 12, 2014  1st revision: July 1, 2014 2nd revision: August 26, 2014 Address reprint request to Young-Yool Chung, MDDepartment of Orthopaedic Surgery, Kwangju Christian Hospital,37 Yangrim-ro, Nam-gu, Gwangju 503-715, KoreaTEL: +82-62-650-5064  FAX: +82-62-650-5066 E-mail: paedic@chol.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/46/hp-26-143.PMC4971139.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(3): 150-156, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.150 Copyright ⓒ2014 by Korean Hip Society 150Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION The position of the implant is a critical factorinfluencing both functions and outcomes of total hip arthroplasty (THA)1).",Non-OADS,/arxiv_data1/oa_pdf/9d/02/hp-26-150.PMC4971140.pdf
"Key Words : Hip, Acetabular deformity, Revision, Acetabular cup fixation, Imageless navigation Submitted: July 7, 2014  1st revision: July 28, 2014 2nd revision: August 6, 2014 3rd revision: August 7, 2014 4rd revision: August 12, 2014 Final acceptance: August 18, 2014 Address reprint request to Ho Hyun Yun, MDDepartment of Orthopedic Surgery, Seoul Veterans Hospital, 53Jinhwangdo-ro 61-gil, Gangdong-gu, Seoul 134-791, KoreaTEL: +82-2-2226-1114  FAX: +82-2-2226-1910 E-mail: 3188yun@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/02/hp-26-150.PMC4971140.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(3): 157-165, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.157 Copyright ⓒ2014 by Korean Hip Society 157Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION For several decades, the treatment of choice for unstable intertrochanteric fractures in elderly has beenopen reduction and internal fixation 1).",Non-OADS,/arxiv_data1/oa_pdf/49/13/hp-26-157.PMC4971141.pdf
"Key Words : Hip, Intertrochanteric femur fracutre, Hip replacement arthroplasty Submitted: April 26, 2014 1st revision: May 20, 2014 2nd revision: July 1, 2014 3rd revision: August 1, 2014 Final acceptance: August 6, 2014 Address reprint request to Su-Hyun Cho, MDDepartment of Orthopaedic Surgery, Good Samsun Hospital, 326Gaya-daero, Sasang-gu, Busan 617-718, KoreaTEL: +82-51-310-9289  FAX: +82-51-310-9348 E-mail: suhyun1123@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/13/hp-26-157.PMC4971141.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(3): 166-172, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.166 Copyright ⓒ2014 by Korean Hip Society 166Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Compression hip screws have been widely utilized as treatments for intertrochanteric fractures; however, highfixation failure rates have been reported when they havebeen used to treat unstable fractures 1,2).",Non-OADS,/arxiv_data1/oa_pdf/08/de/hp-26-166.PMC4971142.pdf
"Key Words : Femur, Intertrochanteric fractures, Compression hip nail Submitted: July 15, 2014  1st revision: August 5, 2014 2nd revision: August 28, 2014 Final acceptance: August 29, 2014 Address reprint request toKye Young Han, MDDepartment of Orthopaedic Surgery, Kangwon National UniversityHospital, 1 Gangwondaehak-gil, Chuncheon 200-701, KoreaTEL: +82-33-258-9256  FAX: +82-33-244-2205 E-mail: hkyljh@kangwon.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/de/hp-26-166.PMC4971142.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(3): 173-177, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.173 Copyright ⓒ2014 by Korean Hip Society 173Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Snapping hip, also known as coxa saltans, is characterizedby an audible snapping sound or sensation felt when the hip is in motion, and may be associated with pain1).",Non-OADS,/arxiv_data1/oa_pdf/20/23/hp-26-173.PMC4971143.pdf
"Key Words : External snapping hip, Arthroscopy, Iliotibial band release, Gluteal sling release Submitted: July 23, 2014 1st revision: August 6, 2014 Final acceptance: September 1, 2014 Address reprint request to Pil Whan Yoon, MDDepartment of Orthopaedic Surgery, Asan Medical Center,University of Ulsan College of Medicine, 88 Olympic-ro 43-gil,Songpa-gu, Seoul 138-736, KoreaTEL: +82-2-3010-3535  FAX: +82-2-488-7877 E-mail: orthoyoon@amc.seoul.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/23/hp-26-173.PMC4971143.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(3): 178-184, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.178 Copyright ⓒ2014 by Korean Hip Society 178Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Adhesive capsulitis of the hip (ACH) has also been referred to as “frozen hip”1)or “capsular constriction”2).",Non-OADS,/arxiv_data1/oa_pdf/c3/91/hp-26-178.PMC4971144.pdf
"Key Words : Idiopathic adhesive capsulitis of hip, Magnetic resonance arthrography, Capsule thickness Submitted: July 25, 2014  1st revision: August 8, 2014 2nd revision: August 22, 2014 Final acceptance: August 28, 2014 Address reprint request to Kwang-Jun Oh, MD, PhDDepartment of Orthopedic Surgery, Konkuk University School ofMedicine, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-729, KoreaTEL: +82-2-2030-7616  FAX: +82-2-2030-7369 E-mail: damioh@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/91/hp-26-178.PMC4971144.pdf
"CASE REPORT Hip Pelvis 26(3): 185-188, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.185 Copyright ⓒ2014 by Korean Hip Society 185Print ISSN 2287-3260 Online ISSN 2287-3279 Fractures of the acetabulum pose a difficult problem for the patient and the surgeon because of the commonlyexperienced late complications of posttraumatic osteoarthrosis, osteonecrosis (ON) of the femoral head,and heterotopic ossification.",Non-OADS,/arxiv_data1/oa_pdf/c2/a4/hp-26-185.PMC4971145.pdf
"Key Words : Acetabular fracture, Osteonecrosis of the femoral head, Acetabulum fracture complication Submitted: June 17, 2014  1st revision: July 22, 2014 2nd revision: August 18, 2014 Final acceptance: August 20, 2014 Address reprint request toKwang-Jun Oh, MD, PhDDepartment of Orthopedic Surgery, Konkuk University School ofMedicine, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-729, KoreaTEL: +82-2-2030-7615  FAX: +82-2-2030-7369 E-mail: damioh@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/a4/hp-26-185.PMC4971145.pdf
"CASE REPORT Hip Pelvis 26(3): 189-193, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.189 Copyright ⓒ2014 by Korean Hip Society 189Print ISSN 2287-3260 Online ISSN 2287-3279 Rapidly destructive coxarthrosis (RDC) is a rare syndrome that involves severe pain in the hip andclaudication with the etiology remaining elusive.",Non-OADS,/arxiv_data1/oa_pdf/00/43/hp-26-189.PMC4971146.pdf
"Key Words : Iiopsoas bursa, Rapidly destructive coxarthrosis Submitted: March 17, 2014  1st revision: April 24, 2014 2nd revision: June 5, 2014 3rd revision: July 9, 2014 Final acceptance: July 28, 2014 Address reprint request toHong-Man Cho, MDDepartment of Orthopedic Surgery, Gwangju Veterans Hospital,99 Cheomdanwolbong-ro, Gwangsan-gu, Gwangju 506-705, KoreaTEL: +82-62-602-6162  FAX: +82-62-602-6164 E-mail: chm1228@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/43/hp-26-189.PMC4971146.pdf
"CASE REPORT Hip Pelvis 26(3): 194-197, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.194 Copyright ⓒ2014 by Korean Hip Society 194Print ISSN 2287-3260 Online ISSN 2287-3279 The crescent fracture has been named by the shape of a fracture fragment of posterior superior iliac spine,which looks like a crescent.",Non-OADS,/arxiv_data1/oa_pdf/69/23/hp-26-194.PMC4971147.pdf
"Key Words : Pelvic bones, Crescent fracture, V ertical shear injury Submitted: March 17, 2014  1st revision: April 8, 2014 2nd revision: May 20, 2014 3rd revision: July 28, 2014 Final acceptance: July 29, 2014 Address reprint request to Weon-Yoo Kim, MDDepartment of Orthopedic Surgery, The Catholic University ofKorea, Daejeon St. Mary’s Hospital, 64 Daeheung-ro, Jung-gu,Daejeon 301-723, KoreaTEL: +82-42-220-9530  FAX: +82-42-221-0429 E-mail: weonkim@hotmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/23/hp-26-194.PMC4971147.pdf
"CASE REPORT Hip Pelvis 26(3): 198-201, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.198 Copyright ⓒ2014 by Korean Hip Society 198Print ISSN 2287-3260 Online ISSN 2287-3279 Focal Myositis around Hip Joint: 3 Cases Report Kwang-Kyoun Kim, MD, Hyeun Jin Yoo, MD Department of Orthopedic Surgery, College of Medicine, Konyang University, Daejeon, Korea Focal myositis, a benign myositis which mostly occurs at lower extremity, is a disease that is spontaneously improved by conservative treatments such as bed rest and administration of nonsteroidal anti-inflammatory drug.Focal myositis is known to occur mostly at lower extremity, but we could not find a report of occurrence aroundhip.",Non-OADS,/arxiv_data1/oa_pdf/3e/1a/hp-26-198.PMC4971148.pdf
"From T2 fat suppressionimage and T1 contrast enhanced fat suppression image Submitted: July 4, 2014  1st revision: July 28, 2014 2nd revision: August 28, 2014 Final acceptance: September 6, 2014 Address reprint request to Kwang-Kyoun Kim, MDDepartment of Orthopedic Surgery, College of Medicine, KonyangUniversity, 158 Gwanjeodong-ro, Seo-gu, Daejeon 302-812, KoreaTEL: +82-42-600-6902  FAX: +82-42-545-2373 E-mail: ajouos@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/1a/hp-26-198.PMC4971148.pdf
"CASE REPORT Hip Pelvis 26(3): 202-205, 2014 http://dx.doi.org/10.5371/hp.2014.26.3.202 Copyright ⓒ2014 by Korean Hip Society 202Print ISSN 2287-3260 Online ISSN 2287-3279 Although aneurysmal bone cysts are characterized by local damage and active lesions with in the bloodstream, they have been classified as a benign tumor.These cysts are mostly swellings of eccentric form in themetaphyseal area of the upper or lower long bone andthe posterior spine; bone destruction, pathologicalfractures, and local recurrence are some of the relatedproblems.",Non-OADS,/arxiv_data1/oa_pdf/8c/c3/hp-26-202.PMC4971149.pdf
"Key Words : Pelvic iliac bone, Aneurysmal bone cysts, Curettage, Electric cauterization, Chemical sclerotherapy Submitted: March 27, 2014  1st revision: May 8, 2014 2nd revision: June 16, 2014 Final acceptance: July 9, 2014 Address reprint request to Seok Hyun Kweon, MDDepartment of Orthopaedic Surgery, Wonkwang UniversityHospital, 895 Muwang-ro, Iksan 570-711, KoreaTEL: +82-63-859-1360  FAX: +82-63-852-9329 E-mail: osksh@wku.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/c3/hp-26-202.PMC4971149.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/e6/main.PMC4971150.pdf
http://dx.doi.org/10.1016/j.idcr.2016.07.006 2214-2509/ ã2016 The Authors.,OADS,/arxiv_data1/oa_pdf/ff/e6/main.PMC4971150.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases 5 (2016) 54 –56 Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/ff/e6/main.PMC4971150.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/fd/main.PMC4971151.pdf
http://dx.doi.org/10.1016/j.idcr.2016.07.008 2214-2509/ ã2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/fd/main.PMC4971151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases 5 (2016) 57 –59 Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/b1/fd/main.PMC4971151.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/35/main.PMC4971152.pdf
http://dx.doi.org/10.1016/j.ejro.2016.07.005 2352-0477/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/88/35/main.PMC4971152.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/35/main.PMC4971152.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MetagenomicBiosamplesFungiNext generation sequencingITS.,Non-OADS,/arxiv_data1/oa_pdf/80/fa/main.PMC4971153.pdf
Direct link to deposited datahttp://www.ncbi.nlm.ni h.gov/sra?term=SRP0697421.,OADS,/arxiv_data1/oa_pdf/80/fa/main.PMC4971153.pdf
Direct link to the data http://www.ncbi.nlm.nih.gov/sra?term=SRP069742 .,OADS,/arxiv_data1/oa_pdf/80/fa/main.PMC4971153.pdf
http://dx.doi.org/10.1016/j.gdata.2016.07.008 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/80/fa/main.PMC4971153.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/fa/main.PMC4971153.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/63/main.PMC4971154.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2016.07.003 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/63/main.PMC4971154.pdf
"World Health Organisation (WHO), model list of essential medicines, 19th list (April) 2015, http://www.who.int/selection_medicines/committees/expert/20/ EML_2015_FINAL_amended_AUG2015.pdf?ua ¼1, Last time accessed: June 27th, 2016.D.",Non-OADS,/arxiv_data1/oa_pdf/0b/63/main.PMC4971154.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/57/main.PMC4971155.pdf
"However, the involvement of H 2O2in numerous types of cell andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.07.004 2213-2317/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/6a/57/main.PMC4971155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/57/main.PMC4971155.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2016.07.004 .,OADS,/arxiv_data1/oa_pdf/6a/57/main.PMC4971155.pdf
"), Oxidatives Stress and Diseases, InTech Publishing Inc., Rijeka, Croatia, http://dx.doi.org/10.5772/2535 .",Non-OADS,/arxiv_data1/oa_pdf/6a/57/main.PMC4971155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mangrovibacter sp.,Non-OADS,/arxiv_data1/oa_pdf/c8/6b/main.PMC4971156.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/nuccore/LYRP00000000 2.,OADS,/arxiv_data1/oa_pdf/c8/6b/main.PMC4971156.pdf
"To date only two species, Mangrovibacter plantisponsor DSM 19579 [1]and Mangrovibacter yixingensis KCTC42181 [2]have been described under the genus Mangrovibacter (http://www.bacterio.net/mangrovibacter.html ).",Non-OADS,/arxiv_data1/oa_pdf/c8/6b/main.PMC4971156.pdf
http://dx.doi.org/10.1016/j.gdata.2016.07.007 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/c8/6b/main.PMC4971156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/6b/main.PMC4971156.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Saccharomyces cerevisiae Origin of replication Autonomous replicating sequencesComputational methods 1.,Non-OADS,/arxiv_data1/oa_pdf/95/08/main.PMC4971157.pdf
http://dx.doi.org/10.1016/j.gdata.2016.07.005 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/08/main.PMC4971157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/08/main.PMC4971157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/72/main.PMC4971158.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.07.003 2213-2244/Published by Elsevier Ltd on behalf of Australian Society for Parasitology.,Non-OADS,/arxiv_data1/oa_pdf/43/72/main.PMC4971158.pdf
"Cornell Lab of Ornithology, Ithaca bna online: http://bna.birds.cornell.edu/bna/species/369 .",Non-OADS,/arxiv_data1/oa_pdf/43/72/main.PMC4971158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/af/main.PMC4971229.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.016 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/29/af/main.PMC4971229.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/8c/main.PMC4971230.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.022 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/ab/8c/main.PMC4971230.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Primary ovarian carcinoid tumor CD56SynaptophysinChromograninKi-67Diagnostic framework 1.,Non-OADS,/arxiv_data1/oa_pdf/98/2d/main.PMC4971231.pdf
http://dx.doi.org/10.1016/j.gore.2016.07.003 2352-5789/Crown Copyright © 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/98/2d/main.PMC4971231.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/2d/main.PMC4971231.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/9a/main.PMC4971232.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.07.039 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/37/9a/main.PMC4971232.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/0c/main.PMC4971233.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.07.004 2213-2244/Published by Elsevier Ltd on behalf of Australian Society for Parasitology.,Non-OADS,/arxiv_data1/oa_pdf/74/0c/main.PMC4971233.pdf
"These expeditions weretelepresence-enabled, with live video feeds transmitted back to shore in real time ( http://oceanexplorer.noaa.gov/okeanos/media/ exstream/exstream.html ), allowing scientists on shore and on the ship to interact during the dives via an Internet chat room and satellite teleconference line.",Non-OADS,/arxiv_data1/oa_pdf/74/0c/main.PMC4971233.pdf
"All statistical tests were con- ducted in R v 3.1 ( R Core Team., 2015 ;http://www.R-project.org ).",Non-OADS,/arxiv_data1/oa_pdf/74/0c/main.PMC4971233.pdf
"Although ROV lights and noise can alter individual ﬁsh behavior ( Stoner et al., 2008 ), abnormal swimming behaviors were likely not an effect of the ROV because these behaviors were not observed in numerous unin- fected individuals.Supplementary video related to this article can be found at http://dx.doi.org/10.1016/j.ijppaw.2016.07.004 .",OADS,/arxiv_data1/oa_pdf/74/0c/main.PMC4971233.pdf
http://dx.doi.org/10.1007/s00338-008-0377-4 .,Non-OADS,/arxiv_data1/oa_pdf/74/0c/main.PMC4971233.pdf
http://dx.doi.org/10.1371/journal.pone.0139904 .,Non-OADS,/arxiv_data1/oa_pdf/74/0c/main.PMC4971233.pdf
Available at: http://www.nrmp.org/match-process/match-algorithm 2.,Non-OADS,/arxiv_data1/oa_pdf/05/96/KITP-13-27916.PMC4971261.pdf
Available at: http://www.acgme.org/acgmeweb 3.,Non-OADS,/arxiv_data1/oa_pdf/05/96/KITP-13-27916.PMC4971261.pdf
Available at: http://www.uptodate.com/home,Non-OADS,/arxiv_data1/oa_pdf/05/96/KITP-13-27916.PMC4971261.pdf
http://www.mna-elderly.com/forms/mna_guide_english_sf.pdf] [last access 27.04.2015].,Non-OADS,/arxiv_data1/oa_pdf/a0/d3/KITP-13-27918.PMC4971263.pdf
Available from: http://www.who.int/mediacentre/factsheets/  fs311/en/.,Non-OADS,/arxiv_data1/oa_pdf/7c/88/KITP-13-27935.PMC4971280.pdf
The new Polish version of CAM was accepted for publication among the other official  translations on the HeLP webpage: (http://www.hospital- elderlifeprogram.org/uploads/disclaimers/CAM_Polish.pdf).,Non-OADS,/arxiv_data1/oa_pdf/06/57/KITP-13-27936.PMC4971281.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2016.07.001 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/j.nano.2014.09.018 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1017/S0031182009991223 .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.5935/0103-5053.20140062 .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1021/jm401067s .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/S0140- 6736(09)61422-7 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
"Nature 465, S6 eS7.http://dx.doi.org/10.1038/nature09221 .",Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1007/s00436-006-0190-3 .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/ j.actatropica.2011.08.011 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/ j.bbrc.2014.05.004 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1371/ journal.ppat.1004618 .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.3109/ 14756366.2015.1077330 .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1017/S003118201300142X .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/ j.jinorgbio.2005.11.005 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/ 10.1016/j.ejmech.2010.04.022 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/j.bmcl.2013.12.071 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/ j.biopha.2011.04.024 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1067/mjd.2003.218 .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1021/jm400282d .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
"16, 28 e39.http://dx.doi.org/ 10.1016/j.micinf.2013.10.007 .",OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
"http://dx.doi.org/ 10.1016/j.resmic.2014.01.006 .Kinnamon, K.E., Poon, B.T., Hanson, W.L., Waits, V.B., 1996.",OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/ j.bbrc.2006.12.238 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/j.bmc.2008.07.035 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1021/bi020195i .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1042/0264- 6021:3390363 .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1056/NEJMoa1507574 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1371/ journal.pntd.0004359 .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
"371, 966. http://dx.doi.org/ 10.1056/NEJMc1407914 .",Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/j.ejmech.2011.05.035 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1093/jb/mvq126 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1128/IAI.73.12.8322-8333.2005 .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/ 10.1016/j.jinsphys.2006.01.004 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
"13, 196. http://dx.doi.org/10.1186/1471-2180-13-196 .",Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1074/jbc.M112.414078 .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/ 10.1111/j.1610-0387.2007.06177.x .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
"128, 26 e31.http://dx.doi.org/ 10.1016/j.exppara.2011.01.018 .",OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
"35, 29 e33.http://dx.doi.org/ 10.1248/bpb.35.29 .G.C.",Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1097/QCO.,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/j.ijid.2011.03.021 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
"2011, 873230. http://dx.doi.org/10.4061/2011/873230 .",Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://dx.doi.org/10.1016/j.bmcl.2013.02.054 .,OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
http://www.who.int/mediacentre/factsheets/fs340/en/ .,Non-OADS,/arxiv_data1/oa_pdf/c6/40/main.PMC4971285.pdf
"EDITORIAL Hip Pelvis 26(4): 207-213, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.207 Copyright ⓒ2014 by Korean Hip Society 207Print ISSN 2287-3260 Online ISSN 2287-3279 Multiple complications can occur after hip arthroplasty.",Non-OADS,/arxiv_data1/oa_pdf/b0/b1/hp-26-207.PMC4971395.pdf
"In addition, antithromboticagents have been administered to patients at high riskExperience of Complications of Hip Arthroplasty Sung Kwan Hwang, MD, PhD Department of Orthopaedic Surgery, Yonsei University Wonju College of Medicine, Seoul, Korea Submitted: October 20, 2014  1st revision: November 10, 2014 Final acceptance: December 10, 2014 Address reprint request toSung Kwan Hwang, MD, PhDDepartment of Orthopaedic Surgery, Yonsei University WonjuCollege of Medicine, 20 Ilsan-ro, Wonju 220-701, KoreaTEL: +82-33-741-1360  FAX: +82-33-746-7326 E-mail: hwtonlka@yonsei.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/b1/hp-26-207.PMC4971395.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(4): 214-219, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.214 Copyright ⓒ2014 by Korean Hip Society 214Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Legg-Calve ´-Perthes disease (LCPD) is represented by osteonecrosis of the femoral head during childhood,which typically develops in children aged 3 to 10 years 1-4).",Non-OADS,/arxiv_data1/oa_pdf/aa/b9/hp-26-214.PMC4971396.pdf
"Key Words : Legg-Calve ´-Perthes  disease, LCP Sequelae, Total hip arthroplasty Submitted: October 17, 2014  1st revision: November 10, 2014 2nd revision: November 24, 2014 Final acceptance: December 8, 2014 Address reprint request toYong Sik Kim, MD, PhDDepartment of Orthopaedic Surgery, Seoul St. Mary’s Hospital,College of Medicine, The Catholic University of Korea, 202 Banpo-daero, Seocho-gu, Seoul 137-701, KoreaTEL: +82-2-2258-2837  FAX: +82-2-535-9834 E-mail: yongsik@korea.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/b9/hp-26-214.PMC4971396.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(4): 220-226, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.220 Copyright ⓒ2014 by Korean Hip Society 220Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Until today, total hip arthroplasty (THA) procedure has been recognized as the wonderful procedure interms of patient’s satisfaction.",Non-OADS,/arxiv_data1/oa_pdf/ca/87/hp-26-220.PMC4971397.pdf
"Key Words : 36-mm femoral head, Highly cross-linked polyethylene, Total hip arthroplasty, Minimum 7-years follow-up Submitted: July 23, 2014  1st revision: August 4, 2014 2nd revision: August 26, 2014 3rd revision: October 6, 2014 Final acceptance: October 24, 2014 Address reprint request to  Myung-Rae Cho, MD Department of Orthopaedic Surgery, Daegu Catholic UniversityHospital, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea TEL: +82-53-650-4277  FAX: +82-53-652-4272 E-mail: cmr0426@cu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/87/hp-26-220.PMC4971397.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(4): 227-234, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.227 Copyright ⓒ2014 by Korean Hip Society 227Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Prosthetic joint infection (PJI) is one of the major complications following arthroplasty.",Non-OADS,/arxiv_data1/oa_pdf/f8/17/hp-26-227.PMC4971398.pdf
"Key Words : Hip arthroplasty, Prosthetic infection, Debridement Submitted: November 7, 2013 1st revision: December 30, 2013 2nd revision: April 3, 2014 3rd revision: August 7, 2014 4rd revision: September 24, 2014 Final acceptance: October 2, 2014 Address reprint request toWon Yong Shon, MDDepartment of Orthopaedic Surgery, Korea University GuroHospital, 148 Gurodong-ro, Guro-gu, Seoul 152-703, KoreaTEL: +82-2-2626-1163  FAX: +82-2-2626-1164 E-mail: Shonwy@hotmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/17/hp-26-227.PMC4971398.pdf
Available from:http://www.cdc.gov/hicpac/Disinfection_Sterilization/acknowledg.html.,Non-OADS,/arxiv_data1/oa_pdf/f8/17/hp-26-227.PMC4971398.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(4): 235-242, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.235 Copyright ⓒ2014 by Korean Hip Society 235Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Periprosthetic joint infection (PJI) after hip and knee arthroplasty is one of the most serious complications.Despite routine use of prophylactic antibiotics for surgery,dental procedures, the incidence of PJI remains 0.3-1.7%for total knee arthroplasty (TKA) and 0.8-1.9% of totalhip arthroplasty (THA) 1-3).",Non-OADS,/arxiv_data1/oa_pdf/83/2a/hp-26-235.PMC4971399.pdf
"Key Words : Arthroplasty, Infection, Methicillin-resistant Staphylococcus aureus , Antibiotic resistance, Vancomycin Submitted: July 30, 2014  1st revision: September 1, 2014 2nd revision: October 23, 2014 Final acceptance: October 28, 2014 Address reprint request toJoon Soon Kang, MD, PhDDepartment of Orthopedic Surgery, Inha University Hospital, 27Inhang-ro, Jung-gu, Incheon 400-711, KoreaTEL: +82-32-890-3043  FAX: +82-32-890-3047 E-mail: kangjoon@inha.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/2a/hp-26-235.PMC4971399.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(4): 243-249, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.243 Copyright ⓒ2014 by Korean Hip Society 243Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Along with the substantial growth of the elderly population thanks to the improved life expectancy, thereis an in increase in the number of elderly patientsreceiving hip hemiarthroplasty due to femoral neckfractures.",Non-OADS,/arxiv_data1/oa_pdf/25/79/hp-26-243.PMC4971400.pdf
"Key Words : Bone cement syndrome, Hip arthroplasty, Pressurization, Elderly patients Submitted: July 26, 2014  1st revision: August 18, 2014 2nd revision: October 6, 2014 Final acceptance: November 1, 2014 Address reprint request toJoon Cheol Choi, MDDepartment of Orthopaedic Surgery, Bundang Jesaeng GeneralHospital, Daejin Medical Center, 20, Seohyeon-ro 180beon-gil,Bundang-gu, Seongnam 463-774, KoreaTEL: +82-31-779-0175  FAX: +82-31-779-0179 E-mail: cjc@dmc.or.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/79/hp-26-243.PMC4971400.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(4): 250-255, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.250 Copyright ⓒ2014 by Korean Hip Society 250Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Osteoporosis is a common skeletal disease in the elderly, and osteoporosis-related fractures are one of themost serious medical problems that pose a considerablesocioeconomic burden 1-3).",Non-OADS,/arxiv_data1/oa_pdf/16/f5/hp-26-250.PMC4971401.pdf
"Key Words : Hip fractures, Second hip fracture, Incidence, Mortality Submitted: October 8, 2014 1st revision: November 17, 2014 Final acceptance: December 10, 2014 Address reprint request toYong-Chan Ha, MDDepartment of Orthopaedic Surgery, Chung-Ang University Collegeof Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 156-755, KoreaTEL: +82-2-6299-1577  FAX: +82-2-822-1710 E-mail: hayongch@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/f5/hp-26-250.PMC4971401.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(4): 256-262, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.256 Copyright ⓒ2014 by Korean Hip Society 256Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Displaced femoral neck fractures typically require surgical management.",Non-OADS,/arxiv_data1/oa_pdf/b8/40/hp-26-256.PMC4971402.pdf
"Key Words : Elderly, Osteoporosis, Femur neck fractures, Cementless arthroplasty Submitted: October 16, 2014  1st revision: November 1, 2014 2nd revision: November 4, 2014  3rd revision: November 24, 2014 Final acceptance: November 26, 2014 Address reprint request toByung Ho Lim, MDDepartment of Orthopaedic Surgery, Seoul Medical Center, 156Sinnae-ro, Jungnang-gu, Seoul 131-795, KoreaTEL: +82-2-2276-8605  FAX: +82-2-539-1262 E-mail: bh.lim1359@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/40/hp-26-256.PMC4971402.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(4): 263-268, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.263 Copyright ⓒ2014 by Korean Hip Society 263Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Femoral neck fractures with marked displacement in the elderly patients are primarily treated witharthroplasty as opposed to internal fixation, for itscomparatively better improvement in pain, functionalrecovery of hip, reoperation, satisfaction of patients,quality of life and economical burdens 1-7).",Non-OADS,/arxiv_data1/oa_pdf/a3/f4/hp-26-263.PMC4971403.pdf
"Key Words : Valgus, Impacted, Femoral neck fracture, Internal fixation, Elderly patient Submitted: August 1, 2014  1st revision: August 18, 2014 2nd revision: October 7, 2014 Final acceptance: October 10, 2014 Address reprint request to Joo-Hyoun Song, MD, PhDDepartment of Orthopedic Surgery, The Catholic University ofKorea, St. Vincent’s Hospital, 93 Jungbudaero, Paldal-gu, Suwon442-723, KoreaTEL: +82-31-249-8172  FAX: +82-31-254-7186 E-mail: delmarsong@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/f4/hp-26-263.PMC4971403.pdf
"ORIGINAL ARTICLE Hip Pelvis 26(4): 269-274, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.269 Copyright ⓒ2014 by Korean Hip Society 269Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION AO type C pelvic ring injuries are complete disruption ofanterior or posterior pelvic rings following a severe traumatic force.",Non-OADS,/arxiv_data1/oa_pdf/ba/2c/hp-26-269.PMC4971404.pdf
"Key Words : Pelvis, AO type C pelvic ring injury, Prognostic factor Submitted: January 12, 2014  1st revision: February 24, 2014 2nd revision: March 24, 2014  3rd revision: July 22, 2014 Final acceptance: October 10, 2014 Address reprint request toJang-Seok Choi, MDDepartment of Orthopedic Surgery, Gachon University Gil MedicalCenter, 21 Namdong-daero 774 beon-gil, Namdong-gu, Incheon405-760, KoreaTEL: +82-32-460-3384  FAX: +82-32-423-3384 E-mail: chlwkdtjr@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/2c/hp-26-269.PMC4971404.pdf
"CASE REPORT Hip Pelvis 26(4): 275-278, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.275 Copyright ⓒ2014 by Korean Hip Society 275Print ISSN 2287-3260 Online ISSN 2287-3279 Obturator (Inferior) dislocation of the hip joint is very rare.",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/hp-26-275.PMC4971405.pdf
"Key Words : Greater trochanter, Avulsion fracture, Obturator (Inferior) type hip dislocation, Closed reduction Submitted: September 9, 2014  1st revision: October 6, 2014 2nd revision: November 10, 2014 Final acceptance: December 3, 2014 Address reprint request toKwang-Jun Oh, MD, PhDDepartment of Orthopaedic Surgery, Konkuk University School ofMedicine, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-729, KoreaTEL: +82-2-2030-7615  FAX: +82-2-2030-7369 E-mail: damioh@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/4a/hp-26-275.PMC4971405.pdf
"CASE REPORT Hip Pelvis 26(4): 279-283, 2014 http://dx.doi.org/10.5371/hp.2014.26.4.279 Copyright ⓒ2014 by Korean Hip Society 279Print ISSN 2287-3260 Online ISSN 2287-3279 Necrotizing fasciitis (NF) is an orthopedic emergency characterized by rapidly progressing necrosis of thefascia and subcutaneous tissue.",Non-OADS,/arxiv_data1/oa_pdf/b1/7b/hp-26-279.PMC4971406.pdf
"Key Words : Hip, Necrotizing fasciitis, Fournier gangrene, Bilateral Submitted: October 17, 2014  1st revision: November 10, 2014 2nd revision: November 24, 2014 Final acceptance: December 3, 2014 Address reprint request toSe Hyuk Im, MDDepartment of Orthopedic Surgery, National Police Hospital, 123Songi-ro, Songpa-gu, Seoul 138-708, KoreaTEL: +82-2-3400-1244  FAX: +82-2-449-2120 E-mail: ish0524@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/7b/hp-26-279.PMC4971406.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.STEM CELLS AND DEVELOPMENT Volume 25, Number 15, 2016 Mary Ann Liebert, Inc. DOI: 10.1089/scd.2015.0383 1119",Non-OADS,/arxiv_data1/oa_pdf/94/fe/scd.2015.0383.PMC4971413.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 32, Number 8, 2016Mary Ann Liebert, Inc.DOI: 10.1089/aid.2015.0225 763",Non-OADS,/arxiv_data1/oa_pdf/c7/02/aid.2015.0225.PMC4971422.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(8) 1–3 DOI: 10.1177/2054270416653684",Non-OADS,/arxiv_data1/oa_pdf/71/9e/10.1177_2054270416653684.PMC4971594.pdf
"Urinary incontinence in women: the management ofurinary incontinence in women (Clinical guideline 171), http://guidance.nice.org.uk/CG171 (2013, accessed December 2015).",Non-OADS,/arxiv_data1/oa_pdf/71/9e/10.1177_2054270416653684.PMC4971594.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 7(8) 1–5 DOI: 10.1177/2054270416654646",Non-OADS,/arxiv_data1/oa_pdf/d2/98/10.1177_2054270416654646.PMC4971596.pdf
"155(2) 324–331 /C211American Academy of Otolaryngology—Head and Neck Surgery Foundation 2016 Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/0194599816645526http://otojournal.org Albert H. Park, MD1, David R. White, MD2, Jonathan R. Moss, MD3, Moraye Bear, MS4, and Carl LeBel, PhD5 Sponsorships or competing interests that may be relevant to content are dis- closed at the end of this article.",Non-OADS,/arxiv_data1/oa_pdf/be/40/10.1177_0194599816645526.PMC4971606.pdf
"Retrieved from http://www.hscic.gov.uk/pubs/ hse08physicalactivity Crawford, N. R., Yamaguchi, G. T., & Dickman, C. A.",OADS,/arxiv_data1/oa_pdf/32/c3/10.1177_0018720816646508.PMC4971607.pdf
"2012, http://w3.cns.org/dp/2012CNS/1394.pdf (accessed 4 October 2012).",Non-OADS,/arxiv_data1/oa_pdf/f8/85/10.1177_0271678X16648711.PMC4971608.pdf
"2011, http://ston.jsc.nasa.gov/collec-tions/trs/_techrep/TP-2011-216160.pdf (accessed 8 June 2014).95.",Non-OADS,/arxiv_data1/oa_pdf/f8/85/10.1177_0271678X16648711.PMC4971608.pdf
"Retrieved from http://asrs.arc.nasa.gov/briefing_nf.htm#2 Newell, A., & Card, S. K. (1985).",OADS,/arxiv_data1/oa_pdf/cf/c7/10.1177_0018720816644872.PMC4971609.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.204834.116.© 2016 Nguyen et al.",OADS,/arxiv_data1/oa_pdf/05/e9/1023.PMC4971761.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/05/e9/1023.PMC4971761.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 26:1023 –1033 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/16; www.genome.org Genome Research 1023 www.genome.org",OADS,/arxiv_data1/oa_pdf/05/e9/1023.PMC4971761.pdf
Data access The sequencing data from this study are described in Supplemental Table S6 and have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under acces- sion number GSE77213.,OADS,/arxiv_data1/oa_pdf/05/e9/1023.PMC4971761.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.202432.115.",OADS,/arxiv_data1/oa_pdf/e9/67/1145.PMC4971764.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Inter- national), as described at http://creativecommons.org/licenses/by-nc/4.0/.Resource 26:1145 –1159 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/16; www.genome.org Genome Research 1145 www.genome.org",Non-OADS,/arxiv_data1/oa_pdf/e9/67/1145.PMC4971764.pdf
"We applied very stringent rules to construct an atlas of high-confidence poly(A) sites, and the entire set of putative cleavage sites that result-ed from mapping all of the reads obtained in these 3 ′end sequenc-ing studies is available as Supplemental Data S1 (human) and S2(mouse), as well as online at http://www.polyasite.unibas.ch, where users can filter sites of interest based on the number of sup-porting protocols, the identified poly(A) signals, and/or the geno-mic context of the clusters.",OADS,/arxiv_data1/oa_pdf/e9/67/1145.PMC4971764.pdf
"In conclusion, PolyAsite, available at http://www.polyasite.",OADS,/arxiv_data1/oa_pdf/e9/67/1145.PMC4971764.pdf
All ver- sions are publicly available and online at http://www.polyasite.unibas.ch.,OADS,/arxiv_data1/oa_pdf/e9/67/1145.PMC4971764.pdf
"PolyA-seq: Processed, tissue-specific data were downloaded as a BED file (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?",OADS,/arxiv_data1/oa_pdf/e9/67/1145.PMC4971764.pdf
"APASdb: Processed, tissue-specific data for human poly(A) sites were downloaded from http://mosas.sysu.edu.cn/utr/download_datasets.php.",OADS,/arxiv_data1/oa_pdf/e9/67/1145.PMC4971764.pdf
"2011), Gene Expression Omnibus (GEO; http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/e9/67/1145.PMC4971764.pdf
Data access The sequencing data from this study have been submitted to theNCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/e9/67/1145.PMC4971764.pdf
https://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/e9/67/1145.PMC4971764.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.199166.115.© 2016 Sharmin et al.",OADS,/arxiv_data1/oa_pdf/55/f2/1110.PMC4971765.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/55/f2/1110.PMC4971765.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Method 1110 Genome Research 26:1110 –1123 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/16; www.genome.org www.genome.org",OADS,/arxiv_data1/oa_pdf/55/f2/1110.PMC4971765.pdf
"Notably, not all ENCODE data sets provide q-values, and in that sit- uation, we generated the list of q-values from the given P-values us- ing the qvalue package in R (http://github.com/jdstorey/qvalue).",Non-OADS,/arxiv_data1/oa_pdf/55/f2/1110.PMC4971765.pdf
We used the Adaboost framework implemented in R gbm package (https://cran.r-project.org/package=gbm).,OADS,/arxiv_data1/oa_pdf/55/f2/1110.PMC4971765.pdf
We modified the R implementation of gbm package (https://cran.r-project.org/package=gbm) for fea-ture importance to accommodate the calculation for single tree or the submodel in question.,OADS,/arxiv_data1/oa_pdf/55/f2/1110.PMC4971765.pdf
or the pooled set of submodels across all cell types for a TF using fpc package in R (https://cran.r-project.org/package=fpc).,OADS,/arxiv_data1/oa_pdf/55/f2/1110.PMC4971765.pdf
We then esti- mated skewness (https://cran.r-project.org/package=e1071) for each multi-cell-type based on the numbers of submodels contrib- uted to the cluster by various cell types.,OADS,/arxiv_data1/oa_pdf/55/f2/1110.PMC4971765.pdf
Software availability Sample data and code are available for download from the Supplemental Material and from the following GitHub repository: https://github.com/mhfzsharmin/trisectrTRISECT Genome Research 1121 www.genome.org,OADS,/arxiv_data1/oa_pdf/55/f2/1110.PMC4971765.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.203182.115.© 2016 Galazka et al.",OADS,/arxiv_data1/oa_pdf/bf/fb/1069.PMC4971769.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/bf/fb/1069.PMC4971769.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/ by-nc/4.0/.Research 26:1069 –1080 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/16; www.genome.org Genome Research 1069 www.genome.org",OADS,/arxiv_data1/oa_pdf/bf/fb/1069.PMC4971769.pdf
Linkage Group (LG) modeling was done with the programs TADbit (http://3dgenomes.github.io/tadbit/) and IMP (https://integrativemodeling.org/) in the Python script“tadbitModel.py.,OADS,/arxiv_data1/oa_pdf/bf/fb/1069.PMC4971769.pdf
Data access All raw Hi-C and processed data from this study have been submit-ted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/bf/fb/1069.PMC4971769.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.202465.115.© 2016 Vega-Vaquero et al.",OADS,/arxiv_data1/oa_pdf/a3/24/1047.PMC4971770.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a3/24/1047.PMC4971770.pdf
These sequences were identified using the PatMatch tool and theTAIR10 Whole Genome database (BAC clones) in The Arabidopsis Information Resource (TAIR; http://www.Arabidopsis.org).,OADS,/arxiv_data1/oa_pdf/a3/24/1047.PMC4971770.pdf
"We used the PatMatch tool in The Arabidopsis Information Resource (TAIR; http://www.Arabidopsis.org) and searched for the sequence (YYYTAAA) 7in the TAIR10 Whole- Genome (BAC clones) database, which contained 135,670,227bytes.",OADS,/arxiv_data1/oa_pdf/a3/24/1047.PMC4971770.pdf
http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/a3/24/1047.PMC4971770.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.205948.116.© 2016 Sriswasdi et al.",OADS,/arxiv_data1/oa_pdf/d0/1f/1081.PMC4971771.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d0/1f/1081.PMC4971771.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 26:1081 –1090 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/16; www.genome.org Genome Research 1081 www.genome.org",OADS,/arxiv_data1/oa_pdf/d0/1f/1081.PMC4971771.pdf
"Protein sequences for C. neoformans ,S. cerevisiae ,C. glabrata , and L. waltii were down- loaded from the National Center for Biotechnology Information (NCBI), the Saccharomyces Genome Database, the Candida Genome Database, and the Yeast Gene Order Browser database(http://ygob.ucd.ie/), respectively.",OADS,/arxiv_data1/oa_pdf/d0/1f/1081.PMC4971771.pdf
Protein complex and protein –protein interaction analyses The protein complex data set for S. cerevisiae was downloaded from http://wodaklab.org/cyc2008/ (Pu et al.,OADS,/arxiv_data1/oa_pdf/d0/1f/1081.PMC4971771.pdf
"2012) at http://downloads.yeastgenome.org/curation/literature/interaction_data.tab, in July 2014.",OADS,/arxiv_data1/oa_pdf/d0/1f/1081.PMC4971771.pdf
"Data access Assembled genome sequences from this study have been sub- mitted to the NCBI Whole Genome Shotgun database (WGS; http://www.ncbi.nlm.nih.gov/Traces/wgs/) under accession num- bers JXYK00000000 ( T. faecale ), JXYL00000000 ( T. coremiiforme ), JXYM00000000 ( T. inkin ), and JXYN00000000 ( T. ovoides ).",OADS,/arxiv_data1/oa_pdf/d0/1f/1081.PMC4971771.pdf
Raw sequence reads are available at NCBI BioProject (http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/d0/1f/1081.PMC4971771.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome.org/cgi/doi/10.1101/gr.203612.115.© 2016 Notwell et al.",OADS,/arxiv_data1/oa_pdf/83/0b/1013.PMC4971772.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publicationdate (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/83/0b/1013.PMC4971772.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by- nc/4.0/.Research 26:1013 –1022 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/16; www.genome.org Genome Research 1013 www.genome.org",OADS,/arxiv_data1/oa_pdf/83/0b/1013.PMC4971772.pdf
"Sequencing reads were mapped to the mouse reference genome (NCBI37/ mm9) using version 0.7.12-r1039 of the BWA sampe and aln map- ping algorithms (Li and Durbin 2009) with default parameters.ChIP-seq quality was assessed using phantompeakqualtools ver- sion 2.0 (https://code.google.com/p/phantompeakqualtools/), and all replicates received the highest quality score ( Supplemental Table S5 ) based on the relative strand cross-correlation coefficient (RSC).",OADS,/arxiv_data1/oa_pdf/83/0b/1013.PMC4971772.pdf
2011) October 2010 version using a threshold of 0.01 as previously described (https://sites.google.com/site/anshulkundaje/projects/idr).,Non-OADS,/arxiv_data1/oa_pdf/83/0b/1013.PMC4971772.pdf
"RVIS scores computed from ExAC release 0.3 were last downloaded on October 22, 2015 (http://genic-intolerance.org/data/RVIS_Unpublished_ExAC_May2015.txt), and genes were mapped from human gene symbols to Ensembl IDs using map- pings from Ensembl Biomart (Ensembl 78; Cunningham et al.",OADS,/arxiv_data1/oa_pdf/83/0b/1013.PMC4971772.pdf
Data access The ChIP-seq data from this study have been submitted to theNCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/83/0b/1013.PMC4971772.pdf
Available from: http://www.swgdrug.org/tools.,Non-OADS,/arxiv_data1/oa_pdf/5a/ab/PM-12-321.PMC4971951.pdf
Available from: http://www.llifle.com.,Non-OADS,/arxiv_data1/oa_pdf/14/96/PM-12-346.PMC4971955.pdf
"The  image was subsequently analyzed using the freely available image  processing software ImageJ Version 1.46 (Rasband, National Institutes  of Health [NIH], Bethesda, Maryland, USA: http://rsb.info.nih.gov/ij/)  including the LSM reader plug into open LSM5 formatted image stack  created by the microscope software.",OADS,/arxiv_data1/oa_pdf/0e/52/PM-12-363.PMC4971958.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs134/en/.,Non-OADS,/arxiv_data1/oa_pdf/91/79/PM-12-384.PMC4971961.pdf
Available from: http://www.frca.,Non-OADS,/arxiv_data1/oa_pdf/34/15/ACA-19-463.PMC4971974.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/4b/d1/ACA-19-542.PMC4971990.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/14/57/ACA-19-572.PMC4971999.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/14/57/ACA-19-572.PMC4971999.pdf
"Pathological axial elongation leads to a change in the  eyeball structure and has greatly increased the incidence of  many complications, such as glaucoma, nuclear cataract, and Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> Received 31 October 2015 | Accepted 29 July 2016 | Published 31 July 2016© 2016 Molecular Vision 933Quantitative proteomics analysis with iTRAQ in human lenses  with nuclear cataracts of different axial lengths Haiyan Zhou,1,2 Hong Yan,1,3 Weijia Yan,4 Xinchuan Wang,5 Yong Ma,2 Jianping Wang2 1Department of Ophthalmology, Tangdu Hospital, Fourth Military Medical University, Xi’an, China,; 2Department of  Ophthalmology, Shaanxi Provincial People’ s Hospital, Xi’an, China,; 3Chongqing Key Laboratory of Ophthalmology, Chongqing  Eye Institute, the First Affiliated Hospital, Chongqing Medical University, Chongqing, China.",Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> © 2016 Molecular Vision  934retinal detachment [ 5].,Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
"Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> © 2016 Molecular Vision  935(A, D), standard axis length (B, E), and shorter axial length  (C, F; Table 1): Group A: mean axial length 28.7±1.5 mm; average age  59.8±1.9 years, grade IV on the LOCS II scale, n = 6; Group B: mean axial length 23.0±0.4 mm; average age  60.3±2.5 years, grade III on the LOCS II scale, n = 6; Group C: mean axial length 19.9±0.5 mm; average age  55.1±2.5 years, grade III on the LOCS II scale, n = 6; Group D: mean axial length 28.7±1.4 mm; average age  58.0±4.0 years, grade IV on the LOCS II scale, n = 6; Group E: mean axial length 23.0±0.3 mm; average age  56.9±4.2 years, grade III on the LOCS II scale, n = 6; Group F: mean axial length 20.7±0.6 mm; average age  57.6±5.3 years, grade III on the LOCS II scale, n = 6.",Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
"Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> © 2016 Molecular Vision  936the kit protocol (Applied Biosystems, Foster, CA).",Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
"Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> © 2016 Molecular Vision  937acetonitrile, 5% water, and 0.1% formic acid.",Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
"Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> © 2016 Molecular Vision  938Table  2. d Ifferen TIally  expressed  pro TeIns In The longer  axIal leng Th groups  (a=114) and The oThers   groups  wITh dIfferen T axIal leng Th (b=115,C=116, e=118, f=119).",Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
"Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> © 2016 Molecular Vision  939Table  3. d Ifferen TIally  expressed  pro TeIns In The longer  axIal leng Th groups  (d=117) and The oThers   groups  wITh dIfferen T axIal leng Th (b=115,C=116, e=118, f=119).",Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> © 2016 Molecular Vision  940Validation of differently expressed proteins identified:   CRBB2 was selected for this purpose.,Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> © 2016 Molecular Vision  941subfamily.,Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
"Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> © 2016 Molecular Vision  942Medical School, Fudan University, for its assistance in  iTRAQ reagent labeling, 2D-LC and MS/MS.",Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
Molecular Vision  2016; 22:933-943 <http://www.molvis.org/molvis/v 22/933> © 2016 Molecular Vision  94330.,Non-OADS,/arxiv_data1/oa_pdf/40/a2/mv-v22-933.PMC4972033.pdf
"Our results indicated  that NETs are involved in the immune response following  fungal infection and the number of NETs was highly related  to the prognosis for this disease.Molecular Vision  2016; 22:944-952 <http://www.molvis.org/molvis/v 22/944> Received 3 February 2016 | Accepted 30 July 2016 | Published 2 August 2016© 2016 Molecular Vision 944Neutrophil extracellular traps involvement in corneal fungal  infection Xiuming Jin,1 Yingying Zhao,1 Fan Zhang,2 Ting Wan,1 Fangli Fan,1 Xin Xie,1 Zhenyun Lin3 1Eye Center of the 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China;  2Zhejiang University School of Medicine, Hangzhou, China; 3Department of Obstetrics and Gynecology, Hangzhou Maternity  Hospital, Hangzhou, China Purpose:  Neutrophils release neutrophil extracellular traps (NETs) when defending against invading microorganisms.",Non-OADS,/arxiv_data1/oa_pdf/df/2a/mv-v22-944.PMC4972034.pdf
"Molecular Vision  2016; 22:944-952 <http://www.molvis.org/molvis/v 22/944> © 2016 Molecular Vision  945METHODS Patients:  Fourteen patients with unilateral fungal  keratitis who presented at the Eye Center of the 2nd  Affiliated Hospital, School of Medicine, Zhejiang  University in China were included in this study, which  took place between June 2013 and October 2015.",Non-OADS,/arxiv_data1/oa_pdf/df/2a/mv-v22-944.PMC4972034.pdf
Molecular Vision  2016; 22:944-952 <http://www.molvis.org/molvis/v 22/944> © 2016 Molecular Vision  946Table 1.,Non-OADS,/arxiv_data1/oa_pdf/df/2a/mv-v22-944.PMC4972034.pdf
Molecular Vision  2016; 22:944-952 <http://www.molvis.org/molvis/v 22/944> © 2016 Molecular Vision  947NETs were identified in all 14 patients with fungal kera - titis (Figure 1).,Non-OADS,/arxiv_data1/oa_pdf/df/2a/mv-v22-944.PMC4972034.pdf
Molecular Vision  2016; 22:944-952 <http://www.molvis.org/molvis/v 22/944> © 2016 Molecular Vision  948stage of fungal keratitis.,Non-OADS,/arxiv_data1/oa_pdf/df/2a/mv-v22-944.PMC4972034.pdf
Molecular Vision  2016; 22:944-952 <http://www.molvis.org/molvis/v 22/944> © 2016 Molecular Vision  949 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/df/2a/mv-v22-944.PMC4972034.pdf
Molecular Vision  2016; 22:944-952 <http://www.molvis.org/molvis/v 22/944> © 2016 Molecular Vision  950 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/df/2a/mv-v22-944.PMC4972034.pdf
Molecular Vision  2016; 22:944-952 <http://www.molvis.org/molvis/v 22/944> © 2016 Molecular Vision  951degradation is needed to achieve maximal NET immunity  [18].,Non-OADS,/arxiv_data1/oa_pdf/df/2a/mv-v22-944.PMC4972034.pdf
Molecular Vision  2016; 22:944-952 <http://www.molvis.org/molvis/v 22/944> © 2016 Molecular Vision  95212.,Non-OADS,/arxiv_data1/oa_pdf/df/2a/mv-v22-944.PMC4972034.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/77/mjiri-30-387.PMC4972047.pdf
Vol.30:387.http://mjiri.iums.ac.irsponsiveness of health systems for the Ir a- nian populations (6).,Non-OADS,/arxiv_data1/oa_pdf/e3/77/mjiri-30-387.PMC4972047.pdf
"Vol.30:387.  http://mjiri.iums.ac.irused afive-point Likert scale where 5was very important/very good, and 1 represen t- ed least important/very poor.",Non-OADS,/arxiv_data1/oa_pdf/e3/77/mjiri-30-387.PMC4972047.pdf
"Vol.30:387.http://mjiri.iums.ac.irhealth insurance coverage, and 44.7 % were illiterate (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/e3/77/mjiri-30-387.PMC4972047.pdf
Vol.30:387. http://mjiri.iums.ac.irhealth system and the health system’s r e- sponsiveness to the patients (18).,Non-OADS,/arxiv_data1/oa_pdf/e3/77/mjiri-30-387.PMC4972047.pdf
Vol.30:387.http://mjiri.iums.ac.irrooms.,Non-OADS,/arxiv_data1/oa_pdf/e3/77/mjiri-30-387.PMC4972047.pdf
Vol.30:387. http://mjiri.iums.ac.irPerformance of the health system in China and Asia as measured by responsiveness.,Non-OADS,/arxiv_data1/oa_pdf/e3/77/mjiri-30-387.PMC4972047.pdf
"World Health Organization; 2000.Available from: http://www.who.int/entity/ responsiveness/papers/paper21.pdf?ua=1, Accessed by 6/2/2015.",Non-OADS,/arxiv_data1/oa_pdf/e3/77/mjiri-30-387.PMC4972047.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________ _____________________________________________ 1.PhD candidate of Nutrition, Department of Clinical Nutrition, School of Public Health, Iran University of Medical Sciences, T ehran, Iran , & PhD candidate of Nutrition, Evaz school of health, LarestanSchoolof Medical Sciences , Larestan, Iran.s_yousai2006@yahoo.com 2.",Non-OADS,/arxiv_data1/oa_pdf/38/f0/mjiri-30-376.PMC4972048.pdf
"Vol.30:376.http://mjiri.iums.ac.irsition, stress, nutritional, lifestyle factors, and abnormal hormonal status have been suggested (9).",Non-OADS,/arxiv_data1/oa_pdf/38/f0/mjiri-30-376.PMC4972048.pdf
Vol.30:376. http://mjiri.iums.ac.irBlood pressure was measured twice sep a- rately over a 3 -minute time interval.,OADS,/arxiv_data1/oa_pdf/38/f0/mjiri-30-376.PMC4972048.pdf
"Vol.30:376.http://mjiri.iums.ac.irdifferences were found between the three groups in terms of age, sex and marital st a- tus (Table 1)(p>0.05).",OADS,/arxiv_data1/oa_pdf/38/f0/mjiri-30-376.PMC4972048.pdf
"Vol.30:376. http://mjiri.iums.ac.irDiscussion To our knowledge, this was the first study to examine the associations between obes i- ty, MetS and diet quality in the three groups using HEI -2010.",Non-OADS,/arxiv_data1/oa_pdf/38/f0/mjiri-30-376.PMC4972048.pdf
"Vol.30:376.http://mjiri.iums.ac.irHEI  component  scores  from  the highest to  the lowest were  meat  (8.9),  sodium (8.5),  fat  (8.1),  cholesterol (8.1),  satura t- ed  fat  (7.0),  variety  (6.7),  grain  (4.7), fruit (4.9) and milk (4.6)(26).",Non-OADS,/arxiv_data1/oa_pdf/38/f0/mjiri-30-376.PMC4972048.pdf
Vol.30:376. http://mjiri.iums.ac.ir2006;54:797-810.,Non-OADS,/arxiv_data1/oa_pdf/38/f0/mjiri-30-376.PMC4972048.pdf
